Acinetobacter baumannii (DSM 30007, ATCC 19606, CIP 70.34)

Name: Acinetobacter baumannii (DSM 30007, ATCC 19606, CIP 70.34)
Creator: BacDive
License: http://creativecommons.org/licenses/by/4.0/

BacDive ID 8093

Type strain

Strain Designation 2208, 81

Culture col. no. DSM 30007 ATCC 19606 CIP 70.34 DSM 6974 2208 11 more

NCBI tax ID(s) 575584 470

Special Collections DSMZ CCUG JCM KCTC CIP

History <- ATCC; ATCC 19606 <- R. Hugh; 2208 <- E. O. King; <- I. G. Schaub; 81 (Bacterium anitratum) ATCC 19606 <-- R. Hugh 2208 <-- E. O. King <-- I. G. Schaub 81. CIP <- 1970, M. Piéchaud, Inst. Pasteur, Paris, France, Moraxella glucidolytica var. nonliquefaciens <- 1969, ATCC, Achromobacter anitratum <- R. Hugh: strain 2208 <- E.O. King <- I.G. Schaub: strain 81

Links

Acinetobacter baumannii 2208 is an obligate aerobe, mesophilic, Gram-negative prokaryote that has multiple antibiotic resistances and was isolated from urine.

antibiotic resistance Gram-negative oval-shaped obligate aerobe mesophilic genome sequence 16S sequence

Name and taxonomic classification

SI-ID 92085

LMG 1041,ATCC 19606,CCUG 19096,DSM 30007,IAM 12088,LMG 10545,NCIMB 12457,NCTC 12156,NBRC-109757,DSM 6974,NCIB 12457,JCM 6841,LMD 85.21,KCTC 2508,NCCB 85021,NCCB 96002,LMD 96.2,NCCB 96128,LMD 96.128,BCRC 10591,CCRC 10591,NCAIM B.01930,CIP 7034,NCAIM B.02074,CNCTC 6168,VTT E-981116,CIP 70.34

@ref 20215

Last LPSN update 2026-02-09 11:19:37

Domain Bacteria

Phylum Pseudomonadota

Class Gammaproteobacteria

Order Pseudomonadales

Family Moraxellaceae

Genus Acinetobacter

Species Acinetobacter baumannii

Full scientific name Acinetobacter baumannii Bouvet and Grimont 1986

BacDive ID	Other strains from **Acinetobacter baumannii** (155)	Type strain
8094	A. baumannii 2197, Biol. 1, DSM 30008, ATCC 15308, CCM ...
8095	A. baumannii DSM 30011, ATCC 23220, NCIMB 8208, NRRL B-551, ...
131595	A. baumannii DSM 102930, SG 1112
131594	A. baumannii DSM 102929, SG 698
24223	A. baumannii 1032, DSM 24110
132687	A. baumannii Piéchaud 5377, Piéchaud strain Rochefort, ...
134613	A. baumannii BM4702, CIP 110580
134623	A. baumannii CIP 70.9, ATCC 15150
134629	A. baumannii BM4710, CIP 110574
134630	A. baumannii BM4709, CIP 110575
134631	A. baumannii BM4704, CIP 110578
134706	A. baumannii CIP 110426, NIPH 70
134717	A. baumannii CIP 110428, NIPH 146
134718	A. baumannii CIP 110429, NIPH 190
134722	A. baumannii CIP 110434, NIPH 410
134783	A. baumannii CIP 110436, NIPH 528, CCM 7290, LMG 10541, ...
134820	A. baumannii CIP 70.24, ATCC 9955
134981	A. baumannii CIP 110437, NIPH 601
135229	A. baumannii CIP 110424, NIPH 60
135233	A. baumannii CIP 110432, NIPH 329
135420	A. baumannii CIP 53.66
135455	A. baumannii CIP 53.79
135467	A. baumannii CIP 103572, ATCC 49139
135558	A. baumannii CIP 110425, NIPH 67
135561	A. baumannii CIP 110431, NIPH 290
135562	A. baumannii 12A133, CIP 110464, NIPH 1669
135661	A. baumannii CIP 70.10, ATCC 15151
135667	A. baumannii D5/62, CIP 70.21, ATCC 17957
135763	A. baumannii CIP 110467, NIPH 2061
135771	A. baumannii CIP 64.1, ATCC 17904, NCTC 10303, CCUG 890
136376	A. baumannii 7827, CIP 70.33, ATCC 17959
136439	A. baumannii Ab41, CIP 105742
136585	A. baumannii BM4714, CIP 110572
136610	A. baumannii BM4708, CIP 110576
136642	A. baumannii RYC 52763/97, CIP 107292
136755	A. baumannii CIP 110438, NIPH 615
136766	A. baumannii CIP 110463, NIPH 1362
136768	A. baumannii CIP 54.97
136828	A. baumannii CIP 110466, NIPH 1734
136890	A. baumannii BM4711, CIP 110573
136892	A. baumannii BM4703, CIP 110579
137126	A. baumannii D 409, 2315, CIP 70.35, ATCC 19568, NCIMB ...
137199	A. baumannii CIP 110423, NIPH 24
137208	A. baumannii CIP 110435, NIPH 527, CCM 7289, LMG 10543, ...
137405	A. baumannii CIP 110499, ANC 4097
137459	A. baumannii CIP 110433, NIPH 335
137521	A. baumannii CIP 70.28, ATCC 19003
137643	A. baumannii CIP 103655, ATCC 49467
138367	A. baumannii Valentin, CIP 54.147
138370	A. baumannii AMA-1, CIP 106882
138562	A. baumannii 7788, CIP 70.32, ATCC 17961
138786	A. baumannii CIP 110430, NIPH 201
138788	A. baumannii CIP 110427, NIPH 80
138907	A. baumannii 38 bis, CIP 110268, CRBIP200878
138932	A. baumannii CIP 110269, CRBIP200439
138938	A. baumannii CIP 70.8, ATCC 15149
139030	A. baumannii BM4701, CIP 110581
139048	A. baumannii CIP 70.22, ATCC 17945
139546	A. baumannii R4, CIP 110874, CIP 200003
139560	A. baumannii CIP 110875, CIP 200004
139576	A. baumannii A640 II, CIP 110834, CIP 200105
139578	A. baumannii CIP 110878, CIP 200007
139579	A. baumannii CIP 110880, CIP 200009
141187	A. baumannii CCUG 55
141509	A. baumannii CCUG 2488
141776	A. baumannii CCUG 6644
146203	A. baumannii CCUG 30593
155203	A. baumannii CCUG 56897
155238	A. baumannii CCUG 57035
155258	A. baumannii CCUG 57123
155299	A. baumannii CCUG 57249
155300	A. baumannii CCUG 57250
155619	A. baumannii CCUG 58437
155963	A. baumannii CCUG 59798
156173	A. baumannii CCUG 60610
156174	A. baumannii CCUG 60611
156265	A. baumannii CCUG 60931
156279	A. baumannii CCUG 61012
156817	A. baumannii CCUG 65543
156985	A. baumannii CCUG 68164
157915	A. baumannii G7, DSM 25645
157916	A. baumannii DSM 101993, RUH 2037
157917	A. baumannii Phage host, DSM 106838
159206	A. baumannii UKK-172, DSM 101650
160333	A. baumannii DSM 102928, SG 626
160334	A. baumannii DSM 102931, SG 1280
160335	A. baumannii DSM 102932, SG 1284
160336	A. baumannii DSM 102933, SG 1306
160337	A. baumannii DSM 102934, SG 1324
160338	A. baumannii DSM 102935, SG 1351
169348	A. baumannii UKK_0172, DSM 111794
171138	A. baumannii CIMB4, CIMB 04-7017, CRBIP17.4
171139	A. baumannii Blanc, CIP 110968, CIP 200364
171140	A. baumannii BM4420, A35, CIP 111171
171141	A. baumannii BM4421, A33, CIP 111172
171142	A. baumannii BM4422, M19, CIP 111173
171143	A. baumannii BM4423, A34, CIP 111174
171144	A. baumannii BM4424, V4, B4424, CIP 111204
171145	A. baumannii BM4425, A58, CIP 111205
171146	A. baumannii BM4426, A248, CIP 111206
171147	A. baumannii BM4428, A48, CIP 111208
171148	A. baumannii BM4429, M3, CIP 111209
171149	A. baumannii BM4430, A59, CIP 111210
171150	A. baumannii BM4434, A252, CIP 111214
171151	A. baumannii BM4435, A6427, CIP 111215
171152	A. baumannii BM4436, A5247, CIP 111216
171153	A. baumannii BM4438, AC16, CIP 111218
171154	A. baumannii BM4454-1, BM4542, CIP 111249
171155	A. baumannii BM4546, CIP 111275
171156	A. baumannii BM4543, CIP 111291
171157	A. baumannii BM4712, CIP 111791
171158	A. baumannii BM4454, CIP 111175
174796	A. baumannii patient isolate, DSM 103803
174797	A. baumannii 114617, DSM 114617
174798	A. baumannii 114760, DSM 114760
174799	A. baumannii BWKH 526, DSM 115404
174800	A. baumannii BWKH 527, DSM 115405
174801	A. baumannii BWKH 528, DSM 115406
174802	A. baumannii BWKH 529, DSM 115407
174803	A. baumannii BWKH 530, DSM 115408
174804	A. baumannii BWKH 531, DSM 115409
174805	A. baumannii BWKH 532, DSM 115410
174806	A. baumannii BWKH 533, DSM 115411
174807	A. baumannii BWKH 534, DSM 115412
174808	A. baumannii BWKH 535, DSM 115413
174809	A. baumannii BWKH 536, DSM 115414
174810	A. baumannii BWKH 537, DSM 115415
174811	A. baumannii BWKH 538, DSM 115416
174812	A. baumannii BWKH 539, DSM 115417
174813	A. baumannii TX 1944, DSM 115745
174814	A. baumannii 17-HoPe_P1-2, DSM 117586
174815	A. baumannii 17-ZW-P5-2, DSM 117587
174816	A. baumannii U19-Zw-S16-1, DSM 117588
174817	A. baumannii U19-Zw-S30-1, DSM 117589
174818	A. baumannii U19-Zw-S49-1, DSM 117590
174819	A. baumannii U19-Zw-S7.5-1, DSM 117591
174820	A. baumannii U20-Benz-S18-1, DSM 117592
174821	A. baumannii U21-HoPe-S7-1, DSM 117593
174822	A. baumannii 17-HoPe_S7-1, DSM 117594
174823	A. baumannii 17-ZW_S17.2-3, DSM 117595
174824	A. baumannii 17-ZW_S24.2-2, DSM 117597
174825	A. baumannii 17-ZW_S31.5-2, DSM 117600
174826	A. baumannii 17-ZW_S35.2-1, DSM 117601
174827	A. baumannii 17-ZW-S26-3-1, DSM 117602
174828	A. baumannii U17-HoPe-P1-1, DSM 117603
174829	A. baumannii U17-HoPe-P3-1, DSM 117604
174830	A. baumannii U17-HoPeS16.1, DSM 117605
174831	A. baumannii U17-ZWS24.1-1, DSM 117606
174832	A. baumannii U18-HoPe-S14.1, DSM 117607
174833	A. baumannii U18-HoPeS21.1, DSM 117608
174834	A. baumannii U19-StiWa-S4-1, DSM 117609
176694	A. baumannii U17-ZWS25 1-1, DSM 120114
176695	A. baumannii U24-HH-1, DSM 120116
176696	A. baumannii U24-HH-2, DSM 120118
176697	A. baumannii U24-HH-3, DSM 120120

Morphology

Cell morphology

@ref	Gram stain	Cell shape	Motility	Confidence
116742	negative	oval-shaped
125438	negative			98

Colony morphology

@ref	Type of hemolysis	Incubation period
9084	gamma	1-2 days
116742

Culture and growth conditions

Culture medium

@ref	Name	Medium link	Composition
9084	COLUMBIA BLOOD MEDIUM (DSMZ Medium 693)	Medium recipe at MediaDive	Name: COLUMBIA BLOOD MEDIUM (DSMZ Medium 693) Composition: Defibrinated sheep blood 50.0 g/l Columbia agar base
9084	NUTRIENT AGAR (DSMZ Medium 1)	Medium recipe at MediaDive	Name: NUTRIENT AGAR (DSMZ Medium 1) Composition: Agar 15.0 g/l Peptone 5.0 g/l Meat extract 3.0 g/l Distilled water
42141	MEDIUM 72- for trypto casein soja agar		Distilled water make up to (1000.000 ml);Trypto casein soy agar (40.000 g)
9084	TRYPTICASE SOY YEAST EXTRACT MEDIUM (DSMZ Medium 92)	Medium recipe at MediaDive	Name: TRYPTICASE SOY YEAST EXTRACT MEDIUM (DSMZ Medium 92) Composition: Trypticase soy broth 30.0 g/l Agar 15.0 g/l Yeast extract 3.0 g/l Distilled water
116742	CIP Medium 72	Medium recipe at CIP

Culture temp

@ref	Growth	Type	Temperature (°C)	Range
9084	positive	growth	30	mesophilic
9084	positive	growth	37	mesophilic
42141	positive	growth	30	mesophilic
67770	positive	growth	37	mesophilic
116742	positive	growth	22-44
116742	negative	growth	10

Physiology and metabolism

Oxygen tolerance

@ref	Oxygen tolerance	Confidence
116742	obligate aerobe
125439	obligate aerobe	96.8

Antibiotic susceptibility testing

	Test 1	Test 2	Test 3
@ref	9084	9084	9084
Medium	Mueller-Hinton Agar	Mueller Hinton	Müller-Hinton Agar
Manual annotation	1	1	1
	Inhibition zone diameter in mm	Inhibition zone diameter in mm	Inhibition zone diameter in mm
Amikacin 30µg (disc)	20-22	22	18
Ampicillin 10µg (disc)	0	0	0
Aztreonam 30µg (disc)	10	8-10	10
Bacitracin 10Unit	0	0	n.d.
Cefalotin 30µg (disc)	0	0	n.d.
Cefazolin 30µg (disc)	0	0	n.d.
Cefiderocol 30µg (disc)	n.d.	n.d.	28
Cefotaxime 30µg (disc)	12	10-12	10-12
Ceftazidime 10µg (disc)	n.d.	n.d.	16
Ceftriaxone 30µg (disc)	12-14	12-14	12
Chloramphenicol 30µg (disc)	6-8	0	6
Ciprofloxacin 5µg (disc)	n.d.	n.d.	30
Clindamycin 10µg (disc)	0	0	0
Colistin 10µg (disc)	16	16	n.d.
Colistin sulphate 10µg (disc)	n.d.	n.d.	18
Doxycycline 30µg (disc)	30	30	n.d.
Erythromycin 15µg (disc)	12	10	10
Fosfomycin 50µg (disc)	12	8-10	10
Gentamicin 30µg (disc)	n.d.	n.d.	12-14
Gentamycin 10µg (disc)			n.d.
Imipenem 10µg (disc)	32-34	36	38
Kanamycin 30µg (disc)	24	24	22
Levofloxacin 5µg (disc)	n.d.	n.d.	30-32
Lincomycin 15µg (disc)	0	0	n.d.
Linezolid 10µg (disc)	0	0	6
Meropenem 10µg (disc)	n.d.	n.d.	28
Mezlocillin 30µg (disc)	10-12	10	n.d.
Moxifloxacin 5µg (disc)	28	28	30
Neomycin 30µg (disc)	18-20	20	n.d.
Nitrofurantoin 100µg (disc)	6	6	0
Norfloxacin 10µg (disc)	18	16	n.d.
Nystatin 100Unit	0	0	n.d.
Ofloxacin 5µg (disc)	26-28	26	30
Oxacillin 5µg (disc)	0	0	0
Penicillin G 6µg (disc)	0	0	0
Pipemidic acid 20µg (disc)	0	0	n.d.
Piperacillin/Tazobactam 40µg (disc)	24	24	n.d.
Piperacillin/Tazobactam 110µg (disc)	n.d.	n.d.	22-24
Polymyxin B 300Unit	16	18	20
Quinupristin/Dalfopristin 15µg (disc)	0	0	0
Rifampicin 5µg (disc)	n.d.	n.d.	16
Teicoplanin 30µg (disc)	0	0	0
Tetracycline 30µg (disc)	24	24	26
Ticarcillin 75µg (disc)	22	24	22-24
Tigecycline 15µg (disc)	n.d.	n.d.	22
Trimethoprim-sulfamethoxazole (1:19) 10µg (disc)	n.d.	n.d.	8-10
Vancomycin 30µg (disc)	0	0	0

Spore formation

@ref	Spore formation	Confidence
125438		93.527
125439		94.1

Compound production

9084

Compoundsiderophore acinetobactin

Halophily

@ref	Salt	Growth	Tested relation	Concentration
116742	NaCl	positive	growth	0-4 %
116742	NaCl		growth	6 %
116742	NaCl		growth	8 %
116742	NaCl		growth	10 %

Metabolite utilization

@ref	Chebi-ID	Metabolite	Utilization activity	Kind of utilization tested
68369	17128 ChEBI	adipate	+	assimilation	from API 20NE
68371	27613 ChEBI	amygdalin	-	builds acid from	from API 50CH acid
68371	18305 ChEBI	arbutin	-	builds acid from	from API 50CH acid
68369	29016 ChEBI	arginine	-	hydrolysis	from API 20NE
68371	17057 ChEBI	cellobiose	-	builds acid from	from API 50CH acid
68371	17108 ChEBI	D-arabinose	-	builds acid from	from API 50CH acid
68371	18333 ChEBI	D-arabitol	-	builds acid from	from API 50CH acid
68371	15824 ChEBI	D-fructose	-	builds acid from	from API 50CH acid
68371	28847 ChEBI	D-fucose	-	builds acid from	from API 50CH acid
68371	12936 ChEBI	D-galactose	-	builds acid from	from API 50CH acid
68371	17634 ChEBI	D-glucose	-	builds acid from	from API 50CH acid
68371	62318 ChEBI	D-lyxose	-	builds acid from	from API 50CH acid
68371	16899 ChEBI	D-mannitol	-	builds acid from	from API 50CH acid
68369	16899 ChEBI	D-mannitol	-	assimilation	from API 20NE
68371	16024 ChEBI	D-mannose	-	builds acid from	from API 50CH acid
68369	16024 ChEBI	D-mannose	-	assimilation	from API 20NE
68371	16988 ChEBI	D-ribose	-	builds acid from	from API 50CH acid
68371	17924 ChEBI	D-sorbitol	-	builds acid from	from API 50CH acid
68371	16443 ChEBI	D-tagatose	-	builds acid from	from API 50CH acid
68371	65327 ChEBI	D-xylose	-	builds acid from	from API 50CH acid
68369	27689 ChEBI	decanoate	+	assimilation	from API 20NE
68371	17113 ChEBI	erythritol	-	builds acid from	from API 50CH acid
68371	4853 ChEBI	esculin	-	builds acid from	from API 50CH acid
68369	4853 ChEBI	esculin	-	hydrolysis	from API 20NE
68371	16813 ChEBI	galactitol	-	builds acid from	from API 50CH acid
68371	28066 ChEBI	gentiobiose	-	builds acid from	from API 50CH acid
68371	24265 ChEBI	gluconate	-	builds acid from	from API 50CH acid
68369	24265 ChEBI	gluconate	-	assimilation	from API 20NE
116742	17234 ChEBI	glucose	+/-	degradation
68371	17754 ChEBI	glycerol	-	builds acid from	from API 50CH acid
68371	28087 ChEBI	glycogen	-	builds acid from	from API 50CH acid
68371	15443 ChEBI	inulin	-	builds acid from	from API 50CH acid
68371	30849 ChEBI	L-arabinose	-	builds acid from	from API 50CH acid
68369	30849 ChEBI	L-arabinose	+	assimilation	from API 20NE
68371	18403 ChEBI	L-arabitol	-	builds acid from	from API 50CH acid
68371	18287 ChEBI	L-fucose	-	builds acid from	from API 50CH acid
68371	62345 ChEBI	L-rhamnose	-	builds acid from	from API 50CH acid
68371	17266 ChEBI	L-sorbose	-	builds acid from	from API 50CH acid
68371	65328 ChEBI	L-xylose	-	builds acid from	from API 50CH acid
68371	17716 ChEBI	lactose	-	builds acid from	from API 50CH acid
68369	25115 ChEBI	malate	+	assimilation	from API 20NE
68371	17306 ChEBI	maltose	-	builds acid from	from API 50CH acid
68369	17306 ChEBI	maltose	-	assimilation	from API 20NE
68371	6731 ChEBI	melezitose	-	builds acid from	from API 50CH acid
68371	28053 ChEBI	melibiose	-	builds acid from	from API 50CH acid
68371	320061 ChEBI	methyl alpha-D-glucopyranoside	-	builds acid from	from API 50CH acid
68371	43943 ChEBI	methyl alpha-D-mannoside	-	builds acid from	from API 50CH acid
68371	74863 ChEBI	methyl beta-D-xylopyranoside	-	builds acid from	from API 50CH acid
68371	17268 ChEBI	myo-inositol	-	builds acid from	from API 50CH acid
68371	59640 ChEBI	N-acetylglucosamine	-	builds acid from	from API 50CH acid
68369	59640 ChEBI	N-acetylglucosamine	-	assimilation	from API 20NE
116742	17632 ChEBI	nitrate	-	reduction
116742	17632 ChEBI	nitrate	-	respiration
68369	17632 ChEBI	nitrate	-	reduction	from API 20NE
116742	16301 ChEBI	nitrite	-	reduction
68371		Potassium 2-ketogluconate	-	builds acid from	from API 50CH acid
68371		Potassium 5-ketogluconate	-	builds acid from	from API 50CH acid
68371	16634 ChEBI	raffinose	-	builds acid from	from API 50CH acid
68371	15963 ChEBI	ribitol	-	builds acid from	from API 50CH acid
68371	17814 ChEBI	salicin	-	builds acid from	from API 50CH acid
68371	28017 ChEBI	starch	-	builds acid from	from API 50CH acid
68371	17992 ChEBI	sucrose	-	builds acid from	from API 50CH acid
68371	27082 ChEBI	trehalose	-	builds acid from	from API 50CH acid
68369	27897 ChEBI	tryptophan	-	energy source	from API 20NE
68371	32528 ChEBI	turanose	-	builds acid from	from API 50CH acid
68369	16199 ChEBI	urea	-	hydrolysis	from API 20NE
68371	17151 ChEBI	xylitol	-	builds acid from	from API 50CH acid

Antibiotic resistance

@ref	ChEBI	Metabolite	Resistance conc.
116742		0129 (2,4-Diamino-6,7-di-iso-propylpteridine phosphate)
9084	28971	Ampicillin	10 µg (disc)	from Antibiotic test
9084	28669	Bacitracin	10 Unit	from Antibiotic test
9084	124991	Cefalotin	30 µg (disc)	from Antibiotic test
9084	474053	Cefazolin	30 µg (disc)	from Antibiotic test
9084	3745	Clindamycin	10 µg (disc)	from Antibiotic test
9084	6472	Lincomycin	15 µg (disc)	from Antibiotic test
9084	7660	Nystatin	100 Unit	from Antibiotic test
9084	7809	Oxacillin	5 µg (disc)	from Antibiotic test
9084	18208	Penicillin G	6 µg (disc)	from Antibiotic test
9084	75250	Pipemidic acid	20 µg (disc)	from Antibiotic test
9084		Quinupristin/Dalfopristin	15 µg (disc)	from Antibiotic test
9084	29687	Teicoplanin	30 µg (disc)	from Antibiotic test
9084	28001	Vancomycin	30 µg (disc)	from Antibiotic test

Metabolite production

@ref	Chebi-ID	Metabolite	Production
68369	35581 ChEBI	indole		from API 20NE
116742	35581 ChEBI	indole

Metabolite tests

@ref	Chebi-ID	Metabolite	Indole test	Voges-proskauer-test	Methylred-test
116742	15688 ChEBI	acetoin		-
116742	17234 ChEBI	glucose			+
68369	35581 ChEBI	indole	-			from API 20NE

Enzymes

@ref	Value	Activity	Ec
68382	acid phosphatase	+	3.1.3.2	from API zym
68382	alkaline phosphatase	+	3.1.3.1	from API zym
68382	alpha-chymotrypsin	-	3.4.21.1	from API zym
68382	alpha-fucosidase	-	3.2.1.51	from API zym
68382	alpha-galactosidase	-	3.2.1.22	from API zym
68382	alpha-glucosidase	-	3.2.1.20	from API zym
68382	alpha-mannosidase	-	3.2.1.24	from API zym
68369	arginine dihydrolase	-	3.5.3.6	from API 20NE
68382	beta-galactosidase	-	3.2.1.23	from API zym
116742	beta-galactosidase	-	3.2.1.23
68382	beta-glucosidase	-	3.2.1.21	from API zym
68369	beta-glucosidase	-	3.2.1.21	from API 20NE
68382	beta-glucuronidase	-	3.2.1.31	from API zym
9084	catalase	+	1.11.1.6
116742	catalase	+	1.11.1.6
68382	cystine arylamidase	-	3.4.11.3	from API zym
68369	cytochrome oxidase	-	1.9.3.1	from API 20NE
68382	esterase (C 4)	+		from API zym
68382	esterase lipase (C 8)	+		from API zym
116742	gamma-glutamyltransferase	+	2.3.2.2
116742	gelatinase	-
68382	leucine arylamidase	+	3.4.11.1	from API zym
68382	lipase (C 14)	-		from API zym
68382	N-acetyl-beta-glucosaminidase	-	3.2.1.52	from API zym
68382	naphthol-AS-BI-phosphohydrolase	+		from API zym
116742	oxidase	-
68382	trypsin	-	3.4.21.4	from API zym
116742	urease	-	3.5.1.5
68369	urease	-	3.5.1.5	from API 20NE
68382	valine arylamidase	-		from API zym

API zym

@ref	Control	Alkaline phosphatase	Esterase (C 4)	2-naphtyl caprylateEsterase Lipase (C 8)	Lipase (C 14)	L-leucyl-2-naphthylamideLeucine arylamidase	L-valyl-2-naphthylamideValine arylamidase	L-cystyl-2-naphthylamideCystine arylamidase	Trypsin	alpha- Chymotrypsin	Acid phosphatase	Naphthol-AS-BI-phosphateNaphthol-AS-BI-phosphohydrolase	alpha- Galactosidase	beta- Galactosidase	beta- Glucuronidase	alpha- Glucosidase	beta- Glucosidase	N-acetyl-beta- glucosaminidase	alpha- Mannosidase	alpha- Fucosidase
116742	-	+	+	+	-	+	-	-	-	-	+	+	-	-	-	-	-	-	-	-

API 20NE

@ref	Reduction of nitratesNO3	TRP	GLU_ Ferm	ADH (Arg)	URE	ESC	GEL	PNPG	GLU_ Assim	ARA	MNE	MAN	NAG	MAL	GNT	CAP	ADI	MLT	CIT	PAC	OX
9084	-	-	+	-	-	-	-	-	+/-	+	-	-	-	-	-	+	+	+	+	+	-
9084	-	-	+	-	-	-	-	-	-	+	-	-	-	-	-	+	+	+	+	+	-
9084	-	-	-	-	-	-	+	-	-	+	-	-	-	-	-	+	+	+	+	+	-
9084	-	-	-	-	-	-	-	-	+	+	-	-	-	-	-	+	+	+	+	+	-
9084	-	-	+	-	-	-	-	-	-	+	-	-	-	-	-	+	+	+	+	+	-
9084	-	-	+	-	-	-	-	-	-	+	-	-	-	-	-	+	+	+	+	+	not determinedn.d.
9084	-	-	+	-	-	-	-	-	+/-	+	-	-	-	-	-	+	+	+	+	+	not determinedn.d.
9084	-	-	+	-	-	-	-	-	+/-	+	-	-	-	-	-	+	+	+	+	+	-
9084	-	-	+	-	-	-	-	-	-	+	-	-	-	-	-	+	+	+	+	+	-

API 50CHac

@ref	ControlQ	GLY	ERY	DARA	LARA	RIB	DXYL	LXYL	ADO	MDX	GAL	GLU	FRU	MNE	SBE	RHA	DUL	INO	MAN	SOR	MDM	MDG	NAG	AMY	ARB	ESC	SAL	CEL	MAL	LAC	MEL	SAC	TRE	INU	MLZ	RAF	AMD	GLYG	XLT	GEN	TUR	LYX	TAG	DFUC	LFUC	DARL	LARL	GNT	2KG	5KG
116742	not determinedn.d.	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

API biotype100

@ref	ControlQ	D-glucose as carbon sourceGLU	D-fructose as carbon sourceFRU	D-galactose as carbon sourceGAL	D-trehalose as carbon sourceTRE	D-mannose as carbon sourceMNE	L-sorbose as carbon sourceSBE	D-melibiose as carbon sourceMEL	sucrose as carbon sourceSAC	D-raffinose as carbon sourceRAF	maltotriose as carbon sourceMTE	maltose as carbon sourceMAL	lactose as carbon sourceLAC	lactulose as carbon sourceLTE	1-O-methyl-beta-galactopyranoside as carbon sourceMbGa	1-O-methyl-alpha-galactopyranoside as carbon sourceMaGa	D-cellobiose as carbon sourceCEL	gentiobiose as carbon sourceGEN	1-O-methyl-beta-D-glucopyranoside as carbon sourceMbGu	esculin as carbon sourceESC	D-ribose as carbon sourceRIB	L-arabinose as carbon sourceARA	D-xylose as carbon sourceXYL	palatinose as carbon sourcePLE	L-rhamnose as carbon sourceRHA	L-fucose as carbon sourceFUC	D-melezitose as carbon sourceMLZ	D-arabitol as carbon sourceDARL	L-arabitol as carbon sourceLARL	xylitol as carbon sourceXLT	dulcitol as carbon sourceDUL	D-tagatose as carbon sourceTAG	glycerol as carbon sourceGLY	myo-inositol as carbon sourceINO	D-mannitol as carbon sourceMAN	maltitol as carbon sourceMTL	D-turanose as carbon sourceTUR	D-sorbitol as carbon sourceSOR	adonitol as carbon sourceADO	hydroxyquinoline-beta-glucuronide as carbon sourceHBG	D-lyxose as carbon sourceLYX	i-erythritol as carbon sourceERY	1-O-methyl-alpha-D-glucoside as carbon sourceMDG	3-O-methyl-D-glucose as carbon source3MDG	D-saccharate as carbon sourceSAT	mucate as carbon sourceMUC	L-tartrate as carbon sourceLTAT	D-tartrate as carbon sourceDTAT	meso-tartrate as carbon sourceMTAT	D-malate as carbon sourceDMLT	L-malate as carbon sourceLMLT	cis-aconitate as carbon sourceCATE	trans-aconitate as carbon sourceTATE	tricarballylate as carbon sourceTTE	citrate as carbon sourceCIT	D-glucuronate as carbon sourceGRT	D-galacturonate as carbon sourceGAT	2-ketogluconate as carbon source2KG	5-ketogluconate as carbon source5KG	tryptophan as carbon sourceTRY	N-acetyl-D-glucosamine as carbon sourceNAG	D-gluconate as carbon sourceGNT	phenylacetate as carbon sourcePAC	protocatechuate as carbon sourcePAT	4-hydroxybenzoate as carbon sourcepOBE	quinate as carbon sourceQAT	gentisate as carbon sourceGTE	3-hydroxybenzoate as carbon sourcemOBE	benzoate as carbon sourceBAT	3-phenylpropionate as carbon sourcePPAT	m-coumarate as carbon sourceCMT	trigonelline as carbon sourceTGE	betaine as carbon sourceBET	putrescine as carbon sourcePCE	4-aminobutyrate as carbon sourceABT	histamine as carbon sourceHIN	DL-lactate as carbon sourceLAT	caprate as carbon sourceCAP	caprylate as carbon sourceCYT	L-histidine as carbon sourceHIS	succinate as carbon sourceSUC	fumarate as carbon sourceFUM	glutarate as carbon sourceGRE	DL-glycerate as carbon sourceGYT	5-aminovalerate as carbon sourceAVT	ethanolamine as carbon sourceETN	tryptamine as carbon sourceTTN	D-glucosamine as carbon sourceGLN	itaconate as carbon sourceITA	3-hydroxybutyrate as carbon source3OBU	L-aspartate as carbon sourceAPT	L-glutamate as carbon sourceGTT	L-proline as carbon sourcePRO	D-alanine as carbon sourceDALA	L-alanine as carbon sourceLALA	L-serine as carbon sourceSER	malonate as carbon sourceMNT	propionate as carbon sourcePROP	L-tyrosine as carbon sourceTYR	2-ketoglutarate as carbon source2KT
116742	not determinedn.d.	+	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	+	+	+	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	+	+	-	-	-	+	+	+	+	+	+	-	-	-	-	+	-	-	+	+	+	+	-	-	+	-	-	+	-	+	+	-	+	+	+	+	+	+	+	-	-	-	-	-	-	+	+	+	+	+	+	-	+	+	+	-

Isolation, sampling and environmental information

Isolation source categories

Cat1	Cat2	Cat3
#Host Body Product	#Fluids	#Urine

Isolation

@ref	Sample type
9084	urine
67770	Urine
116742	Urine

Taxonmaps

69479

Global distribution of 16S sequence Z93435 (>99% sequence identity) for Acinetobacter baumannii from Microbeatlas

Aquatic Samples	4013
Soil Samples	605
Animal Samples	5073
Plant Samples	534
Total Samples	10225

Interaction and safety

Risk assessment

@ref	Biosafety level	Biosafety level comment
9084	2	Risk group (German classification) According to TRBA 466
116742	1	Risk group (French classification) According to TRBA 466

Sequence information

Genome sequences

@ref	Description	Assembly level	INSDC accession	BV-BRC accession	IMG accession	NCBI tax ID	Score
124043	ASM2599507v1 assembly for Acinetobacter baumannii ATCC 19606	complete	GCA_025995075	470.19231	8119607308	470	99.53
66792	ASM1467275v1 assembly for Acinetobacter baumannii ATCC 19606	complete	GCA_014672755	470.12191	8008097835	470	99.44
124043	ASM2287004v1 assembly for Acinetobacter baumannii PartI-Abaumannii-RM8376	complete	GCA_022870045	470.17368		470	99.43
66792	ASM2091198v1 assembly for Acinetobacter baumannii ATCC 19606	complete	GCA_020911985	470.15027	8007989954	470	99.26
66792	ASM2246697v1 assembly for Acinetobacter baumannii ATCC19606-VUB	complete	GCA_022466975	470.16153	8008024684	470	99.26
66792	ASM975968v1 assembly for Acinetobacter baumannii ATCC 19606	complete	GCA_009759685	470.9626	8008082303	470	99.15
66792	ASM903584v1 assembly for Acinetobacter baumannii ATCC 19606	complete	GCA_009035845	470.11567	8007993847	470	99.07
66792	ASM1933165v1 assembly for Acinetobacter baumannii ATCC 19606 = CIP 70.34 = JCM 6841	complete	GCA_019331655	575584.58	8008105593	575584	99.07
66792	34576_B02 assembly for Acinetobacter baumannii NCTC12156	contig	GCA_900444725	470.5453	8117487761	470	79.11
66792	ASM281117v1 assembly for Acinetobacter baumannii ATCC 19606 = CIP 70.34 = JCM 6841	scaffold	GCA_002811175	575584.33		575584	77.13
66792	ASM73714v1 assembly for Acinetobacter baumannii ATCC 19606 = CIP 70.34 = JCM 6841	scaffold	GCA_000737145	575584.19	2609460113	575584	76.08
66792	Acin_baum_CIP_70_34T_V1 assembly for Acinetobacter baumannii ATCC 19606 = CIP 70.34 = JCM 6841	scaffold	GCA_000369385	575584.18	2534682196	575584	73.34
66792	ASM1709014v1 assembly for Acinetobacter baumannii DSM 30007	contig	GCA_017090145	470.13019	8117087881	470	72.41
66792	ASM1411679v1 assembly for Acinetobacter baumannii ATCC 19606	scaffold	GCA_014116795	470.11740		470	70.54
66792	ASM1411676v1 assembly for Acinetobacter baumannii ATCC 19606_3M	scaffold	GCA_014116765	470.11738		470	69.34
66792	ASM93175v1 assembly for Acinetobacter baumannii NBRC 109757	contig	GCA_000931755	470.1319	2700989282	470	69.18
124043	ASM4505567v1 assembly for Acinetobacter baumannii ATCC 19606	contig	GCA_045055675			470	68.94
66792	ASM1411678v1 assembly for Acinetobacter baumannii ATCC 19606_5M	scaffold	GCA_014116785	470.11739		470	68.74
124043	ASM5194811v1 assembly for Acinetobacter baumannii ATCC 19606	scaffold	GCA_051948115			470	60.66
67770	ASM16229v1 assembly for Acinetobacter baumannii ATCC 19606 = CIP 70.34 = JCM 6841	scaffold	GCA_000162295	575584.3	647533101	575584	59.14
66792	ASM1674603v1 assembly for Acinetobacter baumannii 81	contig	GCA_016746035	470.12707	8119611039	470	58.37
66792	ATCC19606 assembly for Acinetobacter baumannii	contig	GCA_900011295	470.2129	2916668946	470	54.95
124043	ASM1139851v1 assembly for Acinetobacter baumannii ATCC 19606	contig	GCA_011398515	470.10973		470	51.31
66792	PDT001010899.1 assembly for Acinetobacter baumannii 81	contig	GCA_018123985	470.20762	8112390111	470	49.82
66792	ASM61470v1 assembly for Acinetobacter baumannii ATCC 19606 = CIP 70.34 = JCM 6841	contig	GCA_000614705	1236532.3	2585427930	575584	18.88
66792	ASM2591990v1 assembly for Acinetobacter baumannii ATCC 19606	contig	GCA_025919905	470.19204		470

16S sequences

@ref	Description	Accession	Length	NCBI tax ID
20218	Acinetobacter baumannii 16S rRNA gene, partial	AJ247197	452	470
20218	Acinetobacter baumannii strain CIP 70.34 16S ribosomal RNA gene, partial sequence	FJ867354	1528	470
20218	Acinetobacter baumannii 16S rRNA gene, strain ATCC 19606	HE651907	1529	470
20218	Acinetobacter baumannii 16S-23S ribosomal RNA intergenic spacer, including Ile-tRNA and Ala-tRNA genes	U60279	621	470
20218	Acinetobacter baumanni 16S rRNA gene (strain ATCC 19606T)	Z93435	1416	470
9084	A.baumannii 16S rRNA gene (DSM30007)	X81660	1459	470
9084	Acinetobacter baumannii partial 16S rRNA gene, type strain DSM 30007T	HE978267	1515	470
67770	Acinetobacter baumannii gene for 16S rRNA, partial sequence, strain: JCM 6841	AB594765	1459	470
124043	Acinetobacter baumannii strain CIP 70.34 16S ribosomal RNA gene, partial sequence.	ON754042	1528	470
124043	Acinetobacter baumannii strain DSM 30007 16S ribosomal RNA gene, partial sequence.	OP849667	416	470
124043	Acinetobacter baumannii strain DSM 30007 16S ribosomal RNA gene, partial sequence.	KY952683	1517	470
124043	Acinetobacter baumannii strain ATCC 19606 16S ribosomal RNA gene, partial sequence.	MK351229	1385	470
124043	Acinetobacter baumannii strain JCM 6841 16S ribosomal RNA gene, partial sequence.	MK351230	1390	470

Genome-based predictions

Predictions

Predictions from Deep Learning for Genome Sequence Data. R package version 0.3.1 based on: Acinetobacter baumannii ATCC 19606
NCBI: GCA_009035845

@ref	Trait	Model	Prediction	Confidence in %	In training data
125439	oxygen_tolerance	BacteriaNetⓘ	obligate aerobe	96.80	no
125439	gram_stain	BacteriaNetⓘ	negative	88.00	no
125439	motility	BacteriaNetⓘ	no	52.90	no
125439	spore_formation	BacteriaNetⓘ	no	94.10	no

Predictions from bacterial phenotypic traits through improved machine learning using high-quality, curated datasets based on: Acinetobacter baumannii ATCC 19606 = CIP 70.34 = JCM 6841 ATCC 19606
NCBI: GCA_019331655.1

@ref	Trait	Model	Prediction	Confidence in %	In training data
125438	gram-positive	gram-positiveⓘ	no	98.00	no
125438	anaerobic	anaerobicⓘ	no	98.29	yes
125438	aerobic	aerobicⓘ	yes	89.42	yes
125438	spore-forming	spore-formingⓘ	no	93.53	no
125438	thermophilic	thermophileⓘ	no	100.00	no
125438	flagellated	motile2+ⓘ	no	76.92	no

Literature

Topic	Title	Authors	Journal	DOI	Year
	Microbiome-derived antimicrobial peptides show therapeutic activity against the critically important priority pathogen, Acinetobacter baumannii.	Alexander PJ, Oyama LB, Olleik H, Godoy Santos F, O'Brien S, Cookson A, Cochrane SA, Gilmore BF, Maresca M, Huws SA.	NPJ Biofilms Microbiomes	10.1038/s41522-024-00560-2	2024
Genetics	High intra-laboratory reproducibility of nanopore sequencing in bacterial species underscores advances in its accuracy.	Abdel-Glil MY, Brandt C, Pletz MW, Neubauer H, Sprague LD.	Microb Genom	10.1099/mgen.0.001372	2025
	Evaluation of a microfluidic-based point-of-care prototype with customized chip for detection of bacterial clusters.	Treffon J, Isserstedt-John N, Klemm R, Gartner C, Mellmann A.	Microbiol Spectr	10.1128/spectrum.00862-24	2024
	Bioprospecting cultivable bacteria associated with deep sea (mesopelagic) fish of the North Atlantic Ocean.	Oppong-Danquah E, Heumann J, Moosbauer H, Blumel M, Wenzel-Storjohann A, Tasdemir D.	Nat Prod Bioprospect	10.1007/s13659-025-00527-6	2025
	Synthesis of Second-Generation Analogs of Temporin-SHa Peptide Having Broad-Spectrum Antibacterial and Anticancer Effects.	Khan AI, Nazir S, Haque MNU, Maharjan R, Khan FA, Olleik H, Courvoisier-Dezord E, Maresca M, Shaheen F.	Antibiotics (Basel)	10.3390/antibiotics13080758	2024
	Natural peptides and their synthetic congeners acting against Acinetobacter baumannii through the membrane and cell wall: latest progress.	Kumar G.	RSC Med Chem	10.1039/d4md00745j	2025
	An organometallic hybrid antibiotic of metronidazole with a Gold(I) N-Heterocyclic Carbene overcomes metronidazole resistance in Clostridioides difficile.	Bussing R, Bublitz A, Karge B, Bronstrup M, Strowig T, Ott I.	J Biol Inorg Chem	10.1007/s00775-024-02064-y	2024
	Cefsulodin and Vancomycin: A Supplement for Chromogenic Coliform Agar for Detection of Escherichia coli and Coliform Bacteria from Different Water Sources.	Schalli M, Inwinkl SM, Platzer S, Baumert R, Reinthaler FF, Ofner-Kopeinig P, Haas D.	Microorganisms	10.3390/microorganisms10122499	2022
Enzymology	Comparison of the mechanism of antimicrobial action of the gold(I) compound auranofin in Gram-positive and Gram-negative bacteria.	Quadros Barse L, Ulfig A, Varatnitskaya M, Vazquez-Hernandez M, Yoo J, Imann AM, Lupilov N, Fischer M, Becker K, Bandow JE, Leichert LI.	Microbiol Spectr	10.1128/spectrum.00138-24	2024
	New Genetically Engineered Derivatives of Antibacterial Darobactins Underpin Their Potential for Antibiotic Development.	Seyfert CE, Muller AV, Walsh DJ, Birkelbach J, Kany AM, Porten C, Yuan B, Krug D, Herrmann J, Marlovits TC, Hirsch AKH, Muller R.	J Med Chem	10.1021/acs.jmedchem.3c01660	2023
	Characterization of the Antibacterial Activity of Quinone-Based Compounds Originating from the Alnumycin Biosynthetic Gene Cluster of a Streptomyces Isolate.	Sagurna L, Heinrich S, Kaufmann LS, Ruckert-Reed C, Busche T, Wolf A, Eickhoff J, Klebl B, Kalinowski J, Bandow JE.	Antibiotics (Basel)	10.3390/antibiotics12071116	2023
	1,5-Diarylidene-4-Piperidones as Promising Antifungal Candidates Against Cryptococcus neoformans.	Courvoisier-Dezord E, Ragusa H, Grande A, Denudt L, Charmasson Y, Dumur F, Siri D, Maresca M, Nechab M.	Antibiotics (Basel)	10.3390/antibiotics14090883	2025
	Potency of all-D amino acid antimicrobial peptides derived from the bovine rumen microbiome on tuberculous and non-tuberculous mycobacteria.	Boidin-Wichlacz C, Maresca M, Correia I, Lequin O, Point V, Casanova M, Reinbold A, Iranzo O, Huws SA, Brodin P, Oyama LB, Tasiemski A, Canaan S, Cavalier JF.	Curr Res Microb Sci	10.1016/j.crmicr.2025.100395	2025
Genetics	Extended Spectrum Beta-Lactamase-Producing Gram-Negative Bacteria Recovered From an Amazonian Lake Near the City of Belém, Brazil.	Freitas DY, Araujo S, Folador ARC, Ramos RTJ, Azevedo JSN, Tacao M, Silva A, Henriques I, Barauna RA.	Front Microbiol	10.3389/fmicb.2019.00364	2019
	Antimicrobial activity of iron-depriving pyoverdines against human opportunistic pathogens.	Vollenweider V, Rehm K, Chepkirui C, Perez-Berlanga M, Polymenidou M, Piel J, Bigler L, Kummerli R.	Elife	10.7554/elife.92493	2024
	Biological Activities of Ruthenium NHC Complexes: An Update.	Catalano A, Mariconda A, Sinicropi MS, Ceramella J, Iacopetta D, Saturnino C, Longo P.	Antibiotics (Basel)	10.3390/antibiotics12020365	2023
Phylogeny	Polyextremophilic Bacteria from High Altitude Andean Lakes: Arsenic Resistance Profiles and Biofilm Production.	Zannier F, Portero LR, Ordonez OF, Martinez LJ, Farias ME, Albarracin VH.	Biomed Res Int	10.1155/2019/1231975	2019
Genetics	Genomic characterization of four novel bacteriophages infecting the clinical pathogen Klebsiella pneumoniae.	Bonilla E, Costa AR, van den Berg DF, van Rossum T, Hagedoorn S, Walinga H, Xiao M, Song W, Haas PJ, Nobrega FL, Brouns SJJ.	DNA Res	10.1093/dnares/dsab013	2021
	Novel integrated computational AMP discovery approaches highlight diversity in the helminth AMP repertoire.	Irvine A, McKenzie D, McCoy CJ, Graham RLJ, Graham C, Huws SA, Atkinson LE, Mousley A.	PLoS Pathog	10.1371/journal.ppat.1011508	2023
	The Rare Actinobacterium Crossiella sp. Is a Potential Source of New Bioactive Compounds with Activity against Bacteria and Fungi.	Gonzalez-Pimentel JL, Dominguez-Monino I, Jurado V, Laiz L, Caldeira AT, Saiz-Jimenez C.	Microorganisms	10.3390/microorganisms10081575	2022
Pathogenicity	Identification of antibiotic resistance genes in the multidrug-resistant Acinetobacter baumannii strain, MDR-SHH02, using whole-genome sequencing.	Wang H, Wang J, Yu P, Ge P, Jiang Y, Xu R, Chen R, Liu X.	Int J Mol Med	10.3892/ijmm.2016.2844	2017
	Establishment of a Real-Time PCR Assay for the Detection of Devriesea agamarum in Lizards.	Brockmann M, Leineweber C, Hellebuyck T, Martel A, Pasmans F, Gentil M, Muller E, Marschang RE.	Animals (Basel)	10.3390/ani13050881	2023
	Bioactivity Profiling and Untargeted Metabolomics of Microbiota Associated with Mesopelagic Jellyfish Periphylla periphylla.	Oppong-Danquah E, Miranda M, Blumel M, Tasdemir D.	Mar Drugs	10.3390/md21020129	2023
Enzymology	Evaluation of Ruthenium(II) N-Heterocyclic Carbene Complexes as Antibacterial Agents and Inhibitors of Bacterial Thioredoxin Reductase.	Burmeister H, Dietze P, Preu L, Bandow JE, Ott I.	Molecules	10.3390/molecules26144282	2021
Proteome	Identification of Microorganisms by Liquid Chromatography-Mass Spectrometry (LC-MS¹) and in Silico Peptide Mass Libraries.	Lasch P, Schneider A, Blumenscheit C, Doellinger J.	Mol Cell Proteomics	10.1074/mcp.tir120.002061	2020
	Design, Synthesis and Characterization of [G10a]-Temporin SHa Dendrimers as Dual Inhibitors of Cancer and Pathogenic Microbes.	Khan AI, Nazir S, Ullah A, Haque MNU, Maharjan R, Simjee SU, Olleik H, Courvoisier-Dezord E, Maresca M, Shaheen F.	Biomolecules	10.3390/biom12060770	2022
	Bacillamide D produced by Bacillus cereus from the mouse intestinal bacterial collection (miBC) is a potent cytotoxin in vitro.	Hohmann M, Brunner V, Johannes W, Schum D, Carroll LM, Liu T, Sasaki D, Bosch J, Clavel T, Sieber SA, Zeller G, Tschurtschenthaler M, Janssen KP, Gulder TAM.	Commun Biol	10.1038/s42003-024-06208-3	2024
Enzymology	Microbial diversity similarities in periodontal pockets and atheromatous plaques of cardiovascular disease patients.	Serra e Silva Filho W, Casarin RC, Nicolela EL, Passos HM, Sallum AW, Goncalves RB.	PLoS One	10.1371/journal.pone.0109761	2014
Enzymology	Silver Organometallics that are Highly Potent Thioredoxin and Glutathione Reductase Inhibitors: Exploring the Correlations of Solution Chemistry with the Strong Antibacterial Effects.	Esarev IV, Karge B, Zeng H, Lippmann P, Jones PG, Schrey H, Bronstrup M, Ott I.	ACS Infect Dis	10.1021/acsinfecdis.4c00104	2024
	Two-in-One Biointerfaces-Antimicrobial and Bioactive Nanoporous Gallium Titanate Layers for Titanium Implants.	Yamaguchi S, Nath S, Sugawara Y, Divakarla K, Das T, Manos J, Chrzanowski W, Matsushita T, Kokubo T.	Nanomaterials (Basel)	10.3390/nano7080229	2017
	Bioactivity and Metabolome Mining of Deep-Sea Sediment-Derived Microorganisms Reveal New Hybrid PKS-NRPS Macrolactone from Aspergillus versicolor PS108-62.	Magot F, Van Soen G, Buedenbender L, Li F, Soltwedel T, Grauso L, Mangoni A, Blumel M, Tasdemir D.	Mar Drugs	10.3390/md21020095	2023
	Improved broad-spectrum antibiotics against Gram-negative pathogens via darobactin biosynthetic pathway engineering.	Gross S, Panter F, Pogorevc D, Seyfert CE, Deckarm S, Bader CD, Herrmann J, Muller R.	Chem Sci	10.1039/d1sc02725e	2021
	Biological Activities of Two Major Copaiba Diterpenoids and Their Semi-synthetic Derivatives.	Cicek SS, Wenzel-Storjohann A, Girreser U, Tasdemir D.	Rev Bras Farmacogn	10.1007/s43450-020-00002-y	2020
	Gut and Gill-Associated Microbiota of the Flatfish European Plaice (Pleuronectes platessa): Diversity, Metabolome and Bioactivity against Human and Aquaculture Pathogens.	Ghotbi M, Kelting O, Blumel M, Tasdemir D.	Mar Drugs	10.3390/md20090573	2022
Pathogenicity	2-Hydroxysorangiadenosine: Structure and Biosynthesis of a Myxobacterial Sesquiterpene-Nucleoside.	Okoth DA, Hug JJ, Garcia R, Sproer C, Overmann J, Muller R.	Molecules	10.3390/molecules25112676	2020
Genetics	Genomic and proteomic evidences unravel the UV-resistome of the poly-extremophile Acinetobacter sp. Ver3.	Kurth D, Belfiore C, Gorriti MF, Cortez N, Farias ME, Albarracin VH.	Front Microbiol	10.3389/fmicb.2015.00328	2015
Metabolism	Diversity, Bioactivity Profiling and Untargeted Metabolomics of the Cultivable Gut Microbiota of Ciona intestinalis.	Utermann C, Echelmeyer VA, Oppong-Danquah E, Blumel M, Tasdemir D.	Mar Drugs	10.3390/md19010006	2020
Metabolism	Integrating Molecular Networking and ¹H NMR Spectroscopy for Isolation of Bioactive Metabolites from the Persian Gulf Sponge Axinella sinoxea.	Mohsenian Kouchaksaraee R, Moridi Farimani M, Li F, Nazemi M, Tasdemir D.	Mar Drugs	10.3390/md18070366	2020
	A Glacier Bacterium Produces High Yield of Cryoprotective Exopolysaccharide.	Ali P, Shah AA, Hasan F, Hertkorn N, Gonsior M, Sajjad W, Chen F.	Front Microbiol	10.3389/fmicb.2019.03096	2019
	Three New Stigmatellin Derivatives Reveal Biosynthetic Insights of Its Side Chain Decoration.	Okoth DA, Hug JJ, Garcia R, Muller R.	Molecules	10.3390/molecules27144656	2022
Pathogenicity	Gold(I) and Gold(III) N-Heterocyclic Carbene Complexes as Antibacterial Agents and Inhibitors of Bacterial Thioredoxin Reductase.	Bussing R, Karge B, Lippmann P, Jones PG, Bronstrup M, Ott I.	ChemMedChem	10.1002/cmdc.202100381	2021
Enzymology	Antimicrobial, antioxidant and anti-tyrosinase properties of extracts of the Mediterranean parasitic plant Cytinus hypocistis.	Zucca P, Pintus M, Manzo G, Nieddu M, Steri D, Rinaldi AC.	BMC Res Notes	10.1186/s13104-015-1546-5	2015
Phylogeny	Comparative Analysis of 37 Acinetobacter Bacteriophages.	Turner D, Ackermann HW, Kropinski AM, Lavigne R, Sutton JM, Reynolds DM.	Viruses	10.3390/v10010005	2017
	Bacterial hitchhikers derive benefits from fungal housing.	Venkatesh N, Greco C, Drott MT, Koss MJ, Ludwikoski I, Keller NM, Keller NP.	Curr Biol	10.1016/j.cub.2022.02.017	2022
Metabolism	Bacterial Periplasmic Oxidoreductases Control the Activity of Oxidized Human Antimicrobial beta-Defensin 1.	Wendler J, Ehmann D, Courth L, Schroeder BO, Malek NP, Wehkamp J.	Infect Immun	10.1128/iai.00875-17	2018
	Insights into the Spectrum of Activity and Mechanism of Action of MGB-BP-3.	Hind C, Clifford M, Woolley C, Harmer J, McGee LMC, Tyson-Hirst I, Tait HJ, Brooke DP, Dancer SJ, Hunter IS, Suckling CJ, Beveridge R, Parkinson JA, Sutton JM, Scott FJ.	ACS Infect Dis	10.1021/acsinfecdis.2c00445	2022
Phylogeny	Development of a multilocus sequence typing scheme for characterization of clinical isolates of Acinetobacter baumannii.	Bartual SG, Seifert H, Hippler C, Luzon MA, Wisplinghoff H, Rodriguez-Valera F.	J Clin Microbiol	10.1128/jcm.43.9.4382-4390.2005	2005
Genetics	Identification of Antimicrobial Resistance Determinants in Aeromonas veronii Strain MS-17-88 Recovered From Channel Catfish (Ictalurus punctatus).	Tekedar HC, Arick MA, Hsu CY, Thrash A, Blom J, Lawrence ML, Abdelhamed H.	Front Cell Infect Microbiol	10.3389/fcimb.2020.00348	2020
Metabolism	Characterization of two diesel fuel degrading microbial consortia enriched from a non acclimated, complex source of microorganisms.	Zanaroli G, Di Toro S, Todaro D, Varese GC, Bertolotto A, Fava F.	Microb Cell Fact	10.1186/1475-2859-9-10	2010
	Culture-Dependent Microbiome of the Ciona intestinalis Tunic: Isolation, Bioactivity Profiling and Untargeted Metabolomics.	Utermann C, Echelmeyer VA, Blumel M, Tasdemir D.	Microorganisms	10.3390/microorganisms8111732	2020
	Tuning the activity of a short arg-trp antimicrobial Peptide by lipidation of a C- or N-terminal lysine side-chain.	Albada HB, Prochnow P, Bobersky S, Langklotz S, Schriek P, Bandow JE, Metzler-Nolte N.	ACS Med Chem Lett	10.1021/ml300148v	2012
	An organometallic structure-activity relationship study reveals the essential role of a Re(CO)₃ moiety in the activity against gram-positive pathogens including MRSA.	Patra M, Wenzel M, Prochnow P, Pierroz V, Gasser G, Bandow JE, Metzler-Nolte N.	Chem Sci	10.1039/c4sc02709d	2015
Metabolism	Genomics- and Metabolomics-Based Investigation of the Deep-Sea Sediment-Derived Yeast, Rhodotorula mucilaginosa 50-3-19/20B.	Buedenbender L, Kumar A, Blumel M, Kempken F, Tasdemir D.	Mar Drugs	10.3390/md19010014	2020
	Biscarbene gold(i) complexes: structure-activity-relationships regarding antibacterial effects, cytotoxicity, TrxR inhibition and cellular bioavailability.	Schmidt C, Karge B, Misgeld R, Prokop A, Bronstrup M, Ott I.	Medchemcomm	10.1039/c7md00269f	2017
	Microbial Biofilm Decontamination on Dental Implant Surfaces: A Mini Review.	Dhaliwal JS, Abd Rahman NA, Ming LC, Dhaliwal SKS, Knights J, Albuquerque Junior RF.	Front Cell Infect Microbiol	10.3389/fcimb.2021.736186	2021
	Modulating the activity of short arginine-tryptophan containing antibacterial peptides with N-terminal metallocenoyl groups.	Albada HB, Chiriac AI, Wenzel M, Penkova M, Bandow JE, Sahl HG, Metzler-Nolte N.	Beilstein J Org Chem	10.3762/bjoc.8.200	2012
Metabolism	Allicin Induces Thiol Stress in Bacteria through S-Allylmercapto Modification of Protein Cysteines.	Muller A, Eller J, Albrecht F, Prochnow P, Kuhlmann K, Bandow JE, Slusarenko AJ, Leichert LI.	J Biol Chem	10.1074/jbc.m115.702308	2016
Phylogeny	A rapid culture independent methodology to quantitatively detect and identify common human bacterial pathogens associated with contaminated high purity water.	Minogue E, Tuite NL, Smith CJ, Reddington K, Barry T.	BMC Biotechnol	10.1186/s12896-015-0124-1	2015
Pathogenicity	N-Pyrazinoyl Substituted Amino Acids as Potential Antimycobacterial Agents-The Synthesis and Biological Evaluation of Enantiomers.	Juhas M, Kucerova L, Horacek O, Jandourek O, Kubicek V, Konecna K, Kucera R, Barta P, Janousek J, Paterova P, Kunes J, Dolezal M, Zitko J.	Molecules	10.3390/molecules25071518	2020
Phylogeny	Evaluation of matrix-assisted laser desorption ionization-time-of-flight mass spectrometry in comparison to 16S rRNA gene sequencing for species identification of nonfermenting bacteria.	Mellmann A, Cloud J, Maier T, Keckevoet U, Ramminger I, Iwen P, Dunn J, Hall G, Wilson D, Lasala P, Kostrzewa M, Harmsen D.	J Clin Microbiol	10.1128/jcm.00157-08	2008
Proteome	Analysis of variations in cell envelope subproteome and cell length in Acinetobacter baumannii ATCC 19606^T populations by effect of temperature and desiccation.	Orruno M, Bravo Z, Martinez I, Arana I.	Int Microbiol	10.1007/s10123-025-00706-y	2025
Transcriptome	Roles of GacSA and DJ41_1407 in Acinetobacter baumannii ATCC 19606.	Toh YH, Wen MY, Lin GH.	Int J Mol Sci	10.3390/ijms262110620	2025
	AaeAP2a, a scorpion-derived antimicrobial peptide, combats carbapenem-resistant Acinetobacter baumannii via membrane disruption and triggered metabolic collapse.	Luo W, Zhang L, Gao H, Li H, Li X, Wen Y, Sun H, Hang B, Zhang L, Zhang W, Liu X, Wang R, Wen B, Shen J, Zhu C, Bai Y, Wang L, Ding K, Hu J.	Front Microbiol	10.3389/fmicb.2025.1673333	2025
	Genomic and Phenotypic Characterization of a Drug-Susceptible Acinetobacter baumannii Reveals Increased Virulence-Linked Traits and Stress Tolerance.	Foong WE, He W, Xiang X, Huang J, Tam HK.	Biology (Basel)	10.3390/biology14091201	2025
	Growth inhibition of Acinetobacter by 5-chloro-indole-3-acetic acid.	Laird TS, Gaeni A, Leveau JHJ.	Microbiol Spectr	10.1128/spectrum.01858-25	2025
	Killing two birds with one stone: emergence of colistin and cefiderocol resistance in a mucoid MDR Acinetobacter baumannii under colistin pressure.	Fox V, Vrenna G, Rossitto M, Paris I, Papa R, Artini M, Selan L, Raimondi S, Tuccio Guarna Assanti V, Essa N, Lepanto MS, Cortazzo V, Agosta M, Boni A, Cristiani L, Cutrera R, Perno CF, Bernaschi P.	Front Microbiol	10.3389/fmicb.2025.1650028	2025
	Susceptibility of Acinetobacter baumannii isolates from different sources to biocides: a matter of biofilm.	Hamze L, Saras E, Azaiez S, Mansour W, Madec JY, Destanque T, Haenni M, Lupo A.	Antimicrob Resist Infect Control	10.1186/s13756-025-01658-8	2025
	Bakuchiol kills Staphylococcus aureus persisters and potentiates colistin activity against Acinetobacter baumannii persisters.	Suh K, Lee Y, Baek S, Kim J, Seo J, Yang YH, Kim JS, Lee W, Seo EK, Kim W.	Front Pharmacol	10.3389/fphar.2025.1592183	2025
	Synthesis of disaccharide and trisaccharide substructures of an A. baumannii lipooligosaccharide core.	Conrad BJ, Armstrong JM, Du S, Agarkar V, Kgoadi L, Wexler A, Ragains JR.	Carbohydr Res	10.1016/j.carres.2025.109639	2025
Genetics	A Scavenger Hunt for a DyP-Peroxidase from a Metagenome: Curated Peroxidase Database-Assisted Primer Design and Protein Structure Elucidation.	Tarek S, ElMaghloob Y, Smith H, Smith TJ, ElRakaiby MT, Habib MH.	ACS Chem Biol	10.1021/acschembio.5c00323	2025
Biotechnology	Acinetobacter baumannii as a Model for the Study and Application of Gram-Negative Outer Membrane Vesicles: A Systematic Review.	Cano-Castano B, Lopez-Siles M, Nonnoi F, Perez A, Corral Lugo A, McConnell MJ.	Microb Biotechnol	10.1111/1751-7915.70207	2025
Genetics	Hybrid Genome and Clinical Impact of Emerging Extensively Drug-Resistant Priority Bacterial Pathogen Acinetobacter baumannii in Saudi Arabia.	Borgio JF.	Life (Basel)	10.3390/life15071094	2025
	Investigation of colistin heteroresistance in multidrug-resistant Acinetobacter baumannii clinical isolates.	Hematian A, Karami-Zarandi M, Rahdar HA, Heidari H, Kazemian H.	New Microbes New Infect	10.1016/j.nmni.2025.101633	2025
	Neutral plasma-activated solution reverses polymyxin to inhibit polymyxin-resistant Acinetobacter baumannii by promoting the release of ROS and destroying the outer membrane in vitro.	Yuan W, Yu T, Yang X, Lin T, Guo T, Wang X, Li G, Gong K, Liu W.	mSystems	10.1128/msystems.00784-25	2025
	Synthesis, biological evaluation, and mechanistic investigation of tetrahydrothieno[2,3-c]pyridine derivatives as anti-Gram-negative bacterial agents.	Bian C, Shi W, Zhao S, Li B, Yuan M, Gao P, Li Y, Si S, Chen X.	Eur J Med Chem	10.1016/j.ejmech.2025.118179	2026
	Hydrogel dressing containing natural extracts inhibits dual-species biofilms of Staphylococcus aureus and Acinetobacter baumannii in ex vivo wound infection models.	Lethongkam S, Paosen S, Kurakaeo S, Bilhman S, Wannaboworn S, Chumpraman A, Daus M, Voravuthikunchai SP.	Sci Rep	10.1038/s41598-025-18150-3	2025
	The novel polymyxin analogue SPR206 exhibits higher activity than colistin against both colistin-susceptible and colistin-resistant strains of Acinetobacter baumannii.	Outeda-Garcia M, Garcia-Pose A, Guijarro-Sanchez P, Rodriguez-Coello A, Baez-Barroso GA, Maceiras R, Alonso-Garcia I, Arca-Suarez J, Vazquez-Ucha JC, Bou G, Beceiro A, Spanish National Acinetobacter spp. 2020 Study Group.	Antimicrob Agents Chemother	10.1128/aac.01940-24	2025
	Cross resistance emergence to polymyxins in Acinetobacter baumannii exposed in vitro to an antimicrobial peptide.	Ritz E, Rossel T, Jacquier N.	NPJ Antimicrob Resist	10.1038/s44259-025-00120-4	2025
	H-NS is a Transcriptional Repressor of the CRISPR-Cas System in Acinetobacter baumannii ATCC 19606.	Kim K, Islam MM, Bang S, Kim J, Lee CY, Lee JC, Shin M.	J Microbiol	10.1007/s12275-024-00182-5	2024
	Potential Use of Cefiderocol and Nanosilver in Wound Dressings to Control Multidrug-Resistant Gram-Negative Bacteria	Binert-Kusztal Z, Krakowska A, Skiba-Kurek I, Luty-Blocho M, Kula A, Olechowska-Jarzab A, Dorozynski P, Skalski T.	Molecules		2025
	Antibiotic Persister Cells in Acinetobacter baumannii: Overview of Molecular Mechanisms and Removal Strategies.	Vergoz D, De E, Loutelier-Bourhis C, Alexandre S.	Environ Microbiol	10.1111/1462-2920.70207	2025
	Genotyping of Acinetobacter baumannii clinical isolates from Polish hospitals uncovers novel sequence types.	Sidor-Dzitkowska K, Marszalik A, Krasnicka A, Zalewska M, Wroblewska M, Bakula Z, Popowska M, Boguslawska J, Skirecki T, Jagielski T, Stachowiak R.	Sci Rep	10.1038/s41598-025-23877-0	2025
	Inhibition of biofilm formation and preformed biofilm in Acinetobacter baumannii by resveratrol, chlorhexidine and benzalkonium: modulation of efflux pump activity.	Migliaccio A, Stabile M, Triassi M, De E, De Gregorio E, Zarrilli R.	Front Microbiol	10.3389/fmicb.2024.1494772	2024
Enzymology	Antivirulence drugs against Acinetobacter baumannii: where do they stand?	Elanany AA, Khalifa AG, Attia AS.	World J Microbiol Biotechnol	10.1007/s11274-025-04593-3	2025
Genetics	Genomic insights into biofilm-associated virulence in extensively drug-resistant Acinetobacter baumannii.	Wiradiputra MRD, Khuntayaporn P, Thirapanmethee K, Wanapaisan P, Chomnawang MT.	Curr Res Microb Sci	10.1016/j.crmicr.2025.100434	2025
	Divergent Synthesis and Antigenicity Evaluation of Core Oligosaccharides of the Lipopolysaccharides from Acinetobacter baumannii SMAL and ATCC 19606.	Luo S, Xu ZJ, Wang X, Hu XQ, Shang K, Zhang Z, He C, Qin Y, Yang JS.	Org Lett	10.1021/acs.orglett.4c02892	2024
	Discovery of Two New Neuroprotective Isocoumarin Dimers From the Dendrobium huoshanense-derived Streptomyces sp. AHMU XC001.	Ding W, Xie C, Wang H, Liu J, Zhang R, Ling C, Xie Y, Chen Q.	Chem Biodivers	10.1002/cbdv.202501134	2025
	Omp34-Mediated Acinetobacter baumannii Invasion of Human Cervical Carcinoma Epithelial, HeLa Cells, and the Influence of Anti-Omp34 Antibodies.	Hosseini SF, Jalali Nadoushan M, Fekrirad Z, Rasooli I.	Anal Cell Pathol (Amst)	10.1155/ancp/1931119	2025
	Variation in type IV pilus stability modulates DNA uptake and biofilm formation.	Yu Y, Mahdi R, Al-Hilfy Leon A, Vo N, Lofgren R, Mutabazi JL, Piepenbrink KH.	J Biol Chem	10.1016/j.jbc.2025.110787	2025
	Evaluation of Colistin Susceptibility in Carbapenem-Resistant Acinetobacter baumannii Isolates Using Broth Microdilution, MICRONAUT-MIC-Strip, and VITEK MS.	Akilli FM, Ilki A.	Microbiologyopen	10.1002/mbo3.70046	2025
	Evaluation of Antimicrobial Activity of Novel Chimeric M-PEX12 Peptide Against Acinetobacter baumannii.	Rakhshani Y, Mahmoodzadeh Hosseini H, Mirhosseini SA, Sotoodehnejadnematalahi F, Amani J.	Iran J Pharm Res	10.5812/ijpr-154484	2025
	On-Site Dual Detection of Airborne Acinetobacter baumannii and Its Carbapenem-Resistant Gene bla_OXA-23 Using a One-Pot Visual LAMP-CRISPR/Cas12a-Based Platform.	Lu H, Zhang T, Huang W, Zhu J, Qin H, Chen X, Zhao W, Sui G.	Microorganisms	10.3390/microorganisms13050976	2025
Pathogenicity	A decade of genomic and phenotypic adaptation of carbapenem-resistant Acinetobacter baumannii.	Tagueha AD, D'Agostini C, Scribano D, Fiorilla C, Limongi D, Fillo S, Corrent L, Lipari M, Lista F, Nencioni L, Palamara AT, Ambrosi C.	Front Cell Infect Microbiol	10.3389/fcimb.2025.1527488	2025
	Tolerance mechanisms and molecular epidemiology of reduced susceptibility to chlorhexidine digluconate in different species of the Acinetobacter baumannii complex.	Chen L, Liu S, Huang N, Xu C, Zhou C, Wang L, Zheng X, Zhou T, Yu P.	Can J Microbiol	10.1139/cjm-2024-0174	2025
	mRNA-LNP Vaccines Targeting SmpA-PLD and OmpK-Omp22 Induce Protective Immunity Against Acinetobacter baumannii.	Liu C, Wang X, Zheng Y, Gao X, Jin J, Cheng X, He Y, Wang PG.	Vaccines (Basel)	10.3390/vaccines13070764	2025
	Improving the Activity and Selectivity of a Scorpion-Derived Peptide, A3a, against Acinetobacter baumannii through Rational Design.	Moller DS, van der Walt M, Oosthuizen C, Serian M, Serem JC, Lorenz CD, Mason AJ, Bester MJ, Gaspar ARM.	ACS Omega	10.1021/acsomega.4c09593	2025
	Molecular insights into silver nanoparticle resistance in Acinetobacter baumannii and unique adaptations to ionic silver.	McNeilly O, Mediati DG, Pittorino MJ, Mann R, Soderstrom B, Hamidian M, Gunawan C.	NPJ Antimicrob Resist	10.1038/s44259-025-00161-9	2025
	Establishment of Specific Multiplex PCR Detection Methods for the Predominant tet(X)-Positive Acinetobacter Species.	Chen C, Liu J, Gao J, Wu T, Huang J.	Microorganisms	10.3390/microorganisms13112584	2025
	Linarin and Hyperoside Inhibit lptD/msbA to Disrupt Membranes of Multidrug-Resistant Acinetobacter baumannii.	Yang Y, Li X, Chen Y, Zhang Y, Li L, Chai Y, Pu X, Liu X.	Biology (Basel)	10.3390/biology14081087	2025
Genetics	Genomic characteristics of the multiresistant Acinetobacter baumannii global clone 1 reference strain A297/RUH875.	Koong J, Hall RM, Hamidian M.	J Antimicrob Chemother	10.1093/jac/dkaf160	2025
Proteome	Deep learning reveals antibiotics in the archaeal proteome.	Torres MDT, Wan F, de la Fuente-Nunez C.	Nat Microbiol	10.1038/s41564-025-02061-0	2025
	An Immunoinformatics-Based Multi-Peptide Vaccine Provides Antibody-Mediated Protection Against Acinetobacter baumannii Infection.	Jeffreys S, Aki J, Tompkins MP, Prather ND, Murthy AK, Chambers JP, Guentzel MN, Hung CY, Arulanandam BP, Yu JJ.	Vaccines (Basel)	10.3390/vaccines13030236	2025
	Acinetobacter baumannii Clinical Isolates Resist Complement-Mediated Lysis by Inhibiting the Complement Cascade and Improperly Depositing MAC.	Magda M, Boschloo W, Bettoni S, Fairley D, Russo TA, Giske CG, Tellapragada C, Rooijakkers SHM, Riesbeck K, Blom AM.	J Innate Immun	10.1159/000543664	2025
	Insight into the biological activities of Fagonia Arabica L. and its phytochemical constituents.	Mahmoud NN, Mekky AE, Mahmoud E, El-Azab MM, Haggag MI.	AMB Express	10.1186/s13568-025-01918-1	2025
	In Silico Design of Antimicrobial Peptides against Carbapenem-Resistant Acinetobacter baumannii Infections with Enhanced Activity by Nanoformulation.	Richardson L, Yang TY, Chen YW, Lin SY, Wang YT, Lu PL, Chan YH, Lin HC.	ACS Appl Bio Mater	10.1021/acsabm.5c00679	2025
	Characterization of carbapenem-resistant biofilm forming Acinetobacter baumannii isolates from clinical and surveillance samples.	Choudhary J, Shariff M.	Sci Rep	10.1038/s41598-025-09530-w	2025
	Loss of Lipooligosaccharide Synthesis in Acinetobacter baumannii Produces Changes in Outer Membrane Vesicle Protein Content.	Cano-Castano B, Corral-Lugo A, Gato E, Terron MC, Martin-Galiano AJ, Sotillo J, Perez A, McConnell MJ.	Int J Mol Sci	10.3390/ijms25179272	2024
	The Comparative Characterization of a Hypervirulent Acinetobacter baumannii Bacteremia Clinical Isolate Reveals a Novel Mechanism of Pathogenesis.	Benyamini P.	Int J Mol Sci	10.3390/ijms25189780	2024
	Synthesis, biological evaluation and validation of IMB-881 derivatives as anti-Gram-negative bacterial agents.	Liu C, Zhu X, Shi W, Duan Q, Yuan M, Zheng Y, Wei Y, You B, Zhang J, Si S, Li Y.	Bioorg Med Chem	10.1016/j.bmc.2025.118066	2025
Pathogenicity	Recent advances in host models in studying virulence factors and pathogenesis of Acinetobacter baumannii.	Garomsa TL, Shenkutie AM, Leung PHM.	Front Cell Infect Microbiol	10.3389/fcimb.2025.1715193	2025
	Carbapenem-induced beta-lactamase-isoform expression trends in Acinetobacter baumannii.	Benin BM, Hillyer T, Aguirre N, Sham YY, Willard B, Shin WS.	Sci Rep	10.1038/s41598-024-81501-z	2024
	Fluopsin C Promotes Biofilm Removal of XDR Acinetobacter baumannii and Presents an Additive Effect with Polymyxin B on Planktonic Cells.	Afonso L, Grzegorczyk KG, Salomao JM, Basso KR, Alves LC, Silva MCD, Chryssafidis AL, Gionco-Cano B, Yamada-Ogatta SF, Andrade G.	Antibiotics (Basel)	10.3390/antibiotics13090875	2024
	Rapid 65-min SYBR-Green PCR Assay for Carbapenem Resistant Klebsiella and Acinetobacter Detection.	Bukavaz S, Gungor K, Kunduracilar H, Yulugkural Z.	Microorganisms	10.3390/microorganisms13112590	2025
	A novel mRNA multi-epitope vaccine of Acinetobacter baumannii based on multi-target protein design in immunoinformatic approach.	Xu Y, Zhu F, Zhou Z, Ma S, Zhang P, Tan C, Luo Y, Qin R, Chen J, Pan P.	BMC Genomics	10.1186/s12864-024-10691-7	2024
	Comparison of Hypervirulent and Non-Hypervirulent Carbapenem-Resistant Acinetobacter baumannii Isolated from Bloodstream Infections: Mortality, Potential Virulence Factors, and Combination Therapy In Vitro.	Yao L, Liu N, Guo Y, Zhuo C, Yang X, Wang Y, Wang J, Li F, Li J, He N, Chen J, Lin Y, Xiao S, Zhuo C.	Antibiotics (Basel)	10.3390/antibiotics13090807	2024
	Contribution of RND superfamily multidrug efflux pumps AdeABC, AdeFGH, and AdeIJK to antimicrobial resistance and virulence factors in multidrug-resistant Acinetobacter baumannii AYE.	Xie L, Li J, Peng Q, Liu X, Lin F, Dai X, Ling B.	Antimicrob Agents Chemother	10.1128/aac.01858-24	2025
Genetics	Phylogenomic analysis of OXA-23-positive and genetic context of rare NDM-1-producing carbapenem-resistant Acinetobacter baumannii isolates in a teaching hospital in China.	Dong S, Lou J, Mao C, Fang Y, Zhang H.	Front Microbiol	10.3389/fmicb.2025.1575257	2025
	Draft genome sequence and intact prophage characterisation of multidrug-resistant Acinetobacter baumannii isolate ABU3 from a tracheal suction specimen in Thailand.	Yasawong M, Santaweesuk P, Phatcharaharikarn M, Songngamsuk T, Wongchitrat P, Yordpratum U, Pasharawipas T, Pochairach R, Woradulayapinij W.	Data Brief	10.1016/j.dib.2025.112002	2025
	Co-translational protein aggregation and ribosome stalling as a broad-spectrum antibacterial mechanism.	Khodaparast L, Khodaparast L, Duran-Romana R, Wu G, Houben B, Duverger W, De Vleeschouwer M, Konstantoulea K, Nysen F, Schalck T, Curwen DJ, Martin LL, Carpentier S, Scorneaux B, Michiels J, Schymkowitz J, Rousseau F.	Nat Commun	10.1038/s41467-025-56873-z	2025
	Lipidome of Acinetobacter baumannii antibiotic persister cells.	Vergoz D, Schaumann A, Schmitz I, Afonso C, De E, Loutelier-Bourhis C, Alexandre S.	Biochim Biophys Acta Mol Cell Biol Lipids	10.1016/j.bbalip.2024.159539	2024
Phylogeny	Phage Therapy for Acinetobacter baumannii Infections: A Review on Advances in Classification, Applications, and Translational Roadblocks.	Wang Y, Li L, Liang Y, Xu K, Ye Y, He M.	Antibiotics (Basel)	10.3390/antibiotics14111134	2025
	Alternative lipid synthesis in response to phosphate limitation promotes antibiotic tolerance in Gram-negative ESKAPE pathogens.	Olea-Ozuna RJ, Campbell MJ, Quintanilla SY, Nandy S, Brodbelt JS, Boll JM.	PLoS Pathog	10.1371/journal.ppat.1012933	2025
	Molybdate uptake interplay with ROS tolerance modulates bacterial pathogenesis.	Jiao M, He W, Ouyang Z, Yu Q, Zhang J, Qin Q, Wang R, Guo X, Liu R, He X, Hwang PM, Zheng F, Wen Y.	Sci Adv	10.1126/sciadv.adq9686	2025
	A Systematic Review and Meta-Analysis of Molecular Characteristics on Colistin Resistance of Acinetobacter baumannii.	Ciftci IH, Kahraman Kilbas EP, Kilbas I.	Diagnostics (Basel)	10.3390/diagnostics14222599	2024
	A light-controlled one-tube detection platform combining CRISPR-Cas12a and RPA: an innovative approach for rapid diagnosis of Acinetobacter baumannii.	Zhou Z, Pan L, Luo S, Ma J, Ren B, Liang L, Li X, Wei G.	Front Bioeng Biotechnol	10.3389/fbioe.2025.1663915	2025
	New antibacterial candidates against Acinetobacter baumannii discovered by in silico-driven chemogenomics repurposing.	Borges KCM, Costa VAF, Neves B, Kipnis A, Junqueira-Kipnis AP.	PLoS One	10.1371/journal.pone.0307913	2024
	Synergistic Ciprofloxacin-RWn Peptide Therapy Overcomes Drug Resistance in Gram-Negative Bacteria.	Almarwani B, Phambu N, Sunda-Meya A.	ACS Omega	10.1021/acsomega.5c02285	2025
	Development of acute Pseudomonas aeruginosa and Acinetobacter baumannii lung mono-challenge models in mice using oropharyngeal aspiration.	Jurado-Martin I, Ma C, Rezk N, Sainz-Mejias M, Hou Y, Baugh JA, McClean S.	Access Microbiol	10.1099/acmi.0.000860.v3	2024
	Genetic alterations in the pmrAB two-component system and lipid A biosynthesis genes of polymyxin-resistant Acinetobacter baumannii isolates.	El Mrimar N, Belouad EM, Benaissa E, Bssaibis F, Jazouli M, El Alaoui MA, Maleb A, Elouennass M.	Acta Microbiol Immunol Hung	10.1556/030.2024.02268	2024
	Toxicity and antimicrobial interactions with conventional antimicrobials of commonly traded medicinal plants from Faraday muthi market (Johannesburg, South Africa)	Booth Z, Khumalo G, Van Vuuren S.	S Afr J Bot		2024
	Droplet Digital PCR for Acinetobacter baumannii Diagnosis in Bronchoalveolar Lavage Samples from Patients with Ventilator-Associated Pneumonia.	Giselle Moreira M, Guimaraes Oliveira AG, Ul Haq I, Pinheiro de Oliveira TF, Alonazi WB, Fonseca Junior AA, Nobre Junior VA, Santos SGD.	Antibiotics (Basel)	10.3390/antibiotics13090878	2024
	Antimicrobial and antioxidant activities of peptide derived from turmeric plant (Curcuma longa L).	Roytrakul S, Charoenlappanit S, Kittisenachai S, Siangpro N, Sichaem J, Chuakrut S, Sarin S, Jutakanoke R.	PLoS One	10.1371/journal.pone.0314482	2024
Proteome	Deciphering the Intracellular Action of the Antimicrobial Peptide A11 via an In-Depth Analysis of Its Effect on the Global Proteome of Acinetobacter baumannii.	Thitirungreangchai T, Roytrakul S, Aunpad R.	ACS Infect Dis	10.1021/acsinfecdis.4c00160	2024
	Unveiling the role of adhesin proteins in controlling Acinetobacter baumannii infections: a systematic review.	Pereira IL, Hartwig DD.	Infect Immun	10.1128/iai.00348-24	2025
	Racemosol Derivatives and Other Metabolites from Bauhinia malabarica Bark with Antibacterial Activity.	Sirisarn W, Somteds A, Jadsadajerm S, Kaennakam S, Yodsin N, Wisetsai A.	Molecules	10.3390/molecules30214308	2025
	Targeting BamA, the essential component of the Acinetobacter baumannii beta-barrel assembly machinery, hinders its ability to adhere to and invade human alveolar basal epithelial cell line.	Momeni M, Fekrirad Z, Jalali Nadoushan M, Rasooli I.	Heliyon	10.1016/j.heliyon.2024.e34371	2024
	In Vitro Antibacterial Efficacy of Recombinant Phage-Derived Endolysin LysTAC1 Against Carbapenem-Resistant Acinetobacter baumannii.	Ullah I, Cui S, Yan Q, Ullah H, Sha S, Ma Y.	Antibiotics (Basel)	10.3390/antibiotics14100975	2025
	Exploring the genetic diversity and the association of drug resistance and biofilm production in Acinetobacter baumannii strains isolated from burn wound infections	Khashei S, Fazeli H, Rahimi F, Karbasizade V.	Iran J Microbiol		2025
	Divalent Cations (Ca²⁺, Mg²⁺, Mn²⁺, Fe²⁺, Ni²⁺, and Zn²⁺) Enhance Growth of Xanthomonas citri and X. campestris by Reducing Generation Time.	Merighi DGS, Goncalves CAB, Ferrari ASA, Andrade MO, Guzzo CR.	ACS Omega	10.1021/acsomega.5c02786	2025
Cultivation	Impact of nutritional factors on in vitro PK/PD modelling of polymyxin B against various strains of Acinetobacter baumannii.	Lacroix M, Moreau J, Zampaloni C, Bissantz C, Shirvani H, Marchand S, Couet W, Chauzy A.	Int J Antimicrob Agents	10.1016/j.ijantimicag.2024.107189	2024
	PmrAB, the two-component system of Acinetobacter baumannii, controls the phosphoethanolamine modification of lipooligosaccharide in response to metal ions.	Yamada N, Kamoshida G, Shiraishi T, Yamaguchi D, Matsuoka M, Yamauchi R, Kanda N, Kamioka R, Takemoto N, Morita Y, Fujimuro M, Yokota S-i, Yahiro K.	J Bacteriol	10.1128/jb.00435-23	2024
	PmrA Mutations in Drug-Resistant Acinetobacter baumannii Affect Sensor Kinase-Response Regulator Interaction and Phosphotransfer.	Jaimes FE, Hondros AD, Kinkead J, Milton ME, Thompson RJ, Figg AM, Melander C, Cavanagh J.	Microorganisms	10.3390/microorganisms13112600	2025
	Efficacy of Endolysin LysAB1245 Combined with Colistin as Adjunctive Therapy Against Colistin-Resistant Gram-Negative Bacteria.	Soontarach R, Voravuthikunchai SP, Srimanote P, Chusri S.	Antibiotics (Basel)	10.3390/antibiotics14060538	2025
	Cinnamaldehyde and baicalin reverse colistin resistance in Enterobacterales and Acinetobacter baumannii strains.	Mireles NA, Malla CF, Tavio MM.	Eur J Clin Microbiol Infect Dis	10.1007/s10096-024-04884-x	2024
	Investigation of Peppermint (Mentha piperita) Extract on the Inhibition of Biofilm Formation by Acinetobacter baumannii Strains Isolated from Clinical Samples.	Majidi Fard Z, Irani Mavi N, Akbari S, Erfani Y, Eghtedari S.	Iran J Pharm Res	10.5812/ijpr-160772	2025
	Characterization of a novel bacteriophage endolysin (LysAB1245) with extended lytic activity against distinct capsular types associated with Acinetobacter baumannii resistance.	Soontarach R, Srimanote P, Arechanajan B, Nakkaew A, Voravuthikunchai SP, Chusri S.	PLoS One	10.1371/journal.pone.0296453	2024
	Correlation of RND efflux pump expression and AdeRS mutations in tigecycline-resistant Acinetobacter baumannii from Thai clinical isolates.	Boonsilp S, Homkaew A, Wongsuk T, Thananon K, Oonanant W.	Eur J Microbiol Immunol (Bp)	10.1556/1886.2024.00070	2024
	Exploring Biofilm-Related Traits and Bile Salt Efficacy as Anti-Biofilm Agents in MDR Acinetobacter baumannii.	Aleksic Sabo V, Skoric D, Jovanovic-Santa S, Knezevic P.	Antibiotics (Basel)	10.3390/antibiotics13090880	2024
	Jelleine-I Membrane Interaction-related Biological Properties and Antimicrobial Activity against MDR, XDR, and PDR-Acinetobacter baumannii Clinical Isolates.	Pieve de Castro A, Brito JCM, Candido WAB, Felix AS, Verly RM, Resende JM, Lopes-de-Souza L, Chavez-Olortegui C, Fernandes SOA, Cardoso VN.	ACS Omega	10.1021/acsomega.4c09073	2025
	Loop-mediated isothermal amplification assay detects multiple alleles of bla _OXA-51-like genes in Acinetobacter baumannii and other Gram-negative bacteria despite primer-template mismatches.	Carascal MB, Macalalad LS, Petronio-Santos JA, Destura RV, Rivera WL.	Heliyon	10.1016/j.heliyon.2024.e35653	2024
	IMT-P8 potentiates Gram-positive specific antibiotics in intrinsically resistant Gram-negative bacteria.	Singh V, Nandanwar H.	Antimicrob Agents Chemother	10.1128/aac.00753-24	2024
	Mathematical modelling of synergistic triple-antibiotic therapy against carbapenem-resistant Acinetobacter baumannii at clinically achievable concentrations.	Huynh T, Lam T, Pham N, Luong L, Jusselme MD.	J Med Microbiol	10.1099/jmm.0.002086	2025
	Homo and Hetero-Branched Lipopeptide Dendrimers: Synthesis and Antimicrobial Activity.	Lamba S, Heruka De Zoysa G, Wang K, Lu J, Swift S, Sarojni V.	Bioorg Chem	10.1016/j.bioorg.2024.107567	2024
	Molecular determinants of substrate specificity in the efflux pump CraA from Acinetobacter baumannii.	Foong WE, Xiang X, Pos KM, Tam H-K.	Microbiol Spectr	10.1128/spectrum.01119-25	2025
	Prevalence and risk factors associated with infections linked to carbapenemase-producing Acinetobacter species circulating in the city of Yaoundé, Cameroon.	Tchinda CF, Djim-Adjim-Ngana K, Mbogning TA, Simo BFN, Baira SB, Feudjieu GE, Matchuenkam SG, Nfor GN, Takuissu GRN, Essola KJ, Walyaro CCG, Tchamgoue AD.	IJID Reg	10.1016/j.ijregi.2025.100698	2025
	A new bactericidal chlorinated derivative containing 2-aminooxazole potentiates antibacterial action of colistin against multidrug-resistant acinetobacter baumannii.	Diepoltova A, Nawrot DE, Jandourek O, Juhas M, Barta P, Vavrova P, Pallabothula VSK, Dudasova-Hatokova P, Vejsova M, Voxova B, Osterreicher J, Sterbova-Kovarikova P, Nachtigal P, Zitko J, Konecna K.	Med Microbiol Immunol	10.1007/s00430-025-00854-y	2025
	A chionodracine-derived peptide, KHS-Cnd, as an anti-virulence agent against multidrug-resistant Acinetobacter baumannii clinical strains.	Artini M, Paris I, Imperlini E, Buonocore F, Vrenna G, Papa R, Selan L.	Front Cell Infect Microbiol	10.3389/fcimb.2025.1526246	2025
	Computational exploration of global venoms for antimicrobial discovery with Venomics artificial intelligence.	Guan C, Torres MDT, Li S, de la Fuente-Nunez C.	Nat Commun	10.1038/s41467-025-60051-6	2025
	Predominance of extensively-drug resistant Acinetobacter baumannii carrying bla OXA-23 in Jordanian patients admitted to the intensive care units.	Ababneh Q, Aldaken N, Jaradat Z, Al-Rousan E, Inaya Z, Alsaleh D, Alawneh D, Al Sbei S, Saadoun I.	PLoS One	10.1371/journal.pone.0317798	2025
Metabolism	Gene Expression of Ethanol and Acetate Metabolic Pathways in the Acinetobacter baumannii EmaSR Regulon.	Huang YW, Shu HY, Lin GH.	Microorganisms	10.3390/microorganisms12020331	2024
	Development of a novel bacterial production system for recombinant bioactive proteins completely free from endotoxin contamination.	Kamoshida G, Yamaguchi D, Kaya Y, Yamakado T, Yamashita K, Aoyagi M, Nagai S, Yamada N, Kawagishi Y, Sugano M, Sakairi Y, Ueno M, Takemoto N, Morita Y, Ishizaka Y, Yahiro K.	PNAS Nexus	10.1093/pnasnexus/pgae328	2024
	Combination of aloe emodin, emodin, and rhein from Aloe with EDTA sensitizes the resistant Acinetobacter baumannii to polymyxins.	Zhao Y, Zhang T, Liang Y, Xie X, Pan H, Cao M, Wang S, Wu D, Wang J, Wang C, Hu W.	Front Cell Infect Microbiol	10.3389/fcimb.2024.1467607	2024
Genetics	Genomic characterization of multidrug-resistant clinical Acinetobacter baumannii isolates from a hospital in Paraguay.	Sanchez-Urtaza S, Alfonso-Alarcon L, Arazo Del Pino R, Burgwinkel T, Ocampo-Sosa A, Gonzalez R, Xanthopoulou K, Higgins PG, Alkorta I, Gallego L.	Front Cell Infect Microbiol	10.3389/fcimb.2025.1620479	2025
	Synthesis, Characterization, and Antimicrobial Activity of Some New 2,4-Dihydro-3H-1,2,4-Triazole-3-thione Derivatives.	Tok F, Damar Celik D.	Turk J Pharm Sci	10.4274/tjps.galenos.2025.77834	2025
	Molecular Characterization of Culturable Yeasts and Nonspore-Forming Bacteria Associated With Fermented Kapok Seeds (Kantong), a Traditional Food Condiment in Ghana.	Ametefe EN, Thorsen L, Danwonno H, Agoha RK, Glover RLK, Dzogbefia VP, Jespersen L.	Int J Food Sci	10.1155/ijfo/6452183	2025
	Susceptibility toward cefiderocol and sulbactam-durlobactam in extensively drug-resistant Acinetobacter baumannii detected from ICU admission screening in Hanoi, Vietnam, 2023.	Boutin S, Toan NQ, Mai Pham TA, My TN, Phuong NTK, Sy BT, Trong NV, Gopel L, Huber L, Kocer K, Linh LTK, Thanh Tung T, The NT, Song LH, Velavan TP, Nurjadi D.	Microbiol Spectr	10.1128/spectrum.00832-25	2025
	Phytochemical Composition and Antimicrobial and Antibiofilm Effect of Myrciaria cauliflora Hydroethanolic Extract against Staphylococcus aureus and Acinetobacter baumannii.	de Oliveira LD, Ribeiro ALM, Dias SO, da Cruz GM, de Menezes RT, de Carvalho LS, Diamantino MGG, Pereira TC, Marcucci MC, Abu Hasna A.	Methods Protoc	10.3390/mps7040060	2024
	Guava Leaf Extract Exhibits Antimicrobial Activity in Extensively Drug-Resistant (XDR) Acinetobacter baumannii.	Gutierrez-Montiel D, Guerrero-Barrera AL, Ramirez-Castillo FY, Galindo-Guerrero F, Ornelas-Garcia IG, Chavez-Vela NA, de O Costa M, Avelar-Gonzalez FJ, Moreno-Flores AC, Vazquez-Pedroza E, Arreola-Guerra JM, Gonzalez-Gamez M.	Molecules	10.3390/molecules30010070	2024
Genetics	Characterization and genomic analysis of the highly virulent Acinetobacter baumannii ST1791 strain dominating in Anhui, China.	He Z, Huang Y, Li W, Zhang H, Cao R, Ali MR, Dai Y, Lu H, Wang W, Niu Q, Sun B, Li Y.	Antimicrob Agents Chemother	10.1128/aac.01262-24	2025
	Chemical genomics informs antibiotic and essential gene function in Acinetobacter baumannii.	Tran JS, Ward RD, Iruegas-Lopez R, Ebersberger I, Peters JM.	PLoS Genet	10.1371/journal.pgen.1011642	2025
	Farnesol repurposing for prevention and treatment of Acinetobacter baumannii biofilms.	Tan L, Ma R, Katz AJ, Levi N.	Biofilm	10.1016/j.bioflm.2024.100198	2024
	Outer membrane permeability of mcr-positive bacteria reveals potent synergy of colistin and macromolecular antibiotics against colistin-resistant Acinetobacter baumannii.	Li M, Ma F, Zhao H, Zhou D, Liang L, Lv R, Li J, Wang Y, Xu L, Liu C, Tian GB, Feng S, Xia Y.	Front Microbiol	10.3389/fmicb.2024.1468682	2024
	Oligostyrylbenzene Derivatives with Antiparasitic and Antibacterial Activity as Potent G-Quadruplex Ligands.	Perez-Soto M, Penalver P, Munoz-Baez P, Tolosa J, Garcia-Martinez JC, Cebrian R, Morales JC.	Molecules	10.3390/molecules29245875	2024
Genetics	Genomic Characterization of Multidrug-Resistant Acinetobacter baumannii in Pneumonia Patients in Kazakhstan.	Strochkov V, Beloussov V, Orkara S, Lavrinenko A, Solomadin M, Yegorov S, Sandybayev N.	Diagnostics (Basel)	10.3390/diagnostics15060704	2025
	Vitamins Can Increase Antibiotic Effects Against Multidrug-Resistant Pseudomonas aeruginosa and Acinetobacter baumannii in an In Vitro Infection Model.	Celebi O, Celebi D, Baser S, Yilmaz A, Yildirim S.	Eurasian J Med	10.5152/eurasianjmed.2024.23145	2024
	Genome Sequence of Clinical Acinetobacter baumannii Strain V15.	Permingeat V, Perez Mora B, Torres Manno M, Giordano R, Arana N, Muller G, Krasauskas R, Mussi MA.	Microbiol Resour Announc	10.1128/mra.00169-23	2023
	Antimicrobial peptide thanatin fused endolysin PA90 (Tha-PA90) for the control of Acinetobacter baumannii infection in mouse model.	Lim J, Myung H, Lim D, Song M.	J Biomed Sci	10.1186/s12929-024-01027-4	2024
	Antibacterial and Antibiofilm Properties of the Alexidine Dihydrochloride (MMV396785) against Acinetobacter baumannii.	Upmanyu K, Rizwanul Haq QM, Singh R.	Antibiotics (Basel)	10.3390/antibiotics12071155	2023
	Characterization and Biofilm Inhibition of Multidrug-Resistant Acinetobacter baumannii Isolates.	Yadav P, Shrestha S, Basyal D, Tiwari A, Sah R, Sah AK, Yadav B, Willcox M, Mishra SK.	Int J Microbiol	10.1155/ijm/5749982	2024
	Population pharmacokinetics study on nebulized and intravenous administration of polymyxin B in patients with pneumonia caused by multidrug-resistant gram-negative bacteria.	Li X, Zhou L, Wang D, Wu Q, Huang X, Zhang H, Wu W, Liu M, Wu X, Qiu H, Cheng Y.	Antimicrob Agents Chemother	10.1128/aac.00044-25	2025
	Effect of Meropenem, Sulbactam, and Colistin Combinations on Resistance Gene Expression in Multidrug-Resistant A. baumannii Clinical Isolates from Panama.	Moreno JE, Querol-Audi J, Tejada AM, Medina-Sanchez JR, Archibold AD.	Antibiotics (Basel)	10.3390/antibiotics14100999	2025
	Gallium Liquid Metal Nanoparticles as Agents to Treat Multidrug-Resistant Bacterial Infections.	Nguyen HT, Puangseree J, Nguyen TT, Nguyen MT, Leigh C, Venter H, Vasilev K, Chuanchuen R, Trott DJ, Truong VK, Ogunniyi AD.	Microbiologyopen	10.1002/mbo3.70078	2025
Genetics	Antimicrobial resistance and virulence factors analysis of a multidrug-resistant Acinetobacter baumannii isolated from chickens using whole-genome sequencing.	Yu L, Zhao Y, Zhang S, Ni W, Zhang L, Xue C, Wang P, Zhang X.	BMC Microbiol	10.1186/s12866-024-03694-7	2024
	Antibacterial Cu-doped cotton textile against respiratory pathogens for preventing hospital-acquired infections.	Gao J, Liu D, Lin Z, Zhou Y, He Z, Dai X, Zhao P, Lu H, Zheng M.	Front Bioeng Biotechnol	10.3389/fbioe.2025.1641123	2025
	Investigating the Link Between Biofilm Formation and Antibiotic Resistance in Clinical Isolates of Acinetobacter baumannii.	Javadi K, Ghaemian P, Baziboron M, Pournajaf A.	Int J Microbiol	10.1155/ijm/1009049	2025
	Can flow cytometric measurements of reactive oxygen species levels determine minimal inhibitory concentrations and antibiotic susceptibility testing for Acinetobacter baumannii?	Yeo JH, Low JQ, Begam N, Leow WT, Kwa AL.	PLoS One	10.1371/journal.pone.0305939	2024
Phylogeny	First Characterization of Acinetobacter baumannii-Specific Filamentous Phages.	Narancic J, Gavric D, Kostanjsek R, Knezevic P.	Viruses	10.3390/v16060857	2024
	Biogenic silver nanomaterials synthesized from Ocimum sanctum leaf extract exhibiting robust antimicrobial and anticancer activities: Exploring the therapeutic potential.	Ahmad N, Ansari MA, Al-Mahmeed A, Joji RM, Saeed NK, Shahid M.	Heliyon	10.1016/j.heliyon.2024.e35486	2024
	DcaP-Family Porins are Required for Carboxylic Acid Catabolism in Acinetobacter baumannii	Noel H, Winkelman J, Palmer L.	bioRxiv		2025
	In vitro and in vivo antimicrobial potential of lithium complex against multi-drug resistant Acinetobacter baumannii.	Zehra M, Usmani Y, Shafiq J, Khan A, Zafar M, Raza Mirza M, Shah SR, Al-Harrasi A, Hasan SM, Farooqui A, Ahmed A.	Microbiol Spectr	10.1128/spectrum.01930-23	2023
	Simultaneous effect of medicinal plants as natural photosensitizers and low-level laser on photodynamic inactivation.	Aghaebrahimi Z, Sabaghzadeh J, Soudi S, Tanhayi Ahary M, Nabavi SH, Ranjbaran M.	Lasers Med Sci	10.1007/s10103-024-04037-8	2024
	Feature architecture aware phylogenetic profiling indicates a functional diversification of type IVa pili in the nosocomial pathogen Acinetobacter baumannii.	Iruegas R, Pfefferle K, Gottig S, Averhoff B, Ebersberger I.	PLoS Genet	10.1371/journal.pgen.1010646	2023
	Synergistic immunoprotection by Oma87 and Bap against Acinetobacter baumannii sepsis model.	Mansouri M, Sadeghpoor M, Abdollahi M, Vafaei AJ, Jalali Nadoushan M, Rasooli I.	Int Immunopharmacol	10.1016/j.intimp.2023.110650	2023
	Evolution of One Species Increases Resistance to Invasion in a Simple Synthetic Community.	de Scally SZ, McDonald MJ.	Microb Ecol	10.1007/s00248-025-02618-w	2025
	Identification and characterization of a novel pathway for aldopentose degradation in Acinetobacter baumannii.	Alberti L, Konig P, Zeidler S, Poehlein A, Daniel R, Averhoff B, Muller V.	Environ Microbiol	10.1111/1462-2920.16471	2023
	Interferon signalling and non-canonical inflammasome activation promote host protection against multidrug-resistant Acinetobacter baumannii.	Li FJ, Starrs L, Mathur A, Enosi Tuipulotu D, Man SM, Burgio G.	Commun Biol	10.1038/s42003-024-07204-3	2024
	A two-protein cocktail elicits a protective immune response against Acinetobacter baumannii in a murine infection model.	Mirali M, Jahangiri A, Jalali Nadoushan M, Rasooli I.	Microb Pathog	10.1016/j.micpath.2023.106262	2023
	Inter- and intra-bacterial strain diversity remains the "elephant in the (living) room".	Valcek A, Kroger C, de Dios R, McCarthy RR, Coenye T, Trent MS, Karah N, Uhlin BE, Classen AY, Higgins PG, Ebersberger I, Laaberki MH, Charpentier X, Visca P, Rather PN, Van der Henst C.	NPJ Antimicrob Resist	10.1038/s44259-025-00138-8	2025
	In vitro antimicrobial activity and resistance mechanisms of cefiderocol against clinical carbapenem-resistant gram-negative bacteria.	Yan R, Ji J, Wang L, Zou Y, Shen H, Yuan J, Cao X.	Front Microbiol	10.3389/fmicb.2025.1670179	2025
	Carbapenem-resistance in Acinetobacter baumannii: prevalence, antibiotic resistance profile and carbapenemase genes in clinical and hospital environmental strains	Adeyemi F, Akinlade E, Yusuf-Omoloye N, Ajigbewu O, Dare A, Wahab A, Oyedara O, Isiaka H, Usamat A.	BMC Infect Dis		2025
	Assessment of a rapid diagnostic test based on loop-mediated isothermal amplification (LAMP) to identify the most frequent pathogens causing hospital-acquired pneumonia.	Sellares-Crous A, Martinez-Trejo A, Arnalda-Munoz N, Gatti G, Villanueva-Lopez M, Vergara-Gomez A, Marco-Reverte F, Espasa-Soley M, Vila-Estape J.	Front Cell Infect Microbiol	10.3389/fcimb.2025.1609666	2025
	Enhanced Gram-Negative Membrane Disruption and In Vivo Efficacy via Lysine-Arginine Enrichment of Opis16a.	van der Walt M, Oosthuizen CB, Serian M, Lorenz CD, Mason AJ, Bester MJ, Gaspar ARM.	ACS Med Chem Lett	10.1021/acsmedchemlett.5c00038	2025
Genetics	Secondary bacterial infections of Carbapenem-Resistant Acinetobacter baumannii in patients with COVID-19 admitted to Chinese ICUs.	Chen F, Lin J, Yang W, Chen J, Qian X, Yan T, Liu X, Lu Y, Chen Q.	BMC Microbiol	10.1186/s12866-025-04032-1	2025
	Enhancing Antibiotic Efficacy with Natural Compounds: Synergistic Activity of Tannic Acid and Nerol with Commercial Antibiotics against Pathogenic Bacteria.	Lorca G, Ballestero D, Langa E, Pino-Otin MR.	Plants (Basel)	10.3390/plants13192717	2024
	AbOmpA in Acinetobacter baumannii: exploring virulence mechanisms of outer membrane-integrated and outer membrane vesicle-associated AbOmpA and developing anti-infective agents targeting AbOmpA.	Oh MH, Islam MM, Kim N, Choi CH, Shin M, Shin WS, Lee JC.	J Biomed Sci	10.1186/s12929-025-01147-5	2025
	Broad-Spectrum Gramicidin S Derivatives with Potent Activity Against Multidrug-Resistant Gram-Negative ESKAPE Pathogens.	Kalyvas JT, Wang Y, Romeo O, Horsley JR, Abell AD.	Antibiotics (Basel)	10.3390/antibiotics14050423	2025
	Colistin Resistance Mechanism and Management Strategies of Colistin-Resistant Acinetobacter baumannii Infections.	Islam MM, Jung DE, Shin WS, Oh MH.	Pathogens	10.3390/pathogens13121049	2024
Enzymology	Phenotypic Characterization of pilA, pilB, and pilD Mutants of Acinetobacter baumannii 5075: Impacts on Growth, Biofilm Formation, and Tazobactam Response	Salinas J, Gordesli-Duatepe F, Diaz-Sanchez A, Abu-Lail N.	Antibiotics (Basel)		2025
	Investigating the Effectiveness of Ceragenins against Acinetobacter baumannii to Develop New Antimicrobial and Anti-Adhesive Strategies.	Karasinski M, Wnorowska U, Daniluk T, Deptula P, Luckiewicz M, Paprocka P, Durnas B, Sklodowski K, Sawczuk B, Savage PB, Piktel E, Bucki R.	Int J Mol Sci	10.3390/ijms25137036	2024
	Retrospective Analysis of Antimicrobial Resistance Trends in Pseudomonas aeruginosa and Acinetobacter baumannii.	Ravella Venkatasubramanyam N, Easwaran S, Prabhakaran N.	Cureus	10.7759/cureus.69166	2024
	Characterization of Increased Extracellular Vesicle-Mediated Tigecycline Resistance in Acinetobacter baumannii.	Cho H, Sondak T, Kim KS.	Pharmaceutics	10.3390/pharmaceutics15041251	2023
Phylogeny	Phenotypical and Molecular Characterization of Acinetobacter baumannii Isolated from Hospitalized Patients During the COVID-19 Pandemic in Brazil.	de Souza PA, Santos MCND, Miranda RVDSL, da Costa LV, da Silva RPP, Miranda CAC, Conceicao GMSD, Forsythe SJ, Villas Boas MHS, Brandao MLL.	Life (Basel)	10.3390/life15040623	2025
	Ciprofloxacin- and levofloxacin-loaded nanoparticles efficiently suppressed fluoroquinolone resistance and biofilm formation in Acinetobacter baumannii.	Aboelenin AM, El-Mowafy M, Saleh NM, Shaaban MI, Barwa R.	Sci Rep	10.1038/s41598-024-53441-1	2024
	Antimicrobial activity and synergistic effect of phage-encoded antimicrobial peptides with colistin and outer membrane permeabilizing agents against Acinetobacter baumannii.	Rothong P, Leungtongkam U, Khongfak S, Homkaew C, Samathi S, Tandhavanant S, Ngoenkam J, Vitta A, Thanwisai A, Sitthisak S.	PeerJ	10.7717/peerj.18722	2024
	NRX-101 (D-Cycloserine + Lurasidone) Is Active against Drug-Resistant Urinary Pathogens In Vitro.	Sapko MT, Manyak M, Panicucci R, Javitt JC.	Antibiotics (Basel)	10.3390/antibiotics13040308	2024
	Contribution of Iron-Transport Systems and beta-Lactamases to Cefiderocol Resistance in Clinical Isolates of Acinetobacter baumannii Endemic to New York City.	Asrat H, Samaroo-Campbell J, Ata S, Quale J.	Antimicrob Agents Chemother	10.1128/aac.00234-23	2023
	Selection and validation of reference genes suitable for gene expression analysis by Reverse Transcription Quantitative real-time PCR in Acinetobacter baumannii.	de Oliveira PAA, Baboghlian J, Ramos COA, Mancano ASF, Porcari AM, Girardello R, Ferraz LFC.	Sci Rep	10.1038/s41598-024-51499-5	2024
	Contribution of RND-Type Efflux Pumps in Reduced Susceptibility to Biocides in Acinetobacter baumannii.	Meyer C, Lucaben K, Gerson S, Xanthopoulou K, Wille T, Seifert H, Higgins PG.	Antibiotics (Basel)	10.3390/antibiotics11111635	2022
Enzymology	Modular, inducible, and titratable expression systems for Escherichia coli and Acinetobacter baumannii.	Bacon EE, Tran JS, Nadig N, Peters JM.	Microbiol Spectr	10.1128/spectrum.01306-24	2024
	The aryl hydrocarbon receptor and FOS mediate cytotoxicity induced by Acinetobacter baumannii.	Kew C, Prieto-Garcia C, Bhattacharya A, Tietgen M, MacNair CR, Carfrae LA, Mello-Vieira J, Klatt S, Cheng YL, Rathore R, Gradhand E, Fleming I, Tan MW, Gottig S, Kempf VAJ, Dikic I.	Nat Commun	10.1038/s41467-024-52118-7	2024
Enzymology	Neutropenic Rat Thigh Infection Model for Evaluation of the Pharmacokinetics/Pharmacodynamics of Anti-Infectives.	Yedle R, Reniguntla MK, Puttaswamy R, Puttarangappa P, Hiremath S, Nanjundappa M, Jayaraman R.	Microbiol Spectr	10.1128/spectrum.00133-23	2023
	Preclinical evaluation of a novel antibiotic-eluting BioEnvelope for CIED infection prevention.	Garrigos ZE, Catanzaro JN, Deegan D, Zhang J, Sohail MR.	Front Drug Deliv	10.3389/fddev.2024.1441956	2024
	Characterization of the antagonistic secondary metabolites of Paenibacillus polymyxa MEZ6 against Staphylococcus aureus.	Zhao N, Huang M, Yang Y, Cai R, Peng J, Guo G.	Front Microbiol	10.3389/fmicb.2025.1617807	2025
	Isolation and Characterization of Novel Bacteriophages to Target Carbapenem-Resistant Acinetobacter baumannii.	Choi YJ, Kim S, Shin M, Kim J.	Antibiotics (Basel)	10.3390/antibiotics13070610	2024
	The response to desiccation in Acinetobacter baumannii.	Lucidi M, Capecchi G, Spagnoli C, Basile A, Artuso I, Persichetti L, Fardelli E, Capellini G, Visaggio D, Imperi F, Rampioni G, Leoni L, Visca P.	Virulence	10.1080/21505594.2025.2490209	2025
Genetics	Characterizing arginine, ornithine, and putrescine pathways in enteric pathobionts.	Lillie IM, Booth CE, Horvath AE, Mondragon M, Engevik MA, Horvath TD.	Microbiologyopen	10.1002/mbo3.1408	2024
	Comparative study of phenotypic and genotypic expression of virulence factors in colonizing and pathogenic carbapenem resistant Acinetobacter baumannii (CRAB).	Sharma S, Singh K, Chaurasiya A, Banerjee T, Singh R, Yadav G, Kumar A.	BMC Microbiol	10.1186/s12866-024-03727-1	2025
	Evaluating the in vitro activity of cefoperazone-sulbactam against Gram negative pathogens in blood stream infections using automated systems.	Qadri U, Zaffar S, Wani SJ, Roohi S, Aman M, Bhat S, Majid U.	Iran J Microbiol	10.18502/ijm.v16i6.17245	2024
	Secapin: a promising antimicrobial peptide against multidrug-resistant Acinetobacter baumannii.	Sadeghi Rad Z, Farahmand M, Kavousi M.	GMS Hyg Infect Control	10.3205/dgkh000491	2024
	Phenotypic and Genomic Characterization of Nine String-Positive Carbapenem-Resistant Acinetobacter baumannii Isolates from Israel.	Rakovitsky N, Lurie-Weinberger MN, Hameir A, Wulffhart L, Keren Paz A, Schwartz D, Carmeli Y.	Microbiol Spectr	10.1128/spectrum.03002-22	2023
	Inside-out, antimicrobial resistance mediated by efflux pumps in clinical strains of Acinetobacter baumannii isolated from burn wound infections.	Hernandez-Duran M, Colin-Castro CA, Fernandez-Rodriguez D, Delgado G, Morales-Espinosa R, Martinez-Zavaleta MG, Shekhar C, Ortiz-Alvarez J, Garcia-Contreras R, Franco-Cendejas R, Lopez-Jacome LE.	Braz J Microbiol	10.1007/s42770-024-01461-4	2024
	Carbon Dots as Multifunctional Nanomaterials: A Review on Antimicrobial Activities and Fluorescence-Based Microbial Detection.	Romulo A, Suryoprabowo S, Setiarto RHB, Guo Y.	Molecules	10.3390/molecules30193969	2025
	Evaluating Anti-ESKAPE Potential of Valeriana Officinalis L. Extract against Healthcare-Associated Infections in Tertiary Hospitals of Al-Kharj Governorate: An In Vitro Study.	Khan MS, Bari MN.	J Pharm Bioallied Sci	10.4103/jpbs.jpbs_1253_24	2024
	Aromatic hydrazides: A potential solution for Acinetobacter baumannii infections.	Green KD, Thamban Chandrika N, Vu LY, Pang AH, Tsodikov OV, Garneau-Tsodikova S.	Eur J Med Chem	10.1016/j.ejmech.2023.115165	2023
	The effects of the combined use of carbon quantum dots and antibacterial agents on pathogenic bacteria.	Doganay D, Avsar IS, Ozcan Aykol SM, Camlik G, Bilakaya B, Degim IT.	Turk J Biol	10.55730/1300-0152.2774	2025
	In vitro, genomic characterization and pre-clinical evaluation of a new thermostable lytic Obolenskvirus phage formulated as a hydrogel against carbapenem-resistant Acinetobacter baumannii.	Sherif MM, Abdelaziz NA, Alshahrani MY, Saleh SE, Aboshanab KM.	Sci Rep	10.1038/s41598-025-99788-x	2025
Phenotype	Phenotypic Characterization and Heterogeneity among Modern Clinical Isolates of Acinetobacter baumannii.	Valcek A, Philippe C, Whiteway C, Robino E, Nesporova K, Bove M, Coenye T, De Pooter T, De Coster W, Strazisar M, Van der Henst C.	Microbiol Spectr	10.1128/spectrum.03061-22	2023
	The Development of a CRISPR-FnCpf1 System for Large-Fragment Deletion and Multiplex Gene Editing in Acinetobacter baumannii.	Wang S, Ding Y, Rong H, Wang Y.	Curr Issues Mol Biol	10.3390/cimb46010037	2024
	Humoral response induced after intranasal vaccination with heat inactivated Acinetobacter baumannii protects immunodeficient mice against hypervirulent LAC-4 strain.	Rouma T, Barbieux E, Bossi L, Poncin K, Denanglaire S, Tafesse Y, Vermijlen D, Delbauve S, Flamand V, Van Buylaere J, Van der Henst C, De Bolle X, Andris F, Muraille E.	Front Immunol	10.3389/fimmu.2025.1641997	2025
	Vitamin D and vitamin K1 as novel inhibitors of biofilm in Gram-negative bacteria.	Lutfi LL, Shaaban MI, Elshaer SL.	BMC Microbiol	10.1186/s12866-024-03293-6	2024
Enzymology	Discovery of GuaB inhibitors with efficacy against Acinetobacter baumannii infection.	Kofoed EM, Aliagas I, Crawford T, Mao J, Harris SF, Xu M, Wang S, Wu P, Ma F, Clark K, Sims J, Xu Y, Peng Y, Skippington E, Yang Y, Reeder J, Ubhayakar S, Baumgardner M, Yan Z, Chen J, Park S, Zhang H, Yen C-W, Lorenzo M, Skelton N, Liang X, Chen L, Hoag B, Li CS, Liu Z, Wai J, Liu X, Liang J, Tan MW.	mBio	10.1128/mbio.00897-24	2024
	Paving the way for new antimicrobial peptides through molecular de-extinction.	Osiro KO, Gil-Ley A, Fernandes FC, de Oliveira KBS, de la Fuente-Nunez C, Franco OL.	Microb Cell	10.15698/mic2025.02.841	2025
Genetics	Genomic characterization and pre-clinical evaluation of a new polyvalent lytic Loughborough phage.	Sherif MM, Abdelaziz NA, Saleh SE, Aboshanab KM.	Appl Microbiol Biotechnol	10.1007/s00253-025-13559-2	2025
	Boron Compound-Based Treatments Against Multidrug-Resistant Bacterial Infections in Lung Cancer In Vitro Model.	Celebi D, Celebi O, Aydin E, Baser S, Guler MC, Yildirim S, Taghizadehghalehjoughi A.	Biol Trace Elem Res	10.1007/s12011-023-03912-9	2024
	Implications of deduplication on the detection rates of multidrug-resistant organism (MDRO) in various specimens: insights from the hospital infection surveillance program.	Li Z, Zhu D, Ma X, Zang F, Zhang W, Luo C, Zhu C, Chen W, Zhu P.	Antimicrob Resist Infect Control	10.1186/s13756-024-01408-2	2024
	Enhancing effect of natural adjuvant, panduratin A, on antibacterial activity of colistin against multidrug-resistant Acinetobacter baumannii.	Thadtapong N, Chaturongakul S, Napaswad C, Dubbs P, Soodvilai S.	Sci Rep	10.1038/s41598-024-60627-0	2024
	Preferential Selection of Low-Frequency, Lipopolysaccharide-Modified, Colistin-Resistant Mutants with a Combination of Antimicrobials in Acinetobacter baumannii.	Kamoshida G, Yamada N, Nakamura T, Yamaguchi D, Kai D, Yamashita M, Hayashi C, Kanda N, Sakaguchi M, Morimoto H, Sawada T, Okada T, Kaya Y, Takemoto N, Yahiro K.	Microbiol Spectr	10.1128/spectrum.01928-22	2022
	Computer-Based Identification of Potential Druggable Targets in Multidrug-Resistant Acinetobacter baumannii: A Combined In Silico, In Vitro and In Vivo Study.	Badie OH, Basyony AF, Samir R.	Microorganisms	10.3390/microorganisms10101973	2022
	K⁺ homeostasis is important for survival of Acinetobacter baumannii ATCC 19606 in the nosocomial environment.	Konig P, Averhoff B, Muller V.	Int Microbiol	10.1007/s10123-023-00389-3	2024
Phenotype	A panel of genotypically and phenotypically diverse clinical Acinetobacter baumannii strains for novel antibiotic development.	Sun C, Zhou D, He J, Liu H, Fu Y, Zhou Z, Leptihn S, Yu Y, Hua X, Xu Q.	Microbiol Spectr	10.1128/spectrum.00086-24	2024
	Anti-Acinetobacter baumannii single-chain variable fragments show direct bactericidal activity.	Basardeh E, Piri-Gavgani S, Soltanmohammadi B, Ghanei M, Omrani MD, Soezi M, Shokrgozar MA, Azizi M, Fateh A, Vaziri F, Siadat SD, Sharifzadeh Z, Rahimi-Jamnani F.	Iran J Basic Med Sci	10.22038/ijbms.2022.64062.14106	2022
	Acinetobacter baumannii Global Clone-Specific Resistomes Explored in Clinical Isolates Recovered from Egypt.	Hamed SM, Elkhatib WF, Brangsch H, Gesraha AS, Moustafa S, Khater DF, Pletz MW, Sprague LD, Neubauer H, Wareth G.	Antibiotics (Basel)	10.3390/antibiotics12071149	2023
	Synergistic action between peptide-neomycin conjugates and polymyxin B against multidrug-resistant gram-negative pathogens.	Story S, Jiang L, Leutou AS, Arya DP.	Front Microbiol	10.3389/fmicb.2025.1605813	2025
	Prevalence and antibiotic resistance patterns of Pseudomonas aeruginosa and Acinetobacter baumannii strains isolated from chicken droppings on poultry farms in Gondar city, Northwest Ethiopia.	Tigabie M, Assefa M, Gashaw Y, Amare A, Ambachew A, Biset S, Moges F.	Sci One Health	10.1016/j.soh.2024.100099	2025
	Phytochemical Composition and Antimicrobial Efficacy of Salvadora persica Root Extracts Against Carbapenem-Resistant Acinetobacter baumannii.	Wan Alias WAS, Ismail N, Hasan HB, Nik Abdul Ghani NR, Abdulrazak MH, Hassan SA.	Cureus	10.7759/cureus.58660	2024
	Rifampicin Enhanced Carbapenem Activity with Improved Antibacterial Effects and Eradicates Established Acinetobacter baumannii Biofilms.	Nwabor LC, Chukamnerd A, Nwabor OF, Pomwised R, Voravuthikunchai SP, Chusri S.	Pharmaceuticals (Basel)	10.3390/ph16040477	2023
	Human neutrophil alpha-defensin HNP1 interacts with bacterial OmpA to promote Acinetobacter baumannii biofilm formation.	Liao C, Liu Q, Luo G, Luo Y, Yao D, Wang Q, Zhang J, Wu Y, Jin J, Xu D, Lu W.	Nat Commun	10.1038/s41467-025-60935-7	2025
Enzymology	The evolutionary replacement of restriction-modification by Ssp antiviral systems is associated with the distribution of prophages in the major clonal group of Acinetobacter baumannii.	Moreno-Rodriguez A, Rubio A, Garzon A, Smani Y, Perez-Pulido AJ.	mBio	10.1128/mbio.02135-25	2025
	Could the Adoptive Transfer of Memory Lymphocytes be an Alternative Treatment for Acinetobacter baumannii Infections?	Cebrero-Cangueiro T, Herrera-Espejo S, Paniagua M, Labrador-Herrera G, Cisneros JM, Pachon J, Pachon-Ibanez ME.	Int J Mol Sci	10.3390/ijms251910550	2024
	The RND Efflux Pump Gene Expression in the Biofilm Formation of Acinetobacter baumannii.	Abd El-Rahman OA, Rasslan F, Hassan SS, Ashour HM, Wasfi R.	Antibiotics (Basel)	10.3390/antibiotics12020419	2023
	Overexpression of a DNA Methyltransferase Increases Persister Cell Formation in Acinetobacter baumannii.	Kim H, Kim JH, Cho H, Ko KS.	Microbiol Spectr	10.1128/spectrum.02655-22	2022
	The antimicrobial and antibiofilm effects of gentamicin, imipenem, and fucoidan combinations against dual-species biofilms of Staphylococcus aureus and Acinetobacter baumannii isolated from diabetic foot ulcers.	Nazari M, Taheri M, Nouri F, Bahmanzadeh M, Alikhani MY.	Ann Clin Microbiol Antimicrob	10.1186/s12941-024-00760-w	2024
	Designing New Chimeric Proline-Rich Antimicrobial Peptides to Enhance Efficacy Toward the ESKAPE+E: Beyond Sequence Extension.	Di Stasi A, de Pascale L, Morici M, Wilson DN, Scocchi M, Mardirossian M.	Biomolecules	10.3390/biom15060776	2025
	Development of a Multiplex PCR Assay for the Detection of Extended-Spectrum Beta-Lactamase Genes in Acinetobacter Baumannii Isolates in Tehran City, Iran.	Mottaghiyan Z, Esmaeili D, Ahmadi MH, Niakan.	Indian J Microbiol	10.1007/s12088-023-01118-0	2024
	Characterization of antibiotic and disinfectant susceptibility in biofilm-forming Acinetobacter baumannii: A focus on environmental isolates.	Pallos P, Gajdacs M, Urban E, Szabados Y, Szalai K, Hevesi L, Horvath A, Kuklis A, Morjaria D, Iffat W, Hetta HF, Piredda N, Donadu MG.	Eur J Microbiol Immunol (Bp)	10.1556/1886.2024.00014	2024
	A multiplex RPA coupled with CRISPR-Cas12a system for rapid and cost-effective identification of carbapenem-resistant Acinetobacter baumannii.	Zhou Z, Liang L, Liao C, Pan L, Wang C, Ma J, Yi X, Tan M, Li X, Wei G.	Front Microbiol	10.3389/fmicb.2024.1359976	2024
	The Direction of the Antibacterial Effect of Rutin Hydrate and Amikacin.	Miklasinska-Majdanik M, Kepa M, Wasik TJ, Zapletal-Pudelko K, Klim M, Wojtyczka RD.	Antibiotics (Basel)	10.3390/antibiotics12091469	2023
	Designing of a novel chimeric antimicrobial peptide against Acinetobacter baumannii using three different bioinformatics methods and evaluation of its antimicrobial activity in vitro.	Rakhshani Y, Amani J, Hosseini HM, Mirhosseini SA, Nematalahi FSN.	Res Pharm Sci	10.4103/rps.rps_70_23	2025
	Alteration in the Morphological and Transcriptomic Profiles of Acinetobacter baumannii after Exposure to Colistin.	Yoon EJ, Mo JW, Kim JW, Jeong MC, Yoo JS.	Microorganisms	10.3390/microorganisms12081644	2024
	A novel function of short cationic peptide FP-CATH9 without antimicrobial activity reverses resistance to minocycline in common multidrug-resistant gram-negative bacteria.	Tang Y, Liu J, Yan J, Xie Z, Zhong L.	Microbiol Spectr	10.1128/spectrum.02908-24	2025
Pathogenicity	Antimicrobial spectrum against wound pathogens and cytotoxicity of star-arranged poly-l-lysine-based antimicrobial peptide polymers.	Doherty A, Murphy R, Heise A, Fitzpatrick F, Fitzgerald-Hughes D.	J Med Microbiol	10.1099/jmm.0.001886	2024
	Exploring the metabolic profile of A. baumannii for antimicrobial development using genome-scale modeling.	Leonidou N, Xia Y, Friedrich L, Schutz MS, Drager A.	PLoS Pathog	10.1371/journal.ppat.1012528	2024
	Comprehensive study of Algerian nettles: Phenolic content and multifunctional activities of Urtica pilulifera and Urtica urens.	Bouhenni H, Doukani K, Danilovic B, Zvezdanovic J, Cvetkovic D, Islam F, Sweilam SH, Othman GA, Emran TB.	Animal Model Exp Med	10.1002/ame2.70084	2025
	The alpha-Helical Amphipathic Peptide Alleviates Colistin-Induced Nephrotoxicity by Maintaining Mitochondrial Function in Both In Vitro and In Vivo Infection Models.	Kook MS, Kim H, Choi Y, Bae SM, Yu J, Kim YS.	Antibiotics (Basel)	10.3390/antibiotics14050445	2025
	Coumarin-Dithiocarbamate Derivatives as Biological Agents.	Wilinski P, Kurzatkowski A, Ostrowska K.	Int J Mol Sci	10.3390/ijms26199667	2025
	Synergistic Activity of Colistin in Combination with Clofoctol against Colistin Resistant Gram-Negative Pathogens.	Collalto D, Fortuna A, Visca P, Imperi F, Rampioni G, Leoni L.	Microbiol Spectr	10.1128/spectrum.04275-22	2023
	Sub-minimum inhibitory concentrations (sub-MICs) of colistin on Acinetobacter baumannii biofilm formation potency, adherence, and invasion to epithelial host cells: an experimental study in an Iranian children's referral hospital.	Yousefi Nojookambari N, Eslami G, Sadredinamin M, Vaezjalali M, Nikmanesh B, Dehbanipour R, Yazdansetad S, Ghalavand Z.	Microbiol Spectr	10.1128/spectrum.02523-23	2024
	A Novel Truncated CHAP Modular Endolysin, CHAP^SAP26-161, That Lyses Staphylococcus aureus, Acinetobacter baumannii, and Clostridioides difficile, and Exhibits Therapeutic Effects in a Mouse Model of A. baumannii Infection.	Choi YJ, Kim S, Dahal RH, Kim J.	J Microbiol Biotechnol	10.4014/jmb.2402.02042	2024
	Outer membrane vesicles of Acinetobacter baumannii DS002 carry circular DNA similar to bovine meat and milk factors (BMMFs) and SPHINX 2.36 and probably play a role in interdomain lateral gene transfer.	Dhurve G, Behera SR, Kodetham G, Siddavattam D.	Microbiol Spectr	10.1128/spectrum.00817-24	2024
	Investigating the anti-growth, anti-resistance, and anti-virulence activities of Schoepfia schreberi J.F.Gmel. against the superbug Acinetobacter baumannii.	Uc-Cachon AH, Dzul-Beh A, Gonzalez-Cortazar M, Zamilpa-Alvarez A, Molina-Salinas GM.	Heliyon	10.1016/j.heliyon.2024.e31420	2024
	Rosemary Extract: Phytochemical Composition and Potential for Eliminating Polymicrobial Biofilm of Candida albicans and Multidrug-Resistant Bacteria.	Cintra TMF, Menezes RT, de Carvalho LS, de Miguel Nazario L, Hantao LW, Marcucci MC, Oliveira LD, Meccatti-Domiciano VM.	BioTech (Basel)	10.3390/biotech14030061	2025
	Mechanisms of action and resistance prevention of synergistic thymol and carvacrol combinations with antibiotics in Staphylococcus aureus and Acinetobacter baumannii	Gan C, Langa E, Wang G, Van Bambeke F, Ballestero D, Pino-Otin M.	Nat Prod Bioprospect		2025
	A Synthetic Phage-Peptide Conjugate as a Potent Antibacterial Agent for Pseudomonas aeruginosa Infections.	Yang Y, Vexler S, Jordan MC, Abbondante S, Kang D, Peng H, Marshall M, Naini BV, Jain S, Lai YC, Annabi N, Roos KP, Pearlman E, Chen IA.	ACS Cent Sci	10.1021/acscentsci.5c00562	2025
	Quaternary Phosphonium Compound Unveiled as a Potent Disinfectant against Highly Resistant Acinetobacter baumannii Clinical Isolates.	Michaud ME, Allen RA, Morrison-Lewis KR, Sanchez CA, Minbiole KPC, Post SJ, Wuest WM.	ACS Infect Dis	10.1021/acsinfecdis.2c00382	2022
	Evaluation of Cinnamon Essential Oil and Its Emulsion on Biofilm-Associated Components of Acinetobacter baumannii Clinical Strains.	Ganic T, Pecinar I, Nikolic B, Kekic D, Tomic N, Cvetkovic S, Vuletic S, Mitic-Culafic D.	Antibiotics (Basel)	10.3390/antibiotics14010106	2025
	OmpH is Involved in the Decrease of Acinetobacter baumannii Biofilm by the Antimicrobial Peptide Cec4.	Qiu Z, Ran J, Yang Y, Wang Y, Zeng Y, Jiang Y, Hu Z, Zeng Z, Peng J.	Drug Des Devel Ther	10.2147/dddt.s481225	2024
	Novel antimicrobial peptides and peptide-microbiome crosstalk in Appalachian salamander skin.	Muletz-Wolz CR, Urrutia-Carter J, Osborne O, Kutos S, Meneses Montano J, Madison JD, Gratwicke B, Racharaks R, Roncal NE, Jimenez RR, Ellison A, Cleland TP.	NPJ Biofilms Microbiomes	10.1038/s41522-025-00837-0	2025
	Treatment Strategies of Colistin Resistance Acinetobacter baumannii Infections.	Papazachariou A, Tziolos RN, Karakonstantis S, Ioannou P, Samonis G, Kofteridis DP.	Antibiotics (Basel)	10.3390/antibiotics13050423	2024
	A novel strategy to characterize the pattern of beta-lactam antibiotic-induced drug resistance in Acinetobacter baumannii.	Hillyer T, Benin BM, Sun C, Aguirre N, Willard B, Sham YY, Shin WS.	Sci Rep	10.1038/s41598-023-36475-9	2023
	Comparative genotypic characterization related to antibiotic resistance phenotypes of clinical carbapenem-resistant Acinetobacter baumannii MTC1106 (ST2) and MTC0619 (ST25).	Wiradiputra MRD, Thirapanmethee K, Khuntayaporn P, Wanapaisan P, Chomnawang MT.	BMC Genomics	10.1186/s12864-023-09734-2	2023
	Structural interactions of BWC0977 with Klebsiella pneumoniae topoisomerase IV and biochemical basis of its broad-spectrum activity.	Nandishaiah R, Murakami S, Hameed P S, Aoki M, Okada U, Yamashita E, Venkatesan S, Bharatham N, Sarma S, Shanbhag AP, Sharma S, Rao R, Ramachandran V, Balasubramanian V, Datta S, Katagihallimath N.	Commun Biol	10.1038/s42003-025-09055-y	2025
	Trends of Colistin MIC Among Acinetobacter Baumannii and Pseudomonas aeruginosa at a First-Class Hospital in Vietnam.	Nguyen THN, Nguyen HQ, Le NTT, Nguyen HTN, Dinh HC, Nguyen TN, Nguyen HM.	J Trop Med	10.1155/jotm/6165665	2025
	Clonality and the Phenotype-Genotype Correlation of Antimicrobial Resistance in Acinetobacter baumannii Isolates: A Multicenter Study of Clinical Isolates from Romania.	Pana AG, Schiopu P, Toc DA, Neculicioiu VS, Butiuc-Keul A, Farkas A, Dobrescu MS, Flonta M, Costache C, Szasz IE, Junie LM.	Microorganisms	10.3390/microorganisms13010176	2025
	Optimizing Bothropstoxin-I-Derived Peptides: Exploring the Antibacterial Potential of p-BthW.	Marinho Righetto G, Alves Santos-Filho N, Oliveira Catarin Nunes L, Andre C, Souza JM, Andricopulo AD, Martins Bispo PJ, Cilli EM, Camargo ILBDC.	ACS Omega	10.1021/acsomega.4c01303	2024
	In-vitro evaluation of different antimicrobial combinations with and without colistin against carbapenem-resistant Acinetobacter baumannii clinical isolates.	Muderris T, Dursun Manyasli G, Sezak N, Kaya S, Demirdal T, Gul Yurtsever S.	Eur J Med Res	10.1186/s40001-024-01885-6	2024
	Mucoid Acinetobacter baumannii enhances anti-phagocytosis through reducing C3b deposition.	Gong X, Zhao Q, Wu Y, Zhou H, Ding S, Zhu K.	Front Med (Lausanne)	10.3389/fmed.2022.879361	2022
	Antimicrobial triazinedione inhibitors of the translocase MraY-protein E interaction site: synergistic effects with bacitracin imply a new mechanism of action.	Fairbairn JA, Kerr RV, Pierre-White NA, Jacovides A, Baileeves BWA, Stansfeld PJ, Bringmann G, Merritt AT, Bugg TDH.	RSC Med Chem	10.1039/d4md00937a	2025
	What was old is new again: Phenotypic screening of a unique fungal library yields pyridoxatin, a promising lead against extensively resistant Acinetobacter baumannii (AB5075).	Winter HL, Flores-Bocanegra L, Cank KB, Crandall WJ, Rotich FC, Tillman MN, Todd DA, Graf TN, Raja HA, Pearce CJ, Oberlies NH, Cech NB.	Phytochem Lett	10.1016/j.phytol.2023.04.002	2023
	Differential activation of NLRP3 inflammasome by Acinetobacter baumannii strains.	Li FJ, Starrs L, Mathur A, Ishii H, Man SM, Burgio G.	PLoS One	10.1371/journal.pone.0277019	2022
	Resistance to Cefiderocol Involved Expression of PER-1 beta-Lactamase and Downregulation of Iron Transporter System in Carbapenem-Resistant Acinetobacter baumannii.	He Y, Wang Y, Ma X, Zhao L, Guan J, Zhao J, Yu W, Li Y, Ni W, Gao Z.	Infect Drug Resist	10.2147/idr.s392241	2022
	In vitro and in vivo synergistic effect of chrysin in combination with colistin against Acinetobacter baumannii.	Zhao Y, Liu Y, Feng L, Xu M, Wen H, Yao Z, Shi S, Wu Q, Zhou C, Cao J, Zhou T.	Front Microbiol	10.3389/fmicb.2022.961498	2022
	Influence of Lipopolysaccharide-Interacting Peptides Fusion with Endolysin LysECD7 and Fatty Acid Derivatization on the Efficacy against Acinetobacter baumannii Infection In Vitro and In Vivo.	Li X, Shangguan W, Yang X, Hu X, Li Y, Zhao W, Feng M, Feng J.	Viruses	10.3390/v16050760	2024
	Isolation of Halophilic and Halotolerant Bacterial Strains, Screening for Bioactive Compounds and Characterisation of Metabolites Produced by Pseudoalteromonas sp. ASV78.	Azpiazu-Muniozguren M, Valganon-Perez E, Garcia-Martinez M, Rodriguez-Paniagua A, Clark HP, Justicia C, Martin J, Moreno MC, Reyes F, Laorden L, Martinez-Malaxetxebarria I, Martinez-Ballesteros I.	Environ Microbiol Rep	10.1111/1758-2229.70159	2025
	Designing a Multiplex PCR for Rapid and Accurate Detection of Metallobetalactamases Resistant Genes from Acinetobacter baumaniiIsolates in Tehran City, Iran.	Mottaghiyan Z, Esmaeili D, Ahmadi MH, Niakan M.	Iran J Pathol	10.30699/ijp.2023.2007142.3144	2023
	Iron Acquisition Mechanisms and Their Role in the Virulence of Acinetobacter baumannii.	Cook-Libin S, Sykes EME, Kornelsen V, Kumar A.	Infect Immun	10.1128/iai.00223-22	2022
	Supercharged precision killers: Genetically engineered biomimetic drugs of screened metalloantibiotics against Acinetobacter baumanni.	Wei X, Xue B, Ruan S, Guo J, Huang Y, Geng X, Wang D, Zhou C, Zheng J, Yuan Z.	Sci Adv	10.1126/sciadv.adk6331	2024
	Aerosolized delivery of ESKAPE pathogens for murine pneumonia models.	Rox K, Medina E.	Sci Rep	10.1038/s41598-024-52958-9	2024
	Multidrug-Resistant ESKAPEEc Pathogens From Bloodstream Infections in South Africa: A Cross-Sectional Study Assessing Resistance to WHO AWaRe Antibiotics.	Hetsa BA, Asante J, Amoako DG, Abia ALK, Mbanga J, Essack SY.	Health Sci Rep	10.1002/hsr2.70897	2025
	Beyond antiparasitic activity: elucidating the antibacterial potency of pyrvinium pamoate.	Alcaraz-Martinez A, Munoz-Baez P, Penalver P, Morales JC, Cebrian R.	Microbiol Spectr	10.1128/spectrum.02158-25	2025
	Synthesis and Degradation of the Phytohormone Indole-3-Acetic Acid by the Versatile Bacterium Paraburkholderia xenovorans LB400 and Its Growth Promotion of Nicotiana tabacum Plant.	Vega-Celedon P, Castillo-Novales D, Bravo G, Cardenas F, Romero-Silva MJ, Seeger M.	Plants (Basel)	10.3390/plants13243533	2024
Genetics	Characteristics of a Carbapenem-Resistant Acinetobacter baumannii Strain Causing Community-Acquired Pneumonia in a Young Healthy Women.	Chen Y, Xu L, Wang J.	Infect Drug Resist	10.2147/idr.s439614	2023
	Lipoic Acid Based Redox-Responsive Degradable Antimicrobial Polymers.	Giri A, Aquib M, Choudhury A, Kannaujiya VK, Lim JL, Gu Z, Lenardon MD, Boyer C.	Macromol Rapid Commun	10.1002/marc.202500224	2025
	Antibacterial activity of vB_AbaM_PhT2 phage hydrophobic amino acid fusion endolysin, combined with colistin against Acinetobacter baumannii.	Sitthisak S, Manrueang S, Khongfak S, Leungtongkam U, Thummeepak R, Thanwisai A, Burton N, Dhanoa GK, Tsapras P, Sagona AP.	Sci Rep	10.1038/s41598-023-33822-8	2023
	Novel antibacterial peptide HfAMP against methicillin-resistant Staphylococcus aureus.	Lin F, Jin W, Yang L, Tian C, Zhang J, Jiao Z, Peng J, Guo G.	BMC Microbiol	10.1186/s12866-025-04343-3	2025
	Structure-Activity Relationship of the Diaminobutyric Acid Residues in Polymyxins.	Ma W, Jiang X, Mu K, Tian S, Yu HH, Wickremasinghe H, Velkov T, Roberts KD, Patil NA, Li J.	JACS Au	10.1021/jacsau.5c00587	2025
	Chemical Profile, Antibacterial, Antibiofilm, and Antiviral Activities of Pulicaria crispa Most Potent Fraction: An In Vitro and In Silico Study.	Abo-Elghiet F, Rushdi A, Ibrahim MH, Mahmoud SH, Rabeh MA, Alshehri SA, El Menofy NG.	Molecules	10.3390/molecules28104184	2023
	Hybrid antigens expressing surface loops of BauA from Acinetobacter baumannii are capable of inducing protection against infection.	Chaudhuri S, Rasooli I, Oskouei RH, Pishgahi M, Jahangir A, Andisi VF, Schryvers AB.	Front Immunol	10.3389/fimmu.2022.933445	2022
	Autofluorescence properties of wound-associated bacteria cultured under various temperature, salinity, and pH conditions.	Sun X, Wang Y, Du A, Dong M, Wang Y, Zhang Y, Zhang Y, Huang Y, Huang X, Liu Y, Ni J.	BMC Microbiol	10.1186/s12866-025-04200-3	2025
Genetics	Retained colistin susceptibility in clinical Acinetobacter baumannii isolates with multiple mutations in pmrCAB and lpxACD operons.	Zafer MM, Hussein AFA, Al-Agamy MH, Radwan HH, Hamed SM.	Front Cell Infect Microbiol	10.3389/fcimb.2023.1229473	2023
	Molecular Characterization of Resistance-Nodulation-cell Division Efflux Pump Genes in Multidrug-Resistant Acinetobacter baumannii.	Raza S, Gautam H, Mohapatra S, Sood S, Dhawan B, Chaudhry R, Kapil A, Das BK.	J Glob Infect Dis	10.4103/jgid.jgid_404_20	2021
	Sequence-Specific Electrochemical Genosensor for Rapid Detection of bla_OXA-51-like Gene in Acinetobacter baumannii.	Kanapathy S, Obande GA, Chuah C, Shueb RH, Yean CY, Banga Singh KK.	Microorganisms	10.3390/microorganisms10071413	2022
	Growth kinetics of multiple Acinetobacter baumannii resistotype after meropenem-based antibiotic combination exposure.	Rivani E, Endraswari PD, Widodo ADW.	F1000Res	10.12688/f1000research.122221.2	2022
	Chemical Profile and Bioactivities of Three Species of Mentha Growing in the Campania Region, Southern Italy.	Francolino R, Martino M, Nazzaro F, Sirignano C, Fratianni F, Coppola F, De Martino L, Formisano C, De Feo V.	Plants (Basel)	10.3390/plants14030360	2025
Phenotype	Increased Capsule Thickness and Hypermotility Are Traits of Carbapenem-Resistant Acinetobacter baumannii ST3 Strains Causing Fulminant Infection.	Rakovitsky N, Lellouche J, Ben David D, Frenk S, Elmalih P, Weber G, Kon H, Schwartz D, Wolfhart L, Temkin E, Carmeli Y.	Open Forum Infect Dis	10.1093/ofid/ofab386	2021
	Simple dual filter workflow for facilitating blood culture-free and sensitive detection of pathogenic bacteria from blood.	Park DJM, Wu T, Chen L, Lee PW, Hsieh K, Wang TH.	Sci Rep	10.1038/s41598-025-08987-z	2025
	Aromaticity Tuning in Biaryl Monophosphines and Their Derivatives.	Miroslaw B, Rejmak P, Dybala I, Kosikowska U, Andrzejczuk S, Swiatek L, Salwa K, Demchuk OM.	Molecules	10.3390/molecules30194018	2025
	Potential Medicinal Fungi from Freshwater Environments as Resources of Bioactive Compounds.	Cicero I, Mirabile G, Venturella G.	J Fungi (Basel)	10.3390/jof11010054	2025
	Cinnamon essential oil and its emulsion as efficient antibiofilm agents to combat Acinetobacter baumannii.	Ganic T, Vuletic S, Nikolic B, Stevanovic M, Kuzmanovic M, Kekic D, Durovic S, Cvetkovic S, Mitic-Culafic D.	Front Microbiol	10.3389/fmicb.2022.989667	2022
Genetics	Genotypic and phenotypic mechanisms underlying antimicrobial resistance and synergistic efficacy of rifampicin-based combinations against carbapenem-resistant Acinetobacter baumannii.	Nwabor LC, Chukamnerd A, Nwabor OF, Surachat K, Pomwised R, Jeenkeawpiam K, Chusri S.	Heliyon	10.1016/j.heliyon.2024.e27326	2024
	Antibacterial and Anti-Biofilm Efficacy of Endolysin LysAB1245 against a Panel of Important Pathogens.	Soontarach R, Srimanote P, Voravuthikunchai SP, Chusri S.	Pharmaceuticals (Basel)	10.3390/ph17020155	2024
	Cliotide U1, a Novel Antimicrobial Peptide Isolated From Urtica Dioica Leaves.	Taheri MN, Seyedjavadi SS, Goudarzi M, Ebrahimipour G, Hashemi A.	Bioinform Biol Insights	10.1177/11779322251315291	2025
	AI-guided discovery and optimization of antimicrobial peptides through species-aware language model.	Bae D, Kim M, Seo J, Nam H.	Brief Bioinform	10.1093/bib/bbaf343	2025
	Nanostructured Sr-Doped Hydroxyapatite: A Material with Antimicrobial Potential.	Mirkovic M, Sknepnek A, Kalijadis A, Krstic A, Suljagic M, Peric M, Andjelkovic L.	Nanomaterials (Basel)	10.3390/nano15211651	2025
	Arginine-Tryptophan Peptides Enhancing Antibacterial and Anticancer Effects of Ruthenium(II) Polypyridyl Complex Photosensitizers.	Ng XY, Fong KW, Kiew LV, Chung PY, Liew YK, Delsuc N, Lim WM, Zulkefeli M, Low ML.	ACS Omega	10.1021/acsomega.5c00997	2025
	Tigecycline Suppresses the Virulence Factors of Multidrug-Resistant Acinetobacter baumannii Allowing Human Neutrophils to Act.	Sato Y, Hatayama N, Ubagai T, Tansho-Nagakawa S, Ono Y, Yoshino Y.	Infect Drug Resist	10.2147/idr.s368890	2022
Genetics	Comparative genomics and molecular epidemiology of colistin-resistant Acinetobacter baumannii.	Kabic J, Novovic K, Kekic D, Trudic A, Opavski N, Dimkic I, Jovcic B, Gajic I.	Comput Struct Biotechnol J	10.1016/j.csbj.2022.12.045	2023
	Development of triaryl antimicrobials by scaffold hopping from an aminopropanol hit targeting bacterial RNA polymerase-NusG interactions.	Liu T, Kan CH, Zheng Y, Tsang TF, Liu Y, Tsang MW, Fang H, Lam LY, Yang X, Ma C.	J Enzyme Inhib Med Chem	10.1080/14756366.2025.2543923	2025
	Enzymatically-crosslinked gelatin hydrogels containing paenipeptin and clarithromycin against carbapenem-resistant pathogen in murine skin wound infection.	Moon SH, Kaufmann Y, Fujiwara R, Huang E.	BMC Microbiol	10.1186/s12866-021-02383-z	2021
	Development of Nanoparticle Adaptation Phenomena in Acinetobacter baumannii: Physiological Change and Defense Response.	McNeilly O, Mann R, Cummins ML, Djordjevic SP, Hamidian M, Gunawan C.	Microbiol Spectr	10.1128/spectrum.02857-22	2023
	Enhancement of Acinetobacter baumannii biofilm growth by cephem antibiotics via enrichment of protein and extracellular DNA in the biofilm matrices.	Yamabe K, Arakawa Y, Shoji M, Miyamoto K, Tsuchiya T, Minoura K, Akeda Y, Tomono K, Onda M.	J Appl Microbiol	10.1111/jam.15712	2022
	Association between Pneumonia Development and Virulence Gene Expression in Carbapenem-Resistant Acinetobacter baumannii Isolated from Clinical Specimens.	Bae JY, Yun I, Jun KI, Kim CJ, Lee M, Choi HJ.	Can J Infect Dis Med Microbiol	10.1155/2023/8265683	2023
	In vitro activity of human defensins HNP-1 and hBD-3 against multidrug-resistant ESKAPE Gram-negatives of clinical origin and selected peptidoglycan recycling-defective mutants.	Escobar-Salom M, Barcelo IM, Rojo-Molinero E, Jordana-Lluch E, Cabot G, Oliver A, Juan C.	Microbiol Spectr	10.1128/spectrum.00358-24	2024
	Prevalence and Clinical Consequences of Colistin Heteroresistance and Evolution into Full Resistance in Carbapenem-Resistant Acinetobacter baumannii.	Kon H, Hameir A, Nutman A, Temkin E, Keren Paz A, Lellouche J, Schwartz D, Weiss DS, Kaye KS, Daikos GL, Skiada A, Durante-Mangoni E, Dishon Benattar Y, Yahav D, Daitch V, Bernardo M, Iossa D, Friberg LE, Theuretzbacher U, Leibovici L, Dickstein Y, Pollak D, Mendelsohn S, Paul M, Carmeli Y.	Microbiol Spectr	10.1128/spectrum.05093-22	2023
	Genomic and phenotypic characterization of six multidrug-resistant Acinetobacter pittii isolates	Rakovitsky N, Lurie-Weinberger M, Keren-Paz A, Carmeli Y.	Sci Rep		2025
Metabolism	Role of EmaSR in Ethanol Metabolism by Acinetobacter baumannii.	Shu HY, Huang YW, Tsai PY, Hsieh KS, Lin GH.	Int J Mol Sci	10.3390/ijms232012606	2022
	Inhibitors of the Bacterioferritin Ferredoxin Complex Dysregulate Iron Homeostasis and Kill Acinetobacter baumannii and Biofilm-Embedded Pseudomonas aeruginosa Cells.	Behm AM, Yao H, Eze EC, Alli SA, Baugh SDP, Ametsetor E, Powell KM, Battaile KP, Seibold S, Lovell S, Bunce RA, Reitz AB, Rivera M.	ACS Infect Dis	10.1021/acsinfecdis.5c00209	2025
	Formulating co-loaded nanoliposomes with gallic acid and quercetin for enhanced cancer therapy.	Al-Samydai A, Al Qaraleh M, Al Azzam KM, Mayyas A, Nsairat H, Abu Hajleh MN, Al-Halaseh LK, Al-Karablieh N, Akour A, Alshaik F, Alshaer W.	Heliyon	10.1016/j.heliyon.2023.e17267	2023
	Seasonal and hospital settings variations in antimicrobial resistance among clinical isolates from cardiac patients: insights from a 7-Year study.	Asghar MU, Zaidi AH, Tariq M, Ain NU.	BMC Infect Dis	10.1186/s12879-025-11171-3	2025
Enzymology	Evaluation of an improved rapid bacterial assay with untreated and pathogen-reduced platelets: Detection of Acinetobacter strains.	LaVerda D, Shinefeld L, Best N, Lisitu J, Tambolleo G, Vallejo YR.	Transfusion	10.1111/trf.16514	2021
	Computational Design of Pore-Forming Peptides with Potent Antimicrobial and Anticancer Activities.	Deb R, Torres MDT, Boudny M, Koberska M, Cappiello F, Popper M, Dvorakova Bendova K, Drabinova M, Hanackova A, Jeannot K, Petrik M, Mangoni ML, Balikova Novotna G, Mraz M, de la Fuente-Nunez C, Vacha R.	J Med Chem	10.1021/acs.jmedchem.4c00912	2024
	Disinfection of methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus faecium and Acinetobacter baumannii using Klaran WD array system.	Mariita RM, Randive RV.	Access Microbiol	10.1099/acmi.0.000194	2021
	Antimicrobial combination effects against multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa strains: A cross-sectional study.	Kazemian H, Karami-Zarandi M, Heidari H, Ghanavati R, Khoshnood S.	Health Sci Rep	10.1002/hsr2.2061	2024
	Near-infrared in vivo imaging system for dynamic visualization of lung-colonizing bacteria in mouse pneumonia.	Yamaguchi D, Kamoshida G, Kawakubo S, Azuma S, Tsuji T, Kitada N, Saito-Moriya R, Yamada N, Tanaka R, Okuda A, Ueyama K, Isaka S, Tomita M, Nakano R, Morita Y, Yano H, Maki SA, Yahiro K, Kato S.	Microbiol Spectr	10.1128/spectrum.00828-24	2024
	Global emergence of a hypervirulent carbapenem-resistant Escherichia coli ST410 clone.	Ba X, Guo Y, Moran RA, Doughty EL, Liu B, Yao L, Li J, He N, Shen S, Li Y, van Schaik W, McNally A, Holmes MA, Zhuo C.	Nat Commun	10.1038/s41467-023-43854-3	2024
	Conventional Antimicrobial and Medicinal Plants from a Traditional Medicine Market in South Africa: An Interactive Antimicrobial and Toxicity Study.	Booth Z, Essack S, van Vuuren S.	Antibiotics (Basel)	10.3390/antibiotics14050512	2025
	Antimicrobial Photodynamic Therapy Mediated by Fotenticine and Methylene Blue on Planktonic Growth, Biofilms, and Burn Infections of Acinetobacter baumannii.	Figueiredo-Godoi LMA, Garcia MT, Pinto JG, Ferreira-Strixino J, Faustino EG, Pedroso LLC, Junqueira JC.	Antibiotics (Basel)	10.3390/antibiotics11050619	2022
	CsrA-Controlled Proteins Reveal New Dimensions of Acinetobacter baumannii Desiccation Tolerance.	Oda Y, Shapiro MM, Lewis NM, Zhong X, Huse HK, Zhong W, Bruce JE, Manoil C, Harwood CS.	J Bacteriol	10.1128/jb.00479-21	2022
	Prevalence of Carbapenemases in Carbapenem-Resistant Acinetobacter baumannii Isolates from the Kingdom of Bahrain.	Al-Rashed N, Bindayna KM, Shahid M, Saeed NK, Darwish A, Joji RM, Al-Mahmeed A.	Antibiotics (Basel)	10.3390/antibiotics12071198	2023
	Treatment of Clinically Important Bacteria With Cold Atmospheric Plasma.	Ding R, Song J, Huang X, Tan L, Rao X, Yang Y.	Microb Biotechnol	10.1111/1751-7915.70219	2025
	Quorum sensing regulators and non-ribosomal peptide synthetases govern antibacterial secretions in Xenorhabdus szentirmaii.	Dey R, Valle DO, Chakraborty A, Mayer KA, Uppala JK, Chakraborty A, Mirza S, Skwor T, Forst S, Dey M.	Front Microbiol	10.3389/fmicb.2025.1560663	2025
Genetics	Phage (cocktail)-antibiotic synergism: a new frontier in addressing Klebsiella pneumoniae resistance.	Karthika C, Malligarjunan N, Hari Prasath N, Karutha Pandian S, Gowrishankar S.	Front Microbiol	10.3389/fmicb.2025.1588472	2025
	Evaluation Report of the Colistin Broth Disk Elution Method with Acinetobacter baumannii Isolates from a Low-Resource Setting.	Sharma S, Banerjee T, Garg R, Das P.	Microbiol Spectr	10.1128/spectrum.00871-22	2022
	Isolation and Identification of Effective Probiotics on Drug-Resistant Acinetobacter baumannii Strains and Their Biofilms.	Abbasi Z, Ghasemi SM, Ahmadi Y, Shokri D.	Can J Infect Dis Med Microbiol	10.1155/2024/8570521	2024
	Essential Oil Compounds in Combination with Conventional Antibiotics for Dermatology.	Simbu S, Orchard A, Vuuren SV.	Molecules	10.3390/molecules29061225	2024
	Fatty Acid Profile and Some Useful Biological Aspects of Borage, Calophyllum, and Prickly Pear Seed Oils: Implications for Health and Dietary Use.	Fratianni F, Coppola F, Tavaniello S, Ombra MN, De Giulio B, D'Agostino N, Zengin G, Coppola R, Nazzaro F.	Antioxidants (Basel)	10.3390/antiox14060661	2025
	Non-antibiotic prevention and treatment against Acinetobacter baumannii infection: Are vaccines and adjuvants effective strategies?	Hu Y, Zhang X, Deng S, Yue C, Jia X, Lyu Y.	Front Microbiol	10.3389/fmicb.2023.1049917	2023
	Inhibition of LpxC Increases the Activity of Iron Chelators and Gallium Nitrate in Multidrug-Resistant Acinetobacter baumannii.	Vinuesa V, Cruces R, Nonnoi F, McConnell MJ.	Antibiotics (Basel)	10.3390/antibiotics10050609	2021
	Effectiveness Evaluation of a UV-C-Photoinactivator against Selected ESKAPE-E Pathogens.	Rangel K, Cabral FO, Lechuga GC, Villas-Boas MHS, Midlej V, De-Simone SG.	Int J Environ Res Public Health	10.3390/ijerph192416559	2022
	Genome sequences of 70 multidrug-resistant Gram-negative isolates in high-risk neonates in the Northeast of Mexico.	Rodriguez-Orduna L, Lara-Diaz VJ, Alcorta-Garcia MR, Lopez-Villasenor CN, Licona-Cassani C.	Microbiol Resour Announc	10.1128/mra.00274-24	2024
	Antimicrobial Peptide Cec4 Eradicates Multidrug-Resistant Acinetobacter baumannii in vitro and in vivo.	Peng J, Wang Y, Wu Z, Mao C, Li L, Cao H, Qiu Z, Guo G, Liang G, Shen F.	Drug Des Devel Ther	10.2147/dddt.s405579	2023
	Achieving pre-eminence of antimicrobial resistance among non-fermenting Gram-negative bacilli causing septicemia in intensive care units: A single center study of a tertiary care hospital.	Kumar H, Kaur N, Kumar N, Chauhan J, Bala R, Chauhan S.	Germs	10.18683/germs.2023.1374	2023
	Bioprospecting of culturable marine biofilm bacteria for novel antimicrobial peptides.	Fan S, Qin P, Lu J, Wang S, Zhang J, Wang Y, Cheng A, Cao Y, Ding W, Zhang W.	Imeta	10.1002/imt2.244	2024
	Association of biofilm formation, antimicrobial resistance, clinical characteristics, and clinical outcomes among Acinetobacter baumannii isolates from patients with ventilator-associated pneumonia.	Chukamnerd A, Saipetch N, Singkhamanan K, Ingviya N, Assanangkornchai N, Surachat K, Chusri S.	Clin Respir J	10.1111/crj.13732	2024
Genetics	Bacterial Community and Genomic Analysis of Carbapenem-Resistant Acinetobacter baumannii Isolates from the Environment of a Health Care Facility in the Western Region of Saudi Arabia.	Yasir M, Subahi AM, Shukri HA, Bibi F, Sohrab SS, Alawi M, Sindi AA, Jiman-Fatani AA, Azhar EI.	Pharmaceuticals (Basel)	10.3390/ph15050611	2022
Genetics	Metagenome-inspired libraries to engineer phage M13 for targeted killing of Gram-negative bacterial species.	Yang Y, Kang D, Mihalache B, Vexler S, Jain S, Peng H, Annabi N, Yang S, Chen IA.	Nucleic Acids Res	10.1093/nar/gkaf984	2025
	Antimicrobial, Quorum Sensing Inhibition, and Anti-Cancer Activities of Silver Nanoparticles Synthesized from Kenyan Bacterial Endophytes of Teclea nobilis.	Mohamed F, Chenia HY.	Int J Mol Sci	10.3390/ijms26073306	2025
	Genomic investigation unveils colistin resistance mechanism in carbapenem-resistant Acinetobacter baumannii clinical isolates.	Vijayakumar S, Swetha RG, Bakthavatchalam YD, Vasudevan K, Abirami Shankar B, Kirubananthan A, Walia K, Ramaiah S, Biswas I, Veeraraghavan B, Anbarasu A.	Microbiol Spectr	10.1128/spectrum.02511-23	2024
	Antibacterial Activity and Proposed Mode of Action of Extracts from Selected Zimbabwean Medicinal Plants against Acinetobacter baumannii.	Machingauta A, Mukanganyama S.	Adv Pharmacol Pharm Sci	10.1155/2024/8858665	2024
	Comprehensive Approaches to Combatting Acinetobacter baumannii Biofilms: From Biofilm Structure to Phage-Based Therapies.	Grygiel I, Bajrak O, Wojcicki M, Krusiec K, Jonczyk-Matysiak E, Gorski A, Majewska J, Letkiewicz S.	Antibiotics (Basel)	10.3390/antibiotics13111064	2024
Pathogenicity	Virulence Factors and Pathogenicity Mechanisms of Acinetobacter baumannii in Respiratory Infectious Diseases.	Yao Y, Chen Q, Zhou H.	Antibiotics (Basel)	10.3390/antibiotics12121749	2023
	Comparative Transcriptomic Profiling of Pellicle and Planktonic Cells from Carbapenem-Resistant Acinetobacter baumannii.	Ng HK, Puah SM, Teh CSJ, Idris N, Chua KH.	Antibiotics (Basel)	10.3390/antibiotics12071185	2023
	LysSYL: a broad-spectrum phage endolysin targeting Staphylococcus species and eradicating S. aureus biofilms.	Liu H, Wei X, Wang Z, Huang X, Li M, Hu Z, Zhang K, Hu Q, Peng H, Shang W, Yang Y, Wang Y, Lu S, Rao X.	Microb Cell Fact	10.1186/s12934-024-02359-4	2024
Pathogenicity	Carbapenem Resistance in Acinetobacter nosocomialis and Acinetobacter junii Conferred by Acquisition of bla_OXA-24/40 and Genetic Characterization of the Transmission Mechanism between Acinetobacter Genomic Species.	Lasarte-Monterrubio C, Guijarro-Sanchez P, Belles A, Vazquez-Ucha JC, Arca-Suarez J, Fernandez-Lozano C, Bou G, Beceiro A, Spanish National Study Acinetobacter spp. 2020 Group.	Microbiol Spectr	10.1128/spectrum.02734-21	2022
	Inhibition of Acinetobacter baumannii Biofilm Formation by Terpenes from Oregano (Lippia graveolens) Essential Oil.	Tapia-Rodriguez MR, Cantu-Soto EU, Vazquez-Armenta FJ, Bernal-Mercado AT, Ayala-Zavala JF.	Antibiotics (Basel)	10.3390/antibiotics12101539	2023
	Understanding the mechanisms of antimicrobial resistance and potential therapeutic approaches against the Gram-negative pathogen Acinetobacter baumannii.	Jamwal V, Palmo T, Singh K.	RSC Med Chem	10.1039/d4md00449c	2024
Biotechnology	A modular phage vector platform for targeted photodynamic therapy of Gram-negative bacterial pathogens.	Petrosino A, Saporetti R, Starinieri F, Sarti E, Ulfo L, Boselli L, Cantelli A, Morini A, Zadran SK, Zuccheri G, Pasquini Z, Di Giosia M, Prodi L, Pompa PP, Costantini PE, Calvaresi M, Danielli A.	iScience	10.1016/j.isci.2023.108032	2023
Genetics	Whole-Genome Analysis of Acinetobacter baumannii Strain AB43 Containing a Type I-Fb CRISPR-Cas System: Insights into the Relationship with Drug Resistance.	Guo T, Yang J, Sun X, Wang Y, Yang L, Kong G, Jiao H, Bao G, Li G.	Molecules	10.3390/molecules27175665	2022
	Rosaceae Honey: Antimicrobial Activity and Prebiotic Properties.	Coppola F, Coppola F, Abdalrazeq M, Fratianni F, Ombra MN, Testa B, Zengin G, Ayala Zavala JF, Nazzaro F.	Antibiotics (Basel)	10.3390/antibiotics14030298	2025
	First Detection of Acinetobacter baumannii in Pediculus humanus capitis from Latin America.	Larkin K, Toloza AC, Gabrie JA, Rodriguez CA, Rueda MM, Matamoros G, Palacio O, Jamani S, Fontecha G, Sanchez AL.	Trop Med Infect Dis	10.3390/tropicalmed8070345	2023
	Antimicrobial Performance of a Novel Drug-Eluting Bioenvelope.	Garrigos ZE, Kapur S, Williams ML, Sohail MR.	Antibiotics (Basel)	10.3390/antibiotics14040330	2025
	Antimicrobial Peptide with a Bent Helix Motif Identified in Parasitic Flatworm Mesocestoides corti.	Roncevic T, Gerdol M, Pacor S, Cvitanovic A, Begic A, Weber I, Krce L, Caporale A, Mardirossian M, Tossi A, Zoranic L.	Int J Mol Sci	10.3390/ijms252111690	2024
	A Chimeric Cationic Peptide Composed of Human beta-Defensin 3 and Human beta-Defensin 4 Exhibits Improved Antibacterial Activity and Salt Resistance.	Yu W, Ning N, Xue Y, Huang Y, Guo F, Li T, Yang B, Luo D, Sun Y, Li Z, Wang J, He Z, Cheng S, Zhang X, Wang H.	Front Microbiol	10.3389/fmicb.2021.663151	2021
	Identification of Novel tet(X3) Variants Resistant To Tigecycline in Acinetobacter Species.	Cheng Y, Li Y, Yu R, Ma M, Yang M, Si H.	Microbiol Spectr	10.1128/spectrum.01333-22	2022
	Facial amphiphilic naphthoic acid-derived antimicrobial polymers against multi-drug resistant gram-negative bacteria and biofilms.	Kurnaz LB, Barman S, Yang X, Fisher C, Outten FW, Nagarkatti P, Nagarkatti M, Tang C.	Biomaterials	10.1016/j.biomaterials.2023.122275	2023
	Overcoming addition of phosphoethanolamine to lipid A mediated colistin resistance in Acinetobacter baumannii clinical isolates with colistin-sulbactam combination therapy.	Srisakul S, Wannigama DL, Higgins PG, Hurst C, Abe S, Hongsing P, Saethang T, Luk-In S, Liao T, Kueakulpattana N, Shein AMS, Gan L, Kupwiwat R, Tanasatitchai C, Wapeesittipan P, Phattharapornjaroen P, Badavath VN, Leelahavanichkul A, Chatsuwan T.	Sci Rep	10.1038/s41598-022-15386-1	2022
	Comparison of loop-mediated isothermal amplification, multiplex PCR, and REP- PCR techniques for identification of carbapenem-resistant Acinetobacter baumannii clinical isolates.	Al Jebur AA, Soleimani N, Hosseini SM.	Iran J Microbiol	10.18502/ijm.v15i5.13871	2023
	Acinetobacter nosocomialis Causes as Severe Disease as Acinetobacter baumannii in Northeast Thailand: Underestimated Role of A. nosocomialis in Infection.	Nithichanon A, Kewcharoenwong C, Da-Oh H, Surajinda S, Khongmee A, Koosakunwat S, Wren BW, Stabler RA, Brown JS, Lertmemongkolchai G.	Microbiol Spectr	10.1128/spectrum.02836-22	2022
	The Protective Role of Interleukin 17A in Acinetobacter baumannii Pneumonia Is Associated with Candida albicans in the Airway.	Tang J, Li J, Pan J, Shen X, Ye X, Zhou J, Wang N, Xie L, Fuchs BB, Lionakis MS, Mylonakis E, Tan X.	Infect Immun	10.1128/iai.00378-22	2023
	L-Serine enables reducing the virulence of Acinetobacter baumannii and modulating the SIRT1 pathway to eliminate the pathogen.	Zhou J, Feng D, Li X, Chen Y, Zhang M, Wu W, Zhu J, Li H, Peng X, Zhang T.	Microbiol Spectr	10.1128/spectrum.03226-23	2024
	Enhanced activity of Ellagic acid in lipid nanoparticles (EA-liposomes) against Acinetobacter baumannii in immunosuppressed mice.	Allemailem KS.	Saudi J Biol Sci	10.1016/j.sjbs.2023.103707	2023
	Comparative analysis of machine learning algorithms on the microbial strain-specific AMP prediction.	Vishnepolsky B, Grigolava M, Managadze G, Gabrielian A, Rosenthal A, Hurt DE, Tartakovsky M, Pirtskhalava M.	Brief Bioinform	10.1093/bib/bbac233	2022
	Isolation and characterization of a VHH targeting the Acinetobacter baumannii cell surface protein CsuA/B.	Lei EK, Ryan S, van Faassen H, Foss M, Robotham A, Baltat I, Fulton K, Henry KA, Chen W, Hussack G.	Appl Microbiol Biotechnol	10.1007/s00253-023-12594-1	2023
	Glycodiversification of gentamicins through in vivo glycosyltransferase swapping enabled the creation of novel hybrid aminoglycoside antibiotics with potent activity and low ototoxicity.	Jian X, Wang C, Wu S, Sun G, Huang C, Qiu C, Liu Y, Leadlay PF, Liu D, Deng Z, Zhou F, Sun Y.	Acta Pharm Sin B	10.1016/j.apsb.2024.04.030	2024
	Gram-Negative Bacilli Blood Stream Infection in Patients with Severe Burns: Microbiological and Clinical Evidence from a 9-Year Cohort.	Fuentes-Gonzalez MF, Fernandez-Rodriguez D, Colin-Castro CA, Hernandez-Duran M, Lopez-Jacome LE, Franco-Cendejas R.	Int J Mol Sci	10.3390/ijms251910458	2024
	Retargeting Gram-Positive-Only Adarotene-Derived Antibacterials to Broad-Spectrum Antibiotics.	Princiotto S, Cutarella L, Fortuna A, Mellini M, Casciaro B, Loffredo MR, Temprano AG, Cappiello F, Leoni L, Mangoni ML, Mori M, Musso L, Sacchi F, Pinna C, Rampioni G, Dallavalle S, Pisano C.	Antibiotics (Basel)	10.3390/antibiotics14090956	2025
	Proline-Modified (RW)n Peptides: Enhancing the Antimicrobial Efficacy and Selectivity against Multidrug-Resistant Pathogens.	Sunda-Meya A, Phambu N.	ACS Omega	10.1021/acsomega.4c10757	2025
	Phylogenomic and phenotypic analyses highlight the diversity of antibiotic resistance and virulence in both human and non-human Acinetobacter baumannii.	Sykes EME, Mateo-Estrada V, Engelberg R, Muzaleva A, Zhanel G, Dettman J, Chapados J, Gerdis S, Akineden O, Khan IUH, Castillo-Ramirez S, Kumar A.	mSphere	10.1128/msphere.00741-23	2024
	The pH-Insensitive Antimicrobial and Antibiofilm Activities of the Frog Skin Derived Peptide Esc(1-21): Promising Features for Novel Anti-Infective Drugs.	Loffredo MR, Cappiello F, Cappella G, Capuozzo E, Torrini L, Diaco F, Di YP, Mangoni ML, Casciaro B.	Antibiotics (Basel)	10.3390/antibiotics13080701	2024
	Antibacterial potential and in silico analysis of inflorescence-derived essential oils from three Eucalyptus species.	Khedhri S, Polito F, Amri I, Nazzaro F, Fratianni F, De Feo V, Hamrouni L.	Sci Rep	10.1038/s41598-025-24957-x	2025
	Specific egg yolk antibody raised to biofilm associated protein (Bap) is protective against murine pneumonia caused by Acinetobacter baumannii.	Ranjbar A, Rasooli I, Jahangiri A, Ramezanalizadeh F.	Sci Rep	10.1038/s41598-022-16894-w	2022
	Extensive Drug Resistance of Strong Biofilm-Producing Acinetobacter baumannii Strains Isolated from Infections and Colonization Hospitalized Patients in Southern Poland.	Kasperski T, Romaniszyn D, Jachowicz-Matczak E, Pomorska-Wesolowska M, Wojkowska-Mach J, Chmielarczyk A.	Pathogens	10.3390/pathogens12080975	2023
	Antimicrobial activity of D-amino acid in combination with photo-sonoactivated hypericin nanoparticles against Acinetobacter baumannii.	Pourhajibagher M, Hosseini N, Bahador A.	BMC Microbiol	10.1186/s12866-023-02758-4	2023
	Effect of Phenylalanine-Arginine Beta-Naphthylamide on the Values of Minimum Inhibitory Concentration of Quinolones and Aminoglycosides in Clinical Isolates of Acinetobacter baumannii.	Plasencia-Rebata S, Levy-Blitchtein S, Del Valle-Mendoza J, Silva-Caso W, Pena-Tuesta I, Vicente Taboada W, Barreda Bolanos F, Aguilar-Luis MA.	Antibiotics (Basel)	10.3390/antibiotics12061071	2023
	Co-Occurrence of Two Plasmids Encoding Transferable bla_NDM-1 and tet(Y) Genes in Carbapenem-Resistant Acinetobacter bereziniae.	Opazo-Capurro A, Xanthopoulou K, Arazo Del Pino R, Gonzalez-Munoz P, Matus-Kohler M, Amsteins-Romero L, Jerez-Olate C, Hormazabal JC, Vera R, Aguilera F, Fuller S, Higgins PG, Gonzalez-Rocha G.	Genes (Basel)	10.3390/genes15091213	2024
	Acinetobacter baumannii outer membrane protein A induces autophagy in bone marrow-derived dendritic cells involving the PI3K/mTOR pathway.	Tan H, Cao L.	Immun Inflamm Dis	10.1002/iid3.830	2023
	Resveratrol Reverts Tolerance and Restores Susceptibility to Chlorhexidine and Benzalkonium in Gram-Negative Bacteria, Gram-Positive Bacteria and Yeasts.	Migliaccio A, Stabile M, Bagattini M, Triassi M, Berisio R, De Gregorio E, Zarrilli R.	Antibiotics (Basel)	10.3390/antibiotics11070961	2022
Pathogenicity	Therapeutic Effects of Inhibitor of ompA Expression against Carbapenem-Resistant Acinetobacter baumannii Strains.	Na SH, Jeon H, Oh MH, Kim YJ, Chu M, Lee IY, Lee JC.	Int J Mol Sci	10.3390/ijms222212257	2021
	Polymerase Chain Reaction-Lateral Flow Strip for Detecting Escherichia coli and Salmonella enterica Harboring blaCTX-M	Hatrongjit R, Chaisaeng S, Sitthichotthumrong K, Boueroy P, Chopjitt P, Ungcharoen R, Kerdsin A.	Antibiotics (Basel)		2025
	Modulation of NK Cell Properties by ESKAPE Group Bacteria.	Grebenkina P, Juchina V, Tyshchuk E, Gulina A, Denisova E, Korobova Z, Orlov S, Totolian A, Kraeva L, Sokolov D.	Int J Mol Sci	10.3390/ijms26178449	2025
Proteome	Structural characterization of the POTRA domains from A. baumannii reveals new conformations in BamA.	Cottom CO, Stephenson R, Ricci D, Yang L, Gumbart JC, Noinaj N.	Structure	10.1016/j.str.2024.08.013	2024
	Controlling drug-resistant bacteria in Arabian horses: bacteriophage cocktails for treating wound infections.	Khalid E, Tartor YH, Ammar AM, Abdelaziz R, Mahmmod Y, Abdelkhalek A.	Front Vet Sci	10.3389/fvets.2025.1609955	2025
	The intricacies of Acinetobacter baumannii: a multifaceted comprehensive review of a multidrug-resistant pathogen and its clinical significance and implications.	Yehya A, Ezzeddine Z, Chakkour M, Dhaini Z, Bou Saba MS, Bou Saba AS, Nohra L, Nassar NB, Yassine M, Bahmad HF, Ghssein G.	Front Microbiol	10.3389/fmicb.2025.1565965	2025
	Catheterization of mice triggers resurgent urinary tract infection seeded by a bladder reservoir of Acinetobacter baumannii.	Hazen JE, Di Venanzio G, Hultgren SJ, Feldman MF.	Sci Transl Med	10.1126/scitranslmed.abn8134	2023
Pathogenicity	Antibiofilm and antivirulence efficacy of myrtenol enhances the antibiotic susceptibility of Acinetobacter baumannii.	Selvaraj A, Valliammai A, Sivasankar C, Suba M, Sakthivel G, Pandian SK.	Sci Rep	10.1038/s41598-020-79128-x	2020
	Synergistic Action of Cinnamomum verum Essential Oil with Sertraline.	Barbarossa A, Sblano S, Rosato A, Carrieri A, Corbo F, Clodoveo ML, Fracchiolla G, Carocci A.	Antibiotics (Basel)	10.3390/antibiotics11111617	2022
	A Potential Combination Therapy of Berberine Hydrochloride With Antibiotics Against Multidrug-Resistant Acinetobacter baumannii.	Li X, Song Y, Wang L, Kang G, Wang P, Yin H, Huang H.	Front Cell Infect Microbiol	10.3389/fcimb.2021.660431	2021
Pathogenicity	Molecular mechanism of antimicrobial activity of chlorhexidine against carbapenem-resistant Acinetobacter baumannii.	Biswas D, Tiwari M, Tiwari V.	PLoS One	10.1371/journal.pone.0224107	2019
	Cannabinoids from inflorescences fractions of Trema orientalis (L.) Blume (Cannabaceae) against human pathogenic bacteria.	Napiroon T, Tanruean K, Poolprasert P, Bacher M, Balslev H, Poopath M, Santimaleeworagun W.	PeerJ	10.7717/peerj.11446	2021
	Synthesis and Biological Activity of Ultrashort Antimicrobial Peptides Bearing a Non-Coded Amino Acid.	Peggion C, Schivo A, Rotondo M, Oancea S, Popovici LF, Calin T, Mkrtchyan A, Saghyan A, Hayriyan L, Khachatryan E, Formaggio F, Biondi B.	J Pept Sci	10.1002/psc.70021	2025
	Lipopolysaccharide-Deficient Acinetobacter baumannii Due to Colistin Resistance Is Killed by Neutrophil-Produced Lysozyme.	Kamoshida G, Akaji T, Takemoto N, Suzuki Y, Sato Y, Kai D, Hibino T, Yamaguchi D, Kikuchi-Ueda T, Nishida S, Unno Y, Tansho-Nagakawa S, Ubagai T, Miyoshi-Akiyama T, Oda M, Ono Y.	Front Microbiol	10.3389/fmicb.2020.00573	2020
	Heterologous expression and optimization of the antimicrobial peptide acidocin 4356 in Komagataella phaffii to target Pseudomonas aeruginosa.	Akbari A, Talaee M, Mir-Derikvand M, Dad N, Modiri S, Saadati F, Noorbakhsh N, Zahiri HS, Vali H, Noghabi KA.	Appl Microbiol Biotechnol	10.1007/s00253-025-13584-1	2025
	Antimicrobial Potential of Cannabinoids: A Scoping Review of the Past 5 Years.	Coelho MJ, Araujo MD, Carvalho M, Cardoso IL, Manso MC, Pina C.	Microorganisms	10.3390/microorganisms13020325	2025
	Molecular hybridization strategy for tuning bioactive peptide function.	Pedron CN, Torres MT, Oliveira CS, Silva AF, Andrade GP, Wang Y, Pinhal MAS, Cerchiaro G, da Silva Junior PI, da Silva FD, Radhakrishnan R, de la Fuente-Nunez C, Oliveira Junior VX.	Commun Biol	10.1038/s42003-023-05254-7	2023
Phylogeny	Development of Loop-Mediated Isothermal Amplification Assay for Detection of Clinically Significant Members of Acinetobacter calcoaceticus-baumannii Complex and Associated Carbapenem Resistance.	Sharma A, Gaind R.	Front Mol Biosci	10.3389/fmolb.2021.659256	2021
	BacteSign: Building a Findable, Accessible, Interoperable, and Reusable (FAIR) Database for Universal Bacterial Identification.	Childs A, Chand D, Pereira J, Santra S, Rajaraman S.	Biosensors (Basel)	10.3390/bios14040176	2024
	Antimicrobial effect of methylene blue in microbiologic culture to diagnose periprosthetic joint infection: an in vitro study.	Liu K, Luo Y, Hao L, Chen J.	J Orthop Surg Res	10.1186/s13018-022-03475-w	2022
	Targeting of the Essential acpP, ftsZ, and rne Genes in Carbapenem-Resistant Acinetobacter baumannii by Antisense PNA Precision Antibacterials.	Nejad AJ, Shahrokhi N, Nielsen PE.	Biomedicines	10.3390/biomedicines9040429	2021
	C-Locked Analogs of the Antimicrobial Peptide BP214.	Andersen IKL, Thomsen TT, Rashid J, Bobak TR, Oddo A, Franzyk H, Lobner-Olesen A, Hansen PR.	Antibiotics (Basel)	10.3390/antibiotics11081080	2022
	The synergistic activity of SBC3 in combination with Ebselen against Escherichia coli infection.	Chen H, Lu Q, An H, Li J, Shen S, Zheng X, Chen W, Wang L, Li J, Du Y, Wang Y, Liu X, Baumann M, Tacke M, Zou L, Wang J.	Front Pharmacol	10.3389/fphar.2022.1080281	2022
Pathogenicity	Biofilm formation in Acinetobacter baumannii was inhibited by PAbetaN while it had no association with antibiotic resistance.	Chen L, Li H, Wen H, Zhao B, Niu Y, Mo Q, Wu Y.	Microbiologyopen	10.1002/mbo3.1063	2020
	An Update on the Therapeutic Potential of Antimicrobial Peptides against Acinetobacter baumannii Infections.	Rangel K, Lechuga GC, Provance DW, Morel CM, De Simone SG.	Pharmaceuticals (Basel)	10.3390/ph16091281	2023
	A hydrophilic polyimidazolium antibiotic targeting the membranes of Gram-negative bacteria.	Chen Y, Yong M, Li M, Si Z, Koh CH, Lau P, Chang YW, Teo J, Chan-Park MB, Gan YH.	J Antimicrob Chemother	10.1093/jac/dkad274	2023
	Molecular Characterization of Carbapenem-Resistant Acinetobacter baumannii Isolated from the Intensive Care Unit in a Tertiary Teaching Hospital in Malaysia.	Woon JJ, Teh CSJ, Chong CW, Abdul Jabar K, Ponnampalavanar S, Idris N.	Antibiotics (Basel)	10.3390/antibiotics10111340	2021
	New Life of an Old Drug: Caffeine as a Modulator of Antibacterial Activity of Commonly Used Antibiotics.	Woziwodzka A, Krychowiak-Masnicka M, Golunski G, Losiewska A, Borowik A, Wyrzykowski D, Piosik J.	Pharmaceuticals (Basel)	10.3390/ph15070872	2022
	Antimicrobial properties of a new polymeric material based on poly(2-hydroxyethyl methacrylate).	Chornopyshchuk R, Nagaichuk V, Gerashchenko I, Nazarchuk H, Kukolevska O, Chornopyshchuk N, Sidorenko S.	Acta Biomed	10.23750/abm.v93i1.12243	2022
Enzymology	Biochemical and structural elucidation of the L-carnitine degradation pathway of the human pathogen Acinetobacter baumannii.	Piskol F, Lukat P, Kaufhold L, Heger A, Blankenfeldt W, Jahn D, Moser J.	Front Microbiol	10.3389/fmicb.2024.1446595	2024
	Evaluation of a novel surface-coating formulation with time-extended antimicrobial activity for healthcare environment disinfection.	Marano RBM, Merezhko D, Resnick KA, Moran-Gilad J, Oster Y.	Antimicrob Resist Infect Control	10.1186/s13756-023-01341-w	2023
	Replicative Acinetobacter baumannii strains interfere with phagosomal maturation by modulating the vacuolar pH.	Distel JS, Di Venanzio G, Mackel JJ, Rosen DA, Feldman MF.	PLoS Pathog	10.1371/journal.ppat.1011173	2023
	Synergistic Antibiofilm Action of Cinnamomum verum and Brazilian Green Propolis Hydroethanolic Extracts against Multidrug-Resistant Strains of Acinetobacter baumannii and Pseudomonas aeruginosa and Their Biocompatibility on Human Keratinocytes.	Meccatti VM, Martins KMC, Ramos LP, Pereira TC, de Menezes RT, Marcucci MC, Abu Hasna A, de Oliveira LD.	Molecules	10.3390/molecules28196904	2023
Enzymology	The Pharmacokinetics/Pharmacodynamic Relationship of Durlobactam in Combination With Sulbactam in In Vitro and In Vivo Infection Model Systems Versus Acinetobacter baumannii-calcoaceticus Complex.	O'Donnell JP, Bhavnani SM.	Clin Infect Dis	10.1093/cid/ciad096	2023
	Antibacterial Potential of Extracts and Phytoconstituents Isolated from Syncarpia hillii Leaves In Vitro.	Perera MMN, Dighe SN, Katavic PL, Collet TA.	Plants (Basel)	10.3390/plants11030283	2022
	Development of two multiplex PCR assays for rapid detection of eleven Gram-negative bacteria in children with septicemia	Miringu G, Musyoki A, Muriithi B, Wandera E, Waithiru D, Odoyo E, Shoji H, Menza N, Ichinose Y.	Tropical Medicine and Health		2024
	Loss of a Branch Sugar in the Acinetobacter baumannii K3-Type Capsular Polysaccharide Due To Frameshifts in the gtr6 Glycosyltransferase Gene Leads To Susceptibility To Phage APK37.1.	Timoshina OY, Kasimova AA, Shneider MM, Arbatsky NP, Shashkov AS, Shelenkov AA, Mikhailova YV, Popova AV, Hall RM, Knirel YA, Kenyon JJ.	Microbiol Spectr	10.1128/spectrum.03631-22	2023
	Tigecycline Heteroresistance and Resistance Mechanism in Clinical Isolates of Acinetobacter baumannii.	Jo J, Ko KS.	Microbiol Spectr	10.1128/spectrum.01010-21	2021
	Insights into the Intersection of Biocide Resistance, Efflux Pumps, and Sequence Types in Carbapenem-Resistant Acinetobacter baumannii: A Multicenter Study.	Taj Z, Rasool MH, Khurshid M, Aslam B, Qamar MU.	Pathogens	10.3390/pathogens12070899	2023
	Polyphenol Profile and Biological Activity of the Extracts from Sideritis scardica Griseb. (Lamiaceae) Herb	Walasek-Janusz M, Wojtanowski K, Paplinski R, Grzegorczyk A, Nurzynska-Wierdak R.	Pharmaceuticals (Basel)		2025
	Evaluation of Antibacterial Activity of Thiourea Derivative TD4 against Methicillin-Resistant Staphylococcus aureus via Destroying the NAD+/NADH Homeostasis.	Hou Y, Zhu S, Chen Y, Yu M, Liu Y, Li M.	Molecules	10.3390/molecules28073219	2023
	Outer Membrane Protein, Oma87 Prevents Acinetobacter baumannii Infection.	Rasooli I, Abdolhamidi R, Jahangiri A, Darvish Alipour Astaneh S.	Int J Pept Res Ther	10.1007/s10989-020-10056-0	2020
Phenotype	Rapid identification of capsulated Acinetobacter baumannii using a density-dependent gradient test.	Kon H, Schwartz D, Temkin E, Carmeli Y, Lellouche J.	BMC Microbiol	10.1186/s12866-020-01971-9	2020
	Genomic Analysis of Carbapenem-Resistant Acinetobacter baumannii Isolates Belonging to Major Endemic Clones in South America.	Nodari CS, Cayo R, Streling AP, Lei F, Wille J, Almeida MS, de Paula AI, Pignatari ACC, Seifert H, Higgins PG, Gales AC.	Front Microbiol	10.3389/fmicb.2020.584603	2020
	Recent Advances in Phage-Based Therapeutics for Multi-Drug Resistant Acinetobacter baumannii.	Tan Y, Su J, Fu M, Zhang H, Zeng H.	Bioengineering (Basel)	10.3390/bioengineering10010035	2022
	Small molecule produced by Photorhabdus interferes with ubiquinone biosynthesis in Gram-negative bacteria.	Bargabos R, Iinishi A, Hawkins B, Privalsky T, Pitt N, Son S, Corsetti R, Gates MF, Miller RD, Lewis K.	mBio	10.1128/mbio.01167-24	2024
	Cefiderocol Resistance in Acinetobacter baumannii: Roles of beta-Lactamases, Siderophore Receptors, and Penicillin Binding Protein 3.	Malik S, Kaminski M, Landman D, Quale J.	Antimicrob Agents Chemother	10.1128/aac.01221-20	2020
	Adjuvant antimicrobial activity and resensitization efficacy of geraniol in combination with antibiotics on Acinetobacter baumannii clinical isolates.	Kim CM, Ko YJ, Lee SB, Jang SJ.	PLoS One	10.1371/journal.pone.0271516	2022
	Evaluation of the Synergistic Antibacterial Effects of Fosfomycin in Combination with Selected Antibiotics against Carbapenem-Resistant Acinetobacter baumannii.	Nwabor OF, Terbtothakun P, Voravuthikunchai SP, Chusri S.	Pharmaceuticals (Basel)	10.3390/ph14030185	2021
	Whole genome sequence of pan drug-resistant clinical isolate of Acinetobacter baumannii ST1890.	Wongsuk T, Boonsilp S, Homkaew A, Thananon K, Oonanant W.	PLoS One	10.1371/journal.pone.0264374	2022
	In Vitro Activity of Robenidine Analogues NCL259 and NCL265 against Gram-Negative Pathogens.	Pi H, Venter H, Russell CC, Young KA, McCluskey A, Page SW, Ogunniyi AD, Trott DJ.	Antibiotics (Basel)	10.3390/antibiotics11101301	2022
	Antibacterial and Antifungal Potential of Helichrysum italicum (Roth) G. Don Essential Oil.	Sovljanski O, Acimovic M, Tomic A, Loncar B, Miljkovic A, Cabarkapa I, Pezo L.	Antibiotics (Basel)	10.3390/antibiotics13080722	2024
	Characterization of Virulent T4-Like Acinetobacter baumannii Bacteriophages DLP1 and DLP2.	Peters DL, Davis CM, Harris G, Zhou H, Rather PN, Hrapovic S, Lam E, Dennis JJ, Chen W.	Viruses	10.3390/v15030739	2023
	Biosynthesized Silver Nanoparticles Using Morus alba (White Mulberry) Leaf Extract as Potential Antibacterial and Anticancer Agents.	Kumkoon T, Srisaisap M, Boonserm P.	Molecules	10.3390/molecules28031213	2023
	Light Modulates Important Pathogenic Determinants and Virulence in ESKAPE Pathogens Acinetobacter baumannii, Pseudomonas aeruginosa, and Staphylococcus aureus.	Tuttobene MR, Perez JF, Pavesi ES, Perez Mora B, Biancotti D, Cribb P, Altilio M, Muller GL, Gramajo H, Tamagno G, Ramirez MS, Diacovich L, Mussi MA.	J Bacteriol	10.1128/jb.00566-20	2021
Enzymology	Synthesis, Antimicrobial Activities, and Model of Action of Novel Tetralone Derivatives Containing Aminoguanidinium Moiety.	Zhang QJ, Li YX, Ge WB, Bai LX, Xu X, Yang YJ, Liu XW, Li JY.	Int J Mol Sci	10.3390/ijms26135980	2025
	The role of type VI secretion system genes in antibiotic resistance and virulence in Acinetobacter baumannii clinical isolates.	Li P, Zhang S, Wang J, Al-Shamiri MM, Luo K, Liu S, Mi P, Wu X, Liu H, Tian H, Han B, Lei J, Han S, Han L.	Front Cell Infect Microbiol	10.3389/fcimb.2024.1297818	2024
	Antimicrobial activity of nature-inspired molecules against multidrug-resistant bacteria.	Hamad M, Al-Marzooq F, Srinivasulu V, Sulaiman A, Menon V, Ramadan WS, El-Awady R, Al-Tel TH.	Front Microbiol	10.3389/fmicb.2023.1336856	2023
	Berberine and its nanoformulations and extracts: potential strategies and future perspectives against multi-drug resistant bacterial infections.	Yang X, Wang Y, Li L, Tang D, Yan Z, Li M, Jiang J, Bi D.	Front Microbiol	10.3389/fmicb.2025.1643409	2025
	TC-14, a cathelicidin-derived antimicrobial peptide with broad-spectrum antibacterial activity and high safety profile.	Li C, Cai Y, Luo L, Tian G, Wang X, Yan A, Wang L, Wu S, Wu Z, Zhang T, Chen W, Zhang Z.	iScience	10.1016/j.isci.2024.110404	2024
	Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as potential predictors of nosocomial infection in patients undergoing veno-arterial extracorporeal membrane oxygenation: A cohort study	Xu Z, Qi L, Su S, Xu Z, Geng Y, Shi Y, Wang C, Wu J, Liu R.	PLoS One		2025
Genetics	Genome-scale metabolic modeling in antimicrobial pharmacology.	Zhu Y, Zhao J, Li J.	Eng Microbiol	10.1016/j.engmic.2022.100021	2022
	Biosurfactant from Nile Papyrus endophyte with potential antibiofilm activity against global clones of Acinetobacter baumannii.	Amer MA, Wasfi R, Hamed SM.	Front Cell Infect Microbiol	10.3389/fcimb.2023.1210195	2023
	Carbapenem-Resistant Acinetobacter baumannii: Biofilm-Associated Genes, Biofilm-Eradication Potential of Disinfectants, and Biofilm-Inhibitory Effects of Selenium Nanoparticles.	Smitran A, Lukovic B, Bozic L, Jelic D, Jovicevic M, Kabic J, Kekic D, Ranin J, Opavski N, Gajic I.	Microorganisms	10.3390/microorganisms11010171	2023
Genetics	TolRad, a model for predicting radiation tolerance using Pfam annotations, identifies novel radiosensitive bacterial species from reference genomes and MAGs.	Sweet P, Burroughs M, Jang S, Contreras L.	Microbiol Spectr	10.1128/spectrum.03838-23	2024
	Electrostatic Loading and Photoredox-Accelerated Release of Antibiotics from Oligoviologen-Crosslinked Hydrogels Using Red Light.	Dorsainvil JM, Palmquist MS, Yang J, Delawder AO, Danielson MK, Zhang Y, Saak TM, Gruschka MC, Kong X, Wencewicz TA, Barnes JC.	Mater Today Chem	10.1016/j.mtchem.2023.101847	2024
	Susceptibility profile of bla _OXA-23 and metallo-beta-lactamases co-harbouring isolates of carbapenem resistant Acinetobacter baumannii (CRAB) against standard drugs and combinations.	Sharma S, Banerjee T, Yadav G, Kumar A.	Front Cell Infect Microbiol	10.3389/fcimb.2022.1068840	2022
	Novel Indane-Containing NBTIs with Potent Anti-Gram-Negative Activity and Minimal hERG Inhibition.	Cumming JG, Kreis L, Kuhne H, Wermuth R, Vercruysse M, Cantrill C, Bissantz C, Qiu H, Kramer C, Andreotti D, Fossati G.	ACS Med Chem Lett	10.1021/acsmedchemlett.3c00422	2023
	Phytochemical Investigations and Pharmacological Potential of Organic Extracts of Calotropis gigantea L. Leaves.	Jamal A, Arif A, Kiran S, Shahid MN, Hossain MB.	Scientifica (Cairo)	10.1155/sci5/1669969	2025
	Analysis of the Distribution and Antibiotic Resistance of Pathogens Causing Infections in Hospitals from 2017 to 2019.	Liu G, Qin M.	Evid Based Complement Alternat Med	10.1155/2022/3512582	2022
	Differential Gene Expression of Efflux Pumps and Porins in Clinical Isolates of MDR Acinetobacter baumannii.	AlQumaizi KI, Kumar S, Anwer R, Mustafa S.	Life (Basel)	10.3390/life12030419	2022
	Dual-action thioarylamide-based small molecules to target drug-resistant bacteria and chronic inflammation.	De Fenza M, Gaglione R, Rossi A, Campanile M, Cesaro A, Gugliandolo D, De Fino I, Chino M, Petraccone L, Lombardi A, D'Errico G, Bragonzi A, Arciello A, Pavone V, D'Alonzo D.	iScience	10.1016/j.isci.2025.113674	2025
Genetics	Uncovering encrypted antimicrobial peptides in health-associated Lactobacillaceae by large-scale genomics and machine learning.	Du R, Han F, Li Z, Yu J, Xu Y, Huang Y, Wu Q.	Microbiome	10.1186/s40168-025-02145-3	2025
Metabolism	Distinctive Roles of Two Acinetobactin Isomers in Challenging Host Nutritional Immunity.	Kim M, Kim DY, Song WY, Park SE, Harrison SA, Chazin WJ, Oh MH, Kim HJ.	mBio	10.1128/mbio.02248-21	2021
	Detection of Mtb and NTM: preclinical validation of a new asymmetric PCR-binary deoxyribozyme sensor assay.	Neves YCd, Reis AJ, Rodrigues MA, Chimara E, da Silva Lourenco MC, Fountain J, Ramis IB, von Groll A, Gerasimova Y, Rohde KH, Almeida da Silva PE.	Microbiol Spectr	10.1128/spectrum.03506-23	2024
	Polymyxins with Potent Antibacterial Activity against Colistin-Resistant Pathogens: Fine-Tuning Hydrophobicity with Unnatural Amino Acids.	Jorgensen JS, Mood EH, Knap ASH, Nielsen SE, Nielsen PE, Zabicka D, Matias C, Domraceva I, Bjorkling F, Franzyk H.	J Med Chem	10.1021/acs.jmedchem.3c01908	2024
	Mapping Global Prevalence of Acinetobacter baumannii and Recent Vaccine Development to Tackle It.	Ma C, McClean S.	Vaccines (Basel)	10.3390/vaccines9060570	2021
	Antarctic Marine Bacteria as a Source of Anti-Biofilm Molecules to Combat ESKAPE Pathogens.	Artini M, Papa R, Vrenna G, Trecca M, Paris I, D'Angelo C, Tutino ML, Parrilli E, Selan L.	Antibiotics (Basel)	10.3390/antibiotics12101556	2023
	In Vitro and In Vivo Antimicrobial Activity of the Novel Peptide OMN6 against Multidrug-Resistant Acinetobacter baumannii.	Michaeli J, Mandel S, Maximov S, Zazoun J, Savoia P, Kothari N, Valmont T, Ferrari L, Duncan LR, Hawser S, Cohen-Kutner M, Bachnoff N.	Antibiotics (Basel)	10.3390/antibiotics11091201	2022
	Identification and Characterization of an RRM-Containing, RNA Binding Protein in Acinetobacter baumannii.	Ciani C, Perez-Rafols A, Bonomo I, Micaelli M, Esposito A, Zucal C, Belli R, D'Agostino VG, Bianconi I, Calderone V, Cerofolini L, Massidda O, Whalen MB, Fragai M, Provenzani A.	Biomolecules	10.3390/biom12070922	2022
	Survival of Bacterial Strains on Wood (Quercus petraea) Compared to Polycarbonate, Aluminum and Stainless Steel.	Chen JC, Munir MT, Aviat F, Lepelletier D, Le Pape P, Dubreil L, Irle M, Federighi M, Belloncle C, Eveillard M, Pailhories H.	Antibiotics (Basel)	10.3390/antibiotics9110804	2020
Pathogenicity	Genomic and Phenotypic Evolution of Tigecycline-Resistant Acinetobacter baumannii in Critically Ill Patients.	Zhang J, Xie J, Li H, Wang Z, Yin Y, Wang S, Chen H, Wang Q, Wang H.	Microbiol Spectr	10.1128/spectrum.01593-21	2022
	Development of a Polymicrobial Checkerboard Assay as a Tool for Determining Combinatorial Antibiotic Effectiveness in Polymicrobial Communities.	Black C, Al Mahmud H, Howle V, Wilson S, Smith AC, Wakeman CA.	Antibiotics (Basel)	10.3390/antibiotics12071207	2023
Pathogenicity	Pharmacodynamic evaluation of suppression of in vitro resistance in Acinetobacter baumannii strains using polymyxin B-based combination therapy.	Fedrigo NH, Shinohara DR, Mazucheli J, Nishiyama SAB, Carrara-Marroni FE, Martins FS, Zhu P, Yu M, Sy SKB, Tognim MCB.	Sci Rep	10.1038/s41598-021-90709-2	2021
Genetics	Genetic Diversity of Antimicrobial Resistance and Key Virulence Features in Two Extensively Drug-Resistant Acinetobacter baumannii Isolates.	Marazzato M, Scribano D, Sarshar M, Brunetti F, Fillo S, Fortunato A, Lista F, Palamara AT, Zagaglia C, Ambrosi C.	Int J Environ Res Public Health	10.3390/ijerph19052870	2022
	In-Depth Analysis of the Role of the Acinetobactin Cluster in the Virulence of Acinetobacter baumannii.	Conde-Perez K, Vazquez-Ucha JC, Alvarez-Fraga L, Ageitos L, Rumbo-Feal S, Martinez-Guitian M, Trigo-Tasende N, Rodriguez J, Bou G, Jimenez C, Beceiro A, Poza M.	Front Microbiol	10.3389/fmicb.2021.752070	2021
Pathogenicity	Novel pyrazoles as potent growth inhibitors of staphylococci, enterococci and Acinetobacter baumannii bacteria.	Alkhaibari I, Kc HR, Angappulige DH, Gilmore D, Alam MA.	Future Med Chem	10.4155/fmc-2021-0140	2022
	Antimicrobial Susceptibility of Commensal Escherichia coli from Pig Fecal Samples and Enhanced Sensitivity for Direct Detection of the bla_CTX-M Gene by Nested PCR.	Suchanta N, Ullah N, Santanirand P, Am-In N, Chaichanawongsaroj N.	Animals (Basel)	10.3390/ani14182630	2024
	Antimicrobial Indole-3-Carboxamido-Polyamine Conjugates Target Bacterial Membranes and Are Antibiotic Potentiators.	Sue K, Cadelis MM, Rouvier F, Bourguet-Kondracki ML, Brunel JM, Copp BR.	Biomolecules	10.3390/biom14030261	2024
Metabolism	Virulence role of the outer membrane protein CarO in carbapenem-resistant Acinetobacter baumannii.	Labrador-Herrera G, Perez-Pulido AJ, Alvarez-Marin R, Casimiro-Soriguer CS, Cebrero-Cangueiro T, Moran-Barrio J, Pachon J, Viale AM, Pachon-Ibanez ME.	Virulence	10.1080/21505594.2020.1855912	2020
	Bioprospecting secondary metabolites with antimicrobial properties from soil bacteria in high-temperature ecosystems.	Demisie S, Oh DC, Abera A, Tasew G, Satessa GD, Fufa F, Shenkutie AM, Wolday D, Tafess K.	Microb Cell Fact	10.1186/s12934-024-02589-6	2024
	An outbreak of carbapenem-resistant Acinetobacter baumannii in a COVID-19 dedicated hospital.	Gottesman T, Fedorowsky R, Yerushalmi R, Lellouche J, Nutman A.	Infect Prev Pract	10.1016/j.infpip.2021.100113	2021
	Antibacterial and antitumor activities of a lectin-rich preparation from Microgramma vacciniifolia rhizome.	da Silva GC, de Oliveira AM, Costa WK, da Silva Filho AF, Pitta MGDR, Rego MJBM, Antonia de Souza I, Paiva PMG, Napoleao TH.	Curr Res Pharmacol Drug Discov	10.1016/j.crphar.2022.100093	2022
	Metabolomic profiling of polymyxin-B in combination with meropenem and sulbactam against multi-drug resistant Acinetobacter baumannii.	Zhu S, Zhang J, Song C, Liu Y, Oo C, Heinrichs MT, Lv Z, Zhu Y, Sy SKB, Deng P, Yu M.	Front Microbiol	10.3389/fmicb.2022.1013934	2022
	Antibiofilm and Antimicrobial Potentials of Novel Synthesized Sulfur Camphor Derivatives.	Duda-Madej A, Viscardi S, Pacyga K, Kupczynski R, Maczka W, Grabarczyk M, Pacyga P, Topola E, Ostrowka M, Bania J, Szumny A, Winska K.	Int J Mol Sci	10.3390/ijms252010895	2024
	Synergistic Activity of Capsaicin and Colistin Against Colistin-Resistant Acinetobacter baumannii: In Vitro/Vivo Efficacy and Mode of Action.	Guo T, Li M, Sun X, Wang Y, Yang L, Jiao H, Li G.	Front Pharmacol	10.3389/fphar.2021.744494	2021
Enzymology	Development and clinical validation of a droplet digital PCR assay for detecting Acinetobacter baumannii and Klebsiella pneumoniae in patients with suspected bloodstream infections.	Zheng Y, Jin J, Shao Z, Liu J, Zhang R, Sun R, Hu B.	Microbiologyopen	10.1002/mbo3.1247	2021
	Inhibition of Acinetobacter baumannii Biofilm Formation Using Different Treatments of Silica Nanoparticles.	Natsheh IY, Elkhader MT, Al-Bakheit AA, Alsaleh MM, Alsaleh MM, El-Eswed BI, El-Eswed BI, Hosein NF, Albadawi DK.	Antibiotics (Basel)	10.3390/antibiotics12091365	2023
	A new target of multiple lysine methylation in bacteria.	Inoue S, Yoshimoto S, Hori K.	J Bacteriol	10.1128/jb.00325-24	2025
	Antibacterial Activity and Toxicity of Zinc Oxide Nanoparticles Combined with Supernatants of Lactobacillus spp. Against ESKAPE Bacteria: A Novel Mixture	Soleymanzadeh Moghadam S, Hosseini Doust R, Majidpour A, Adabi M, Minaeian S.	Iran J Pharm Res		2023
Genetics	Genomic characterization of multidrug-resistant Escherichia albertii of fish origin-first isolation and insights into a potential food safety threat.	Srinivas K, Ghatak S, Milton AAP, Das S, Puro KU, Pyngrope DA, Angappan M, Prasad MCB, Bhargavi D, Kader NA, Lyngdoh V, Shilla H, Lamare JP.	Front Microbiol	10.3389/fmicb.2025.1521202	2025
	BonA from Acinetobacter baumannii Forms a Divisome-Localized Decamer That Supports Outer Envelope Function.	Grinter R, Morris FC, Dunstan RA, Leung PM, Kropp A, Belousoff M, Gunasinghe SD, Scott NE, Beckham S, Peleg AY, Greening C, Li J, Heinz E, Lithgow T.	mBio	10.1128/mbio.01480-21	2021
	The effect of photodynamic therapy using Radachlorin on biofilm-forming multidrug-resistant bacteria.	Seo CW, Kim YK, An JL, Kim JS, Kwon PS, Yu YB.	Osong Public Health Res Perspect	10.24171/j.phrp.2022.0150	2022
	Synergistic Activity and Mechanism of Sanguinarine with Polymyxin B against Gram-Negative Bacterial Infections.	Qiao L, Zhang Y, Chen Y, Chi X, Ding J, Zhang H, Han Y, Zhang B, Jiang J, Lin Y.	Pharmaceutics	10.3390/pharmaceutics16010070	2024
	A FtsZ Inhibitor That Can Utilize Siderophore-Ferric Iron Uptake Transporter Systems for Activity against Gram-Negative Bacterial Pathogens.	Bryan EJ, Qiao Q, Wang Y, Roberge JY, LaVoie EJ, Pilch DS.	Antibiotics (Basel)	10.3390/antibiotics13030209	2024
	Antimicrobial resistance and biofilm formation capacity among Acinetobacter baumannii strains isolated from patients with burns and ventilator-associated pneumonia.	Khoshnood S, Sadeghifard N, Mahdian N, Heidary M, Mahdian S, Mohammadi M, Maleki A, Haddadi MH.	J Clin Lab Anal	10.1002/jcla.24814	2023
Genetics	Discovery of antimicrobial peptides in the global microbiome with machine learning.	Santos-Junior CD, Torres MDT, Duan Y, Rodriguez Del Rio A, Schmidt TSB, Chong H, Fullam A, Kuhn M, Zhu C, Houseman A, Somborski J, Vines A, Zhao XM, Bork P, Huerta-Cepas J, de la Fuente-Nunez C, Coelho LP.	Cell	10.1016/j.cell.2024.05.013	2024
	In vitro and in vivo fitness of clinical isolates of carbapenem-resistant and -susceptible Acinetobacter baumannii.	Kumar S, Singhal L, Ray P, Gautam V.	Indian J Med Microbiol	10.4103/ijmm.ijmm_19_468	2020
	A new application of avocado oil to enrich the biological activities of polycaprolactone membranes for tissue engineering.	Yurtsever MC, Aydogan S, Iyigundogdu Z, Comertpay A, Demir D, Ceylan S.	Biopolymers	10.1002/bip.23617	2024
Genetics	Extensively drug-resistant Acinetobacter baumannii: role of conjugative plasmids in transferring resistance.	Ababneh Q, Al Sbei S, Jaradat Z, Syaj S, Aldaken N, Ababneh H, Inaya Z.	PeerJ	10.7717/peerj.14709	2023
	Methanol extract of Iraqi Kurdistan Region Daphne mucronata as a potent source of antioxidant, antimicrobial, and anticancer agents for the synthesis of novel and bioactive polyvinylpyrrolidone nanofibers.	Muzammil K, Kzar MH, Mohammed F, Mohammed ZI, Hamood SA, Hussein TK, Hanoon SJ, Qasim MT, Hussien Alawadi A, Alsalamy A.	Front Chem	10.3389/fchem.2023.1287870	2023
	6-Polyaminosteroid Squalamine Analogues Display Antibacterial Activity against Resistant Pathogens.	Vergoz D, Nilly F, Desriac F, Barreau M, Gery A, Lepetit C, Sichel F, Jeannot K, Giard JC, Garon D, Chevalier S, Muller C, De E, Brunel JM.	Int J Mol Sci	10.3390/ijms24108568	2023
	Diversity of resistant determinants, virulence factors, and mobile genetic elements in Acinetobacter baumannii from India: A comprehensive in silico genome analysis.	Kumkar SN, Kamble EE, Chavan NS, Dhotre DP, Pardesi KR.	Front Cell Infect Microbiol	10.3389/fcimb.2022.997897	2022
	An Explorative Review on Advanced Approaches to Overcome Bacterial Resistance by Curbing Bacterial Biofilm Formation.	Mohamad F, Alzahrani RR, Alsaadi A, Alrfaei BM, Yassin AEB, Alkhulaifi MM, Halwani M.	Infect Drug Resist	10.2147/idr.s380883	2023
	Metformin reverse minocycline to inhibit minocycline-resistant Acinetobacter baumannii by destroy the outer membrane and enhance membrane potential in vitro.	Guo T, Sun X, Yang J, Yang L, Li M, Wang Y, Jiao H, Li G.	BMC Microbiol	10.1186/s12866-022-02629-4	2022
	Controlling Antibacterial Activity Exclusively with Visible Light: Introducing a Tetra-ortho-Chloro-Azobenzene Amino Acid.	Just-Baringo X, Yeste-Vazquez A, Moreno-Morales J, Balleste-Delpierre C, Vila J, Giralt E.	Chemistry	10.1002/chem.202102370	2021
Genetics	Acinetobacter baumannii IC2 and IC5 Isolates with Co-Existing bla_OXA-143-like and bla_OXA-72 and Exhibiting Strong Biofilm Formation in a Mexican Hospital.	Moreno-Manjon J, Castillo-Ramirez S, Jolley KA, Maiden MCJ, Gayosso-Vazquez C, Fernandez-Vazquez JL, Mateo-Estrada V, Giono-Cerezo S, Alcantar-Curiel MD.	Microorganisms	10.3390/microorganisms11092316	2023
	Synthesis and Characterization of Preacinetobactin and 5-Phenyl Preacinetobactin.	Bray JM, Pierce S, Angeles-Boza AM, Peczuh MW.	Molecules	10.3390/molecules27123688	2022
	Evolutionarily stable gene clusters shed light on the common grounds of pathogenicity in the Acinetobacter calcoaceticus-baumannii complex.	Djahanschiri B, Di Venanzio G, Distel JS, Breisch J, Dieckmann MA, Goesmann A, Averhoff B, Gottig S, Wilharm G, Feldman MF, Ebersberger I.	PLoS Genet	10.1371/journal.pgen.1010020	2022
	New N-phenylpyrrolamide inhibitors of DNA gyrase with improved antibacterial activity.	Cotman AE, Fulgheri F, Piga M, Persolja P, Tiz DB, Skok Z, Durcik M, Sterle M, Dernovsek J, Cruz CD, Tammela P, Szili PE, Daruka L, Pal C, Zega A, Masic LP, Ilas J, Tomasic T, Kikelj D, Zidar N.	RSC Adv	10.1039/d4ra04802d	2024
	CRISPR-Cas in Acinetobacter baumannii Contributes to Antibiotic Susceptibility by Targeting Endogenous AbaI.	Wang Y, Yang J, Sun X, Li M, Zhang P, Zhu Z, Jiao H, Guo T, Li G.	Microbiol Spectr	10.1128/spectrum.00829-22	2022
	Overexpression of Efflux Pumps, Mutations in the Pumps' Regulators, Chromosomal Mutations, and AAC(6')-Ib-cr Are Associated With Fluoroquinolone Resistance in Diverse Sequence Types of Neonatal Septicaemic Acinetobacter baumannii: A 7-Year Single Center Study.	Roy S, Chatterjee S, Bhattacharjee A, Chattopadhyay P, Saha B, Dutta S, Basu S.	Front Microbiol	10.3389/fmicb.2021.602724	2021
	In Vitro Evaluation of Antimicrobial Peptide Tridecaptin M in Combination with Other Antibiotics against Multidrug Resistant Acinetobacter baumannii.	Jangra M, Raka V, Nandanwar H.	Molecules	10.3390/molecules25143255	2020
	Self-Assembly, Antimicrobial Properties and Biodegradability of Ester-Functionalized Choline-Based Surface-Active Ionic Liquids.	Garcia MT, Bautista E, Perez L, Vazquez S.	Molecules	10.3390/molecules30061280	2025
	Prevalence of OXA-Type beta-Lactamase Genes among Carbapenem-Resistant Acinetobacter baumannii Clinical Isolates in Thailand.	Thirapanmethee K, Srisiri-A-Nun T, Houngsaitong J, Montakantikul P, Khuntayaporn P, Chomnawang MT.	Antibiotics (Basel)	10.3390/antibiotics9120864	2020
	Synergistic Activity of Thymol with Commercial Antibiotics against Critical and High WHO Priority Pathogenic Bacteria.	Gan C, Langa E, Valenzuela A, Ballestero D, Pino-Otin MR.	Plants (Basel)	10.3390/plants12091868	2023
	Identification of a Novel Ciprofloxacin Tolerance Gene, aciT, Which Contributes to Filamentation in Acinetobacter baumannii.	Naidu V, Shah B, Kamath KS, Chien A, Nagy S, Pokhrel A, Molloy M, Hassan KA, Paulsen IT.	Antimicrob Agents Chemother	10.1128/aac.01400-20	2021
	Dissemination and Genetic Relatedness of Multidrug-Resistant and Extensively Drug-Resistant Acinetobacter baumannii Isolates from a Burn Hospital in Iraq.	Shali AAK, Jalal PJ, Arif SK.	Can J Infect Dis Med Microbiol	10.1155/2022/8243192	2022
	Myrtenol Inhibits Biofilm Formation and Virulence in the Drug-Resistant Acinetobacter baumannii: Insights into the Molecular Mechanisms.	Liu L, Liu B, Li L, He MX, Zhou XD, Li Q.	Infect Drug Resist	10.2147/idr.s379212	2022
	Antimicrobial resistance patterns and their encoding genes among clinical isolates of Acinetobacter baumannii in Ahvaz, Southwest Iran.	Moosavian M, Ahmadi K, Shoja S, Mardaneh J, Shahi F, Afzali M.	MethodsX	10.1016/j.mex.2020.101031	2020
	Carboxy-Amidated AamAP1-Lys has Superior Conformational Flexibility and Accelerated Killing of Gram-Negative Bacteria.	Van Wyk RJ, Serem JC, Oosthuizen CB, Semenya D, Serian M, Lorenz CD, Mason AJ, Bester MJ, Gaspar ARM.	Biochemistry	10.1021/acs.biochem.4c00580	2025
	Combined potential of copaifera officinalis oleoresin and chitosan against oral pathogens.	Gomes TV, de Oliveira MS, Polo AB, Tome BV, Cardoso MM, Tavares GD, Apolonio ACM.	Braz J Microbiol	10.1007/s42770-024-01523-7	2024
	Relationship between the Biofilm-Forming Capacity and Antimicrobial Resistance in Clinical Acinetobacter baumannii Isolates: Results from a Laboratory-Based In Vitro Study.	Donadu MG, Mazzarello V, Cappuccinelli P, Zanetti S, Madlena M, Nagy AL, Stajer A, Burian K, Gajdacs M.	Microorganisms	10.3390/microorganisms9112384	2021
Pathogenicity	Multidrug-resistant Acinetobacter baumannii: differential adherence to HEp-2 and A-549 cells.	Genteluci GL, Gomes DBC, Pereira D, Neves MC, de Souza MJ, Rangel K, Villas Boas MHS.	Braz J Microbiol	10.1007/s42770-020-00252-x	2020
	Development of a Rapid and Efficient RPA-CRISPR/Cas12a Assay for Mycoplasma pneumoniae Detection.	Li F, Xiao J, Yang H, Yao Y, Li J, Zheng H, Guo Q, Wang X, Chen Y, Guo Y, Wang Y, Shen C.	Front Microbiol	10.3389/fmicb.2022.858806	2022
	Maipomycin A, a Novel Natural Compound With Promising Anti-biofilm Activity Against Gram-Negative Pathogenic Bacteria.	Zhang J, Liang X, Zhang S, Song Z, Wang C, Xu Y.	Front Microbiol	10.3389/fmicb.2020.598024	2020
	Chemical Characterization and Antimicrobial Activity of Essential Oils and Nanoemulsions of Eugenia uniflora and Psidium guajava.	Dos Santos RD, Matos BN, Freire DO, da Silva FS, do Prado BA, Gomes KO, de Araujo MO, Bilac CA, Rodrigues LFS, da Silva ICR, de Sa Barreto LCL, Gomes da Camara CA, de Moraes MM, Gelfuso GM, Orsi DC.	Antibiotics (Basel)	10.3390/antibiotics14010093	2025
Pathogenicity	Safety and Therapeutic Efficacy of Thymoquinone-Loaded Liposomes against Drug-Sensitive and Drug-Resistant Acinetobacter baumannii.	Allemailem KS, Alnuqaydan AM, Almatroudi A, Alrumaihi F, Aljaghwani A, Khalilullah H, Younus H, Khan A, Khan MA.	Pharmaceutics	10.3390/pharmaceutics13050677	2021
	Rescue of pyrimidine-defective Pseudomonas aeruginosa through metabolic complementation.	Mahmud HA, Garcia R, Garcia A, Baishya J, Wakeman CA.	Microbiol Spectr	10.1128/spectrum.04226-23	2024
	Molecular Characterization of Carbapenem-Resistant Acinetobacter baumannii Isolated from Intensive Care Unit Patients in Jordanian Hospitals.	Al-Sheboul SA, Al-Moghrabi SZ, Shboul Y, Atawneh F, Sharie AH, Nimri LF.	Antibiotics (Basel)	10.3390/antibiotics11070835	2022
	Evaluation of the Antibacterial Potential of Two Short Linear Peptides YI12 and FK13 against Multidrug-Resistant Bacteria.	Sun J, Kong P, Shi J, Liu Y.	Pathogens	10.3390/pathogens13090797	2024
	Novel adjuvant nano-vaccine induced immune response against Acinetobacter baumannii.	Piri-Gharaghie T, Doosti A, Mirzaei SA.	AMB Express	10.1186/s13568-023-01531-0	2023
Genetics	Antimicrobial Resistance Mechanisms and Virulence of Colistin- and Carbapenem-Resistant Acinetobacter baumannii Isolated from a Teaching Hospital in Taiwan.	Ilsan NA, Lee YJ, Kuo SC, Lee IH, Huang TW.	Microorganisms	10.3390/microorganisms9061295	2021
	Re-evaluation of FDA-approved antibiotics with increased diagnostic accuracy for assessment of antimicrobial resistance.	Heithoff DM, Barnes V L, Mahan SP, Fried JC, Fitzgibbons LN, House JK, Mahan MJ.	Cell Rep Med	10.1016/j.xcrm.2023.101023	2023
	Characteristics and diversity of mutations in regulatory genes of resistance-nodulation-cell division efflux pumps in association with drug-resistant clinical isolates of Acinetobacter baumannii.	Salehi B, Ghalavand Z, Yadegar A, Eslami G.	Antimicrob Resist Infect Control	10.1186/s13756-021-00924-9	2021
	Characterization of Three Different Endolysins Effective against Gram-Negative Bacteria.	Jeong TH, Hong HW, Kim MS, Song M, Myung H.	Viruses	10.3390/v15030679	2023
	Coated nanoparticles enhance immune efficacy of Helicobacter pylori outer membrane vesicles by activating Th1/Th2/Th17 responses.	Ye S, Liu J, Huang S, Chen L, Zeng X, Zhao J, Zhao S.	J Pharmacol Exp Ther	10.1016/j.jpet.2025.103669	2025
	Terpenoids from Marine Sources: A Promising Avenue for New Antimicrobial Drugs.	Liu X, Xin J, Sun Y, Zhao F, Niu C, Liu S.	Mar Drugs	10.3390/md22080347	2024
	Rapid, low-cost colorimetric detection of Salmonella Typhi bacteriophages for environmental surveillance.	da Silva KE, Yokoyama T, Naga SR, Maharjan M, Pereira Dos Santos PC, Fisher KN, Coulibaly JT, Yang MZ, Nelson EJ, Charles RC, Shafer K, Igiraneza B-L, Yusuf S, Mulder E, Neuzil K, Bogoch II, Shrestha R, Tamrakar D, Andrews JR.	mBio	10.1128/mbio.01963-25	2025
	Safety and Prophylactic Efficacy of Liposome-Based Vaccine against the Drug-Resistant Acinetobacter baumannii in Mice.	Khan MA, Allemailem KS, Maswadeh H, Younus H.	Pharmaceutics	10.3390/pharmaceutics14071357	2022
	Antimicrobial Activity of an Fmoc-Plantaricin 149 Derivative Peptide against Multidrug-Resistant Bacteria.	Righetto GM, Lopes JLS, Bispo PJM, Andre C, Souza JM, Andricopulo AD, Beltramini LM, Camargo ILBDC.	Antibiotics (Basel)	10.3390/antibiotics12020391	2023
	A Novel Mismatched PCR-Restriction Fragment Length Polymorphism Assay for Rapid Detection of gyrA and parC Mutations Associated With Fluoroquinolone Resistance in Acinetobacter baumannii.	Kakuta N, Nakano R, Nakano A, Suzuki Y, Tanouchi A, Masui T, Horiuchi S, Endo S, Kakuta R, Ono Y, Yano H.	Ann Lab Med	10.3343/alm.2020.40.1.27	2020
	Impact of an Intervention to Control Imipenem-Resistant Acinetobacter baumannii and Its Resistance Mechanisms: An 8-Year Survey.	Chen L, Tan P, Zeng J, Yu X, Cai Y, Liao K, Guo P, Chen Y, Wu Z, Qu P, Cai R, Chen C, Huang B.	Front Microbiol	10.3389/fmicb.2020.610109	2020
Pathogenicity	Specific egg yolk immunoglobulin as a promising non-antibiotic biotherapeutic product against Acinetobacter baumannii pneumonia infection.	Jahangiri A, Owlia P, Rasooli I, Salimian J, Derakhshanifar E, Aghajani Z, Abdollahi S, Khalili S, Talei D, Eslam ED.	Sci Rep	10.1038/s41598-021-81356-8	2021
Proteome	The Mechanism of Tigecycline Resistance in Acinetobacter baumannii Revealed by Proteomic and Genomic Analysis.	Liu C, Wang L, Wang P, Xiao D, Zou Q.	Int J Mol Sci	10.3390/ijms24108652	2023
	In Vitro Activity of Peptide Antibiotics in Combination With Other Antimicrobials on Extensively Drug-Resistant Acinetobacter baumannii in the Planktonic and Biofilm Cell.	Meng Q, Lin F, Ling B.	Front Pharmacol	10.3389/fphar.2022.890955	2022
	Combatting Planktonic and Biofilm Populations of Carbapenem-Resistant Acinetobacter baumannii with Polymyxin-Based Combinations.	Wences M, Wolf ER, Li C, Singh N, Bah N, Tan X, Huang Y, Bulman ZP.	Antibiotics (Basel)	10.3390/antibiotics11070959	2022
Pathogenicity	Influence of heparin-based anticoagulants on antibiotic therapy.	Cont D, Schildbock C, Kolm C, Kirschner AKT, Farnleitner AH, Hartmann J, Weber V, Harm S.	Front Immunol	10.3389/fimmu.2025.1708169	2025
	A pyrF-Based Efficient Genetic Manipulation Platform in Acinetobacter baumannii To Explore the Vital DNA Components of Adaptive Immunity for I-F CRISPR-Cas.	Wu S, Xu R, Su M, Gao C, Liu Y, Chen Y, Luan G, Jia X, Wang R.	Microbiol Spectr	10.1128/spectrum.01957-22	2022
	Hybrid Antigens Expressing Surface Loops of ZnuD From Acinetobacter baumannii Is Capable of Inducing Protection Against Infection.	Qamsari MM, Rasooli I, Chaudhuri S, Astaneh SDA, Schryvers AB.	Front Immunol	10.3389/fimmu.2020.00158	2020
	Multicentric Surveillance of Antimicrobial Resistance to Generate Data-Driven Regional Antibiograms: A Laboratory-Based Cross-Sectional Study in Pakistan.	Noreen N, Aslam A, Abbas M, Ghulam Mustafa A, Jamshed S, Gajdacs M, Iqbal A, Syed W, Bashatah A, Alqahtani N.	Antibiotics (Basel)	10.3390/antibiotics14111154	2025
	Prediction of Potential Natural Antibiotics Plants Based on Jamu Formula Using Random Forest Classifier.	Nasution AK, Wijaya SH, Gao P, Islam RM, Huang M, Ono N, Kanaya S, Altaf-Ul-Amin M.	Antibiotics (Basel)	10.3390/antibiotics11091199	2022
	Possible Association of Carbapenemase Production with Susceptibility Pattern and Resistance Genes Among Carbapenemase Producing Enterobacterales from Blood Isolates or Bacteremic Patients.	Shakhatreh MAK, Al-Ghawrie HM, Meqdam MM, Shakhatreh Z, Khair IY, Tabnjh AK, Jacob JH, Khabour MO, Alzoubi KH.	Infect Drug Resist	10.2147/idr.s519561	2025
	High-Resolution Bacterial Cytological Profiling Reveals Intrapopulation Morphological Variations upon Antibiotic Exposure.	Samernate T, Htoo HH, Sugie J, Chavasiri W, Pogliano J, Chaikeeratisak V, Nonejuie P.	Antimicrob Agents Chemother	10.1128/aac.01307-22	2023
	A broad-spectrum antibiotic targets multiple-drug-resistant bacteria with dual binding targets and no detectable resistance.	He W, Huan X, Li Y, Deng Q, Chen T, Xiao W, Chen Y, Ma L, Liu N, Shang Z, Wang Z.	Nat Commun	10.1038/s41467-025-62407-4	2025
Genetics	Genomic Characterization of Extensively Drug-Resistant NDM-Producing Acinetobacter baumannii Clinical Isolates With the Emergence of Novel bla _ADC-257.	Zafer MM, Hussein AFA, Al-Agamy MH, Radwan HH, Hamed SM.	Front Microbiol	10.3389/fmicb.2021.736982	2021
	A Gram-negative-selective antibiotic that spares the gut microbiome.	Munoz KA, Ulrich RJ, Vasan AK, Sinclair M, Wen PC, Holmes JR, Lee HY, Hung CC, Fields CJ, Tajkhorshid E, Lau GW, Hergenrother PJ.	Nature	10.1038/s41586-024-07502-0	2024
	Trojan horse peptide conjugates remodel the activity spectrum of clinical antibiotics.	Luo S, Li XR, Gong XT, Kulikovsky A, Qu F, Beis K, Severinov K, Dubiley S, Feng X, Dong SH, Nair SK.	Proc Natl Acad Sci U S A	10.1073/pnas.2319483121	2025
	Influence of tramadol on bacterial burden in the standard neutropenic thigh infection model.	Rox K.	Sci Rep	10.1038/s41598-022-24111-x	2022
	Pan-Drug Resistant Acinetobacter baumannii, but Not Other Strains, Are Resistant to the Bee Venom Peptide Mellitin.	Karyne R, Curty Lechuga G, Almeida Souza AL, Rangel da Silva Carvalho JP, Simoes Villas Boas MH, De Simone SG.	Antibiotics (Basel)	10.3390/antibiotics9040178	2020
	One-step synthesized antimicrobial peptide-functionalized gold nanoclusters for selective imaging and killing of pathogenic bacteria.	Shen Y, Zheng C, Wu Q, Wu Q, Jin M, Jiang Y, Huang F, Lou Y, Zheng L.	Front Microbiol	10.3389/fmicb.2022.1003359	2022
	Anti-Infective Properties, Cytotoxicity, and In Silico ADME Parameters of Novel 4'-(Piperazin-1-yl)benzanilides.	Hermann T, Harzl S, Wallner R, Prettner E, Pferschy-Wenzig EM, Cal M, Maser P, Weis R.	Pharmaceuticals (Basel)	10.3390/ph18071004	2025
Pathogenicity	Dose Optimization of Colistin Combinations against Carbapenem-Resistant Acinetobacter baumannii from Patients with Hospital-Acquired Pneumonia in China by Using an In Vitro Pharmacokinetic/Pharmacodynamic Model.	Bian X, Liu X, Chen Y, Chen D, Li J, Zhang J.	Antimicrob Agents Chemother	10.1128/aac.01989-18	2019
	Evaluation of PLGA nanoparticles containing outer membrane proteins of Acinetobacter baumannii bacterium in stimulating the immune system in mice.	Gholizadeh A, Shapoury R, Pakzad P, Mahdavi M, Danafar H.	Res Pharm Sci	10.4103/1735-5362.350237	2022
Pathogenicity	Pyomelanin biosynthetic pathway in pigment-producer strains from the pandemic Acinetobacter baumannii IC-5.	Fonseca E, Freitas F, Caldart R, Morgado S, Vicente AC.	Mem Inst Oswaldo Cruz	10.1590/0074-02760200371	2020
	Intrinsic Antibacterial Activity of Xeruborbactam In Vitro: Assessing Spectrum and Mode of Action.	Sun D, Tsivkovski R, Pogliano J, Tsunemoto H, Nelson K, Rubio-Aparicio D, Lomovskaya O.	Antimicrob Agents Chemother	10.1128/aac.00879-22	2022
	Vaccination with a combination of planktonic and biofilm virulence factors confers protection against carbapenem-resistant Acinetobacter baumannii strains.	Ramezanalizadeh F, Rasooli I, Owlia P, Darvish Alipour Astaneh S, Abdolhamidi R.	Sci Rep	10.1038/s41598-022-24163-z	2022
	Improving Activity of New Arylurea Agents against Multidrug-Resistant and Biofilm-Producing Staphylococcus epidermidis.	Canale V, Skiba-Kurek I, Klesiewicz K, Papiez M, Ropek M, Pomierny B, Piska K, Koczurkiewicz-Adamczyk P, Empel J, Karczewska E, Zajdel P.	ACS Med Chem Lett	10.1021/acsmedchemlett.3c00536	2024
	Antibiotic Susceptibility, Clonality, and Molecular Characterization of Carbapenem-Resistant Clinical Isolates of Acinetobacter baumannii from Washington DC.	Bansal G, Allen-McFarlane R, Eribo B.	Int J Microbiol	10.1155/2020/2120159	2020
	Resistance mechanisms for Gram-negative bacteria-specific lipopeptides, turnercyclamycins, differ from that of colistin.	Lim AL, Miller BW, Lin Z, Fisher MA, Barrows LR, Haygood MG, Schmidt EW.	Microbiol Spectr	10.1128/spectrum.02306-23	2023
	Proteinase K-pretreated ConA-based ELISA assay: a novel urine LAM detection strategy for TB diagnosis.	Huang H, Qu R, Wu K, Xu J, Li J, Lu S, Sui G, Fan XY.	Front Microbiol	10.3389/fmicb.2023.1236599	2023
	Synthesis of 4,4'-(4-Formyl-1H-pyrazole-1,3-diyl)dibenzoic Acid Derivatives as Narrow Spectrum Antibiotics for the Potential Treatment of Acinetobacter Baumannii Infections.	Delancey E, Allison D, Kc HR, Gilmore DF, Fite T, Basnakian AG, Alam MA.	Antibiotics (Basel)	10.3390/antibiotics9100650	2020
	Assembly and Functional Role of PACE Transporter PA2880 from Pseudomonas aeruginosa.	Zhao J, Hellwig N, Djahanschiri B, Khera R, Morgner N, Ebersberger I, Wang J, Michel H.	Microbiol Spectr	10.1128/spectrum.01453-21	2022
Genetics	Abundance of Colistin-Resistant, OXA-23- and ArmA-Producing Acinetobacter baumannii Belonging to International Clone 2 in Greece.	Palmieri M, D'Andrea MM, Pelegrin AC, Perrot N, Mirande C, Blanc B, Legakis N, Goossens H, Rossolini GM, van Belkum A.	Front Microbiol	10.3389/fmicb.2020.00668	2020
	Synthesis, Characterization, and Study of the Antimicrobial Potential of Dimeric Peptides Derived from the C-Terminal Region of Lys⁴⁹ Phospholipase A₂ Homologs.	Bicho GFH, Nunes LOC, Fiametti LO, Argentin MN, Candido VT, Camargo ILBC, Cilli EM, Santos-Filho NA.	Toxins (Basel)	10.3390/toxins16070308	2024
	Genetic diversity of colistin resistance Nosocomial Acinetobacter baumannii strains from Iran.	Seyyedi M, Shapouri R, Zeighami H, Shokoohizadeh L.	J Res Med Sci	10.4103/jrms.jrms_1023_20	2021
Pathogenicity	Design and synthesis of 4-[4-formyl-3-(2-naphthyl)pyrazol-1-yl]benzoic acid derivatives as potent growth inhibitors of drug-resistant Staphylococcus aureus.	Alnufaie R, Alsup N, Kc HR, Newman M, Whitt J, Chambers SA, Gilmore D, Alam MA.	J Antibiot (Tokyo)	10.1038/s41429-020-0341-2	2020
	Development and Clinical Application of a Recombinase Polymerase Amplification-Lateral Flow Strip Assay for Detection of Carbapenem-Resistant Acinetobacter baumannii.	Wang L, Sun D, Chen L, Zhou P, Wang K, Wang F, Lei X, Wang Y, Lu Y, Huang G, Gao X.	Front Cell Infect Microbiol	10.3389/fcimb.2022.876552	2022
	Multicenter evaluation of the eQUANT system for use with disk diffusion AST of gram-negative bacteria directly from positive blood cultures.	Dutta S, Jacobs MR, Good CE, Abdelhamed AM, Ying YC, Hoyos-Urias A, Sugui DJ, Anaeto JU, Deak E, Valdez R, Rajan NK, Herget MS, Riedel S.	J Clin Microbiol	10.1128/jcm.01606-24	2025
	In-Vitro Antibacterial Activity of Curcumin-Loaded Nanofibers Based on Hyaluronic Acid against Multidrug-Resistant ESKAPE Pathogens.	Snetkov P, Rogacheva E, Kremleva A, Morozkina S, Uspenskaya M, Kraeva L.	Pharmaceutics	10.3390/pharmaceutics14061186	2022
	Biofilm Formation and Detection of Fluoroquinolone- and Carbapenem-Resistant Genes in Multidrug-Resistant Acinetobacter baumannii.	Avila-Novoa MG, Solis-Velazquez OA, Rangel-Lopez DE, Gonzalez-Gomez JP, Guerrero-Medina PJ, Gutierrez-Lomeli M.	Can J Infect Dis Med Microbiol	10.1155/2019/3454907	2019
Pathogenicity	Bacterial Cytological Profiling as a Tool To Study Mechanisms of Action of Antibiotics That Are Active against Acinetobacter baumannii.	Htoo HH, Brumage L, Chaikeeratisak V, Tsunemoto H, Sugie J, Tribuddharat C, Pogliano J, Nonejuie P.	Antimicrob Agents Chemother	10.1128/aac.02310-18	2019
Metabolism	Septal Class A Penicillin-Binding Protein Activity and ld-Transpeptidases Mediate Selection of Colistin-Resistant Lipooligosaccharide-Deficient Acinetobacter baumannii.	Kang KN, Kazi MI, Biboy J, Gray J, Bovermann H, Ausman J, Boutte CC, Vollmer W, Boll JM.	mBio	10.1128/mbio.02185-20	2021
	Biological Control of Acinetobacter baumannii: In Vitro and In Vivo Activity, Limitations, and Combination Therapies.	Havenga B, Reyneke B, Waso-Reyneke M, Ndlovu T, Khan S, Khan W.	Microorganisms	10.3390/microorganisms10051052	2022
Enzymology	High-level biosynthesis and purification of the antimicrobial peptide Kiadin based on non-chromatographic purification and acid cleavage methods.	Zheng L, Yang F, Wang C, Zafir M, Gao Z, Liu P, El-Gohary FA, Zhao X, Xue H.	Biotechnol Biofuels Bioprod	10.1186/s13068-025-02607-8	2025
	Impact of the modification of a cleaning and disinfection method of mechanical ventilators of COVID-19 patients and ventilator-associated pneumonia: One year of experience.	Cureno-Diaz MA, Duran-Manuel EM, Cruz-Cruz C, Ibanez-Cervantes G, Rojo-Gutierrez MI, Moncayo-Coello CV, Loyola-Cruz MA, Castro-Escarpulli G, Hernandez DMR, Bello-Lopez JM.	Am J Infect Control	10.1016/j.ajic.2021.09.012	2021
	Newly isolated terpenoids (covering 2019-2024) from Aspergillus species and their potential for the discovery of novel antimicrobials.	Ojo O, Njanje I, Abdissa D, Swart T, Higgitt RL, Dorrington RA.	Nat Prod Bioprospect	10.1007/s13659-025-00501-2	2025
	Potential Synergy of Fluoxetine and Antibacterial Agents Against Skin and Soft Tissue Pathogens and Drug-Resistant Organisms.	Ahmed SA, Jordan RL, Isseroff RR, Lenhard JR.	Antibiotics (Basel)	10.3390/antibiotics13121165	2024
	Co-regulation of biofilm formation and antimicrobial resistance in Acinetobacter baumannii: from mechanisms to therapeutic strategies.	Mendes SG, Combo SI, Allain T, Domingues S, Buret AG, Da Silva GJ.	Eur J Clin Microbiol Infect Dis	10.1007/s10096-023-04677-8	2023
	Development of a Multiplex Polymerase Chain Reaction-Based DNA Lateral Flow Assay as a Point-of-Care Diagnostic for Fast and Simultaneous Detection of MRSA and Vancomycin Resistance in Bacteremia.	Kashef MT, Helmy OM.	Diagnostics (Basel)	10.3390/diagnostics12112691	2022
Phylogeny	Molecular survey of aminoglycoside-resistant Acinetobacter baumannii isolated from tertiary hospitals in Qazvin, Iran.	Rashvand P, Peymani A, Mohammadi M, Karami AA, Samimi R, Hajian S, Porasgari D, Habibollah-Pourzereshki N.	New Microbes New Infect	10.1016/j.nmni.2021.100883	2021
	Differential Binding of Carbapenems with the AdeABC Efflux Pump and Modulation of the Expression of AdeB Linked to Novel Mutations within Two-Component System AdeRS in Carbapenem-Resistant Acinetobacter baumannii.	Roy S, Junghare V, Dutta S, Hazra S, Basu S.	mSystems	10.1128/msystems.00217-22	2022
	Survey of various carbapenem-resistant mechanisms of Acinetobacter baumannii and Pseudomonas aeruginosa isolated from clinical samples in Iran.	Azimi L, Fallah F, Karimi A, Shirdoust M, Azimi T, Sedighi I, Rahbar M, Armin S.	Iran J Basic Med Sci	10.22038/ijbms.2020.44853.10463	2020
Genetics	pmrCAB Recombination Events among Colistin-Susceptible and -Resistant Acinetobacter baumannii Clinical Isolates Belonging to International Clone 7.	Nodari CS, Fuchs SA, Xanthopoulou K, Cayo R, Seifert H, Gales AC, Dilthey A, Higgins PG.	mSphere	10.1128/msphere.00746-21	2021
	The molecular characterization of colistin-resistant isolates of Acinetobacter baumannii from patients at intensive care units.	Farajnia S, Lotfi F, Dehnad A, Shojaie M, Raisi R, Rahbarnia L, Bazmani A, Naghili B, Shiry S.	Iran J Microbiol	10.18502/ijm.v14i3.9768	2022
	IgM-enriched immunoglobulin improves colistin efficacy in a pneumonia model by Pseudomonas aeruginosa.	Cebrero-Cangueiro T, Labrador-Herrera G, Carretero-Ledesma M, Herrera-Espejo S, Alvarez-Marin R, Pachon J, Cisneros JM, Pachon-Ibanez ME.	Life Sci Alliance	10.26508/lsa.202101349	2022
Pathogenicity	Antibiotic-Resistant Acinetobacter baumannii Is Susceptible to the Novel Iron-Sequestering Anti-infective DIBI In Vitro and in Experimental Pneumonia in Mice.	Parquet MDC, Savage KA, Allan DS, Ang MTC, Chen W, Logan SM, Holbein BE.	Antimicrob Agents Chemother	10.1128/aac.00855-19	2019
Genetics	Molecular Epidemiology and Clone Transmission of Carbapenem-Resistant Acinetobacter baumannii in ICU Rooms.	Zhang X, Li F, Awan F, Jiang H, Zeng Z, Lv W.	Front Cell Infect Microbiol	10.3389/fcimb.2021.633817	2021
	Molecular study of metallo-beta-lactamases and integrons in Acinetobacter baumannii isolates from burn patients.	Nikibakhsh M, Firoozeh F, Badmasti F, Kabir K, Zibaei M.	BMC Infect Dis	10.1186/s12879-021-06513-w	2021
Pathogenicity	Synergistic Inhibitory Effect of Polymyxin B in Combination with Ceftazidime against Robust Biofilm Formed by Acinetobacter baumannii with Genetic Deficiency in AbaI/AbaR Quorum Sensing.	Li Y, Wang B, Lu F, Ahn J, Zhang W, Cai L, Xu J, Yin Y, Cao Q, Ren Z, He X.	Microbiol Spectr	10.1128/spectrum.01768-21	2022
Pathogenicity	Shipworm symbiosis ecology-guided discovery of an antibiotic that kills colistin-resistant Acinetobacter.	Miller BW, Lim AL, Lin Z, Bailey J, Aoyagi KL, Fisher MA, Barrows LR, Manoil C, Schmidt EW, Haygood MG.	Cell Chem Biol	10.1016/j.chembiol.2021.05.003	2021
	Multiplex PCR assay for the rapid detection of Klebsiella pneumoniae pathotypes.	Kulkarni SM, Jacob JJ, Praveen T, Aravind V, Subbulakshmi R, Preethi S, Lal B, Gunasekaran K, Manesh A, Karve SM, Sudarsana J, Bhattacharya S, Shah A, Nagaraj S, Padaki P, Jayakumar S, Mathew R, Rudresh SM, Qureshi S, Nivedhana S, Joe G, Rajni E, Walia K, Veeraraghavan B.	J Med Microbiol	10.1099/jmm.0.002090	2025
	Terrien, a metabolite made by Aspergillus terreus, has activity against Cryptococcus neoformans.	Cadelis M, Grey A, van de Pas S, Geese S, Weir BS, Copp B, Wiles S.	PeerJ	10.7717/peerj.14239	2022
	Bioactivity of Eugenol: A Potential Antibiotic Adjuvant with Minimal Ecotoxicological Impact.	Ferrando N, Pino-Otin MR, Terrado E, Ballestero D, Langa E.	Int J Mol Sci	10.3390/ijms25137069	2024
	Biofilm-Induced Antibiotic Resistance in Clinical Acinetobacter baumannii Isolates.	Shenkutie AM, Yao MZ, Siu GK, Wong BKC, Leung PH.	Antibiotics (Basel)	10.3390/antibiotics9110817	2020
	Survey on Genetic Diversity, Biofilm Formation, and Detection of Colistin Resistance Genes in Clinical Isolates of Acinetobacter baumannii.	Khoshnood S, Savari M, Abbasi Montazeri E, Farajzadeh Sheikh A.	Infect Drug Resist	10.2147/idr.s253440	2020
	Psychrotrophic Antarctic marine bacteria as potential reservoirs for novel antimicrobial genes.	Hwengwere K, January GG, Howell KL, Peck LS, Upton M, Clark MS.	FEMS Microbes	10.1093/femsmc/xtaf004	2025
	Characterization of the 3,4-Dichloroaniline Degradation Gene Cluster in Acinetobacter soli GFJ2.	Gibu N, Kasai D, Sato S, Tabata M, Vangnai A, Fukuda M.	Microorganisms	10.3390/microorganisms12030613	2024
	In Vitro Prebiotic Effects and Antibacterial Activity of Five Leguminous Honeys.	Fratianni F, De Giulio B, d'Acierno A, Amato G, De Feo V, Coppola R, Nazzaro F.	Foods	10.3390/foods12183338	2023
Pathogenicity	Investigation of Novel pmrB and eptA Mutations in Isogenic Acinetobacter baumannii Isolates Associated with Colistin Resistance and Increased Virulence In Vivo.	Gerson S, Betts JW, Lucassen K, Nodari CS, Wille J, Josten M, Gottig S, Nowak J, Stefanik D, Roca I, Vila J, Cisneros JM, La Ragione RM, Seifert H, Higgins PG.	Antimicrob Agents Chemother	10.1128/aac.01586-18	2019
	Enhanced Antimicrobial and Antibiofilm Effect of New Colistin-Loaded Human Albumin Nanoparticles.	Scutera S, Argenziano M, Sparti R, Bessone F, Bianco G, Bastiancich C, Castagnoli C, Stella M, Musso T, Cavalli R.	Antibiotics (Basel)	10.3390/antibiotics10010057	2021
	Antimicrobial, anti-enzymatic and antioxidant activities of essential oils from some Tunisian Eucalyptus species.	Ayed A, Caputo L, De Feo V, Elshafie HS, Fratianni F, Nazzaro F, Hamrouni L, Amri I, Mabrouk Y, Camele I, Polito F.	Heliyon	10.1016/j.heliyon.2024.e34518	2024
	Genomic Diversity, Antimicrobial Susceptibility, and Biofilm Formation of Clinical Acinetobacter baumannii Isolates from Horses.	Ruhl-Teichner J, Jacobmeyer L, Leidner U, Semmler T, Ewers C.	Microorganisms	10.3390/microorganisms11030556	2023
	Discovery of a Series of Indane-Containing NBTIs with Activity against Multidrug-Resistant Gram-Negative Pathogens.	Cumming JG, Kreis L, Kuhne H, Wermuth R, Vercruysse M, Kramer C, Rudolph MG, Xu Z.	ACS Med Chem Lett	10.1021/acsmedchemlett.3c00187	2023
	Synthesis and antibacterial action of 3',6'-disubstituted spectinomycins.	Dharuman S, Phelps GA, Dunn CM, Wilt LA, Murphy PA, Lee RB, Snoke HE, Selchow P, Haldimann K, Bottger EC, Hobbie SN, Sander P, Lee RE.	J Antibiot (Tokyo)	10.1038/s41429-024-00750-2	2024
Pathogenicity	The effect of the efflux pump inhibitor Carbonyl Cyanide m-Chlorophenylhydrazone (CCCP) on the susceptibility to imipenem and cefepime in clinical strains of Acinetobacter baumannii.	Sanchez-Carbonel A, Mondragon B, Lopez-Chegne N, Pena-Tuesta I, Huayan-Davila G, Blitchtein D, Carrillo-Ng H, Silva-Caso W, Aguilar-Luis MA, Del Valle-Mendoza J.	PLoS One	10.1371/journal.pone.0259915	2021
	Emergence of high colistin resistance in carbapenem resistant Acinetobacter baumannii in Pakistan and its potential management through immunomodulatory effect of an extract from Saussurea lappa.	Ahsan U, Mushtaq F, Saleem S, Malik A, Sarfaraz H, Shahzad M, Uhlin BE, Ahmad I.	Front Pharmacol	10.3389/fphar.2022.986802	2022
Pathogenicity	Comparative mechanism based study on disinfectants against multidrug-resistant Acinetobacter baumannii.	Biswas D, Tiwari M, Tiwari V.	J Cell Biochem	10.1002/jcb.27373	2018
	The Novel beta-Lactam Enhancer Zidebactam Augments the In Vivo Pharmacodynamic Activity of Cefepime in a Neutropenic Mouse Lung Acinetobacter baumannii Infection Model.	Bhagwat SS, Periasamy H, Takalkar SS, Palwe SR, Khande HN, Patel MV.	Antimicrob Agents Chemother	10.1128/aac.02146-18	2019
	Characterization of Growth-Promoting Activities of Consortia of Chlorpyrifos Mineralizing Endophytic Bacteria Naturally Harboring in Rice Plants-A Potential Bio-Stimulant to Develop a Safe and Sustainable Agriculture.	Prodhan MY, Rahman MB, Rahman A, Akbor MA, Ghosh S, Nahar MN, Simo, Shamsuzzoha M, Cho KM, Haque MA.	Microorganisms	10.3390/microorganisms11071821	2023
	Detection of Extended-Spectrum beta-Lactamases among Acinetobacter Baumannii Isolated from Hospitals of Qazvin, Iran.	Zarabadi-Pour M, Peymani A, Habibollah-Pourzereshki N, Sarookhani MR, Karami AA, Javadi A.	Ethiop J Health Sci	10.4314/ejhs.v31i2.4	2021
	Association Between Biofilm Formation, Structure, and the Expression Levels of Genes Related to biofilm formation and Biofilm-Specific Resistance of Acinetobacter baumannii Strains Isolated from Burn Infection in Ahvaz, Iran.	Amin M, Navidifar T, Shooshtari FS, Rashno M, Savari M, Jahangirmehr F, Arshadi M.	Infect Drug Resist	10.2147/idr.s228981	2019
	Harnessing advanced computational approaches to design novel antimicrobial peptides against intracellular bacterial infections.	Fang Y, Fan D, Feng B, Zhu Y, Xie R, Tan X, Liu Q, Dong J, Zeng W.	Bioact Mater	10.1016/j.bioactmat.2025.04.016	2025
Genetics	Genomic Analysis and Antimicrobial Components of M7, an Aspergillus terreus Strain Derived from the South China Sea.	Qi J, Chen C, He Y, Wang Y.	J Fungi (Basel)	10.3390/jof8101051	2022
	Glycosphingolipids (GSLs) from Sphingomonas paucimobilis Increase the Efficacy of Liposome-Based Nanovaccine against Acinetobacter baumannii-Associated Pneumonia in Immunocompetent and Immunocompromised Mice.	Khan MA, Allemailem KS, Maswadeh H, Younus H.	Molecules	10.3390/molecules27227790	2022
Pathogenicity	Pharmacokinetic-pharmacodynamic modelling to investigate in vitro synergy between colistin and fusidic acid against MDR Acinetobacter baumannii.	Phee LM, Kloprogge F, Morris R, Barrett J, Wareham DW, Standing JF.	J Antimicrob Chemother	10.1093/jac/dky524	2019
Pathogenicity	An updated view of bacterial endophytes as antimicrobial agents against plant and human pathogens.	Hnamte L, Vanlallawmzuali, Kumar A, Yadav MK, Zothanpuia, Singh PK.	Curr Res Microb Sci	10.1016/j.crmicr.2024.100241	2024
Pathogenicity	Profiling of Potential Antibacterial Compounds of Lactic Acid Bacteria against Extremely Drug Resistant (XDR) Acinetobacter baumannii.	Yap PC, Ayuhan N, Woon JJ, Teh CSJ, Lee VS, Azman AS, AbuBakar S, Lee HY.	Molecules	10.3390/molecules26061727	2021
	Analysis of the Extracellular Proteome of Colistin-Resistant Korean Acinetobacter baumannii Strains.	Lee SY, Yun SH, Lee H, Yi YS, Park EC, Kim W, Kim HY, Lee JC, Kim GH, Kim SI.	ACS Omega	10.1021/acsomega.9b03723	2020
Enzymology	Antibacterial Activity of Squaric Amide Derivative SA2 against Methicillin-Resistant Staphylococcus aureus.	Yu M, Hou Y, Cheng M, Liu Y, Ling C, Zhai D, Zhao H, Li Y, Chen Y, Xue X, Ma X, Jia M, Wang B, Wang P, Li M.	Antibiotics (Basel)	10.3390/antibiotics11111497	2022
Phylogeny	The promiscuous and highly mobile resistome of Acinetobacter baumannii.	Hernandez-Gonzalez IL, Mateo-Estrada V, Castillo-Ramirez S.	Microb Genom	10.1099/mgen.0.000762	2022
	In Vitro Activity of the Ultra-Broad-Spectrum Beta-Lactamase Inhibitor QPX7728 in Combination with Meropenem against Clinical Isolates of Carbapenem-Resistant Acinetobacter baumannii.	Nelson K, Rubio-Aparicio D, Tsivkovski R, Sun D, Totrov M, Dudley M, Lomovskaya O.	Antimicrob Agents Chemother	10.1128/aac.01406-20	2020
	Antibacterial Activity and Prebiotic Properties of Six Types of Lamiaceae Honey.	Nazzaro F, Ombra MN, Coppola F, De Giulio B, d'Acierno A, Coppola R, Fratianni F.	Antibiotics (Basel)	10.3390/antibiotics13090868	2024
Metabolism	Molecular characterization and clonal dynamics of nosocomial blaOXA-23 producing XDR Acinetobacter baumannii.	Royer S, de Campos PA, Araujo BF, Ferreira ML, Goncalves IR, Batistao DWDF, Brigido RTES, Cerdeira LT, Machado LG, de Brito CS, Gontijo-Filho PP, Ribas RM.	PLoS One	10.1371/journal.pone.0198643	2018
	Molecular typing and antibiotic resistance patterns among clinical isolates of Acinetobacter baumannii recovered from burn patients in Tehran, Iran.	Maleki A, Kaviar VH, Koupaei M, Haddadi MH, Kalani BS, Valadbeigi H, Karamolahi S, Omidi N, Hashemian M, Sadeghifard N, Mohamadi J, Heidary M, Khoshnood S.	Front Microbiol	10.3389/fmicb.2022.994303	2022
	Targeting Protein Disorder for the Remediation of Antimicrobial Resistance.	Callaghan JO, Ryan MP, Hudson S, Thompson D.	ACS Omega	10.1021/acsomega.4c08427	2024
	Cu(ii) binding to an antimicrobial shrimp peptide - a small step for structural chemistry, a big leap for medicinal applications.	Miller A, Matera-Witkiewicz A, Mikolajczyk-Tarnawa A, Kola A, Wiloch M, Jonsson-Niedziolka M, Wieczorek R, Watly J, Valensin D, Rowinska-Zyrek M.	Chem Sci	10.1039/d4sc05222f	2025
	Antibiotic properties of Satureja montana L. hydrolate in bacteria and fungus of clinical interest and its impact in non-target environmental microorganisms.	Pino-Otin MR, Gan C, Terrado E, Sanz MA, Ballestero D, Langa E.	Sci Rep	10.1038/s41598-022-22419-2	2022
	Identification and Characterization of a Novel Aminoglycoside 3''-Nucleotidyltransferase, ANT(3'')-IId, From Acinetobacter lwoffii.	Liang J, Zhou K, Li Q, Dong X, Zhang P, Liu H, Lin H, Zhang X, Lu J, Lin X, Li K, Xu T, Zhang H, Bao Q, Zhu M, Hu Y, Ren P.	Front Microbiol	10.3389/fmicb.2021.728216	2021
Pathogenicity	Bioactive Polyketide and Diketopiperazine Derivatives from the Mangrove-Sediment-Derived Fungus Aspergillus sp. SCSIO41407.	Cai J, Chen C, Tan Y, Chen W, Luo X, Luo L, Yang B, Liu Y, Zhou X.	Molecules	10.3390/molecules26164851	2021
Pathogenicity	Elucidating the Pharmacokinetics/Pharmacodynamics of Aerosolized Colistin against Multidrug-Resistant Acinetobacter baumannii and Klebsiella pneumoniae in a Mouse Lung Infection Model.	Lin YW, Zhou QT, Han ML, Chen K, Onufrak NJ, Wang J, Turnidge JD, Howden BP, Forrest A, Chan HK, Li J.	Antimicrob Agents Chemother	10.1128/aac.01790-17	2018
Pathogenicity	Antimicrobial and Anti-Inflammatory Activities of MAF-1-Derived Antimicrobial Peptide Mt6 and Its D-Enantiomer D-Mt6 against Acinetobacter baumannii by Targeting Cell Membranes and Lipopolysaccharide Interaction.	Kong D, Hua X, Zhou R, Cui J, Wang T, Kong F, You H, Liu X, Adu-Amankwaah J, Guo G, Zheng K, Wu J, Tang R.	Microbiol Spectr	10.1128/spectrum.01312-22	2022
	Evaluation the reactivity of a peptide-based monoclonal antibody derived from OmpA with drug resistant pulsotypes of Acinetobacter baumannii as a potential therapeutic approach.	Yeganeh O, Shabani M, Pakzad P, Mosaffa N, Hashemi A.	Ann Clin Microbiol Antimicrob	10.1186/s12941-022-00523-5	2022
Metabolism	Comparative study of phenotypic-based detection assays for carbapenemase-producing Acinetobacter baumannii with a proposed algorithm in resource-limited settings.	Khuntayaporn P, Thirapanmethee K, Kanathum P, Chitsombat K, Chomnawang MT.	PLoS One	10.1371/journal.pone.0259686	2021
	Fluoroamphiphilic polymers exterminate multidrug-resistant Gram-negative ESKAPE pathogens while attenuating drug resistance.	Zhou Q, Li K, Wang K, Hong W, Chen J, Chai J, Yu L, Si Z, Li P.	Sci Adv	10.1126/sciadv.adp6604	2024
	Hydantoin derivative dimers as broad-spectrum antimicrobial agents against ESKAPE pathogens with enhanced killing rate and stability.	Chen Y, Jiang H, Sun Z, Liu F, Su M.	RSC Med Chem	10.1039/d4md00374h	2024
	A conserved zinc-binding site in Acinetobacter baumannii PBP2 required for elongasome-directed bacterial cell shape.	Micelli C, Dai Y, Raustad N, Isberg RR, Dowson CG, Lloyd AJ, Geisinger E, Crow A, Roper DI.	Proc Natl Acad Sci U S A	10.1073/pnas.2215237120	2023
	Development and application of a rapid visual detection technique for VanA gene in vancomycin-resistant Enterococcus faecium.	Ji T, Wang W, Wang L, Gao Y, Wang Y, Gao X.	mSphere	10.1128/msphere.00666-24	2024
Metabolism	Iron/Heme Metabolism-Targeted Gallium(III) Nanoparticles Are Active against Extracellular and Intracellular Pseudomonas aeruginosa and Acinetobacter baumannii.	Choi SR, Britigan BE, Narayanasamy P.	Antimicrob Agents Chemother	10.1128/aac.02643-18	2019
	Comparative analysis of the pathogenicity between multidrug-resistant Acinetobacter baumannii clinical isolates: isolation of highly pathogenic multidrug-resistant A. baumannii and experimental therapeutics with fourth-generation cephalosporin cefozopran.	Nishida S, Ono Y.	Infect Drug Resist	10.2147/idr.s166154	2018
	Outer membrane vesicles as a platform for the discovery of antibodies to bacterial pathogens.	Lei EK, Azmat A, Henry KA, Hussack G.	Appl Microbiol Biotechnol	10.1007/s00253-024-13033-5	2024
Genetics	Genome-Scale Metabolic Modeling Reveals Metabolic Alterations of Multidrug-Resistant Acinetobacter baumannii in a Murine Bloodstream Infection Model.	Zhao J, Zhu Y, Han J, Lin YW, Aichem M, Wang J, Chen K, Velkov T, Schreiber F, Li J.	Microorganisms	10.3390/microorganisms8111793	2020
Pathogenicity	Relationship between Tolerance and Persistence Mechanisms in Acinetobacter baumannii Strains with AbkAB Toxin-Antitoxin System.	Fernandez-Garcia L, Fernandez-Cuenca F, Blasco L, Lopez-Rojas R, Ambroa A, Lopez M, Pascual A, Bou G, Tomas M.	Antimicrob Agents Chemother	10.1128/aac.00250-18	2018
Pathogenicity	Modulatory Effects of Caffeine and Pentoxifylline on Aromatic Antibiotics: A Role for Hetero-Complex Formation.	Woziwodzka A, Krychowiak-Masnicka M, Golunski G, Felberg A, Borowik A, Wyrzykowski D, Piosik J.	Molecules	10.3390/molecules26123628	2021
	Pd(ii) and Pt(ii) complexes of tridentate ligands with selective toxicity against Cryptococcus neoformans and Candida albicans.	Mansour AM.	RSC Adv	10.1039/d1ra06559a	2021
	Enhancing Commercial Antibiotics with Trans-Cinnamaldehyde in Gram-Positive and Gram-Negative Bacteria: An In Vitro Approach.	Ferrando N, Pino-Otin MR, Ballestero D, Lorca G, Terrado EM, Langa E.	Plants (Basel)	10.3390/plants13020192	2024
Pathogenicity	The effect of sub-inhibitory concentrations of antibiotics on natural transformation in Acinetobacter baumannii.	Quinn B, Martinez J, Liu C, Nguyen M, Ramirez MS.	Int J Antimicrob Agents	10.1016/j.ijantimicag.2018.01.026	2018
Genetics	Genetic Configuration of Genomic Resistance Islands in Acinetobacter baumannii Clinical Isolates From Egypt.	Hamed SM, Hussein AFA, Al-Agamy MH, Radwan HH, Zafer MM.	Front Microbiol	10.3389/fmicb.2022.878912	2022
Pathogenicity	LysSAP26, a New Recombinant Phage Endolysin with a Broad Spectrum Antibacterial Activity.	Kim S, Jin JS, Choi YJ, Kim J.	Viruses	10.3390/v12111340	2020
	PDIA, an Iminosugar Compound with a Wide Biofilm Inhibitory Spectrum Covering Both Gram-Positive and Gram-Negative Human Bacterial Pathogens.	Kozien L, Gallienne E, Martin O, Front S, Strus M, Heczko P.	Microorganisms	10.3390/microorganisms10061222	2022
	A novel antibiotic class targeting the lipopolysaccharide transporter.	Zampaloni C, Mattei P, Bleicher K, Winther L, Thate C, Bucher C, Adam JM, Alanine A, Amrein KE, Baidin V, Bieniossek C, Bissantz C, Boess F, Cantrill C, Clairfeuille T, Dey F, Di Giorgio P, du Castel P, Dylus D, Dzygiel P, Felici A, Garcia-Alcalde F, Haldimann A, Leipner M, Leyn S, Louvel S, Misson P, Osterman A, Pahil K, Rigo S, Schaublin A, Scharf S, Schmitz P, Stoll T, Trauner A, Zoffmann S, Kahne D, Young JAT, Lobritz MA, Bradley KA.	Nature	10.1038/s41586-023-06873-0	2024
	Essential Gene Analysis in Acinetobacter baumannii by High-Density Transposon Mutagenesis and CRISPR Interference.	Bai J, Dai Y, Farinha A, Tang AY, Syal S, Vargas-Cuebas G, van Opijnen T, Isberg RR, Geisinger E.	J Bacteriol	10.1128/jb.00565-20	2021
	Uncovering the Secretion Systems of Acinetobacter baumannii: Structures and Functions in Pathogenicity and Antibiotic Resistance.	Li P, Zhang S, Wang J, Al-Shamiri MM, Han B, Chen Y, Han S, Han L.	Antibiotics (Basel)	10.3390/antibiotics12020195	2023
	Enhancing proline-rich antimicrobial peptide action by homodimerization: influence of bifunctional linker.	Li W, Lin F, Hung A, Barlow A, Sani MA, Paolini R, Singleton W, Holden J, Hossain MA, Separovic F, O'Brien-Simpson NM, Wade JD.	Chem Sci	10.1039/d1sc05662j	2022
	Two New Alkaloids and a New Butenolide Derivative from the Beibu Gulf Sponge-Derived Fungus Penicillium sp. SCSIO 41413.	Ye Y, Liang J, She J, Lin X, Wang J, Liu Y, Yang D, Tan Y, Luo X, Zhou X.	Mar Drugs	10.3390/md21010027	2022
	Repurposing of Ciclopirox to Overcome the Limitations of Zidovudine (Azidothymidine) against Multidrug-Resistant Gram-Negative Bacteria.	Cho H, Kim KS.	Pharmaceutics	10.3390/pharmaceutics14030552	2022
	Structure of the 70S Ribosome from the Human Pathogen Acinetobacter baumannii in Complex with Clinically Relevant Antibiotics.	Nicholson D, Edwards TA, O'Neill AJ, Ranson NA.	Structure	10.1016/j.str.2020.08.004	2020
	Synthesis of a novel Cu/DPA-MOF/OP/CS hydrogel with high capability in antimicrobial studies.	Jasim Al-Khafaji HH, Alsalamy A, Abed Jawad M, Ali Nasser H, Dawood AH, Hasan SY, Ahmad I, Gatea MA, Younis Albahadly WK.	Front Chem	10.3389/fchem.2023.1236580	2023
	Pixantrone Sensitizes Gram-Negative Pathogens to Rifampin.	She P, Li Z, Li Y, Liu S, Li L, Yang Y, Zhou L, Wu Y.	Microbiol Spectr	10.1128/spectrum.02114-22	2022
	One-pot five-component high diastereoselective synthesis of polysubstituted 2-piperidinones from aromatic aldehydes, nitriles, dialkyl malonates and ammonium acetate.	Vereshchagin AN, Karpenko KA, Elinson MN, Minaeva AP, Goloveshkin AS, Hansford KA, Egorov MP.	Mol Divers	10.1007/s11030-019-09997-6	2020
	Boric acid and zinc borate doped graphene hydrogels designed for burn treatment: In vitro viability-biocompatibility tests and microbiological analysis.	Bayir Y, Erkayman B, Albayrak A, Palabiyik-Yucelik SS, Can S, Hanci H, Tunc F, Halici H, Civelek MS, Sevim M, Yurdgulu EE, Metin O.	J Biomater Appl	10.1177/08853282241268673	2025
	Fluoroquinolones' Biological Activities against Laboratory Microbes and Cancer Cell Lines.	Suaifan GARY, Mohammed AAM, Alkhawaja BA.	Molecules	10.3390/molecules27051658	2022
Metabolism	iCN718, an Updated and Improved Genome-Scale Metabolic Network Reconstruction of Acinetobacter baumannii AYE.	Norsigian CJ, Kavvas E, Seif Y, Palsson BO, Monk JM.	Front Genet	10.3389/fgene.2018.00121	2018
	Decontamination Effect of Hypochlorous Acid Dry Mist on Selected Bacteria, Viruses, Spores, and Fungi as Well as on Components of Electronic Systems.	Nasilowska B, Wlodarski M, Kaliszewski M, Bogdanowicz Z, Krzowski L, Kopczynski K, Witkowski G, Czeczott-Urban A, Bombalska A, Urbanska M, Garbat K, Sowinska A, Kutwin M, Koperski W, Wozniak R, Mierczyk Z.	Int J Mol Sci	10.3390/ijms25137198	2024
	Antimicrobial cobaltocenium copolymers: tuning amphiphilicity against NDM-1 bacteria.	Hossain MW, Brand I, Barman S, Abidoun A, Hwang J, Parris A, Yang X, Nagarkatti P, Nagarkatti M, Tang C.	Biomater Sci	10.1039/d5bm00497g	2025
	The Kinocidin Interleukin-26 Shows Immediate Antimicrobial Effects Even to Multi-resistant Isolates.	Hansen BT, Maschkowitz G, Podschun R, Fickenscher H.	Front Microbiol	10.3389/fmicb.2021.757215	2021
	Investigating the time to blood culture positivity: why does it take so long?	Falconer K, Hammond R, Parcell BJ, Gillespie SH.	J Med Microbiol	10.1099/jmm.0.001942	2025
	The bactericidal and antibiofilm effects of a lysine-substituted hybrid peptide, CM-10K14K, on biofilm-forming Staphylococcus epidermidis.	Klubthawee N, Wongchai M, Aunpad R.	Sci Rep	10.1038/s41598-023-49302-y	2023
	In Vitro Screening of Antimicrobial and Anti-Coagulant Activities, ADME Profiling, and Molecular Docking Study of Citrus limon L. and Citrus paradisi L. Cold-Pressed Volatile Oils.	Hamdi A, Horchani M, Jannet HB, Snoussi M, Noumi E, Bouali N, Kadri A, Polito F, De Feo V, Edziri H.	Pharmaceuticals (Basel)	10.3390/ph16121669	2023
	Incidence of an Intracellular Multiplication Niche among Acinetobacter baumannii Clinical Isolates.	Rubio T, Gagne S, Debruyne C, Dias C, Cluzel C, Mongellaz D, Rousselle P, Gottig S, Seifert H, Higgins PG, Salcedo SP.	mSystems	10.1128/msystems.00488-21	2022
	High burden of MDR, XDR, PDR, and MBL producing Gram negative bacteria causing infections in Kermanshah health centers during 2019-2020.	Kadivarian S, Rostamian M, Dashtbin S, Kooti S, Zangeneh Z, Abiri R, Alvandi A.	Iran J Microbiol	10.18502/ijm.v15i3.12896	2023
	Bactericidal activity of herbal volatile oil extracts against multidrug-resistant Acinetobacter baumannii.	Intorasoot A, Chornchoem P, Sookkhee S, Intorasoot S.	J Intercult Ethnopharmacol	10.5455/jice.20170411091159	2017
	Investigation of Acinetobacter baumannii Activity in Vascular Surgery Units through Epidemiological Management Based on the Analysis of Antimicrobial Resistance, Biofilm Formation and Genotyping.	Szczypta A, Talaga-Cwiertnia K, Kielar M, Krzysciak P, Gajewska A, Szura M, Bulanda M, Chmielarczyk A.	Int J Environ Res Public Health	10.3390/ijerph18041563	2021
	Outer Membrane Vesicles of Acinetobacter baumannii DS002 Are Selectively Enriched with TonB-Dependent Transporters and Play a Key Role in Iron Acquisition.	Dhurve G, Madikonda AK, Jagannadham MV, Siddavattam D.	Microbiol Spectr	10.1128/spectrum.00293-22	2022
	AdeR-AdeS mutations & overexpression of the AdeABC efflux system in ciprofloxacin-resistant Acinetobacter baumannii clinical isolates.	Lari AR, Ardebili A, Hashemi A.	Indian J Med Res	10.4103/ijmr.ijmr_644_16	2018
	Acquisition of Colistin Resistance Links Cell Membrane Thickness Alteration with a Point Mutation in the lpxD Gene in Acinetobacter baumannii.	Saleh NM, Hesham MS, Amin MA, Samir Mohamed R.	Antibiotics (Basel)	10.3390/antibiotics9040164	2020
	Antibacterial mechanism of peptide Cec4 against Acinetobacter baumannii.	Peng J, Long H, Liu W, Wu Z, Wang T, Zeng Z, Guo G, Wu J.	Infect Drug Resist	10.2147/idr.s214057	2019
	Structure of the Acinetobacter baumannii PmrA receiver domain and insights into clinical mutants affecting DNA binding and promoting colistin resistance.	Palethorpe S, Milton ME, Pesci EC, Cavanagh J.	J Biochem	10.1093/jb/mvab102	2022
Pathogenicity	Mutasynthetic Production and Antimicrobial Characterization of Darobactin Analogs.	Bohringer N, Green R, Liu Y, Mettal U, Marner M, Modaresi SM, Jakob RP, Wuisan ZG, Maier T, Iinishi A, Hiller S, Lewis K, Schaberle TF.	Microbiol Spectr	10.1128/spectrum.01535-21	2021
Pathogenicity	The neutralizing effect of heparin on blood-derived antimicrobial compounds: impact on antibacterial activity and inflammatory response.	Cont D, Harm S, Schildbock C, Kolm C, Kirschner AKT, Farnleitner AH, Pilecky M, Zottl J, Hartmann J, Weber V.	Front Immunol	10.3389/fimmu.2024.1373255	2024
	gamma-Core Guided Antibiotic Design Based on Human Enteric Defensin 5.	Zhao G, Jia C, Zhu C, Fang M, Li C, Chen Y, He Y, Han S, He Y, Gao J, Wang T, Wang C, Wang J.	Membranes (Basel)	10.3390/membranes13010051	2022
	Synergistic effects of polymyxin and vancomycin combinations on carbapenem- and polymyxin-resistant Klebsiella pneumoniae and their molecular characteristics.	Nwabor OF, Chukamnerd A, Terbtothakun P, Nwabor LC, Surachat K, Roytrakul S, Voravuthikunchai SP, Chusri S.	Microbiol Spectr	10.1128/spectrum.01199-23	2023
	The combination effect of meropenem/sulbactam/polymyxin-B on the pharmacodynamic parameters for mutant selection windows against carbapenem-resistant Acinetobacter baumannii.	Zhang J, Diao S, Liu Y, Wang H, Liu Y, Zhu S, Feng K, Tang X, Oo C, Zhu P, Lv Z, Yu M, Sy SKB, Zhu Y.	Front Microbiol	10.3389/fmicb.2022.1024702	2022
	Role of efflux pumps in reduced susceptibility to tigecycline in Acinetobacter baumannii.	Ardehali SH, Azimi T, Fallah F, Owrang M, Aghamohammadi N, Azimi L.	New Microbes New Infect	10.1016/j.nmni.2019.100547	2019
	Antimicrobial, Herbicidal and pesticidal potential of Tunisian eucalyptus species: Chemoprofiling and biological evaluation.	Khedhri S, Polito F, Caputo L, Khammassi M, Dhaouadi F, Amri I, Hamrouni L, Mabrouk Y, Fratianni F, Nazzaro F, De Feo V.	Heliyon	10.1016/j.heliyon.2024.e29905	2024
Metabolism	BlsA integrates light and temperature signals into iron metabolism through Fur in the human pathogen Acinetobacter baumannii.	Tuttobene MR, Cribb P, Mussi MA.	Sci Rep	10.1038/s41598-018-26127-8	2018
	Evaluation of Agar Dilution Method in Susceptibility Testing of Polymyxins for Enterobacteriaceae and Non-Fermentative Rods: Advantages Compared to Broth Microdilution and Broth Macrodilution.	Hu X, Sun L, Nie T, Yang Y, Wang X, Pang J, Lu X, Li X, Lu Y, Li C, Yang X, Meng Y, Li G, You X.	Antibiotics (Basel)	10.3390/antibiotics11101392	2022
	Impregnation of Melaleuca Family Essential Oil Nanoemulsions into Pectin:Polyvinyl Alcohol Patches to Provide an Antibacterial Environment for Infected Wounds.	Demir D, Ceylan S, Ipek SL, Aslan D, Ozbolat V.	ChemistryOpen	10.1002/open.202500117	2025
	Synthesis, Antibacterial and Antifungal Activity of New 3-Aryl-5H-pyrrolo[1,2-a]imidazole and 5H-Imidazo[1,2-a]azepine Quaternary Salts.	Demchenko S, Lesyk R, Yadlovskyi O, Zuegg J, Elliott AG, Drapak I, Fedchenkova Y, Suvorova Z, Demchenko A.	Molecules	10.3390/molecules26144253	2021
	Poly(imidazolium ester) antibiotic forms intracellular polymer-nucleic acid biomolecular condensates and fight drug-resistant bacteria.	Xu X, Korupalli C, Mahajan D, Tan C, Vu QHN, Pham LT, Lu L, Greenberg EP, Dang TT, Chan-Park MB.	Nat Commun	10.1038/s41467-025-64828-7	2025
	Synergistic Killing of Polymyxin B in Combination With the Antineoplastic Drug Mitotane Against Polymyxin-Susceptible and -Resistant Acinetobacter baumannii: A Metabolomic Study.	Tran TB, Bergen PJ, Creek DJ, Velkov T, Li J.	Front Pharmacol	10.3389/fphar.2018.00359	2018
	Evaluating the antimicrobial resistance patterns and molecular frequency of bla _oxa-48 and bla _GES-2 genes in Pseudomonas aeruginosa and Acinetobacter baumannii strains isolated from burn wound infection in Tehran, Iran.	Tarafdar F, Jafari B, Azimi T.	New Microbes New Infect	10.1016/j.nmni.2020.100686	2020
Pathogenicity	Galleria mellonella as a Good Model to Study Acinetobacter baumannii Pathogenesis.	Tao Y, Duma L, Rossez Y.	Pathogens	10.3390/pathogens10111483	2021
Pathogenicity	OMN6 a novel bioengineered peptide for the treatment of multidrug resistant Gram negative bacteria.	Mandel S, Michaeli J, Nur N, Erbetti I, Zazoun J, Ferrari L, Felici A, Cohen-Kutner M, Bachnoff N.	Sci Rep	10.1038/s41598-021-86155-9	2021
Pathogenicity	Effect of Host Human Products on Natural Transformation in Acinetobacter baumannii.	Quinn B, Traglia GM, Nguyen M, Martinez J, Liu C, Fernandez JS, Ramirez MS.	Curr Microbiol	10.1007/s00284-017-1417-5	2019
Pathogenicity	Evaluation of bacteriophage cocktail on septicaemia caused by colistin-resistant Acinetobacter baumannii in immunocompromised mice model.	Patel SR, Pratap CB, Nath G.	Indian J Med Res	10.4103/ijmr.ijmr_2271_18	2021
	Potent synergy and sustained bactericidal activity of polymyxins combined with Gram-positive only class of antibiotics versus four Gram-negative bacteria.	Wang Y, Feng J, Yu J, Wen L, Chen L, An H, Xiao W, Zhang B, Feng H, Zhou M, Jiang Z.	Ann Clin Microbiol Antimicrob	10.1186/s12941-024-00720-4	2024
	Assessment of In Vitro Cefiderocol Susceptibility and Comparators against an Epidemiologically Diverse Collection of Acinetobacter baumannii Clinical Isolates.	Balleste-Delpierre C, Ramirez A, Munoz L, Longshaw C, Roca I, Vila J.	Antibiotics (Basel)	10.3390/antibiotics11020187	2022
	Experimental and DFT studies of sulfadiazine 'piano-stool' Ru(ii) and Rh(iii) complexes.	Mansour AM, Radacki K.	RSC Adv	10.1039/d0ra01085e	2020
	Small Molecules Incorporating Privileged Amidine Moiety as Potential Hits Combating Antibiotic-Resistant Bacteria.	El-Sayed SM, Ahmed SA, Gulia K, Lenhard JR, Hassan AHE, Farahat AA.	Pharmaceuticals (Basel)	10.3390/ph16071040	2023
	Novel Phage Lysin Abp013 against Acinetobacter baumannii.	Chu JJK, Poh WH, Hasnuddin NTB, Hew EY, Dam LC, Sahili AE, Rice SA, Goh BC.	Antibiotics (Basel)	10.3390/antibiotics11020169	2022
	IOX1 activity as sepsis therapy and an antibiotic against multidrug-resistant bacteria.	Lee SJ, You JS, Gharbi A, Kim YJ, Lee MS, Kim DH, Lee KW, Jung ID, Park YM.	Sci Rep	10.1038/s41598-021-82377-z	2021
Pathogenicity	Potent beta-Lactam Enhancer Activity of Zidebactam and WCK 5153 against Acinetobacter baumannii, Including Carbapenemase-Producing Clinical Isolates.	Moya B, Barcelo IM, Bhagwat S, Patel M, Bou G, Papp-Wallace KM, Bonomo RA, Oliver A.	Antimicrob Agents Chemother	10.1128/aac.01238-17	2017
	Gram-Negative Bacteria Holding Together in a Biofilm: The Acinetobacter baumannii Way.	Pompilio A, Scribano D, Sarshar M, Di Bonaventura G, Palamara AT, Ambrosi C.	Microorganisms	10.3390/microorganisms9071353	2021
	Assessment of physiological and electrochemical effects of a repurposed zinc dithiocarbamate complex on Acinetobacter baumannii biofilms.	Yang Q, Olaifa K, Andrew FP, Ajibade PA, Ajunwa OM, Marsili E.	Sci Rep	10.1038/s41598-022-16047-z	2022
	Prevalence of multi-drug resistant (MDR) and extensively drug-resistant (XDR) phenotypes of Pseudomonas aeruginosa and Acinetobacter baumannii isolated in clinical samples from Northeast of Iran.	Mirzaei B, Bazgir ZN, Goli HR, Iranpour F, Mohammadi F, Babaei R.	BMC Res Notes	10.1186/s13104-020-05224-w	2020
	ZnO-Doped Metal-Organic Frameworks Nanoparticles: Antibacterial Activity and Mechanisms.	Zheng H, Zhong B, Wang Q, Li X, Chen J, Liu L, Liu T.	Int J Mol Sci	10.3390/ijms241512238	2023
	Recent Advances in the Pursuit of an Effective Acinetobacter baumannii Vaccine.	Gellings PS, Wilkins AA, Morici LA.	Pathogens	10.3390/pathogens9121066	2020
	Clinical Isolates of Acinetobacter spp. Are Highly Serum Resistant Despite Efficient Recognition by the Complement System.	Magda M, Bettoni S, Laabei M, Fairley D, Russo TA, Riesbeck K, Blom AM.	Front Immunol	10.3389/fimmu.2022.814193	2022
	Bactericidal Effect of Cecropin A Fused Endolysin on Drug-Resistant Gram-Negative Pathogens.	Lim J, Hong J, Jung Y, Ha J, Kim H, Myung H, Song M.	J Microbiol Biotechnol	10.4014/jmb.2205.05009	2022
	A Subset Screen of the Compounds Australia Scaffold Library Identifies 7-Acylaminodibenzoxazepinones as Potent and Selective Hits for Anti-Giardia Drug Discovery.	Hart CJS, Riches AG, Tiash S, Clapper E, Ramu S, Zuegg J, Ryan JH, Skinner-Adams TS.	Biomedicines	10.3390/biomedicines10123182	2022
	Enhancing Antibiotic Efficacy and Combating Biofilm Formation: Evaluating the Synergistic Potential of Origanum vulgare Essential Oil against Multidrug-Resistant Gram-Negative Bacteria.	Saoudi B, Bariz K, Saci S, Belounis Y, Ait Issad H, Abbaci M, Mustapha MA, Nabti EH, Alenazy R, Alhussaini MS, Alyahya AAI, Alqasmi M, Alhumaidi MS, Almufarriji FM, Houali K.	Microorganisms	10.3390/microorganisms12081651	2024
	Identification and bioactivity evaluation of secondary metabolites from Antarctic-derived Penicillium chrysogenum CCTCC M 2020019.	Khan I, Zhang H, Liu W, Zhang L, Peng F, Chen Y, Zhang Q, Zhang G, Zhang W, Zhang C.	RSC Adv	10.1039/d0ra03529g	2020
	Identification of Putative Drug Targets in Highly Resistant Gram-Negative Bacteria; and Drug Discovery Against Glycyl-tRNA Synthetase as a New Target.	Fereshteh S, Noori Goodarzi N, Kalhor H, Rahimi H, Barzi SM, Badmasti F.	Bioinform Biol Insights	10.1177/11779322231152980	2023
	Whole-genome sequencing for the characterization of resistance mechanisms and epidemiology of colistin-resistant Acinetobacter baumannii.	Hahm C, Chung HS, Lee M.	PLoS One	10.1371/journal.pone.0264335	2022
Pathogenicity	Predominance of international clone 2 multidrug-resistant Acinetobacter baumannii clinical isolates in Thailand: a nationwide study.	Khuntayaporn P, Kanathum P, Houngsaitong J, Montakantikul P, Thirapanmethee K, Chomnawang MT.	Ann Clin Microbiol Antimicrob	10.1186/s12941-021-00424-z	2021
	Unsupervised Machine Learning Organization of the Functional Dark Proteome of Gram-Negative "Superbugs": Six Protein Clusters Amenable for Distinct Scientific Applications.	Sicilia C, Corral-Lugo A, Smialowski P, McConnell MJ, Martin-Galiano AJ.	ACS Omega	10.1021/acsomega.2c04076	2022
Pathogenicity	Inhibition of LpxC Increases Antibiotic Susceptibility in Acinetobacter baumannii.	Garcia-Quintanilla M, Caro-Vega JM, Pulido MR, Moreno-Martinez P, Pachon J, McConnell MJ.	Antimicrob Agents Chemother	10.1128/aac.00407-16	2016
	Antimicrobial Activity of Manganese(I) Tricarbonyl Complexes Bearing 1,2,3-Triazole Ligands.	Friaes S, Trigueiros C, Gomes CSB, Fernandes AR, Lenis-Rojas OA, Martins M, Royo B.	Molecules	10.3390/molecules28217453	2023
	Distribution of carbapenemase genes in clinical isolates of Acinetobacter baumannii & a comparison of MALDI-TOF mass spectrometry-based detection of carbapenemase production with other phenotypic methods.	Sharma M, Singhal L, Gautam V, Ray P.	Indian J Med Res	10.4103/ijmr.ijmr_1383_18	2020
Cultivation	Catechol siderophores framed on 2,3-dihydroxybenzoyl-L-serine from Streptomyces varsoviensis.	Liu Z, Huang T, Shi Q, Deng Z, Lin S.	Front Microbiol	10.3389/fmicb.2023.1182449	2023
	KDEON WK-11: A short antipseudomonal peptide with promising potential.	Casciaro B, Loffredo MR, Cappiello F, O'Sullivan N, Tortora C, Manzer R, Karmakar S, Haskell A, Hasan SK, Mangoni ML.	Front Chem	10.3389/fchem.2022.1000765	2022
	Bioactive Compounds from Plant Origin as Natural Antimicrobial Agents for the Treatment of Wound Infections.	Pacyga K, Pacyga P, Topola E, Viscardi S, Duda-Madej A.	Int J Mol Sci	10.3390/ijms25042100	2024
	Antibacterial and Bactericidal Effects of the Er: YAG Laser on Oral Bacteria: A Systematic Review of Microbiological Evidence.	Fiegler-Rudol J, Skaba D, Kawczyk-Krupka A, Wiench R.	J Funct Biomater	10.3390/jfb16060209	2025
	Antimicrobial Activities of Essential Oils of Different Pinus Species from Bosnia and Herzegovina.	Mirkovic S, Tadic V, Milenkovic MT, Usjak D, Racic G, Bojovic D, Zugic A.	Pharmaceutics	10.3390/pharmaceutics16101331	2024
	Identification and detection of pathogenic bacteria from patients with hospital-acquired pneumonia in southwestern Iran; evaluation of biofilm production and molecular typing of bacterial isolates.	Mazloomirad F, Hasanzadeh S, Sharifi A, Nikbakht G, Roustaei N, Khoramrooz SS.	BMC Pulm Med	10.1186/s12890-021-01773-3	2021
	Antimicrobial, Immunomodulatory and Anti-Inflammatory Potential of Liposomal Thymoquinone: Implications in the Treatment of Bacterial Pneumonia in Immunocompromised Mice.	Allemailem KS, Almatroudi A, Alrumaihi F, Aljaghwani A, Alnuqaydan AM, Khalilullah H, Younus H, El-Kady AM, Aldakheel FM, Khan AA, Khan A, Khan MA.	Biomedicines	10.3390/biomedicines9111673	2021
	Amino Alcohols as Potential Antibiotic and Antifungal Leads.	Baker JR, Cossar PJ, Blaskovich MAT, Elliott AG, Zuegg J, Cooper MA, Lewis PJ, McCluskey A.	Molecules	10.3390/molecules27072050	2022
Phylogeny	Antimicrobial Natural Products from Plant Pathogenic Fungi.	Cadelis MM, Li SA, van de Pas SJ, Grey A, Mulholland D, Weir BS, Copp BR, Wiles S.	Molecules	10.3390/molecules28031142	2023
	In vitro and In vivo Activity of Theaflavin-Epicatechin Combinations versus Multidrug-Resistant Acinetobacter baumannii.	Betts JW, Hornsey M, Wareham DW, La Ragione RM.	Infect Dis Ther	10.1007/s40121-017-0161-2	2017
	Boron-Containing Analogs of Fosmidomycin: Benzoxaborole Derivatives Exhibit Promising Activity Against Resistant Pathogens.	Gamrat JM, Orme CL, Mancini G, Burke SJ, Alhthlol LM, Colandrea RC, Figula BC, Tomares DT, Heindl JE, Tomsho JW.	ACS Omega	10.1021/acsomega.5c02701	2025
	A Multiepitope Peptide, rOmp22, Encapsulated in Chitosan-PLGA Nanoparticles as a Candidate Vaccine Against Acinetobacter baumannii Infection.	Du X, Xue J, Jiang M, Lin S, Huang Y, Deng K, Shu L, Xu H, Li Z, Yao J, Chen S, Shen Z, Feng G.	Int J Nanomedicine	10.2147/ijn.s296527	2021
	Validation of Recombinase Polymerase Amplification with In-House Lateral Flow Assay for mcr-1 Gene Detection of Colistin Resistant Escherichia coli Isolates.	Ullah N, Suchanta N, Pimpitak U, Santanirand P, Am-In N, Chaichanawongsaroj N.	Antibiotics (Basel)	10.3390/antibiotics13100984	2024
	Highly Effective Biocides against Pseudomonas aeruginosa Reveal New Mechanistic Insights Across Gram-Negative Bacteria.	Sanchez CA, Vargas-Cuebas GG, Michaud ME, Allen RA, Morrison-Lewis KR, Siddiqui S, Minbiole KPC, Wuest WM.	ACS Infect Dis	10.1021/acsinfecdis.4c00433	2024
Phylogeny	Genomic and phenotypic analyses of diverse non-clinical Acinetobacter baumannii strains reveals strain-specific virulence and resistance capacity.	Hamidian M, Maharjan RP, Farrugia DN, Delgado NN, Dinh H, Short FL, Kostoulias X, Peleg AY, Paulsen IT, Cain AK.	Microb Genom	10.1099/mgen.0.000765	2022
	Isolation of bacteriophages against multidrug resistant Acinetobacter baumannii.	Ghajavand H, Esfahani BN, Havaei A, Fazeli H, Jafari R, Moghim S.	Res Pharm Sci	10.4103/1735-5362.213982	2017
	Discovery of a Novel Lineage Burkholderia cepacia ST 1870 Endophytically Isolated from Medicinal Polygala paniculata Which Shows Potent In Vitro Antileishmanial and Antimicrobial Effects.	de Paula Nogueira Cruz F, Ferreira de Paula A, Nogueira CT, Marques de Andrade PH, Borges LM, Lacava PT, Baratella da Cunha Camargo IL, Anibal FF, Paiva de Sousa C.	Int J Microbiol	10.1155/2021/6618559	2021
	Tetracycline resistance mediated by tet efflux pumps in clinical isolates of Acinetobacter baumannii.	Beheshti M, Ardebili A, Beheshti F, Lari AR, Siyadatpanah A, Pournajaf A, Gautam D, Dolma KG, Nissapatorn V.	Rev Inst Med Trop Sao Paulo	10.1590/s1678-9946202062088	2020
	Development of Novel Bacterial Topoisomerase Inhibitors Assisted by Computational Screening.	Powell JW, Mann CA, Toth PD, Nolan S, Steinert A, Ove C, Seffernick JT, Wozniak DJ, Kebriaei R, Lindert S, Osheroff N, Yalowich JC, Mitton-Fry MJ.	ACS Med Chem Lett	10.1021/acsmedchemlett.4c00162	2024
	Methylation in hangtaimycin biosynthesis and its antibacterial activities.	Luo M, Dong Y, Deng Z, Sun Y.	Synth Syst Biotechnol	10.1016/j.synbio.2023.10.003	2023
Genetics	Single Nucleotide Polymorphism-Based Real-Time PCR Screening Assay for Rapid Tracking of Bacterial Infection Clusters To Complement Whole-Genome Sequencing Efforts during Outbreak Investigations.	Treffon J, Heppner B, Eismann J, Bothe J, Omengo B, Mellmann A.	Microbiol Spectr	10.1128/spectrum.03036-22	2022
	Synergistic Antibacterial Activity of Combined Antimicrobials and the Clinical Outcome of Patients With Carbapenemase-Producing Acinetobacter baumannii Infection.	Qu J, Yu R, Wang Q, Feng C, Lv X.	Front Microbiol	10.3389/fmicb.2020.541423	2020
Pathogenicity	Synergy between Colistin and the Signal Peptidase Inhibitor MD3 Is Dependent on the Mechanism of Colistin Resistance in Acinetobacter baumannii.	Martinez-Guitian M, Vazquez-Ucha JC, Odingo J, Parish T, Poza M, Waite RD, Bou G, Wareham DW, Beceiro A.	Antimicrob Agents Chemother	10.1128/aac.00510-16	2016
	Multidrug-resistant Acinetobacter baumannii strains with NDM-1: Molecular characterization and in vitro efficacy of meropenem-based combinations.	Wang J, Ning Y, Li S, Wang Y, Liang J, Jin C, Yan H, Huang Y.	Exp Ther Med	10.3892/etm.2019.7927	2019
	Design, green synthesis, and quorum sensing quenching potential of novel 2-oxo-pyridines containing a thiophene/furan scaffold and targeting a LasR gene on P. aeruginosa.	Ammar YA, Ragab A, Migahed MA, Al-Sharbasy S, Salem MA, Riad OKM, Selim HMRM, Abd-Elmaksoud GA, Abusaif MS.	RSC Adv	10.1039/d3ra04230h	2023
	Chemical Composition of Essential Oils of Bulbs and Aerial Parts of Two Cultivars of Allium sativum and Their Antibiofilm Activity against Food and Nosocomial Pathogens.	Nazzaro F, Polito F, Amato G, Caputo L, Francolino R, D'Acierno A, Fratianni F, Candido V, Coppola R, De Feo V.	Antibiotics (Basel)	10.3390/antibiotics11060724	2022
	Adoptive macrophage directed photodynamic therapy of multidrug-resistant bacterial infection.	Wang Z, Wu A, Cheng W, Li Y, Li D, Wang L, Zhang X, Xiao Y.	Nat Commun	10.1038/s41467-023-43074-9	2023
	A polytherapy based approach to combat antimicrobial resistance using cubosomes.	Lai X, Han ML, Ding Y, Chow SH, Le Brun AP, Wu CM, Bergen PJ, Jiang JH, Hsu HY, Muir BW, White J, Song J, Li J, Shen HH.	Nat Commun	10.1038/s41467-022-28012-5	2022
	Growth Rate and Biofilm Formation Ability of Clinical and Laboratory-Evolved Colistin-Resistant Strains of Acinetobacter baumannii.	Farshadzadeh Z, Taheri B, Rahimi S, Shoja S, Pourhajibagher M, Haghighi MA, Bahador A.	Front Microbiol	10.3389/fmicb.2018.00153	2018
	Synergism of cationic antimicrobial peptide WLBU2 with antibacterial agents against biofilms of multi-drug resistant Acinetobacter baumannii and Klebsiella pneumoniae.	Swedan S, Shubair Z, Almaaytah A.	Infect Drug Resist	10.2147/idr.s215084	2019
Metabolism	Biological Effects of Glucosinolate Degradation Products from Horseradish: A Horse that Wins the Race.	Popovic M, Maravic A, Cikes Culic V, Dulovic A, Burcul F, Blazevic I.	Biomolecules	10.3390/biom10020343	2020
Pathogenicity	Synthesis and biological evaluation of solithromycin analogs against multidrug resistant pathogens.	Daher SS, Jin X, Patel J, Freundlich JS, Buttaro B, Andrade RB.	Bioorg Med Chem Lett	10.1016/j.bmcl.2019.03.038	2019
	Polymyxins Bind to the Cell Surface of Unculturable Acinetobacter baumannii and Cause Unique Dependent Resistance.	Zhu Y, Lu J, Han ML, Jiang X, Azad MAK, Patil NA, Lin YW, Zhao J, Hu Y, Yu HH, Chen K, Boyce JD, Dunstan RA, Lithgow T, Barlow CK, Li W, Schneider-Futschik EK, Wang J, Gong B, Sommer B, Creek DJ, Fu J, Wang L, Schreiber F, Velkov T, Li J.	Adv Sci (Weinh)	10.1002/advs.202000704	2020
	Impact of a Novel Anticoccidial Analogue on Systemic Staphylococcus aureus Infection in a Bioluminescent Mouse Model.	Nguyen HT, Venter H, Woolford L, Young K, McCluskey A, Garg S, Page SW, Trott DJ, Ogunniyi AD.	Antibiotics (Basel)	10.3390/antibiotics11010065	2022
	Development of a high-throughput minimum inhibitory concentration (HT-MIC) testing workflow.	Tiwari S, Nizet O, Dillon N.	Front Microbiol	10.3389/fmicb.2023.1079033	2023
	Heterogeneous-Backbone Proteomimetic Analogues of Lasiocepsin, a Disulfide-Rich Antimicrobial Peptide with a Compact Tertiary Fold.	Cabalteja CC, Lin Q, Harmon TW, Rao SR, Di YP, Horne WS.	ACS Chem Biol	10.1021/acschembio.2c00138	2022
	Advantages and Challenges of Using Antimicrobial Peptides in Synergism with Antibiotics for Treating Multidrug-Resistant Bacteria.	Goncalves RM, Monges BED, Oshiro KGN, Candido ES, Pimentel JPF, Franco OL, Cardoso MH.	ACS Infect Dis	10.1021/acsinfecdis.4c00702	2025
	Pathogenic Bacterium Acinetobacter baumannii Inhibits the Formation of Neutrophil Extracellular Traps by Suppressing Neutrophil Adhesion.	Kamoshida G, Kikuchi-Ueda T, Nishida S, Tansho-Nagakawa S, Ubagai T, Ono Y.	Front Immunol	10.3389/fimmu.2018.00178	2018
	Antimicrobial and antibiofilm effects of cyclic dipeptide-rich fraction from Lactobacillus plantarum loaded on graphene oxide nanosheets.	Dezaki FS, Narimani T, Ghanadian M, Bidram E, Poursina F.	Front Microbiol	10.3389/fmicb.2024.1391039	2024
	Acinetobacter baumannii Efflux Pumps and Antibiotic Resistance.	Abdi SN, Ghotaslou R, Ganbarov K, Mobed A, Tanomand A, Yousefi M, Asgharzadeh M, Kafil HS.	Infect Drug Resist	10.2147/idr.s228089	2020
	Safety and immunogenicity of a new glycoengineered vaccine against Acinetobacter baumannii in mice.	Li X, Pan C, Liu Z, Sun P, Hua X, Feng E, Yu Y, Wu J, Zhu L, Wang H.	Microb Biotechnol	10.1111/1751-7915.13770	2022
	A novel chemical biology and computational approach to expedite the discovery of new-generation polymyxins against life-threatening Acinetobacter baumannii.	Jiang X, Patil NA, Azad MAK, Wickremasinghe H, Yu H, Zhao J, Zhang X, Li M, Gong B, Wan L, Ma W, Thompson PE, Yang K, Yuan B, Schreiber F, Wang L, Velkov T, Roberts KD, Li J.	Chem Sci	10.1039/d1sc03460j	2021
Metabolism	The sensor kinase BfmS controls production of outer membrane vesicles in Acinetobacter baumannii.	Kim SY, Kim MH, Kim SI, Son JH, Kim S, Lee YC, Shin M, Oh MH, Lee JC.	BMC Microbiol	10.1186/s12866-019-1679-0	2019
	Multidrug Resistant Acinetobacter baumannii Biofilms: Evaluation of Phenotypic-Genotypic Association and Susceptibility to Cinnamic and Gallic Acids.	Sherif MM, Elkhatib WF, Khalaf WS, Elleboudy NS, Abdelaziz NA.	Front Microbiol	10.3389/fmicb.2021.716627	2021
	Biosynthesis and characterisation of antimicrobial silver nanoparticles from a selection of fever-reducing medicinal plants of South Africa	Lediga ME, Malatjie TS, Olivier DK, Ndinteh DT, van Vuuren SF.	S Afr J Bot	10.1016/j.sajb.2018.08.022	2018
	Peptide/beta-Peptoid Hybrids with Ultrashort PEG-Like Moieties: Effects on Hydrophobicity, Antibacterial Activity and Hemolytic Properties.	Frederiksen N, Louka S, Mudaliar C, Domraceva I, Kreicberga A, Pugovics O, Zabicka D, Tomczak M, Wygoda W, Bjorkling F, Franzyk H.	Int J Mol Sci	10.3390/ijms22137041	2021
	Phenotypic and genotypic characterization of clinical carbapenem-resistant Acinetobacter species harboring the metallo-beta-lactamases IMP-8 or NDM-1 in China.	Xu Q, Mu X, He J, Liu H, Liu X, Wang Y, Hua X, Yu Y.	Microbiol Spectr	10.1128/spectrum.01158-24	2025
	Pimenta Oil as A Potential Treatment for Acinetobacter Baumannii Wound Infection: In Vitro and In Vivo Bioassays in Relation to Its Chemical Composition.	Ismail MM, Samir R, Saber FR, Ahmed SR, Farag MA.	Antibiotics (Basel)	10.3390/antibiotics9100679	2020
Enzymology	Susceptibility Testing of Colistin for Acinetobacter baumannii: How Far Are We from the Truth?	Sacco F, Visca P, Runci F, Antonelli G, Raponi G.	Antibiotics (Basel)	10.3390/antibiotics10010048	2021
	Virulence determinants and biofilm formation of Acinetobacter baumannii isolated from hospitalized patients.	Aliramezani A, Soleimani M, Fard RMN, Nojoomi F.	Germs	10.18683/germs.2019.1171	2019
	Bioactivity of EtOH and MeOH Extracts of Basidiomycetes Mushroom (Stereum hirsutum) on Atherosclerosis.	Sevindik M, Ozdemir B, Bal C, Selamoglu Z.	Arch Razi Inst	10.22092/ari.2019.126283.1340	2021
Pathogenicity	Untargeted metabolomics analysis reveals key pathways responsible for the synergistic killing of colistin and doripenem combination against Acinetobacter baumannii.	Maifiah MH, Creek DJ, Nation RL, Forrest A, Tsuji BT, Velkov T, Li J.	Sci Rep	10.1038/srep45527	2017
Pathogenicity	Bacteremia by colistin-resistant Acinetobacter baumannii isolate: a case report.	Garcia Casallas JC, Robayo-Amortegui H, Corredor-Rozo Z, Carrasco-Marquez AM, Escobar-Perez J.	J Med Case Rep	10.1186/s13256-019-2062-3	2019
	Challenge in the Discovery of New Drugs: Antimicrobial Peptides against WHO-List of Critical and High-Priority Bacteria.	Roque-Borda CA, da Silva PB, Rodrigues MC, Azevedo RB, Di Filippo L, Duarte JL, Chorilli M, Festozo Vicente E, Pavan FR.	Pharmaceutics	10.3390/pharmaceutics13060773	2021
	Assessment of the risk associated with Bacillus cereus isolates and potential combat with methanolic Artemisia vulgaris extract.	Fareid MA, El-Sherbiny GM, Elafandy NM, Eltoum NE, Othman MS, Sharaf MH, Abu-Elghait M, Elkhashab DM, Hamada FA.	Front Microbiol	10.3389/fmicb.2025.1640200	2025
Metabolism	Acinetobacter baumannii Lipopolysaccharide Influences Adipokine Expression in 3T3-L1 Adipocytes.	Unno Y, Sato Y, Nishida S, Nakano A, Nakano R, Ubagai T, Ono Y.	Mediators Inflamm	10.1155/2017/9039302	2017
	Endophytic Lifestyle of Global Clones of Extended-Spectrum beta-Lactamase-Producing Priority Pathogens in Fresh Vegetables: a Trojan Horse Strategy Favoring Human Colonization?	Lopes R, Fuentes-Castillo D, Fontana H, Rodrigues L, Dantas K, Cerdeira L, Henriques I, Lincopan N.	mSystems	10.1128/msystems.01125-20	2021
	Prevalence and phenotypic pattern of antibiotic resistance of Acinetobacter baumannii isolated from different types of raw meat samples in Isfahan, Iran.	Askari N, Momtaz H, Tajbakhsh E.	Vet Med Sci	10.1002/vms3.199	2020
	The Distribution and Source of MRDOs Infection: A Retrospective Study in 8 ICUs, 2013-2019.	Li ZJ, Wang KW, Liu B, Zang F, Zhang Y, Zhang WH, Zhou SM, Zhang YX.	Infect Drug Resist	10.2147/idr.s332196	2021
	Study on the Detection and Infection Distribution of Multidrug-Resistant Organisms in Different Specimens.	Li Z, Zhang Y, Zhang W, Zhang Y, Zhou S, Chen W, Liu Y.	Infect Drug Resist	10.2147/idr.s375682	2022
	The antibacterial effect of tellurite is achieved through intracellular acidification and magnesium disruption.	Peng W, Fu Y, Wang Y, Deng Z, Chen D, Lin S, Liang R.	mLife	10.1002/mlf2.70028	2025
	Phytochemical Investigation and Biofilm-Inhibitory Activity of Bachtiari Savory (Satureja bachtiarica Bunge) Aerial Parts.	Rahmani Samani M, D'Urso G, Nazzaro F, Fratianni F, Masullo M, Piacente S.	Plants (Basel)	10.3390/plants13010067	2023
	Multidrug Resistant Acinetobacter Isolates Release Resistance Determinants Through Contact-Dependent Killing and Bacteriophage Lysis.	Crippen CS, Jr MJR, Sanchez S, Szymanski CM.	Front Microbiol	10.3389/fmicb.2020.01918	2020
	In vitro Antimicrobial Activity of Robenidine, Ethylenediaminetetraacetic Acid and Polymyxin B Nonapeptide Against Important Human and Veterinary Pathogens.	Khazandi M, Pi H, Chan WY, Ogunniyi AD, Sim JXF, Venter H, Garg S, Page SW, Hill PB, McCluskey A, Trott DJ.	Front Microbiol	10.3389/fmicb.2019.00837	2019
	Bloodstream infections caused by ST2 Acinetobacter baumannii: risk factors, antibiotic regimens, and virulence over 6 years period in China.	Yu K, Zeng W, Xu Y, Liao W, Xu W, Zhou T, Cao J, Chen L.	Antimicrob Resist Infect Control	10.1186/s13756-020-00876-6	2021
	A Proof-of-Concept Study of the Efficacy of Systemically Administered Polymyxins in Mouse Burn Wound Infection Caused by Multidrug-Resistant Gram-Negative Pathogens.	Lin YW, Chen K, Wang J, Velkov T, Zhou QT, Li J.	Antimicrob Agents Chemother	10.1128/aac.02527-17	2018
Pathogenicity	Platinum Cyclooctadiene Complexes with Activity against Gram-positive Bacteria.	Frei A, Ramu S, Lowe GJ, Dinh H, Semenec L, Elliott AG, Zuegg J, Deckers A, Jung N, Brase S, Cain AK, Blaskovich MAT.	ChemMedChem	10.1002/cmdc.202100157	2021
	Zn(II) and Cu(II) Coordination Enhances the Antimicrobial Activity of Piscidin 3, but Not That of Piscidins 1 and 2.	Adriana M, Aleksandra M, Denise B, Kinga G, Joanna W, Aleksandra H, Robert W, Agnieszka MW, Magdalena RZ.	Inorg Chem	10.1021/acs.inorgchem.4c01659	2024
	Essential Oils of Tunisian Tetraclinis articulata (Vahl) Mast.: Chemical and Biological Insights.	Ayed A, Caputo L, De Feo V, Nazzaro F, Fratianni F, Amri I, Hamrouni L, Mabrouk Y, Polito F.	Chem Biodivers	10.1002/cbdv.202401618	2025
	Establishment and application of a rapid visual diagnostic method for Streptococcus agalactiae based on recombinase polymerase amplification and lateral flow strips.	Ji T, Cai Y, Gao Y, Wang G, Miao Y, Gao X.	Sci Rep	10.1038/s41598-024-56138-7	2024
	Easy One-Pot Low-Temperature Synthesized Ag-ZnO Nanoparticles and Their Activity Against Clinical Isolates of Methicillin-Resistant Staphylococcus aureus.	Naskar A, Lee S, Kim KS.	Front Bioeng Biotechnol	10.3389/fbioe.2020.00216	2020
Pathogenicity	Structure and Function of the PiuA and PirA Siderophore-Drug Receptors from Pseudomonas aeruginosa and Acinetobacter baumannii.	Moynie L, Luscher A, Rolo D, Rolo D, Pletzer D, Tortajada A, Weingart H, Braun Y, Page MG, Naismith JH, Kohler T.	Antimicrob Agents Chemother	10.1128/aac.02531-16	2017
	Role of aminoglycoside-modifying enzymes and 16S rRNA methylase (ArmA) in resistance of Acinetobacter baumannii clinical isolates against aminoglycosides.	Jouybari MA, Ahanjan M, Mirzaei B, Goli HR.	Rev Soc Bras Med Trop	10.1590/0037-8682-0599-2020	2021
Metabolism	Light Modulates Metabolic Pathways and Other Novel Physiological Traits in the Human Pathogen Acinetobacter baumannii.	Muller GL, Tuttobene M, Altilio M, Martinez Amezaga M, Nguyen M, Cribb P, Cybulski LE, Ramirez MS, Altabe S, Mussi MA.	J Bacteriol	10.1128/jb.00011-17	2017
Pathogenicity	Determining the Development of Persisters in Extensively Drug-Resistant Acinetobacter baumannii upon Exposure to Polymyxin B-Based Antibiotic Combinations Using Flow Cytometry.	Wong FH, Cai Y, Leck H, Lim TP, Teo JQ, Lee W, Koh TH, Tan TT, Tan KW, Kwa AL.	Antimicrob Agents Chemother	10.1128/aac.01712-19	2020
	Importance of twitching and surface-associated motility in the virulence of Acinetobacter baumannii.	Corral J, Perez-Varela M, Sanchez-Osuna M, Cortes P, Barbe J, Aranda J.	Virulence	10.1080/21505594.2021.1950268	2021
	Natural Products from Chilean and Antarctic Marine Fungi and Their Biomedical Relevance.	Arrieche D, Cabrera-Pardo JR, San-Martin A, Carrasco H, Taborga L.	Mar Drugs	10.3390/md21020098	2023
	In-vitro evaluation of the effect of okra (Abelmoschus esculentus L.) extract on periodontal cells: a comprehensive study of cellular and molecular impacts.	Tosun UU, Aydin ST, Tiryaki A, Baykara D, Yakut A, Rayaman E, Taskin T, Ekinci Dogan C, Gunduz O, Agrali OB.	BMC Complement Med Ther	10.1186/s12906-025-04828-8	2025
	Interaction of Staphylococcus aureus and Acinetobacter baumannii during In Vitro beta-Lactam Exposure.	Smith NM, Ang A, Tan F, Macias K, James S, Sidhu J, Lenhard JR.	Antimicrob Agents Chemother	10.1128/aac.02414-20	2021
	Baicalein Resensitizes Multidrug-Resistant Gram-Negative Pathogens to Doxycycline.	Wang Y, Su J, Zhou Z, Yang J, Liu W, Zhang Y, Zhang P, Guo T, Li G.	Microbiol Spectr	10.1128/spectrum.04702-22	2023
	Enhancing Antibacterial Efficacy: Combining Novel Bacterial Topoisomerase Inhibitors with Efflux Pump Inhibitors and Other Agents Against Gram-Negative Bacteria.	Zorman M, Kokot M, Zdovc I, Senerovic L, Mandic M, Zidar N, Cotman AE, Durcik M, Peterlin Masic L, Minovski N, Anderluh M, Hrast Rambaher M.	Antibiotics (Basel)	10.3390/antibiotics13111081	2024
	High-Throughput Discovery of Synthetic Siderophores for Trojan Horse Antibiotics.	Weber BS, Ritchie NE, Hilker S, Chan DCK, Peukert C, Deisinger JP, Ives R, Ardal C, Burrows LL, Bronstrup M, Magolan J, Raivio TL, Brown ED.	ACS Infect Dis	10.1021/acsinfecdis.4c00359	2024
	Testing Antimicrobial Properties of Human Lactoferrin-Derived Fragments.	Ostrowka M, Duda-Madej A, Pietluch F, Mackiewicz P, Gagat P.	Int J Mol Sci	10.3390/ijms241310529	2023
	Potential cannabidiol (CBD) repurposing as antibacterial and promising therapy of CBD plus polymyxin B (PB) against PB-resistant gram-negative bacilli.	Abichabki N, Zacharias LV, Moreira NC, Bellissimo-Rodrigues F, Moreira FL, Benzi JRL, Ogasawara TMC, Ferreira JC, Ribeiro CM, Pavan FR, Pereira LRL, Brancini GTP, Braga GUL, Zuardi AW, Hallak JEC, Crippa JAS, Lanchote VL, Canton R, Darini ALC, Andrade LN.	Sci Rep	10.1038/s41598-022-10393-8	2022
	Discovery of a family of menaquinone-targeting cyclic lipodepsipeptides for multidrug-resistant Gram-positive pathogens.	Sun R, Zhao D, Yu X, Zhang F, You R, Luo X, Li L.	Commun Biol	10.1038/s42003-024-07159-5	2024
	First identification of multidrug-resistant Acinetobacter bereziniae isolates harboring bla _NDM-1 from hospitals in South China.	Mo XM, Pan Q, Seifert H, Xing XW, Yuan J, Zhou ZY, Luo XY, Liu HM, Xie YL, Yang LQ, Hong XB, Higgins PG, Wong NK.	Heliyon	10.1016/j.heliyon.2022.e12365	2023
	Complete Genome Sequencing of Acinetobacter baumannii AC1633 and Acinetobacter nosocomialis AC1530 Unveils a Large Multidrug-Resistant Plasmid Encoding the NDM-1 and OXA-58 Carbapenemases.	Alattraqchi AG, Mohd Rani F, A Rahman NI, Ismail S, Cleary DW, Clarke SC, Yeo CC.	mSphere	10.1128/msphere.01076-20	2021
	Anti-Biofilm Extracts and Molecules from the Marine Environment.	Caudal F, Roullier C, Rodrigues S, Dufour A, Artigaud S, Le Blay G, Bazire A, Petek S.	Mar Drugs	10.3390/md22070313	2024
	Antioxidant and antimicrobial potentials of mycelial extracts of Hohenbuehelia myxotricha grown in different liquid culture media.	Krupodorova T, Barshteyn V, Sevindik M.	BioTechnologia (Pozn)	10.5114/bta.2022.113912	2022
	Characterization of biofilm production in different strains of Acinetobacter baumannii and the effects of chemical compounds on biofilm formation.	Lin MF, Lin YY, Lan CY.	PeerJ	10.7717/peerj.9020	2020
	Rapid, automated, and reliable antimicrobial susceptibility test from positive blood culture by CAST-R.	Zhu P, Ren L, Zhu Y, Dai J, Liu H, Mao Y, Li Y, He Y, Zheng X, Chen R, Fu X, Zhang L, Sun L, Zhu Y, Ji Y, Ma B, Xu Y, Xu J, Yang Q.	mLife	10.1002/mlf2.12019	2022
Metabolism	Robust Suppression of Lipopolysaccharide Deficiency in Acinetobacter baumannii by Growth in Minimal Medium.	Nagy E, Losick R, Kahne D.	J Bacteriol	10.1128/jb.00420-19	2019
	The utilization of Blaptica dubia cockroaches as an in vivo model to test antibiotic efficacy.	Collins E, Martin C, Blomquist T, Phillips K, Cantlay S, Fisher N, Horzempa J.	Sci Rep	10.1038/s41598-021-03486-3	2021
	Comparison of steam technology and a two-step cleaning (water/detergent) and disinfecting (1,000 resp. 5,000 ppm hypochlorite) method using microfiber cloth for environmental control of multidrug-resistant organisms in an intensive care unit.	Oztoprak N, Kizilates F, Percin D.	GMS Hyg Infect Control	10.3205/dgkh000330	2019
	Integrated Chemical and Biological Evaluation of Linden Honeydew Honey from Bosnia and Herzegovina: Composition and Cellular Effects.	Barbaric A, Saftic Martinovic L, Marijanovic Z, Juretic L, Juric A, Petrovic D, Soljic V, Gobin I.	Foods	10.3390/foods14101668	2025
	Penfluridol synergizes with colistin to reverse colistin resistance in Gram-negative bacilli.	Chatupheeraphat C, Kaewsai N, Anuwongcharoen N, Phanus-Umporn C, Pornsuwan S, Eiamphungporn W.	Sci Rep	10.1038/s41598-025-01303-9	2025
	Carbapenem-Resistant Acinetobacter baumannii in Three Tertiary Care Hospitals in Mexico: Virulence Profiles, Innate Immune Response and Clonal Dissemination.	Alcantar-Curiel MD, Rosales-Reyes R, Jarillo-Quijada MD, Gayosso-Vazquez C, Fernandez-Vazquez JL, Toledano-Tableros JE, Giono-Cerezo S, Garza-Villafuerte P, Lopez-Huerta A, Vences-Vences D, Morfin-Otero R, Rodriguez-Noriega E, Lopez-Alvarez MDR, Espinosa-Sotero MDC, Santos-Preciado JI.	Front Microbiol	10.3389/fmicb.2019.02116	2019
	Antimicrobial Peptides from Rat-Tailed Maggots of the Drone Fly Eristalis tenax Show Potent Activity against Multidrug-Resistant Gram-Negative Bacteria.	Hirsch R, Wiesner J, Bauer A, Marker A, Vogel H, Hammann PE, Vilcinskas A.	Microorganisms	10.3390/microorganisms8050626	2020
	Rapid, Low-Complexity, Simultaneous Bacterial Group Identification and Antimicrobial Susceptibility Testing Performed Directly on Positive Blood Culture Bottles Using Chromogenic Agar.	Robberts FJL, Owusu-Ofori A, Oduro G, Gyampomah TK, Marles N, Fox AT, Chenoweth JG, Schully KL, Clark DV.	Am J Trop Med Hyg	10.4269/ajtmh.22-0278	2022
	Strengthening collaborations at the Biology-Physics interface: trends in antimicrobial photodynamic therapy.	Cabral FV, Dos Santos Souza TH, Sellera FP, Fontes A, Ribeiro MS.	Biophys Rev	10.1007/s12551-023-01066-5	2023
Genetics	Genomics-Driven Discovery of Benzoxazole Alkaloids from the Marine-Derived Micromonospora sp. SCSIO 07395.	Cheng Z, Zhang Q, Peng J, Zhao X, Ma L, Zhang C, Zhu Y.	Molecules	10.3390/molecules28020821	2023
	Rapid Detection of Candida tropicalis in Clinical Samples From Different Sources Using RPA-LFS.	Wang L, Xu A, Zhou P, Zhao M, Xu C, Wang Y, Wang K, Wang F, Miao Y, Zhao W, Gao X.	Front Cell Infect Microbiol	10.3389/fcimb.2022.898186	2022
	Pyridylbenzimidazole based Re(i)(CO)₃ complexes: antimicrobial activity, spectroscopic and density functional theory calculations.	Mansour AM.	RSC Adv	10.1039/c9ra01566c	2019
	Identification of a Novel Plasmid Carrying mcr-4.3 in an Acinetobacter baumannii Strain in China.	Ma F, Shen C, Zheng X, Liu Y, Chen H, Zhong L, Liang Y, Liao K, Xia Y, Tian GB, Yang Y.	Antimicrob Agents Chemother	10.1128/aac.00133-19	2019
	Interplay between Colistin Resistance, Virulence and Fitness in Acinetobacter baumannii.	Da Silva GJ, Domingues S.	Antibiotics (Basel)	10.3390/antibiotics6040028	2017
	Biogenic Silver Nanoparticles Strategically Combined With Origanum vulgare Derivatives: Antibacterial Mechanism of Action and Effect on Multidrug-Resistant Strains.	Scandorieiro S, Rodrigues BCD, Nishio EK, Panagio LA, de Oliveira AG, Duran N, Nakazato G, Kobayashi RKT.	Front Microbiol	10.3389/fmicb.2022.842600	2022
	Assessment of Phage-Mediated Inhibition and Removal of Multidrug-Resistant Pseudomonas aeruginosa Biofilm on Medical Implants.	Amankwah S, Adisu M, Gorems K, Abdella K, Kassa T.	Infect Drug Resist	10.2147/idr.s367460	2022
	Chemical Composition and Agronomic Traits of Allium sativum and Allium ampeloprasum Leaves and Bulbs and Their Action against Listeria monocytogenes and Other Food Pathogens.	Polito F, Amato G, Caputo L, De Feo V, Fratianni F, Candido V, Nazzaro F.	Foods	10.3390/foods11070995	2022
Pathogenicity	Lipopeptide Paenipeptin Analogues Potentiate Clarithromycin and Rifampin against Carbapenem-Resistant Pathogens.	Moon SH, Huang E.	Antimicrob Agents Chemother	10.1128/aac.00329-18	2018
	Chemical Composition, Antibacterial Properties, and Anti-Enzymatic Effects of Eucalyptus Essential Oils Sourced from Tunisia.	Khedhri S, Polito F, Caputo L, De Feo V, Khamassi M, Kochti O, Hamrouni L, Mabrouk Y, Nazzaro F, Fratianni F, Amri I.	Molecules	10.3390/molecules28207211	2023
	Genes Involved in the Biosynthesis and Transport of Acinetobactin in Acinetobacter baumannii.	Hasan T, Choi CH, Oh MH.	Genomics Inform	10.5808/gi.2015.13.1.2	2015
Genetics	Systematically investigating and identifying bacteriocins in the human gut microbiome.	Zhang D, Zou Y, Shi Y, Zhang J, Liu J, Wu G, Zhang J, Gao Y, Chen M, Li YX.	Cell Genom	10.1016/j.xgen.2025.100983	2025
	Investigations into the structure-activity relationship in gemini QACs based on biphenyl and oxydiphenyl linker.	Vereshchagin AN, Frolov NA, Konyuhova VY, Kapelistaya EA, Hansford KA, Egorov MP.	RSC Adv	10.1039/d0ra08900a	2021
	Efficacy of Surgical/Wound Washes against Bacteria: Effect of Different In Vitro Models.	Parvin F, Vickery K, Deva AK, Hu H.	Materials (Basel)	10.3390/ma15103630	2022
	Antimicrobial Activity of Garlic Derivatives on Common Causative Microorganisms of the External Ear Canal and Chronic Middle Ear Infections.	Uzun L, Dal T, Kalcioglu MT, Yurek M, Acikgoz ZC, Durmaz R.	Turk Arch Otorhinolaryngol	10.5152/tao.2019.4413	2019
	A new subclass of intrinsic aminoglycoside nucleotidyltransferases, ANT(3")-II, is horizontally transferred among Acinetobacter spp. by homologous recombination.	Zhang G, Leclercq SO, Tian J, Wang C, Yahara K, Ai G, Liu S, Feng J.	PLoS Genet	10.1371/journal.pgen.1006602	2017
	Design and Evaluation of Novel Polymyxin Fluorescent Probes.	Yun B, Roberts KD, Thompson PE, Nation RL, Velkov T, Li J.	Sensors (Basel)	10.3390/s17112598	2017
Metabolism	Microbiological features and clinical impact of the type VI secretion system (T6SS) in Acinetobacter baumannii isolates causing bacteremia.	Kim J, Lee JY, Lee H, Choi JY, Kim DH, Wi YM, Peck KR, Ko KS.	Virulence	10.1080/21505594.2017.1323164	2017
	Broad-Spectrum Antibacterial Peptide Kills Extracellular and Intracellular Bacteria Without Affecting Epithelialization.	Nepal A, Raeder SB, Sogaard CK, Haugan MS, Otterlei M.	Front Microbiol	10.3389/fmicb.2021.764451	2021
	Broad-Spectrum Antibacterial Activity of Antioxidant Octyl Gallate and Its Impact on Gut Microbiome.	Yang J, Gould TJ, Jeon B, Ji Y.	Antibiotics (Basel)	10.3390/antibiotics13080731	2024
	Potent Antimicrobial and Antibiofilm Activities of Feleucin-K3 Analogs Modified by alpha-(4-Pentenyl)-Ala against Multidrug-Resistant Bacteria.	Guo X, Yan T, Rao J, Yue X, Pei X, Deng J, Sun W, Yang W, Zhang B, Xie J.	Biomolecules	10.3390/biom11050761	2021
Metabolism	Acinetobacter baumannii can use multiple siderophores for iron acquisition, but only acinetobactin is required for virulence.	Sheldon JR, Skaar EP.	PLoS Pathog	10.1371/journal.ppat.1008995	2020
Phylogeny	Microevolution in the major outer membrane protein OmpA of Acinetobacter baumannii.	Viale AM, Evans BA.	Microb Genom	10.1099/mgen.0.000381	2020
	Unveiling the active isomer of cycloalanopine, a cyclic opine from Lactobacillus rhamnosus LS8, through synthesis and analog production.	Antwi I, Chiorean S, van Belkum MJ, Vederas JC.	RSC Med Chem	10.1039/d0md00033g	2020
	Drug Resistance and the Prevention Strategies in Food Borne Bacteria: An Update Review.	Hashempour-Baltork F, Hosseini H, Shojaee-Aliabadi S, Torbati M, Alizadeh AM, Alizadeh M.	Adv Pharm Bull	10.15171/apb.2019.041	2019
	Deciphering the virulence factors, regulation, and immune response to Acinetobacter baumannii infection.	Shadan A, Pathak A, Ma Y, Pathania R, Singh RP.	Front Cell Infect Microbiol	10.3389/fcimb.2023.1053968	2023
	Detection of Salmonella Typhi bacteriophages in surface waters as a scalable approach to environmental surveillance.	Shrestha S, Da Silva KE, Shakya J, Yu AT, Katuwal N, Shrestha R, Shakya M, Shahi SB, Naga SR, LeBoa C, Aiemjoy K, Bogoch II, Saha S, Tamrakar D, Andrews JR.	PLoS Negl Trop Dis	10.1371/journal.pntd.0011912	2024
	A normalized parameter for comparison of biofilm dispersants in vitro.	Tian S, Shi L, Ren Y, van der Mei HC, Busscher HJ.	Biofilm	10.1016/j.bioflm.2024.100188	2024
	Biological sex influences susceptibility to Acinetobacter baumannii pneumonia in mice.	Pires S, Peignier A, Seto J, Smyth DS, Parker D.	JCI Insight	10.1172/jci.insight.132223	2020
	Acinetobacter baumannii and methicillin-resistant Staphylococcus aureus in long-term care facilities in eastern Taiwan.	Tsai HC, Huang TY, Chen JS, Chen WJ, Lin CY, Hsu BM.	Tzu Chi Med J	10.4103/tcmj.tcmj_136_18	2019
	New Phenol Derivatives from the Haima Cold Seep-Derived Fungus Aspergillus subversicolor CYH-17.	Che YH, Ding WP, Xiao ZH, Wu JM, Yin H, Wang FZ, Zhang S.	Mar Drugs	10.3390/md22030117	2024
	Culture-independent identification of bloodstream infections from whole blood: prospective evaluation in specimens of known infection status.	Iyer V, Castro D, Malla B, Panda B, Rabson AR, Horowitz G, Heger N, Gupta K, Singer A, Norwitz ER.	J Clin Microbiol	10.1128/jcm.01498-23	2024
	Endophytic Bacteria Enterobacter hormaechei Fabricated Silver Nanoparticles and Their Antimicrobial Activity.	Monowar T, Rahman MS, Bhore SJ, Sathasivam KV.	Pharmaceutics	10.3390/pharmaceutics13040511	2021
	Role of immunodeficiency in Acinetobacter baumannii associated pneumonia in mice.	Liu AR, Du WJ, Xie JF, Xu JY, Huang YZ, Qiu HB, Yang Y.	Chin Med J (Engl)	10.1097/cm9.0000000000001027	2020
	Molecular Basis of Selectivity and Activity for the Antimicrobial Peptide Lynronne-1 Informs Rational Design of Peptide with Improved Activity.	Jayawant ES, Hutchinson J, Gasparikova D, Lockey C, Prunonosa Lara L, Guy C, Brooks RL, Dixon AM.	Chembiochem	10.1002/cbic.202100151	2021
	Design, synthesis, antimicrobial activity, stability, and mechanism of action of bioresorbable ceragenins.	Gubler S, Zaugg A, Yi R, Sherren E, Milner E, Conyer W, May T, Jack T, Heaton T, Christopherson J, Higbee P, Powers E, Takara M, Linder A, Boyack B, Pauga F, Salmon M, Thomas M, Shiraki M, Deng S, Savage PB.	RSC Med Chem	10.1039/d4md00990h	2025
	Loureirin A is a narrow-spectrum antimicrobial agent against Helicobacter pylori.	Tong Q, Yin C, Hang X, Bai Y, Zhang C, Xu J, Huang Y, Ge Y, Chen T, Zeng L, Jia J, Bi H.	Antimicrob Agents Chemother	10.1128/aac.00314-24	2024
	Antimicrobial Impact of Wood Vinegar Produced Through Co-Pyrolysis of Eucalyptus Wood and Aromatic Herbs.	Gama GSP, Pimenta AS, Feijo FMC, Aires CAM, de Melo RR, Dos Santos CS, de Medeiros LCD, da Costa Monteiro TV, Fasciotti M, de Medeiros PL, de Morais MRM, de Azevedo TKB.	Antibiotics (Basel)	10.3390/antibiotics13111056	2024
	Engineering a vanillate-producing strain of Pseudomonas sp. NGC7 corresponding to aromatic compounds derived from the continuous catalytic alkaline oxidation of sulfite lignin.	Kamada M, Yasuta C, Higuchi Y, Yoshida A, Kurnia I, Sakamoto C, Takeuchi A, Osaka Y, Muraki K, Kamimura N, Masai E, Sonoki T.	Microb Cell Fact	10.1186/s12934-024-02590-z	2024
	Improving bacteria identification from digital melt assay via oligonucleotide-based temperature calibration.	Traylor A, Lee PW, Hsieh K, Wang TH.	Anal Chim Acta	10.1016/j.aca.2024.342371	2024
	Structural and biological characterization of shortened derivatives of the cathelicidin PMAP-36.	Biondi B, de Pascale L, Mardirossian M, Di Stasi A, Favaro M, Scocchi M, Peggion C.	Sci Rep	10.1038/s41598-023-41945-1	2023
	Novel Antimicrobial Compounds as Ophiobolin-Type Sesterterpenes and Pimarane-Type Diterpene From Bipolaris Species TJ403-B1.	Shen L, Liu M, He Y, Al Anbari WH, Li H, Lin S, Chai C, Wang J, Hu Z, Zhang Y.	Front Microbiol	10.3389/fmicb.2020.00856	2020
Metabolism	Gene Transfer Potential of Outer Membrane Vesicles of Gram-Negative Bacteria.	Dell'Annunziata F, Folliero V, Giugliano R, De Filippis A, Santarcangelo C, Izzo V, Daglia M, Galdiero M, Arciola CR, Franci G.	Int J Mol Sci	10.3390/ijms22115985	2021
Pathogenicity	Colistin and Polymyxin B Dosage Regimens against Acinetobacter baumannii: Differences in Activity and the Emergence of Resistance.	Cheah SE, Li J, Tsuji BT, Forrest A, Bulitta JB, Nation RL.	Antimicrob Agents Chemother	10.1128/aac.02927-15	2016
	Identification of the Anti-Infective Aborycin Biosynthetic Gene Cluster from Deep-Sea-Derived Streptomyces sp. SCSIO ZS0098 Enables Production in a Heterologous Host.	Shao M, Ma J, Li Q, Ju J.	Mar Drugs	10.3390/md17020127	2019
	Influence of Kombucha Fermentation on Antioxidant and Antimicrobial Activity of Monofloral Rapeseed Bee-Collected Pollen.	Kostic AZ, Sknepnek A, Milincic DD, Gasic U, Kilibarda S, Pesic MB.	Antioxidants (Basel)	10.3390/antiox14060752	2025
Pathogenicity	Immunomodulatory Role of Clarithromycin in Acinetobacter baumannii Infection via Formation of Neutrophil Extracellular Traps.	Konstantinidis T, Kambas K, Mitsios A, Panopoulou M, Tsironidou V, Dellaporta E, Kouklakis G, Arampatzioglou A, Angelidou I, Mitroulis I, Skendros P, Ritis K.	Antimicrob Agents Chemother	10.1128/aac.02063-15	2016
	Olive oil nanoemulsion containing curcumin: antimicrobial agent against multidrug-resistant bacteria.	Confessor MVA, Agreles MAA, Campos LAA, Silva Neto AF, Borges JC, Martins RM, Scavuzzi AML, Lopes ACS, Kretzschmar EAM, Cavalcanti IMF.	Appl Microbiol Biotechnol	10.1007/s00253-024-13057-x	2024
Pathogenicity	An Amphipathic Undecapeptide with All d-Amino Acids Shows Promising Activity against Colistin-Resistant Strains of Acinetobacter baumannii and a Dual Mode of Action.	Oddo A, Thomsen TT, Kjelstrup S, Gorey C, Franzyk H, Frimodt-Moller N, Lobner-Olesen A, Hansen PR.	Antimicrob Agents Chemother	10.1128/aac.01966-15	2016
Pathogenicity	Proteomics Landscape of Host-Pathogen Interaction in Acinetobacter baumannii Infected Mouse Lung.	Li X, Liu X, Horvatovich P, Hu Y, Zhang J.	Front Genet	10.3389/fgene.2021.563516	2021
	Endophytic Microbes from Medicinal Plants in Fenghuang Mountain as a Source of Antibiotics.	Yang A, Hong Y, Zhou F, Zhang L, Zhu Y, Wang C, Hu Y, Yu L, Chen L, Wang X.	Molecules	10.3390/molecules28176301	2023
Enzymology	Cryo-Electron Microscopy Structure of an Acinetobacter baumannii Multidrug Efflux Pump.	Su CC, Morgan CE, Kambakam S, Rajavel M, Scott H, Huang W, Emerson CC, Taylor DJ, Stewart PL, Bonomo RA, Yu EW.	mBio	10.1128/mbio.01295-19	2019
	Development of a natural product optimization strategy for inhibitors against MraY, a promising antibacterial target.	Yamamoto K, Sato T, Hao A, Asao K, Kaguchi R, Kusaka S, Ruddarraju RR, Kazamori D, Seo K, Takahashi S, Horiuchi M, Yokota SI, Lee SY, Ichikawa S.	Nat Commun	10.1038/s41467-024-49484-7	2024
	A multiplex Taqman PCR assay for MRSA detection from whole blood.	Duraiswamy S, Agarwalla S, Lok KS, Tse YY, Wu R, Wang Z.	PLoS One	10.1371/journal.pone.0294782	2023
	The Immune Response against Acinetobacter baumannii, an Emerging Pathogen in Nosocomial Infections.	Garcia-Patino MG, Garcia-Contreras R, Licona-Limon P.	Front Immunol	10.3389/fimmu.2017.00441	2017
	Evaluation of Polymyxin B Susceptibility Profile and Detection of Drug Resistance Genes among Acinetobacter Baumannii Clinical Isolates in Tehran, Iran during 2015-2016.	Mirnejad R, Heidary M, Bahramian A, Goudarzi M, Pournajaf A.	Mediterr J Hematol Infect Dis	10.4084/mjhid.2018.044	2018
Pathogenicity	Paradoxical Effect of Polymyxin B: High Drug Exposure Amplifies Resistance in Acinetobacter baumannii.	Tsuji BT, Landersdorfer CB, Lenhard JR, Cheah SE, Thamlikitkul V, Rao GG, Holden PN, Forrest A, Bulitta JB, Nation RL, Li J.	Antimicrob Agents Chemother	10.1128/aac.02831-15	2016
	Prevalence of classes 1 and 2 integrons in multidrug-resistant Acinetobacter baumanni isolates recovered from some aquatic environment in South Africa.	Adeniji OO, Elsheikh EAE, Okoh AI.	Sci Rep	10.1038/s41598-022-24724-2	2022
	Halo- and Thiocarbazomycins from Coral- and Coral Reef Sands-Derived Actinomycetes.	Wu Q, Zhu H, Sun C, Zhou L, Wang H, Shi S, Tian X, Ju J.	Mar Drugs	10.3390/md20080537	2022
	Complete Genome Sequence of Acinetobacter baumannii Strain B8342, a Motility-Positive Clinical Isolate.	Vijaykumar S, Balaji V, Biswas I.	Genome Announc	10.1128/genomea.00925-15	2015
	Molecular Genotyping of Acinetobacter baumannii Species Isolated from Patients in Tehran, Iran, by Repetitive Element PCR Fingerprinting.	Kian B, Mirnejad R, Moradli G, Mirkalantari S, Golmohammadi R.	Iran J Pathol	10.30699/ijp.13.2.144	2018
Pathogenicity	Biofilm formation is not associated with worse outcome in Acinetobacter baumannii bacteraemic pneumonia.	Wang YC, Huang TW, Yang YS, Kuo SC, Chen CT, Liu CP, Liu YM, Chen TL, Chang FY, Wu SH, How CK, Lee YT.	Sci Rep	10.1038/s41598-018-25661-9	2018
	Complete Genome Sequence of the Clinical Strain Acinetobacter baumannii R2090 Carrying the Chromosomally Encoded Metallo-beta-Lactamase Gene blaNDM-1.	Krahn T, Wibberg D, Maus I, Winkler A, Nordmann P, Puhler A, Poirel L, Schluter A.	Genome Announc	10.1128/genomea.01008-15	2015
	Antimicrobial and Antifungal Activity of Rare Substituted 1,2,3-Thiaselenazoles and Corresponding Matched Pair 1,2,3-Dithiazoles.	Laitinen T, Baranovsky IV, Konstantinova LS, Poso A, Rakitin OA, Asquith CRM.	Antibiotics (Basel)	10.3390/antibiotics9070369	2020
Metabolism	First Occurrence of OXA-72-Producing Acinetobacter baumannii in Serbia.	Dortet L, Bonnin RA, Bernabeu S, Escaut L, Vittecoq D, Girlich D, Imanci D, Fortineau N, Naas T.	Antimicrob Agents Chemother	10.1128/aac.01016-16	2016
	TXH11106: A Third-Generation MreB Inhibitor with Enhanced Activity against a Broad Range of Gram-Negative Bacterial Pathogens.	Bryan EJ, Sagong HY, Parhi AK, Grier MC, Roberge JY, LaVoie EJ, Pilch DS.	Antibiotics (Basel)	10.3390/antibiotics11050693	2022
	Screening of Polyethylene-Degrading Bacteria from Rhyzopertha Dominica and Evaluation of Its Key Enzymes Degrading Polyethylene.	Zhang Y, Lin Y, Gou H, Feng X, Zhang X, Yang L.	Polymers (Basel)	10.3390/polym14235127	2022
	First Evidence of a Combination of Terpinen-4-ol and alpha-Terpineol as a Promising Tool against ESKAPE Pathogens.	Johansen B, Duval RE, Sergere JC.	Molecules	10.3390/molecules27217472	2022
	Use of Taguchi design for optimization of diesel-oil biodegradation using consortium of Pseudomonas stutzeri, Cellulosimicrobium cellulans, Acinetobacter baumannii and Pseudomonas balearica isolated from tarball in Terengganu Beach, Malaysia.	Nkem BM, Halimoon N, Yusoff FM, Johari WLW.	J Environ Health Sci Eng	10.1007/s40201-022-00812-3	2022
	Acinetobacter baumannii in human body louse.	La Scola B, Raoult D.	Emerg Infect Dis	10.3201/eid1009.040242	2004
	Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features.	Bergogne-Berezin E, Towner KJ.	Clin Microbiol Rev	10.1128/cmr.9.2.148	1996
Phylogeny	Characterization of Acinetobacter type strains and isolates obtained from wastewater treatment plants by PCR fingerprinting.	Wiedmann-al-Ahmad M, Tichy HV, Schon G.	Appl Environ Microbiol	10.1128/aem.60.11.4066-4071.1994	1994
	Antiseptic quaternary ammonium compound tolerance by gram-negative bacteria can be rapidly detected using an impermeant fluorescent dye-based assay.	Gregorchuk BSJ, Reimer SL, Beniac DR, Hiebert SL, Booth TF, Wuzinski M, Funk BE, Milner KA, Cartwright NH, Doucet AN, Mulvey MR, Khajehpour M, Zhanel GG, Bay DC.	Sci Rep	10.1038/s41598-020-77446-8	2020
Enzymology	Label-Free Detection and Discrimination of Bacterial Pathogens Based on Hemin Recognition.	Maltais TR, Adak AK, Younis W, Seleem MN, Wei A.	Bioconjug Chem	10.1021/acs.bioconjchem.6b00236	2016
Metabolism	Rapid Uptake and Photodynamic Inactivation of Staphylococci by Ga(III)-Protoporphyrin IX.	Morales-de-Echegaray AV, Maltais TR, Lin L, Younis W, Kadasala NR, Seleem MN, Wei A.	ACS Infect Dis	10.1021/acsinfecdis.8b00125	2018
	Decarboxylation of the Catalytic Lysine Residue by the C5alpha-Methyl-Substituted Carbapenem NA-1-157 Leads to Potent Inhibition of the OXA-58 Carbapenemase.	Toth M, Stewart NK, Maggiolo AO, Quan P, Khan MMK, Buynak JD, Smith CA, Vakulenko SB.	ACS Infect Dis	10.1021/acsinfecdis.4c00671	2024
	Antibacterial activity of lysozyme-chitosan oligosaccharide conjugates (LYZOX) against Pseudomonas aeruginosa, Acinetobacter baumannii and Methicillin-resistant Staphylococcus aureus.	Saito H, Sakakibara Y, Sakata A, Kurashige R, Murakami D, Kageshima H, Saito A, Miyazaki Y.	PLoS One	10.1371/journal.pone.0217504	2019
	Effects of Inactivation of d,d-Transpeptidases of Acinetobacter baumannii on Bacterial Growth and Susceptibility to beta-Lactam Antibiotics.	Toth M, Lee M, Stewart NK, Vakulenko SB.	Antimicrob Agents Chemother	10.1128/aac.01729-21	2022
	Complete Genome Sequence of Acinetobacter baumannii CIP 70.10, a Susceptible Reference Strain for Comparative Genome Analyses.	Krahn T, Wibberg D, Maus I, Winkler A, Puhler A, Poirel L, Schluter A.	Genome Announc	10.1128/genomea.00850-15	2015
Genetics	Comparative genomic analysis of Acinetobacter strains isolated from murine colonic crypts.	Saffarian A, Touchon M, Mulet C, Tournebize R, Passet V, Brisse S, Rocha EPC, Sansonetti PJ, Pedron T.	BMC Genomics	10.1186/s12864-017-3925-x	2017
	Cellulose Derived Graphene/Polyaniline Nanocomposite Anode for Energy Generation and Bioremediation of Toxic Metals via Benthic Microbial Fuel Cells.	Yaqoob AA, Yaqoob AA, Mohamad Ibrahim MN, Umar K, Bhawani SA, Khan A, Asiri AM, Khan MR, Azam M, AlAmmari AM.	Polymers (Basel)	10.3390/polym13010135	2020
Pathogenicity	Antibacterial Activity of Defatted and Nondefatted Methanolic Extracts of Aframomum melegueta K. Schum. against Multidrug-Resistant Bacteria of Clinical Importance.	Olajuyigbe OO, Adedayo O, Coopoosamy RM.	ScientificWorldJournal	10.1155/2020/4808432	2020
Pathogenicity	Biscatecholate-monohydroxamate mixed ligand siderophore-carbacephalosporin conjugates are selective sideromycin antibiotics that target Acinetobacter baumannii.	Wencewicz TA, Miller MJ.	J Med Chem	10.1021/jm400265k	2013
	Cas12a-assisted precise targeted cloning using in vivo Cre-lox recombination.	Enghiad B, Huang C, Guo F, Jiang G, Wang B, Tabatabaei SK, Martin TA, Zhao H.	Nat Commun	10.1038/s41467-021-21275-4	2021
Genetics	Comparative genomic analysis of Pectobacterium carotovorum subsp. brasiliense SX309 provides novel insights into its genetic and phenotypic features.	Li L, Yuan L, Shi Y, Xie X, Chai A, Wang Q, Li B.	BMC Genomics	10.1186/s12864-019-5831-x	2019
Metabolism	A new genome-mining tool redefines the lasso peptide biosynthetic landscape.	Tietz JI, Schwalen CJ, Patel PS, Maxson T, Blair PM, Tai HC, Zakai UI, Mitchell DA.	Nat Chem Biol	10.1038/nchembio.2319	2017
	Glycosphingolipids Recognized by Acinetobacter baumannii.	Madar Johansson M, Azzouz M, Haggendal B, Saljo K, Malmi H, Zaviolov A, Teneberg S.	Microorganisms	10.3390/microorganisms8040612	2020
Pathogenicity	Mutant prevention concentration of colistin alone and in combination with rifampicin for multidrug-resistant Acinetobacter baumannii.	Nordqvist H, Nilsson LE, Claesson C.	Eur J Clin Microbiol Infect Dis	10.1007/s10096-016-2736-3	2016
	A Novel Antimicrobial Peptide Spampcin_56-86 from Scylla paramamosain Exerting Rapid Bactericidal and Anti-Biofilm Activity In Vitro and Anti-Infection In Vivo.	Jiang M, Chen R, Zhang J, Chen F, Wang KJ.	Int J Mol Sci	10.3390/ijms232113316	2022
	The Long-Term Effect of a Nine Amino-Acid Antimicrobial Peptide AS-hepc3_(48-56) Against Pseudomonas aeruginosa With No Detectable Resistance.	Zhu D, Chen F, Chen YC, Peng H, Wang KJ.	Front Cell Infect Microbiol	10.3389/fcimb.2021.752637	2021
	Mastoparan-S from Sphodromantis viridis exhibits antimicrobial activity by disrupting bacterial membranes.	Park J, Lee S, Kang DD, Oh JH, Kim H, Park Y.	AMB Express	10.1186/s13568-025-01908-3	2025
Pathogenicity	Comparative Antimicrobial Activity of Hp404 Peptide and Its Analogs against Acinetobacter baumannii.	Hong MJ, Kim MK, Park Y.	Int J Mol Sci	10.3390/ijms22115540	2021
Pathogenicity	Antibacterial and Antibiofilm Activity and Mode of Action of Magainin 2 against Drug-Resistant Acinetobacter baumannii.	Kim MK, Kang N, Ko SJ, Park J, Park E, Shin DW, Kim SH, Lee SA, Lee JI, Lee SH, Ha EG, Jeon SH, Park Y.	Int J Mol Sci	10.3390/ijms19103041	2018
	Mechanism of action of antimicrobial peptide P5 truncations against Pseudomonas aeruginosa and Staphylococcus aureus.	Kwon JY, Kim MK, Mereuta L, Seo CH, Luchian T, Park Y.	AMB Express	10.1186/s13568-019-0843-0	2019
	Antibacterial Activity of Green-Synthesized Silver Nanoparticles Using Areca catechu Extract against Antibiotic-Resistant Bacteria.	Choi JS, Jung HC, Baek YJ, Kim BY, Lee MW, Kim HD, Kim SW.	Nanomaterials (Basel)	10.3390/nano11010205	2021
Pathogenicity	Synergistic effects and antibiofilm properties of chimeric peptides against multidrug-resistant Acinetobacter baumannii strains.	Gopal R, Kim YG, Lee JH, Lee SK, Chae JD, Son BK, Seo CH, Park Y.	Antimicrob Agents Chemother	10.1128/aac.02473-13	2014
	Therapeutic Potential of Antimicrobial Peptide PN5 against Multidrug-Resistant E. coli and Anti-Inflammatory Activity in a Septic Mouse Model.	Kang DD, Park J, Park Y.	Microbiol Spectr	10.1128/spectrum.01494-22	2022
	Coralmycin Derivatives with Potent Anti-Gram Negative Activity Produced by the Myxobacteria Corallococcus coralloides M23.	Kim BM, Minh NV, Choi HY, Kim WG.	Molecules	10.3390/molecules24071390	2019
	Investigation of cationicity and structure of pseudin-2 analogues for enhanced bacterial selectivity and anti-inflammatory activity.	Jeon D, Jeong MC, Jacob B, Bang JK, Kim EH, Cheong C, Jung ID, Park Y, Kim Y.	Sci Rep	10.1038/s41598-017-01474-0	2017
	Development of a novel short 12-meric papiliocin-derived peptide that is effective against Gram-negative sepsis.	Kim J, Jacob B, Jang M, Kwak C, Lee Y, Son K, Lee S, Jung ID, Jeong MS, Kwon SH, Kim Y.	Sci Rep	10.1038/s41598-019-40577-8	2019
	Screening of the Potential Bioactivities of Pennyroyal (Mentha pulegium L.) Essential Oil.	Luis A, Domingues F.	Antibiotics (Basel)	10.3390/antibiotics10101266	2021
	Enhanced antimicrobial efficacy and energy efficiency of low irradiance 405-nm light for bacterial decontamination.	Sinclair LG, Anderson JG, MacGregor SJ, MacGregor SJ, Maclean M.	Arch Microbiol	10.1007/s00203-024-03999-1	2024
	Essential Oil from Coriandrum sativum: A review on Its Phytochemistry and Biological Activity.	Al-Khayri JM, Banadka A, Nandhini M, Nagella P, Al-Mssallem MQ, Alessa FM.	Molecules	10.3390/molecules28020696	2023
	Antimicrobial Activity of Some Essential Oils-Present Status and Future Perspectives.	Chouhan S, Sharma K, Guleria S.	Medicines (Basel)	10.3390/medicines4030058	2017
	Essential Oils and Their Components as Modulators of Antibiotic Activity against Gram-Negative Bacteria.	Aelenei P, Miron A, Trifan A, Bujor A, Gille E, Aprotosoaie AC.	Medicines (Basel)	10.3390/medicines3030019	2016
Phylogeny	Acinetobacter Strain KUO11TH, a Unique Organism Related to Acinetobacter pittii and Isolated from the Skin Mucus of Healthy Bighead Catfish and Its Efficacy Against Several Fish Pathogens.	Bunnoy A, Na-Nakorn U, Kayansamruaj P, Srisapoome P.	Microorganisms	10.3390/microorganisms7110549	2019
Enzymology	Development of an rRNA-targeted oligonucleotide probe specific for the genus Acinetobacter and its application for in situ monitoring in activated sludge.	Wagner M, Erhart R, Manz W, Amann R, Lemmer H, Wedi D, Schleifer KH.	Appl Environ Microbiol	10.1128/aem.60.3.792-800.1994	1994
Genetics	Characterization and Genome Structure of Virulent Phage EspM4VN to Control Enterobacter sp. M4 Isolated From Plant Soft Rot.	Thanh NC, Nagayoshi Y, Fujino Y, Iiyama K, Furuya N, Hiromasa Y, Iwamoto T, Doi K.	Front Microbiol	10.3389/fmicb.2020.00885	2020
	Evaluation of Benzguinols as Next-Generation Antibiotics for the Treatment of Multidrug-Resistant Bacterial Infections.	Nguyen HT, Morshed MT, Vuong D, Crombie A, Lacey E, Garg S, Pi H, Woolford L, Venter H, Page SW, Piggott AM, Trott DJ, Ogunniyi AD.	Antibiotics (Basel)	10.3390/antibiotics10060727	2021
	Repurposing of the Fasciolicide Triclabendazole to Treat Infections Caused by Staphylococcus spp. and Vancomycin-Resistant Enterococci.	Pi H, Ogunniyi AD, Savaliya B, Nguyen HT, Page SW, Lacey E, Venter H, Trott DJ.	Microorganisms	10.3390/microorganisms9081697	2021
	Kibdelomycin is a bactericidal broad-spectrum aerobic antibacterial agent.	Singh SB, Dayananth P, Balibar CJ, Garlisi CG, Lu J, Kishii R, Takei M, Fukuda Y, Ha S, Young K.	Antimicrob Agents Chemother	10.1128/aac.00382-15	2015
Enzymology	Sloth hair as a novel source of fungi with potent anti-parasitic, anti-cancer and anti-bacterial bioactivity.	Higginbotham S, Wong WR, Linington RG, Spadafora C, Iturrado L, Arnold AE.	PLoS One	10.1371/journal.pone.0084549	2014
	Sansanmycin natural product analogues as potent and selective anti-mycobacterials that inhibit lipid I biosynthesis.	Tran AT, Watson EE, Pujari V, Conroy T, Dowman LJ, Giltrap AM, Pang A, Wong WR, Linington RG, Mahapatra S, Saunders J, Charman SA, West NP, Bugg TD, Tod J, Dowson CG, Roper DI, Crick DC, Britton WJ, Payne RJ.	Nat Commun	10.1038/ncomms14414	2017
Pathogenicity	Inhibition of predation by Bdellovibrio bacteriovorus and Micavibrio aeruginosavorus via host cell metabolic activity in the presence of carbohydrates.	Dashiff A, Keeling TG, Kadouri DE.	Appl Environ Microbiol	10.1128/aem.02565-10	2011
	Chromogenic hydroxyanthraquinone-based enzyme substrates for the detection of microbial beta-d-galactosidase, beta-d-glucuronidase and beta-d-ribosidase.	Burton M, Garcha A, Marrs ECL, Perry JD, Stanforth SP, Turnbull G, Turner HJ.	RSC Adv	10.1039/d4ra06418f	2025
	Indole-containing arene-ruthenium complexes with broad spectrum activity against antibiotic-resistant bacteria.	Nolan VC, Rafols L, Harrison J, Soldevila-Barreda JJ, Crosatti M, Garton NJ, Wegrzyn M, Timms DL, Seaton CC, Sendron H, Azmanova M, Barry NPE, Pitto-Barry A, Cox JAG.	Curr Res Microb Sci	10.1016/j.crmicr.2021.100099	2022
	Laboratory evaluation of the broad-spectrum antibacterial efficacy of a low-irradiance visible 405-nm light system for surface-simulated decontamination.	Sinclair LG, Dougall LR, Ilieva Z, McKenzie K, Anderson JG, MacGregor SJ, Maclean M.	Health Technol (Berl)	10.1007/s12553-023-00761-3	2023
	Compositional factors driving antibacterial efficacy in healthcare wet wipe products.	Angulo-Pineda C, Lu JR, Cartmell S, McBain AJ.	Front Microbiol	10.3389/fmicb.2025.1582630	2025
	The antimicrobial activity of silver acetate against Acinetobacter baumannii in a Galleria mellonella infection model.	Mannix-Fisher E, McLean S.	PeerJ	10.7717/peerj.11196	2021
Pathogenicity	Potentiation of Antibiotic Activity by a Novel Cationic Peptide: Potency and Spectrum of Activity of SPR741.	Corbett D, Wise A, Langley T, Skinner K, Trimby E, Birchall S, Dorali A, Sandiford S, Williams J, Warn P, Vaara M, Lister T.	Antimicrob Agents Chemother	10.1128/aac.00200-17	2017
	Advances and perspectives for antimicrobial peptide and combinatory therapies.	C S, G R R, L F L, M C G DR, N B C, S C D, O L F.	Front Bioeng Biotechnol	10.3389/fbioe.2022.1051456	2022
	Screening of FDA-Approved Drugs Using a 384-Well Plate-Based Biofilm Platform: The Case of Fingolimod.	Gilbert-Girard S, Savijoki K, Yli-Kauhaluoma J, Fallarero A.	Microorganisms	10.3390/microorganisms8111834	2020
	Antimicrobial activity, cytotoxicity and chemical analysis of lemongrass essential oil (Cymbopogon flexuosus) and pure citral.	Adukwu EC, Bowles M, Edwards-Jones V, Bone H.	Appl Microbiol Biotechnol	10.1007/s00253-016-7807-y	2016
	Characterization of Oxacillinase and Metallo-beta-Lactamas Genes and Molecular Typing of Clinical Isolates of Acinetobacter baumannii in Ahvaz, South-West of Iran.	Shoja S, Moosavian M, Rostami S, Abbasi F, Tabatabaiefar MA, Peymani A.	Jundishapur J Microbiol	10.5812/jjm.32388	2016
	Assessment of the feed additive consisting of red carotenoid-rich Paracoccus carotinifaciens NITE SD 00017 for salmon and trout for the renewal of its authorisation (ENEOS Techno Materials Corporation).	EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP), Bampidis V, Azimonti G, Bastos ML, Christensen H, Durjava M, Dusemund B, Kouba M, Lopez-Alonso M, Lopez Puente S, Marcon F, Mayo B, Pechova A, Petkova M, Ramos F, Villa RE, Woutersen R, Bories G, Brantom P, Gropp J, Dioni A, Galobart J, Holczknecht O, Revez J, Vettori MV.	EFSA J	10.2903/j.efsa.2024.8905	2024
	Distribution of Class D Carbapenemase and Extended-Spectrum beta-Lactamase Genes among Acinetobacter Baumannii Isolated from Burn Wound and Ventilator Associated Pneumonia Infections.	Mohammadi M, Soroush S, Delfani S, Pakzad I, Abbaszadeh A, Bahmani M, Bogdanovic L, Taherikalani M.	J Clin Diagn Res	10.7860/jcdr/2017/25534.10218	2017
	Correlation of Oxacillinase Gene Carriage With the Genetic Fingerprints of Imipenem-Resistant Clinical Isolates of Acinetobacter baumannii.	Zanganeh Z, Eftekhar F.	Jundishapur J Microbiol	10.5812/jjm.26545	2015
	Genotyping of carbapenem resistant Acinetobacter baumannii isolated from tracheal tube discharge of hospitalized patients in intensive care units, Ahvaz, Iran.	Shoja S, Moosavian M, Peymani A, Tabatabaiefar MA, Rostami S, Ebrahimi N.	Iran J Microbiol		2013
	The Prevalence of IS Aba 1 and IS Aba 4 in Acinetobacter baumannii Species of Different International Clone Lineages Among Patients With Burning in Tehran, Iran.	Bahador A, Raoo An R, Farshadzadeh Z, Beitollahi L, Khaledi A, Rahimi S, Mokhtaran M, Mehrabi Tavana A, Esmaeili D.	Jundishapur J Microbiol	10.5812/jjm.17167v2	2015
	Post Neurosurgical Meningitis due to Colistin Heteroresistant Acinetobacter baumannii.	Moosavian M, Shoja S, Nashibi R, Ebrahimi N, Tabatabaiefar MA, Rostami S, Peymani A.	Jundishapur J Microbiol	10.5812/jjm.12287	2014
	Rapid culture-independent loop-mediated isothermal amplification detection of antimicrobial resistance markers from environmental water samples.	Hassan MM, van Vliet AHM, Higgins O, Burke LP, Chueiri A, O'Connor L, Morris D, Smith TJ, La Ragione RM.	Microb Biotechnol	10.1111/1751-7915.14227	2023
Metabolism	The Synthesis of L-Alanyl and beta-Alanyl Derivatives of 2-Aminoacridone and Their Application in the Detection of Clinically-Important Microorganisms.	Cellier M, James AL, Orenga S, Perry JD, Turnbull G, Stanforth SP.	PLoS One	10.1371/journal.pone.0158378	2016
Pathogenicity	Survival of nosocomial bacteria and spores on surfaces and inactivation by hydrogen peroxide vapor.	Otter JA, French GL.	J Clin Microbiol	10.1128/jcm.02004-08	2009
	Isolation and genetic characterization of metallo-beta-lactamase and carbapenamase producing strains of Acinetobacter baumannii from patients at Tehran hospitals.	Shahcheraghi F, Abbasalipour M, Feizabadi M, Ebrahimipour G, Akbari N.	Iran J Microbiol		2011
Pathogenicity	In vitro activity of telavancin in combination with colistin versus Gram-negative bacterial pathogens.	Hornsey M, Longshaw C, Phee L, Wareham DW.	Antimicrob Agents Chemother	10.1128/aac.05870-11	2012
Enzymology	Evaluation of a simple blood culture amplification and antigen detection method for diagnosis of Salmonella enterica serovar typhi bacteremia.	Castonguay-Vanier J, Davong V, Bouthasavong L, Sengdetka D, Simmalavong M, Seupsavith A, Dance DA, Baker S, Le Thi Phuong T, Vongsouvath M, Newton PN.	J Clin Microbiol	10.1128/jcm.02360-12	2013
	Inactivation of bacterial pathogens following exposure to light from a 405-nanometer light-emitting diode array.	Maclean M, MacGregor SJ, Anderson JG, Woolsey G.	Appl Environ Microbiol	10.1128/aem.01892-08	2009
	Evaluation of a Rapid Diagnostic Test for Detection of Burkholderia pseudomallei in the Lao People's Democratic Republic.	Woods KL, Boutthasavong L, NicFhogartaigh C, Lee SJ, Davong V, AuCoin DP, Dance DAB.	J Clin Microbiol	10.1128/jcm.02002-17	2018
Pathogenicity	Bactericidal action of positive and negative ions in air.	Fletcher LA, Gaunt LF, Beggs CB, Shepherd SJ, Sleigh PA, Noakes CJ, Kerr KG.	BMC Microbiol	10.1186/1471-2180-7-32	2007
	Overexpression of BIT33_RS14560 Enhances the Biofilm Formation and Virulence of Acinetobacter baumannii.	Yang R, Lai B, Liao K, Liu B, Huang L, Li S, Gu J, Lin Z, Chen Y, Wang S, Qiu Y, Deng J, Chen S, Zhuo C, Zhou Y	Front Microbiol	10.3389/fmicb.2022.867770	2022
	Ketoprofen, piroxicam and indomethacin-suppressed quorum sensing and virulence factors in Acinetobacter baumannii.	Elshaer SL, Shaldam MA, Shaaban MI	J Appl Microbiol	10.1111/jam.15609	2022
	Mechanisms Underlying Synergistic Killing of Polymyxin B in Combination with Cannabidiol against Acinetobacter baumannii: A Metabolomic Study.	Hussein M, Allobawi R, Levou I, Blaskovich MAT, Rao GG, Li J, Velkov T	Pharmaceutics	10.3390/pharmaceutics14040786	2022
	Immunity induced by valine-glycine repeat protein G imparts histoprotection of vital body organs against Acinetobacter baumannii.	Alipouri S, Rasooli I, Ghaini MH, Jahangiri A, Darvish Alipour Astaneh S, Ramezanalizadeh F	J Genet Eng Biotechnol	10.1186/s43141-022-00325-4	2022
	Inhibition of AdeB, AceI, and AmvA Efflux Pumps Restores Chlorhexidine and Benzalkonium Susceptibility in Acinetobacter baumannii ATCC 19606.	Migliaccio A, Esposito EP, Bagattini M, Berisio R, Triassi M, De Gregorio E, Zarrilli R	Front Microbiol	10.3389/fmicb.2021.790263	2022
	The Involvement of the csy1 Gene in the Antimicrobial Resistance of Acinetobacter baumannii.	Guo T, Sun X, Li M, Wang Y, Jiao H, Li G	Front Med (Lausanne)	10.3389/fmed.2022.797104	2022
	Ciprofloxacin-Tethered 1,2,3-Triazole Conjugates: New Quinolone Family Compounds to Upgrade Our Antiquated Approach against Bacterial Infections.	Agarwal A, Singh P, Maurya A, Patel UK, Singh A, Nath G	ACS Omega	10.1021/acsomega.1c05303	2022
Phylogeny	Genome diversity of domesticated Acinetobacter baumannii ATCC 19606(T) strains.	Artuso I, Lucidi M, Visaggio D, Capecchi G, Lugli GA, Ventura M, Visca P	Microb Genom	10.1099/mgen.0.000749	2022
Pathogenicity	Antimicrobial and anti-biofilm potencies of dermcidin-derived peptide DCD-1L against Acinetobacter baumannii: an in vivo wound healing model.	Farshadzadeh Z, Pourhajibagher M, Taheri B, Ekrami A, Modarressi MH, Azimzadeh M, Bahador A	BMC Microbiol	10.1186/s12866-022-02439-8	2022
	Histopathological Analysis of Acinetobacter baumannii Lung Infection in a Mouse Model.	Tansho-Nagakawa S, Sato Y, Ubagai T, Kikuchi-Ueda T, Kamoshida GO, Nishida S, Ono Y	Pol J Microbiol	10.33073/pjm-2021-044	2021
	Subinhibitory Concentrations of Clinically-Relevant Antimicrobials Affect Resistance-Nodulation-Division Family Promoter Activity in Acinetobacter baumannii.	Prieto Martin Gil S, Tajuelo A, Lopez-Siles M, McConnell MJ	Front Microbiol	10.3389/fmicb.2021.780201	2021
	Anti-Omp34 antibodies protect against Acinetobacter baumannii in a murine sepsis model.	Naghipour Erami A, Rasooli I, Jahangiri A, Darvish Alipour Astaneh S	Microb Pathog	10.1016/j.micpath.2021.105291	2021
Pathogenicity	Integrating transcriptomics and metabolomics analysis on kojic acid combating Acinetobacter baumannii biofilm and its potential roles.	Li H, Du X, Chen C, Qi J, Wang Y	Microbiol Res	10.1016/j.micres.2021.126911	2021
Metabolism	CsrA Coordinates Compatible Solute Synthesis in Acinetobacter baumannii and Facilitates Growth in Human Urine.	Hubloher JJ, Schabacker K, Muller V, Averhoff B	Microbiol Spectr	10.1128/Spectrum.01296-21	2021
	Combination of AgNPs and Domiphen is Antimicrobial Against Biofilms of Common Pathogens.	Hu L, Yang X, Yin J, Rong X, Huang X, Yu P, He Z, Liu Y	Int J Nanomedicine	10.2147/IJN.S334133	2021
	Effect of Subinhibitory Concentrations of Antibiotics and Disinfectants on ISAba-Mediated Inactivation of Lipooligosaccharide Biosynthesis Genes in Acinetobacter baumannii.	Olmeda-Lopez H, Corral-Lugo A, McConnell MJ	Antibiotics (Basel)	10.3390/antibiotics10101259	2021
Proteome	Strategies for Rapid Identification of Acinetobacter baumannii Membrane Proteins and Polymyxin B's Effects.	Lu Y, Hu X, Nie T, Yang X, Li C, You X	Front Cell Infect Microbiol	10.3389/fcimb.2021.734578	2021
Metabolism	Role of Iron-Containing Alcohol Dehydrogenases in Acinetobacter baumannii ATCC 19606 Stress Resistance and Virulence.	Lin GH, Hsieh MC, Shu HY	Int J Mol Sci	10.3390/ijms22189921	2021
Pathogenicity	Synergism versus Additivity: Defining the Interactions between Common Disinfectants.	Noel DJ, Keevil CW, Wilks SA	mBio	10.1128/mBio.02281-21	2021
Metabolism	Modern Acinetobacter baumannii clinical isolates replicate inside spacious vacuoles and egress from macrophages.	Sycz G, Di Venanzio G, Distel JS, Sartorio MG, Le NH, Scott NE, Beatty WL, Feldman MF	PLoS Pathog	10.1371/journal.ppat.1009802	2021
	Antibiofilm action of Persea americana glycolic extract over Acinetobacter baumannii and absence of toxicity in Galleria mellonella.	Dos Santos Liberato SF, da Cruz Vegian MR, Abu Hasna A, de Alvarenga JA, Dos Santos JG, Tini IRP, Amendola I, Junqueira JC, de Oliveira LD	J Complement Integr Med	10.1515/jcim-2021-0051	2021
Pathogenicity	Novel Phenyl-Based Bis-quaternary Ammonium Compounds as Broad-Spectrum Biocides.	Frolov NA, Fedoseeva KA, Hansford KA, Vereshchagin AN	ChemMedChem	10.1002/cmdc.202100284	2021
Pathogenicity	K(+) and its role in virulence of Acinetobacter baumannii.	Konig P, Averhoff B, Muller V	Int J Med Microbiol	10.1016/j.ijmm.2021.151516	2021
Metabolism	Comparison of the Acinetobacter baumannii Reference Strains ATCC 17978 and ATCC 19606 in Antimicrobial Resistance Mediated by the AdeABC Efflux Pump.	Lucassen K, Gerson S, Xanthopoulou K, Wille J, Wille T, Seifert H, Higgins PG	Antimicrob Agents Chemother	10.1128/AAC.00570-21	2021
Genetics	Two Acinetobacter baumannii Isolates Obtained From a Fatal Necrotizing Fasciitis Infection Display Distinct Genomic and Phenotypic Characteristics in Comparison to Type Strains.	Grier JT, Arivett BA, Ramirez MS, Chosed RJ, Bigner JA, Ohneck EJ, Metz ML, Wood CR, Arce S, Tartaro A, Relich RF, Actis LA, Fiester SE	Front Cell Infect Microbiol	10.3389/fcimb.2021.635673	2021
Pathogenicity	PHMB-loaded PDMS and its antimicrobial properties for biomedical applications.	Montemezzo M, Ferrari MD, Kerstner E, Santos VD, Victorazzi Lain V, Wollheim C, Frozza CODS, Roesch-Ely M, Baldo G, Brandalise RN	J Biomater Appl	10.1177/08853282211011921	2021
	Regulation of tert-Butyl Hydroperoxide Resistance by Chromosomal OhrR in A. baumannii ATCC 19606.	Chen SJ, Shu HY, Lin GH	Microorganisms	10.3390/microorganisms9030629	2021
Pathogenicity	Acinetobacter baumannii LOS Regulate the Expression of Inflammatory Cytokine Genes and Proteins in Human Mast Cells.	Kikuchi-Ueda T, Ubagai T, Kamoshida G, Nakano R, Nakano A, Ono Y	Pathogens	10.3390/pathogens10030290	2021
Pathogenicity	Investigation of antibiofilm activity, antibacterial activity, and mechanistic studies of an amphiphilic peptide against Acinetobacter baumannii.	Zeng P, Yi L, Xu J, Gao W, Xu C, Chen S, Chan KF, Wong KY	Biochim Biophys Acta Biomembr	10.1016/j.bbamem.2021.183600	2021
Pathogenicity	AB569, a non-toxic combination of acidified nitrite and EDTA, is effective at killing the notorious Iraq/Afghanistan combat wound pathogens, multi-drug resistant Acinetobacter baumannii and Acinetobacter spp.	Bogue AL, Panmanee W, McDaniel CT, Mortensen JE, Kamau E, Actis LA, Johannigman JA, Schurr MJ, Satish L, Kotagiri N, Hassett DJ	PLoS One	10.1371/journal.pone.0247513	2021
Pathogenicity	Time-kill and post-antibiotic effect of colistin at different static concentrations in in vitro Acinetobacter baumannii.	Rasidin RSM, Suhaili Z, Mohamed AFS, Hod R, Neela V, Amin-Nordin S	Trop Biomed		2020
Pathogenicity	The Low-Alkalinity Polymyxin Derivative, AL-6, Shows High Activity Against Multidrug-Resistant Acinetobacter baumannii Clinical Isolates In Vitro and A. baumannii ATCC 19606 In Vivo: Preliminary Analysis of the Antibacterial Mechanism.	Chen DJ, Cui AL, Chen JR, Yang P, Jin J, Shao L, Li ZR	Microb Drug Resist	10.1089/mdr.2019.0474	2021
Pathogenicity	A small molecule interacts with pMAC-derived hydroperoxide reductase and enhances the activity of aminoglycosides.	Hui Z, Liu S, Cui R, Zhou B, Hu C, Zhang M, Deng Q, Cheng S, Luo Y, Chen H, Wu J, Lu Y, Liu X, Dai L, Huang W	J Antibiot (Tokyo)	10.1038/s41429-020-00401-2	2021
Metabolism	Analysis of Immune Responses in Acinetobacter baumannii-Infected Klotho Knockout Mice: A Mouse Model of Acinetobacter baumannii Infection in Aged Hosts.	Sato Y, Tansho-Nagakawa S, Ubagai T, Ono Y	Front Immunol	10.3389/fimmu.2020.601614	2020
Genetics	Analysis of Complete Genome Sequence of Acinetobacter baumannii Strain ATCC 19606 Reveals Novel Mobile Genetic Elements and Novel Prophage.	Hamidian M, Blasco L, Tillman LN, To J, Tomas M, Myers GSA	Microorganisms	10.3390/microorganisms8121851	2020
Metabolism	In vivo synthesis of monolysocardiolipin and cardiolipin by Acinetobacter baumannii phospholipase D and effect on cationic antimicrobial peptide resistance.	Pfefferle K, Lopalco P, Breisch J, Siemund A, Corcelli A, Averhoff B	Environ Microbiol	10.1111/1462-2920.15231	2020
Phylogeny	Characterization of carbapenem-resistant hypervirulent Acinetobacter baumannii strains isolated from hospitalized patients in the mid-south region of China.	Li J, Yu T, Luo Y, Peng JY, Li YJ, Tao XY, Hu YM, Wang HC, Zou MX	BMC Microbiol	10.1186/s12866-020-01957-7	2020
Metabolism	Trehalose-6-phosphate-mediated phenotypic change in Acinetobacter baumannii.	Hubloher JJ, Zeidler S, Lamosa P, Santos H, Averhoff B, Muller V	Environ Microbiol	10.1111/1462-2920.15148	2020
Pathogenicity	Pan-transcriptomic analysis identified common differentially expressed genes of Acinetobacter baumannii in response to polymyxin treatments.	Li M, Aye SM, Ahmed MU, Han ML, Li C, Song J, Boyce JD, Powell DR, Azad MAK, Velkov T, Zhu Y, Li J	Mol Omics	10.1039/d0mo00015a	2020
Pathogenicity	Prevention of nosocomial Acinetobacter baumannii infections with a conserved immunogenic fimbrial protein.	Mahmoudi Z, Rasooli I, Jahangiri A, Darvish Alipour Astaneh S	APMIS	10.1111/apm.13061	2020
Genetics	Complete Genome Sequence of Acinetobacter baumannii ATCC 19606(T), a Model Strain of Pathogenic Bacteria Causing Nosocomial Infection.	Tsubouchi T, Suzuki M, Niki M, Oinuma KI, Niki M, Kakeya H, Kaneko Y	Microbiol Resour Announc	10.1128/MRA.00289-20	2020
Phylogeny	Decreased carO gene expression and OXA-type carbapenemases among extensively drug-resistant Acinetobacter baumannii strains isolated from burn patients in Tehran, Iran.	Abbasi E, Goudarzi H, Hashemi A, Chirani AS, Ardebili A, Goudarzi M, Sharahi JY, Davoudabadi S, Talebi G, Bostanghadiri N	Acta Microbiol Immunol Hung	10.1556/030.2020.01138	2020
Pathogenicity	Healthcare-associated carbapenem-resistant OXA-72-producing Acinetobacter baumannii of the clonal complex CC79 colonizing migratory and captive aquatic birds in a Brazilian Zoo.	Narciso AC, Martins WMBS, Almeida LGP, Cayo R, Santos SV, Ramos PL, Lincopan N, Vasconcelos ATR, Gales AC	Sci Total Environ	10.1016/j.scitotenv.2020.138232	2020
Pathogenicity	New Mutations Involved in Colistin Resistance in Acinetobacter baumannii.	Sun B, Liu H, Jiang Y, Shao L, Yang S, Chen D	mSphere	10.1128/mSphere.00895-19	2020
Pathogenicity	Deciphering colistin heteroresistance in Acinetobacter baumannii clinical isolates from Wenzhou, China.	Chen L, Lin J, Lu H, Zhang X, Wang C, Liu H, Zhang X, Li J, Cao J, Zhou T	J Antibiot (Tokyo)	10.1038/s41429-020-0289-2	2020
Genetics	Complete genome sequence and genome-scale metabolic modelling of Acinetobacter baumannii type strain ATCC 19606.	Zhu Y, Lu J, Zhao J, Zhang X, Yu HH, Velkov T, Li J	Int J Med Microbiol	10.1016/j.ijmm.2020.151412	2020
Metabolism	Unusual deprivation of compatible solutes in Acinetobacter baumannii.	Zeidler S, Muller V	Environ Microbiol	10.1111/1462-2920.14951	2020
	Tigecycline efflux in Acinetobacter baumannii is mediated by TetA in synergy with RND-type efflux transporters.	Foong WE, Wilhelm J, Tam HK, Pos KM	J Antimicrob Chemother	10.1093/jac/dkaa015	2020
Transcriptome	Integrative analysis of outer membrane vesicles proteomics and whole-cell transcriptome analysis of eravacycline induced Acinetobacter baumannii strains.	Kesavan D, Vasudevan A, Wu L, Chen J, Su Z, Wang S, Xu H	BMC Microbiol	10.1186/s12866-020-1722-1	2020
Pathogenicity	The Acinetobacter trimeric autotransporter adhesin Ata controls key virulence traits of Acinetobacter baumannii.	Weidensdorfer M, Ishikawa M, Hori K, Linke D, Djahanschiri B, Iruegas R, Ebersberger I, Riedel-Christ S, Enders G, Leukert L, Kraiczy P, Rothweiler F, Cinatl J, Berger J, Hipp K, Kempf VAJ, Gottig S	Virulence	10.1080/21505594.2018.1558693	2019
	A lipopolysaccharide-free outer membrane vesicle vaccine protects against Acinetobacter baumannii infection.	Pulido MR, Garcia-Quintanilla M, Pachon J, McConnell MJ	Vaccine	10.1016/j.vaccine.2019.11.043	2019
Pathogenicity	Diversity of amino acid substitutions in PmrCAB associated with colistin resistance in clinical isolates of Acinetobacter baumannii.	Gerson S, Lucassen K, Wille J, Nodari CS, Stefanik D, Nowak J, Wille T, Betts JW, Roca I, Vila J, Cisneros JM, Seifert H, Higgins PG	Int J Antimicrob Agents	10.1016/j.ijantimicag.2019.105862	2019
	Combined Effects Of Low Incubation Temperature, Minimal Growth Medium, And Low Hydrodynamics Optimize Acinetobacter baumannii Biofilm Formation.	Eze EC, El Zowalaty ME	Infect Drug Resist	10.2147/IDR.S203919	2019
Pathogenicity	Multidrug-resistant Acinetobacter baumannii resists reactive oxygen species and survives in macrophages.	Sato Y, Unno Y, Miyazaki C, Ubagai T, Ono Y	Sci Rep	10.1038/s41598-019-53846-3	2019
	Computational screening of antimicrobial peptides for Acinetobacter baumannii.	Majumder A, Biswal MR, Prakash MK	PLoS One	10.1371/journal.pone.0219693	2019
	Efficacy of Poloxamer-Based Wound Dressings on Acinetobacter baumanni Biofilms.	Salisbury AM, Mullin M, Chen R, Percival SL	Adv Wound Care (New Rochelle)	10.1089/wound.2018.0854	2019
Pathogenicity	New Shuttle Vectors for Real-Time Gene Expression Analysis in Multidrug-Resistant Acinetobacter Species: In Vitro and In Vivo Responses to Environmental Stressors.	Lucidi M, Visaggio D, Prencipe E, Imperi F, Rampioni G, Cincotti G, Leoni L, Visca P	Appl Environ Microbiol	10.1128/AEM.01334-19	2019
Pathogenicity	Delineating the Plausible Molecular Vaccine Candidates and Drug Targets of Multidrug-Resistant Acinetobacter baumannii.	Mujawar S, Mishra R, Pawar S, Gatherer D, Lahiri C	Front Cell Infect Microbiol	10.3389/fcimb.2019.00203	2019
Pathogenicity	Analysis of Acinetobacter baumannii survival in liquid media and on solid matrices as well as effect of disinfectants.	Bravo Z, Orruno M, Navascues T, Ogayar E, Ramos-Vivas J, Kaberdin VR, Arana I	J Hosp Infect	10.1016/j.jhin.2019.04.009	2019
Metabolism	The chloramphenicol/H+ antiporter CraA of Acinetobacter baumannii AYE reveals a broad substrate specificity.	Foong WE, Tam HK, Crames JJ, Averhoff B, Pos KM	J Antimicrob Chemother	10.1093/jac/dkz024	2019
	Metabolic Responses to Polymyxin Treatment in Acinetobacter baumannii ATCC 19606: Integrating Transcriptomics and Metabolomics with Genome-Scale Metabolic Modeling.	Zhu Y, Zhao J, Maifiah MHM, Velkov T, Schreiber F, Li J	mSystems	10.1128/mSystems.00157-18	2019
Pathogenicity	Isothiazolopyridine Mannich bases and their antibacterial effect.	Swiatek P, Strzelecka M	Adv Clin Exp Med	10.17219/acem/99310	2019
Pathogenicity	Miltefosine Reduces the Cytolytic Activity and Virulence of Acinetobacter baumannii.	Fiester SE, Arivett BA, Beckett AC, Wagner BR, Ohneck EJ, Schmidt RE, Grier JT, Actis LA	Antimicrob Agents Chemother	10.1128/AAC.01409-18	2018
Metabolism	Identification and characterization of a carnitine transporter in Acinetobacter baumannii.	Breisch J, Waclawska I, Averhoff B	Microbiologyopen	10.1002/mbo3.752	2018
Metabolism	The role of compatible solutes in desiccation resistance of Acinetobacter baumannii.	Zeidler S, Muller V	Microbiologyopen	10.1002/mbo3.740	2018
Metabolism	Biological roles of indole-3-acetic acid in Acinetobacter baumannii.	Lin HR, Shu HY, Lin GH	Microbiol Res	10.1016/j.micres.2018.08.004	2018
	Synergism of fused bicyclic 2-aminothiazolyl compounds with polymyxin B against Klebsiella pneumoniae.	Wang R, Hou S, Dong X, Chen D, Shao L, Qian L, Li Z, Xu X	Medchemcomm	10.1039/c7md00354d	2017
Pathogenicity	Antimicrobial Activity of Selected Antimicrobial Peptides Against Planktonic Culture and Biofilm of Acinetobacter baumannii.	Jaskiewicz M, Neubauer D, Kazor K, Bartoszewska S, Kamysz W	Probiotics Antimicrob Proteins	10.1007/s12602-018-9444-5	2019
Pathogenicity	Characterization and Transcriptome Analysis of Acinetobacter baumannii Persister Cells.	Alkasir R, Ma Y, Liu F, Li J, Lv N, Xue Y, Hu Y, Zhu B	Microb Drug Resist	10.1089/mdr.2017.0341	2018
Metabolism	Phenotypic changes associated with Colistin resistance due to Lipopolysaccharide loss in Acinetobacter baumannii.	Carretero-Ledesma M, Garcia-Quintanilla M, Martin-Pena R, Pulido MR, Pachon J, McConnell MJ	Virulence	10.1080/21505594.2018.1460187	2018
Metabolism	Salt induction and activation of MtlD, the key enzyme in the synthesis of the compatible solute mannitol in Acinetobacter baumannii.	Zeidler S, Hubloher J, Konig P, Ngu ND, Scholz A, Averhoff B, Muller V	Microbiologyopen	10.1002/mbo3.614	2018
Pathogenicity	Sub-minimum inhibitory concentrations of colistin and polymyxin B promote Acinetobacter baumannii biofilm formation.	Sato Y, Unno Y, Ubagai T, Ono Y	PLoS One	10.1371/journal.pone.0194556	2018
Metabolism	A pathway-directed positive growth restoration assay to facilitate the discovery of lipid A and fatty acid biosynthesis inhibitors in Acinetobacter baumannii.	Richie DL, Wang L, Chan H, De Pascale G, Six DA, Wei JR, Dean CR	PLoS One	10.1371/journal.pone.0193851	2018
Pathogenicity	The role of the type VI secretion system vgrG gene in the virulence and antimicrobial resistance of Acinetobacter baumannii ATCC 19606.	Wang J, Zhou Z, He F, Ruan Z, Jiang Y, Hua X, Yu Y	PLoS One	10.1371/journal.pone.0192288	2018
Transcriptome	Mucin acts as a nutrient source and a signal for the differential expression of genes coding for cellular processes and virulence factors in Acinetobacter baumannii.	Ohneck EJ, Arivett BA, Fiester SE, Wood CR, Metz ML, Simeone GM, Actis LA	PLoS One	10.1371/journal.pone.0190599	2018
Pathogenicity	Antimicrobial and Antibiofilm Activity of Human Milk Oligosaccharides against Streptococcus agalactiae, Staphylococcus aureus, and Acinetobacter baumannii.	Ackerman DL, Craft KM, Doster RS, Weitkamp JH, Aronoff DM, Gaddy JA, Townsend SD	ACS Infect Dis	10.1021/acsinfecdis.7b00183	2017
Pathogenicity	In vitro antimicrobial effects of a novel Pentaherbs concoction for atopic dermatitis.	Hon KL, Ip M, Wong CK, Chan BCL, Leung PC, Leung TF	J Dermatolog Treat	10.1080/09546634.2017.1395804	2017
Transcriptome	Characterization of the DNA mismatch repair proteins MutS and MutL in a hypermutator Acinetobacter baumannii.	Deihim B, Hassanzadeh M, Shafiei-Jandaghi NZ, Amanlou M, Douraghi M	Microb Pathog	10.1016/j.micpath.2017.10.001	2017
Metabolism	The Capsular Polysaccharide of Acinetobacter baumannii Is an Obstacle for Therapeutic Passive Immunization Strategies.	Wang-Lin SX, Olson R, Beanan JM, MacDonald U, Balthasar JP, Russo TA	Infect Immun	10.1128/IAI.00591-17	2017
	LpxK Is Essential for Growth of Acinetobacter baumannii ATCC 19606: Relationship to Toxic Accumulation of Lipid A Pathway Intermediates.	Wei JR, Richie DL, Mostafavi M, Metzger LE 4th, Rath CM, Sawyer WS, Takeoka KT, Dean CR	mSphere	10.1128/mSphere.00199-17	2017
Pathogenicity	Antibacterial activity of exogenous glutathione and its synergism on antibiotics sensitize carbapenem-associated multidrug resistant clinical isolates of Acinetobacter baumannii.	Alharbe R, Almansour A, Kwon DH	Int J Med Microbiol	10.1016/j.ijmm.2017.07.009	2017
Enzymology	Phytochemical Studies on Two Australian Anigozanthos Plant Species.	Hendra R, Keller PA	J Nat Prod	10.1021/acs.jnatprod.7b00063	2017
Pathogenicity	Subinhibitory Concentrations of Trimethoprim and Sulfamethoxazole Prevent Biofilm Formation by Acinetobacter baumannii through Inhibition of Csu Pilus Expression.	Moon KH, Weber BS, Feldman MF	Antimicrob Agents Chemother	10.1128/AAC.00778-17	2017
Phylogeny	Identification of Acinetobacter baumannii of Human and Animal Origins by a Gene-Specific PCR.	Hamouda A	Curr Microbiol	10.1007/s00284-017-1283-1	2017
Pathogenicity	Constraint-based modeling identifies new putative targets to fight colistin-resistant A. baumannii infections.	Presta L, Bosi E, Mansouri L, Dijkshoorn L, Fani R, Fondi M	Sci Rep	10.1038/s41598-017-03416-2	2017
Pathogenicity	Identification of unique cardiolipin and monolysocardiolipin species in Acinetobacter baumannii.	Lopalco P, Stahl J, Annese C, Averhoff B, Corcelli A	Sci Rep	10.1038/s41598-017-03214-w	2017
Enzymology	Acinetobacter baumannii transfers the blaNDM-1 gene via outer membrane vesicles.	Chatterjee S, Mondal A, Mitra S, Basu S	J Antimicrob Chemother	10.1093/jac/dkx131	2017
	Antimicrobial effects of Ferula gummosa Boiss gum against extended-spectrum beta-lactamase producing Acinetobacter clinical isolates.	Afshar FF, Saffarian P, Hosseini HM, Sattarian F, Amin M, Fooladi AA	Iran J Microbiol		2016
Enzymology	Filamentous hemagglutinin adhesin FhaB limits A.baumannii biofilm formation.	Darwish Alipour Astaneh S, Rasooli I, Mousavi Gargari SL	Front Biosci (Elite Ed)	10.2741/e801	2017
Pathogenicity	Synergy against extensively drug-resistant Acinetobacter baumannii in vitro by two old antibiotics: colistin and chloramphenicol.	Wei WJ, Yang HF	Int J Antimicrob Agents	10.1016/j.ijantimicag.2016.11.031	2017
Metabolism	Virulence characteristics of Acinetobacter baumannii clinical isolates vary with the expression levels of omps.	Sato Y, Unno Y, Kawakami S, Ubagai T, Ono Y	J Med Microbiol	10.1099/jmm.0.000394	2017
Enzymology	Iron-Regulated Phospholipase C Activity Contributes to the Cytolytic Activity and Virulence of Acinetobacter baumannii.	Fiester SE, Arivett BA, Schmidt RE, Beckett AC, Ticak T, Carrier MV, Ghosh R, Ohneck EJ, Metz ML, Sellin Jeffries MK, Actis LA	PLoS One	10.1371/journal.pone.0167068	2016
Pathogenicity	A penicillin-binding protein inhibits selection of colistin-resistant, lipooligosaccharide-deficient Acinetobacter baumannii.	Boll JM, Crofts AA, Peters K, Cattoir V, Vollmer W, Davies BW, Trent MS	Proc Natl Acad Sci U S A	10.1073/pnas.1611594113	2016
Pathogenicity	Association of biofilm production with colonization among clinical isolates of Acinetobacter baumannii.	Ryu SY, Baek WK, Kim HA	Korean J Intern Med	10.3904/kjim.2015.287	2016
Pathogenicity	High-intensity meropenem combinations with polymyxin B: new strategies to overcome carbapenem resistance in Acinetobacter baumannii.	Lenhard JR, Bulitta JB, Connell TD, King-Lyons N, Landersdorfer CB, Cheah SE, Thamlikitkul V, Shin BS, Rao G, Holden PN, Walsh TJ, Forrest A, Nation RL, Li J, Tsuji BT	J Antimicrob Chemother	10.1093/jac/dkw355	2016
Genetics	Genome Sequence of Jumbo Phage vB_AbaM_ME3 of Acinetobacter baumanni.	Buttimer C, O'Sullivan L, Elbreki M, Neve H, McAuliffe O, Ross RP, Hill C, O'Mahony J, Coffey A	Genome Announc	10.1128/genomeA.00431-16	2016
Metabolism	Toxic Accumulation of LPS Pathway Intermediates Underlies the Requirement of LpxH for Growth of Acinetobacter baumannii ATCC 19606.	Richie DL, Takeoka KT, Bojkovic J, Metzger LE 4th, Rath CM, Sawyer WS, Wei JR, Dean CR	PLoS One	10.1371/journal.pone.0160918	2016
Pathogenicity	Polymyxin B in combination with doripenem against heteroresistant Acinetobacter baumannii: pharmacodynamics of new dosing strategies.	Rao GG, Ly NS, Bulitta JB, Soon RL, San Roman MD, Holden PN, Landersdorfer CB, Nation RL, Li J, Forrest A, Tsuji BT	J Antimicrob Chemother	10.1093/jac/dkw293	2016
Pathogenicity	5-Episinuleptolide Decreases the Expression of the Extracellular Matrix in Early Biofilm Formation of Multi-Drug Resistant Acinetobacter baumannii.	Tseng SP, Hung WC, Huang CY, Lin YS, Chan MY, Lu PL, Lin L, Sheu JH	Mar Drugs	10.3390/md14080143	2016
Pathogenicity	Combinatorial pharmacodynamics of polymyxin B and tigecycline against heteroresistant Acinetobacter baumannii.	Rao GG, Ly NS, Diep J, Forrest A, Bulitta JB, Holden PN, Nation RL, Li J, Tsuji BT	Int J Antimicrob Agents	10.1016/j.ijantimicag.2016.06.006	2016
Pathogenicity	Modulation of virulence in Acinetobacter baumannii cells surviving photodynamic treatment with toluidine blue.	Pourhajibagher M, Boluki E, Chiniforush N, Pourakbari B, Farshadzadeh Z, Ghorbanzadeh R, Aziemzadeh M, Bahador A	Photodiagnosis Photodyn Ther	10.1016/j.pdpdt.2016.07.007	2016
Pathogenicity	Aptamer-nanobody based ELASA for specific detection of Acinetobacter baumannii isolates.	Rasoulinejad S, Gargari SLM	J Biotechnol	10.1016/j.jbiotec.2016.05.024	2016
Pathogenicity	Polymyxin Resistance in Acinetobacter baumannii: Genetic Mutations and Transcriptomic Changes in Response to Clinically Relevant Dosage Regimens.	Cheah SE, Johnson MD, Zhu Y, Tsuji BT, Forrest A, Bulitta JB, Boyce JD, Nation RL, Li J	Sci Rep	10.1038/srep26233	2016
Pathogenicity	Impaired growth under iron-limiting conditions associated with the acquisition of colistin resistance in Acinetobacter baumannii.	Lopez-Rojas R, Garcia-Quintanilla M, Labrador-Herrera G, Pachon J, McConnell MJ	Int J Antimicrob Agents	10.1016/j.ijantimicag.2016.03.010	2016
Pathogenicity	Relationship between Antibiotic Resistance, Biofilm Formation, and Biofilm-Specific Resistance in Acinetobacter baumannii.	Qi L, Li H, Zhang C, Liang B, Li J, Wang L, Du X, Liu X, Qiu S, Song H	Front Microbiol	10.3389/fmicb.2016.00483	2016
Metabolism	Isolation, identification and diesel-oil biodegradation capacities of indigenous hydrocarbon-degrading strains of Cellulosimicrobium cellulans and Acinetobacter baumannii from tarball at Terengganu beach, Malaysia.	Nkem BM, Halimoon N, Yusoff FM, Johari WLW, Zakaria MP, Medipally SR, Kannan N	Mar Pollut Bull	10.1016/j.marpolbul.2016.03.060	2016
Enzymology	Effects of Saline, an Ambient Acidic Environment, and Sodium Salicylate on OXA-Mediated Carbapenem Resistance in Acinetobacter baumannii.	Zander E, Seifert H, Higgins PG	Antimicrob Agents Chemother	10.1128/AAC.03010-15	2016
	Antibacterial Low Molecular Weight Cationic Polymers: Dissecting the Contribution of Hydrophobicity, Chain Length and Charge to Activity.	Grace JL, Huang JX, Cheah SE, Truong NP, Cooper MA, Li J, Davis TP, Quinn JF, Velkov T, Whittaker MR	RSC Adv	10.1039/C5RA24361K	2016
Metabolism	Global metabolic analyses identify key differences in metabolite levels between polymyxin-susceptible and polymyxin-resistant Acinetobacter baumannii.	Maifiah MH, Cheah SE, Johnson MD, Han ML, Boyce JD, Thamlikitkul V, Forrest A, Kaye KS, Hertzog P, Purcell AW, Song J, Velkov T, Creek DJ, Li J	Sci Rep	10.1038/srep22287	2016
Enzymology	Screening of Herbal-Based Bioactive Extract Against Carbapenem-Resistant Strain of Acinetobacter baumannii.	Tiwari M, Roy R, Tiwari V	Microb Drug Resist	10.1089/mdr.2015.0270	2016
Pathogenicity	The long-term survival of Acinetobacter baumannii ATCC 19606(T) under nutrient-deprived conditions does not require the entry into the viable but non-culturable state.	Bravo Z, Orruno M, Parada C, Kaberdin VR, Barcina I, Arana I	Arch Microbiol	10.1007/s00203-016-1200-1	2016
Metabolism	Immunogenicity of conserved cork and beta-barrel domains of baumannii acinetobactin utilization protein in an animal model.	Sangroodi YH, Rasooli I, Nazarian S, Ebrahimizadeh W, Sefid F	Turk J Med Sci	10.3906/sag-1407-45	2015
Pathogenicity	Activity of levofloxacin in combination with colistin against Acinetobacter baumannii: In vitro and in a Galleria mellonella model.	Wei W, Yang H, Hu L, Ye Y, Li J	J Microbiol Immunol Infect	10.1016/j.jmii.2015.10.010	2015
Metabolism	Characterization of an Acinetobacter baumannii lptD Deletion Strain: Permeability Defects and Response to Inhibition of Lipopolysaccharide and Fatty Acid Biosynthesis.	Bojkovic J, Richie DL, Six DA, Rath CM, Sawyer WS, Hu Q, Dean CR	J Bacteriol	10.1128/JB.00639-15	2015
Enzymology	Prevalence of hypermutators among clinical Acinetobacter baumannii isolates.	Komp Lindgren P, Higgins PG, Seifert H, Cars O	J Antimicrob Chemother	10.1093/jac/dkv378	2015
	Genotypic and Antimicrobial Susceptibility of Carbapenem-resistant Acinetobacter baumannii: Analysis of is Aba Elements and bla OXA-23-like Genes Including a New Variant.	Bahador A, Raoofian R, Pourakbari B, Taheri M, Hashemizadeh Z, Hashemi FB	Front Microbiol	10.3389/fmicb.2015.01249	2015
Pathogenicity	Antimicrobial Activity of Gallium Protoporphyrin IX against Acinetobacter baumannii Strains Displaying Different Antibiotic Resistance Phenotypes.	Arivett BA, Fiester SE, Ohneck EJ, Penwell WF, Kaufman CM, Relich RF, Actis LA	Antimicrob Agents Chemother	10.1128/AAC.01472-15	2015
Metabolism	Acinetobacter baumannii Virulence Is Mediated by the Concerted Action of Three Phospholipases D.	Stahl J, Bergmann H, Gottig S, Ebersberger I, Averhoff B	PLoS One	10.1371/journal.pone.0138360	2015
Metabolism	Immunological evaluation of OMV(PagL)+Bap(1-487aa) and AbOmpA(8-346aa)+Bap(1-487aa) as vaccine candidates against Acinetobacter baumannii sepsis infection.	Badmasti F, Ajdary S, Bouzari S, Fooladi AA, Shahcheraghi F, Siadat SD	Mol Immunol	10.1016/j.molimm.2015.07.031	2015
Metabolism	Phoenix dactylifera (date palm) pit aqueous extract mediated novel route for synthesis high stable silver nanoparticles with high antifungal and antibacterial activity.	Khatami M, Pourseyedi S	IET Nanobiotechnol	10.1049/iet-nbt.2014.0052	2015
	Optimisation of the Caenorhabditis elegans model for studying the pathogenesis of opportunistic Acinetobacter baumannii.	Vallejo JA, Beceiro A, Rumbo-Feal S, Rodriguez-Palero MJ, Russo TA, Bou G	Int J Antimicrob Agents	10.1016/j.ijantimicag.2015.05.021	2015
Pathogenicity	Enhancing pili assembly and biofilm formation in Acinetobacter baumannii ATCC19606 using non-native acyl-homoserine lactones.	Luo LM, Wu LJ, Xiao YL, Zhao D, Chen ZX, Kang M, Zhang Q, Xie Y	BMC Microbiol	10.1186/s12866-015-0397-5	2015
Pathogenicity	Simple Method for Markerless Gene Deletion in Multidrug-Resistant Acinetobacter baumannii.	Oh MH, Lee JC, Kim J, Choi CH, Han K	Appl Environ Microbiol	10.1128/AEM.03975-14	2015
Pathogenicity	Biofilm Formation and Colistin Susceptibility of Acinetobacter baumannii Isolated from Korean Nosocomial Samples.	Kim HA, Ryu SY, Seo I, Suh SI, Suh MH, Baek WK	Microb Drug Resist	10.1089/mdr.2014.0236	2015
Metabolism	Heterologous expression of 3-O-deacylase in Acinetobacter baumannii modulates the endotoxicity of lipopolysaccharide.	Badmasti F, Shahcheraghi F, Siadat SD, Bouzari S, Ajdary S, Amin M, Halabian R, Imani Fooladi AA	J Mol Microbiol Biotechnol	10.1159/000371815	2015
Pathogenicity	Novel approach to optimize synergistic carbapenem-aminoglycoside combinations against carbapenem-resistant Acinetobacter baumannii.	Yadav R, Landersdorfer CB, Nation RL, Boyce JD, Bulitta JB	Antimicrob Agents Chemother	10.1128/AAC.04379-14	2015
Metabolism	Role of the carboxy terminus of SecA in iron acquisition, protein translocation, and virulence of the bacterial pathogen Acinetobacter baumannii.	Fiester SE, Nwugo CC, Penwell WF, Neary JM, Beckett AC, Arivett BA, Schmidt RE, Geiger SC, Connerly PL, Menke SM, Tomaras AP, Actis LA	Infect Immun	10.1128/IAI.02925-14	2015
Pathogenicity	Immunization with lipopolysaccharide-deficient whole cells provides protective immunity in an experimental mouse model of Acinetobacter baumannii infection.	Garcia-Quintanilla M, Pulido MR, Pachon J, McConnell MJ	PLoS One	10.1371/journal.pone.0114410	2014
Enzymology	In vivo activity of daptomycin/colistin combination therapy in a Galleria mellonella model of Acinetobacter baumannii infection.	Yang H, Chen G, Hu L, Liu Y, Cheng J, Li H, Ye Y, Li J	Int J Antimicrob Agents	10.1016/j.ijantimicag.2014.10.012	2014
Metabolism	Mutant prevention concentrations of levofloxacin, pazufloxacin and ciprofloxacin for A. baumannii and mutations in gyrA and parC genes.	Sun C, Hao J, Dou M, Gong Y	J Antibiot (Tokyo)	10.1038/ja.2014.150	2014
Proteome	Development and characterization of monoclonal antibodies for rapid detection of Acinetobacter baumannii.	Baig A, Cabral TM, Corbett CR	Monoclon Antib Immunodiagn Immunother	10.1089/mab.2013.0073	2014
	Draft Genome Assembly of Acinetobacter baumannii ATCC 19606.	Davenport KW, Daligault HE, Minogue TD, Bruce DC, Chain PS, Coyne SR, Jaissle JG, Koroleva GI, Ladner JT, Li PE, Palacios GF, Scholz MB, Teshima H, Johnson SL	Genome Announc	10.1128/genomeA.00832-14	2014
Metabolism	The role of filamentous hemagglutinin adhesin in adherence and biofilm formation in Acinetobacter baumannii ATCC19606(T).	Darvish Alipour Astaneh S, Rasooli I, Mousavi Gargari SL	Microb Pathog	10.1016/j.micpath.2014.07.007	2014
Pathogenicity	Recombinant scorpine produced using SUMO fusion partner in Escherichia coli has the activities against clinically isolated bacteria and inhibits the Plasmodium falciparum parasitemia in vitro.	Zhang C, He X, Gu Y, Zhou H, Cao J, Gao Q	PLoS One	10.1371/journal.pone.0103456	2014
Pathogenicity	Synergistic effects of ethnomedicinal plants of Apocynaceae family and antibiotics against clinical isolates of Acinetobacter baumannii.	Chusri S, Siriyong T, Na-Phatthalung P, Voravuthikunchai SP	Asian Pac J Trop Med	10.1016/S1995-7645(14)60074-2	2014
Pathogenicity	Incubation temperature, osmolarity, and salicylate affect the expression of resistance-nodulation-division efflux pumps and outer membrane porins in Acinetobacter baumannii ATCC19606T.	Bazyleu A, Kumar A	FEMS Microbiol Lett	10.1111/1574-6968.12530	2014
	Severe Acinetobacter baumannii sepsis is associated with elevation of pentraxin 3.	Ketter PM, Guentzel MN, Schaffer B, Herzig M, Wu X, Montgomery RK, Parida BK, Fedyk CG, Yu JJ, Jorgensen J, Chambers JP, Cap AP, Arulanandam BP	Infect Immun	10.1128/IAI.01958-14	2014
Enzymology	Chemical constituents and antimicrobial properties of the essential oil and ethanol extract from the stem of Aglaia odorata Lour.	Joycharat N, Thammavong S, Voravuthikunchai SP, Plodpai P, Mitsuwan W, Limsuwan S, Subhadhirasakul S	Nat Prod Res	10.1080/14786419.2014.924934	2014
Enzymology	CpaA a novel protease from Acinetobacter baumannii clinical isolates deregulates blood coagulation.	Tilley D, Law R, Warren S, Samis JA, Kumar A	FEMS Microbiol Lett	10.1111/1574-6968.12496	2014
Metabolism	Bactericidal effect of sulbactam against Acinetobacter baumannii ATCC 19606 studied by 2D-DIGE and mass spectrometry.	Lin CH, Su SC, Ho KH, Hsu YW, Lee KR	Int J Antimicrob Agents	10.1016/j.ijantimicag.2014.03.004	2014
Enzymology	Pathogenicity of ocular isolates of Acinetobacter baumannii in a mouse model of bacterial endophthalmitis.	Talreja D, Kaye KS, Yu FS, Walia SK, Kumar A	Invest Ophthalmol Vis Sci	10.1167/iovs.13-13401	2014
Pathogenicity	Xuebijing Protects Rats from Sepsis Challenged with Acinetobacter baumannii by Promoting Annexin A1 Expression and Inhibiting Proinflammatory Cytokines Secretion.	He XD, Wang Y, Wu Q, Wang HX, Chen ZD, Zheng RS, Wang ZS, Wang JB, Yang Y	Evid Based Complement Alternat Med	10.1155/2013/804940	2013
Pathogenicity	Biological cost of different mechanisms of colistin resistance and their impact on virulence in Acinetobacter baumannii.	Beceiro A, Moreno A, Fernandez N, Vallejo JA, Aranda J, Adler B, Harper M, Boyce JD, Bou G	Antimicrob Agents Chemother	10.1128/AAC.01597-13	2013
Pathogenicity	Holarrhena antidysenterica as a resistance modifying agent against Acinetobacter baumannii: Its effects on bacterial outer membrane permeability and efflux pumps.	Chusri S, Na-Phatthalung P, Siriyong T, Paosen S, Voravuthikunchai SP	Microbiol Res	10.1016/j.micres.2013.09.004	2013
Pathogenicity	Homeostasis of glutathione is associated with polyamine-mediated beta-lactam susceptibility in Acinetobacter baumannii ATCC 19606.	Kwon DH, Hekmaty S, Seecoomar G	Antimicrob Agents Chemother	10.1128/AAC.00692-13	2013
Pathogenicity	Acinetobacter baumannii outer membrane vesicles elicit a potent innate immune response via membrane proteins.	Jun SH, Lee JH, Kim BR, Kim SI, Park TI, Lee JC, Lee YC	PLoS One	10.1371/journal.pone.0071751	2013
Metabolism	Functional features of TonB energy transduction systems of Acinetobacter baumannii.	Zimbler DL, Arivett BA, Beckett AC, Menke SM, Actis LA	Infect Immun	10.1128/IAI.00540-13	2013
Pathogenicity	In vitro activity of daptomycin in combination with low-dose colistin against a diverse collection of Gram-negative bacterial pathogens.	Phee L, Hornsey M, Wareham DW	Eur J Clin Microbiol Infect Dis	10.1007/s10096-013-1875-z	2013
	Cryo-electron tomography analysis of membrane vesicles from Acinetobacter baumannii ATCC19606 T.	Koning RI, de Breij A, Oostergetel GT, Nibbering PH, Koster AJ, Dijkshoorn L	Res Microbiol	10.1016/j.resmic.2013.02.007	2013
Pathogenicity	In vivo efficacy of telavancin/colistin combination therapy in a Galleria mellonella model of Acinetobacter baumannii infection.	Hornsey M, Phee L, Longshaw C, Wareham DW	Int J Antimicrob Agents	10.1016/j.ijantimicag.2012.11.013	2013
Phylogeny	[Changes in expression of gene aba I in biofilm of Acinetobacter baumannii strains isolated from burn patients].	Xiang J, Sun Z, Yang XG, Huan JN	Zhonghua Shao Shang Za Zhi		2012
Pathogenicity	In vitro synergy of colistin combinations against colistin-resistant Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella pneumoniae isolates.	Vidaillac C, Benichou L, Duval RE	Antimicrob Agents Chemother	10.1128/AAC.05996-11	2012
Metabolism	The Acinetobacter baumannii entA gene located outside the acinetobactin cluster is critical for siderophore production, iron acquisition and virulence.	Penwell WF, Arivett BA, Actis LA	PLoS One	10.1371/journal.pone.0036493	2012
Metabolism	Stress response and virulence functions of the Acinetobacter baumannii NfuA Fe-S scaffold protein.	Zimbler DL, Park TM, Arivett BA, Penwell WF, Greer SM, Woodruff TM, Tierney DL, Actis LA	J Bacteriol	10.1128/JB.00213-12	2012
Metabolism	Acinetobacter baumannii outer membrane protein A modulates the biogenesis of outer membrane vesicles.	Moon DC, Choi CH, Lee JH, Choi CW, Kim HY, Park JS, Kim SI, Lee JC	J Microbiol	10.1007/s12275-012-1589-4	2012
Pathogenicity	New heterocyclic compounds from 1,2,4-triazole and 1,3,4-thiadiazole class bearing diphenylsulfone moieties. Synthesis, characterization and antimicrobial activity evaluation.	Barbuceanu SF, Saramet G, Almajan GL, Draghici C, Barbuceanu F, Bancescu G	Eur J Med Chem	10.1016/j.ejmech.2012.01.031	2012
Pathogenicity	Three-dimensional human skin equivalent as a tool to study Acinetobacter baumannii colonization.	de Breij A, Haisma EM, Rietveld M, El Ghalbzouri A, van den Broek PJ, Dijkshoorn L, Nibbering PH	Antimicrob Agents Chemother	10.1128/AAC.05975-11	2012
Pathogenicity	Synergistic activity of coriander oil and conventional antibiotics against Acinetobacter baumannii.	Duarte A, Ferreira S, Silva F, Domingues FC	Phytomedicine	10.1016/j.phymed.2011.11.010	2012
Metabolism	Role of acinetobactin-mediated iron acquisition functions in the interaction of Acinetobacter baumannii strain ATCC 19606T with human lung epithelial cells, Galleria mellonella caterpillars, and mice.	Gaddy JA, Arivett BA, McConnell MJ, Lopez-Rojas R, Pachon J, Actis LA	Infect Immun	10.1128/IAI.06279-11	2012
Pathogenicity	Growth phase-dependent expression of RND efflux pump- and outer membrane porin-encoding genes in Acinetobacter baumannii ATCC 19606.	Fernando D, Kumar A	J Antimicrob Chemother	10.1093/jac/dkr519	2011
Pathogenicity	Establishment of a novel target-based real-time quantitative PCR method for Acinetobacter baumannii detection.	Zhang L, Ding G, Wei L, Pan X, Mei L, Zhang Y, Lu Y	Diagn Mol Pathol	10.1097/PDM.0b013e31821bbb1e	2011
Pathogenicity	Interaction of Acinetobacter baumannii 19606 and 1656-2 with Acanthamoeba castellanii.	Tamang MD, Kim S, Kim SM, Kong HH, Kim J	J Microbiol	10.1007/s12275-011-1063-8	2011
Metabolism	Colistin-resistant, lipopolysaccharide-deficient Acinetobacter baumannii responds to lipopolysaccharide loss through increased expression of genes involved in the synthesis and transport of lipoproteins, phospholipids, and poly-beta-1,6-N-acetylglucosamine.	Henry R, Vithanage N, Harrison P, Seemann T, Coutts S, Moffatt JH, Nation RL, Li J, Harper M, Adler B, Boyce JD	Antimicrob Agents Chemother	10.1128/AAC.05191-11	2011
Pathogenicity	Imipenem: a potent inducer of multidrug resistance in Acinetobacter baumannii.	Kuo HY, Chang KC, Kuo JW, Yueh HW, Liou ML	Int J Antimicrob Agents	10.1016/j.ijantimicag.2011.08.016	2011
	Outer membrane vesicles as an acellular vaccine against Acinetobacter baumannii.	McConnell MJ, Rumbo C, Bou G, Pachon J	Vaccine	10.1016/j.vaccine.2011.06.001	2011
Pathogenicity	[Expressions of pgaABC gene clusters and changes in biofilm phenotype of Acinetobacter baumannii in burn patients].	Xiang J, Sun Z, Song F, Huan JN	Zhonghua Shao Shang Za Zhi		2011
Metabolism	Phosphoethanolamine modification of lipid A in colistin-resistant variants of Acinetobacter baumannii mediated by the pmrAB two-component regulatory system.	Beceiro A, Llobet E, Aranda J, Bengoechea JA, Doumith M, Hornsey M, Dhanji H, Chart H, Bou G, Livermore DM, Woodford N	Antimicrob Agents Chemother	10.1128/AAC.00079-11	2011
Metabolism	Acinetobacter baumannii biofilms: variations among strains and correlations with other cell properties.	McQueary CN, Actis LA	J Microbiol	10.1007/s12275-011-0343-7	2011
Metabolism	Analysis of penicillin-binding proteins (PBPs) in carbapenem resistant Acinetobacter baumannii.	Vashist J, Tiwari V, Das R, Kapil A, Rajeswari MR	Indian J Med Res	IndianJMedRes_2011_133_3_332_78380	2011
Metabolism	Acinetobacter baumannii secretes cytotoxic outer membrane protein A via outer membrane vesicles.	Jin JS, Kwon SO, Moon DC, Gurung M, Lee JH, Kim SI, Lee JC	PLoS One	10.1371/journal.pone.0017027	2011
Pathogenicity	Acinetobacter baumannii-induced lung cell death: role of inflammation, oxidative stress and cytosolic calcium.	Smani Y, Docobo-Perez F, McConnell MJ, Pachon J	Microb Pathog	10.1016/j.micpath.2011.01.008	2011
Enzymology	Demonstration of an outer membrane protein that is antigenically specific for Acinetobacter baumannii.	Islam AH, Singh KK, Ismail A	Diagn Microbiol Infect Dis	10.1016/j.diagmicrobio.2010.09.008	2011
Pathogenicity	Different surface charge of colistin-susceptible and -resistant Acinetobacter baumannii cells measured with zeta potential as a function of growth phase and colistin treatment.	Soon RL, Nation RL, Cockram S, Moffatt JH, Harper M, Adler B, Boyce JD, Larson I, Li J	J Antimicrob Chemother	10.1093/jac/dkq422	2010
Metabolism	Colistin resistance in Acinetobacter baumannii is mediated by complete loss of lipopolysaccharide production.	Moffatt JH, Harper M, Harrison P, Hale JD, Vinogradov E, Seemann T, Henry R, Crane B, St Michael F, Cox AD, Adler B, Nation RL, Li J, Boyce JD	Antimicrob Agents Chemother	10.1128/AAC.00834-10	2010
Metabolism	Deciphering the iron response in Acinetobacter baumannii: A proteomics approach.	Nwugo CC, Gaddy JA, Zimbler DL, Actis LA	J Proteomics	10.1016/j.jprot.2010.07.010	2010
Pathogenicity	In vitro synergistic antibacterial action of certain combinations of gentamicin and essential oils.	Rosato A, Piarulli M, Corbo F, Muraglia M, Carone A, Vitali ME, Vitali C	Curr Med Chem	10.2174/092986710792231996	2010
Metabolism	DnaK and GroEL are induced in response to antibiotic and heat shock in Acinetobacter baumannii.	Cardoso K, Gandra RF, Wisniewski ES, Osaku CA, Kadowaki MK, Felipach-Neto V, Haus LFA, Simao RCG	J Med Microbiol	10.1099/jmm.0.020339-0	2010
Enzymology	fAUC/MIC is the most predictive pharmacokinetic/pharmacodynamic index of colistin against Acinetobacter baumannii in murine thigh and lung infection models.	Dudhani RV, Turnidge JD, Nation RL, Li J	J Antimicrob Chemother	10.1093/jac/dkq226	2010
Genetics	Quantitative profiling and identification of outer membrane proteins of beta-lactam resistant strain of Acinetobacter baumannii.	Vashist J, Tiwari V, Kapil A, Rajeswari MR	J Proteome Res	10.1021/pr9011188	2010
Metabolism	OXA-143, a novel carbapenem-hydrolyzing class D beta-lactamase in Acinetobacter baumannii.	Higgins PG, Poirel L, Lehmann M, Nordmann P, Seifert H	Antimicrob Agents Chemother	10.1128/AAC.00856-09	2009
Pathogenicity	Synthesis, characterization and evaluation of antibacterial activity of some thiazolo[3,2-b][1,2,4]triazole incorporating diphenylsulfone moieties.	Barbuceanu SF, Almajan GL, Saramet I, Draghici C, Tarcomnicu AI, Bancescu G	Eur J Med Chem	10.1016/j.ejmech.2009.06.021	2009
Pathogenicity	CsuA/BABCDE-dependent pili are not involved in the adherence of Acinetobacter baumannii ATCC19606(T) to human airway epithelial cells and their inflammatory response.	de Breij A, Gaddy J, van der Meer J, Koning R, Koster A, van den Broek P, Actis L, Nibbering P, Dijkshoorn L	Res Microbiol	10.1016/j.resmic.2009.01.002	2009
	Therapeutic efficacy of buforin II and rifampin in a rat model of Acinetobacter baumannii sepsis.	Cirioni O, Silvestri C, Ghiselli R, Orlando F, Riva A, Gabrielli E, Mocchegiani F, Cianforlini N, Trombettoni MM, Saba V, Scalise G, Giacometti A	Crit Care Med	10.1097/CCM.0b013e31819c3e22	2009
Pathogenicity	The cost of resistance to colistin in Acinetobacter baumannii: a proteomic perspective.	Fernandez-Reyes M, Rodriguez-Falcon M, Chiva C, Pachon J, Andreu D, Rivas L	Proteomics	10.1002/pmic.200800434	2009
Enzymology	Molecular epidemiology of clinical Acinetobacter baumannii and Acinetobacter genomic species 13TU isolates using a multilocus sequencing typing scheme.	Wisplinghoff H, Hippler C, Bartual SG, Haefs C, Stefanik D, Higgins PG, Seifert H	Clin Microbiol Infect	10.1111/j.1469-0691.2008.02010.x	2008
Pathogenicity	In vitro pharmacodynamics of colistin against Acinetobacter baumannii clinical isolates.	Owen RJ, Li J, Nation RL, Spelman D	J Antimicrob Chemother	10.1093/jac/dkl512	2007
Pathogenicity	Heteroresistance to colistin in multidrug-resistant Acinetobacter baumannii.	Li J, Rayner CR, Nation RL, Owen RJ, Spelman D, Tan KE, Liolios L	Antimicrob Agents Chemother	10.1128/AAC.00103-06	2006
Phylogeny	Genomic species identification of Acinetobacter of clinical isolates by 16S rDNA sequencing.	Misbah S, Hassan H, Yusof MY, Hanifah YA, AbuBakar S	Singapore Med J		2005
Metabolism	The siderophore-mediated iron acquisition systems of Acinetobacter baumannii ATCC 19606 and Vibrio anguillarum 775 are structurally and functionally related.	Dorsey CW, Tomaras AP, Connerly PL, Tolmasky ME, Crosa JH, Actis LA	Microbiology (Reading)	10.1099/mic.0.27371-0	2004
Metabolism	Identification and transcriptional organization of a gene cluster involved in biosynthesis and transport of acinetobactin, a siderophore produced by Acinetobacter baumannii ATCC 19606T.	Mihara K, Tanabe T, Yamakawa Y, Funahashi T, Nakao H, Narimatsu S, Yamamoto S	Microbiology (Reading)	10.1099/mic.0.27141-0	2004
Genetics	The structure of the carbohydrate backbone of the lipopolysaccharide from Acinetobacter baumannii strain ATCC 19606.	Vinogradov EV, Duus JO, Brade H, Holst O	Eur J Biochem	10.1046/j.0014-2956.2001.02647.x	2002
Metabolism	Monoclonal antibodies against the iron regulated outer membrane Proteins of Acinetobacter baumannii are bactericidal.	Goel VK, Kapil A	BMC Microbiol	10.1186/1471-2180-1-16	2001
Pathogenicity	Bactericidal and bacteriostatic activity of gemifloxacin against Acinetobacter spp. in vitro.	Higgins PG, Coleman K, Amyes SG	J Antimicrob Chemother	10.1093/jac/45.suppl_3.71	2000
Enzymology	Cloning and characterization of 3-deoxy-D-manno-oct-2-ulosonic acid (Kdo) transferase genes (kdtA) from Acinetobacter baumannii and Acinetobacter haemolyticus.	Bode CE, Brabetz W, Brade H	Eur J Biochem	10.1046/j.1432-1327.1998.2540404.x	1998
Enzymology	Cloning and expression in Escherichia coli of the gene encoding a novel L-2,4-diaminobutyrate decarboxylase of Acinetobacter baumannii.	Ikai H, Yamamoto S	FEMS Microbiol Lett	10.1016/0378-1097(94)90253-4	1994
Phylogeny	Isolation and structure elucidation of acinetobactin, a novel siderophore from Acinetobacter baumannii.	Yamamoto S, Okujo N, Sakakibara Y	Arch Microbiol	10.1007/BF00301846	1994
Enzymology	Immunobiology of Acinetobacter baumannii and genospecies 3.	Traub WH, Bauer D	Zentralbl Bakteriol	10.1016/s0934-8840(11)80403-2	1993
Transcriptome	Transcriptome Analysis of Acinetobacter baumannii in Rapid Response to Subinhibitory Concentration of Minocycline.	Gao L, Ma X	Int J Environ Res Public Health	10.3390/ijerph192316095	2022
	A novel pentavalent vaccine candidate completely protects against Acinetobacter baumannii in a mouse model of peritonitis.	Hagag YA, Said HS, Kenawy HI, Hassan R	Appl Microbiol Biotechnol	10.1007/s00253-022-12231-3	2022
	Chitosan-Placental ECM Composite Thermos-Responsive Hydrogel as a Biomimetic Wound Dressing with Angiogenic Property.	Azadbakht A, Alizadeh S, Aliakbar Ahovan Z, Khosrowpour Z, Majidi M, Pakzad S, Shojaei S, Chauhan NPS, Jafari M, Gholipourmalekabadi M	Macromol Biosci	10.1002/mabi.202200386	2022
Phylogeny	Analysis of virulence proteins in pathogenic Acinetobacter baumannii to provide early warning of zoonotic risk.	Zou D, Chang J, Lu S, Xu J, Hu P, Zhang K, Sun X, Guo W, Li Y, Liu Z, Ren H	Microbiol Res	10.1016/j.micres.2022.127222	2022
Phylogeny	Molecular Characterization of Bacterial Isolates from Soil Samples and Evaluation of their Antibacterial Potential against MDRS.	Sadiqi S, Hamza M, Ali F, Alam S, Shakeela Q, Ahmed S, Ayaz A, Ali S, Saqib S, Ullah F, Zaman W	Molecules	10.3390/molecules27196281	2022
Metabolism	Acinetobacter baumannii and Cefiderocol, between Cidality and Adaptability.	Stracquadanio S, Bonomo C, Marino A, Bongiorno D, Privitera GF, Bivona DA, Mirabile A, Bonacci PG, Stefani S	Microbiol Spectr	10.1128/spectrum.02347-22	2022
	Cinnamaldehyde derivatives act as antimicrobial agents against Acinetobacter baumannii through the inhibition of cell division.	Chai WC, Whittall JJ, Polyak SW, Foo K, Li X, Dutschke CJ, Ogunniyi AD, Ma S, Sykes MJ, Semple SJ, Venter H	Front Microbiol	10.3389/fmicb.2022.967949	2022
Transcriptome	Transcriptomic analysis reveals the regulatory role of quorum sensing in the Acinetobacter baumannii ATCC 19606 via RNA-seq.	Xiong L, Yi F, Yu Q, Huang X, Ao K, Wang Y, Xie Y	BMC Microbiol	10.1186/s12866-022-02612-z	2022
Pathogenicity	Profiling Antibiotic Resistance in Acinetobacter calcoaceticus.	Glover JS, Ticer TD, Engevik MA	Antibiotics (Basel)	10.3390/antibiotics11070978	2022
Pathogenicity	Synthesis and biological evaluation of antibacterial activity of novel clarithromycin derivatives incorporating 1,2,3-triazole moieties at the 4''- and 11-OH positions.	Qin Y, Sun M, Zhang N, Yang Y, Ma P	Bioorg Chem	10.1016/j.bioorg.2022.106020	2022
Genetics	Genome Sequence and Characterization of Acinetobacter Phage DMU1.	Pehde BM, Niewohner D, Keomanivong FE, Carruthers MD	Phage (New Rochelle)	10.1089/phage.2020.0043	2021
Phylogeny	Investigation on taxonomy, secondary metabolites and antibacterial activity of Streptomyces sediminicola sp. nov., a novel marine sediment-derived Actinobacteria.	Zhang K, Ding W, Han C, Long L, Yin H, Yin J.	Microb Cell Fact	10.1186/s12934-024-02558-z	2024
Genetics	Pradimicin U, a promising antimicrobial agent isolated from a newly found Nonomuraea composti sp. nov.	Duangupama T, Pittayakhajonwut P, Intaraudom C, Suriyachadkun C, Tadtong S, Kuncharoen N, He YW, Tanasupawat S, Thawai C.	Sci Rep	10.1038/s41598-024-60744-w	2024
Genetics	Discovery and biosynthetic assessment of 'Streptomyces ortus' sp. nov. isolated from a deep-sea sponge.	Williams SE, Back CR, Best E, Mantell J, Stach JEM, Williams TA, Race PR, Curnow P.	Microb Genom	10.1099/mgen.0.000996	2023
Genetics	Analysis of the genomic sequences and metabolites of Serratia surfactantfaciens sp. nov. YD25^T that simultaneously produces prodigiosin and serrawettin W2.	Su C, Xiang Z, Liu Y, Zhao X, Sun Y, Li Z, Li L, Chang F, Chen T, Wen X, Zhou Y, Zhao F.	BMC Genomics	10.1186/s12864-016-3171-7	2016
Phylogeny	Description of Lujinxingia vulgaris sp. nov., isolated from coastal sediment via prey-traps.	Wang S, Mu DS, Li GY, Du ZJ	Antonie Van Leeuwenhoek	10.1007/s10482-021-01640-5	2021
Phylogeny	Acinetobacter stercoris sp. nov. isolated from output source of a mesophilic german biogas plant with anaerobic operating conditions.	Pulami D, Schauss T, Eisenberg T, Blom J, Schwengers O, Bender JK, Wilharm G, Kampfer P, Glaeser SP	Antonie Van Leeuwenhoek	10.1007/s10482-021-01517-7	2021
Phylogeny	Streptosporangium minutum sp. nov., isolated from garden soil exposed to microwave radiation.	Le Roes-Hill M, Durrell K, Prins A, Meyers PR	J Antibiot (Tokyo)	10.1038/s41429-018-0036-0	2018

References

#9084	Leibniz Institut DSMZ-Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH ; Curators of the DSMZ; DSM 30007
#20215	Parte, A.C., Sardà Carbasse, J., Meier-Kolthoff, J.P., Reimer, L.C. and Göker, M.: List of Prokaryotic names with Standing in Nomenclature (LPSN) moves to the DSMZ. IJSEM ( DOI 10.1099/ijsem.0.004332 )
#20218	Verslyppe, B., De Smet, W., De Baets, B., De Vos, P., Dawyndt P.: StrainInfo introduces electronic passports for microorganisms.. Syst Appl Microbiol. 37: 42 - 50 2014 ( DOI 10.1016/j.syapm.2013.11.002 , PubMed 24321274 )
#42141	; Curators of the CIP;
#66792	Julia Koblitz, Joaquim Sardà, Lorenz Christian Reimer, Boyke Bunk, Jörg Overmann: Automatically annotated for the DiASPora project (Digital Approaches for the Synthesis of Poorly Accessible Biodiversity Information) .
#67770	Japan Collection of Microorganism (JCM) ; Curators of the JCM;
#68369	Automatically annotated from API 20NE .
#68371	Automatically annotated from API 50CH acid .
#68382	Automatically annotated from API zym .
#69479	João F Matias Rodrigues, Janko Tackmann,Gregor Rot, Thomas SB Schmidt, Lukas Malfertheiner, Mihai Danaila,Marija Dmitrijeva, Daniela Gaio, Nicolas Näpflin and Christian von Mering. University of Zurich.: MicrobeAtlas 1.0 beta .
#116742	Collection of Institut Pasteur ; Curators of the CIP; CIP 70.34
#124043	Isabel Schober, Julia Koblitz: Data extracted from sequence databases, automatically matched based on designation and taxonomy .
#125438	Julia Koblitz, Lorenz Christian Reimer, Rüdiger Pukall, Jörg Overmann: Predicting bacterial phenotypic traits through improved machine learning using high-quality, curated datasets. 2024 ( DOI 10.1101/2024.08.12.607695 )
#125439	Philipp Münch, René Mreches, Martin Binder, Hüseyin Anil Gündüz, Xiao-Yin To, Alice McHardy: deepG: Deep Learning for Genome Sequence Data. R package version 0.3.1 .
#126262	A. Lissin, I. Schober, J. F. Witte, H. Lüken, A. Podstawka, J. Koblitz, B. Bunk, P. Dawyndt, P. Vandamme, P. de Vos, J. Overmann, L. C. Reimer: StrainInfo—the central database for linked microbial strain identifiers. ( DOI 10.1093/database/baaf059 )

Rate our new design

Content

About us

Acinetobacter baumannii (DSM 30007, ATCC 19606, CIP 70.34)

Name and taxonomic classification

Morphology

Cell morphology

Colony morphology

Culture and growth conditions

Culture medium

Culture temp

Physiology and metabolism

Oxygen tolerance

Antibiotic susceptibility testing

Spore formation

Compound production

Halophily

Metabolite utilization

Antibiotic resistance

Metabolite production

Metabolite tests

Enzymes

API zym

API 20NE

API 50CHac

API biotype100

Isolation, sampling and environmental information

Isolation source categories

Isolation

Taxonmaps

Interaction and safety

Risk assessment

Sequence information

Genome sequences

Genome browser: GCA_025995075

16S sequences

Genome-based predictions

Predictions

Literature

Literature

References

BacDive

Help

Social Media